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Abstract
The influence of heterocycle, base and solvent on the recently reported one-pot Julia 
olefination^"^ was investigated. 1-Phenyl-l//-tetrazol-5-yl (FT) sulfones emerged as a 
promising alternative to the previously reported benzothiazol-2-yl (BT) sulfones for use in the 
olefin synthesis. For both BT and FT systems an increase in solvent polarity resulted in a 
heightened trans selectivity for the synthesis of simple 1,2-disubstituted monoenes. However, 
only for the new FT variant was the stereochemical outcome also dependent on base counter 
cation. Potassium derivatives of FT sulfones react with saturated aldehydes in 1,2- 
dimethoxyethane (DME) to produce 1,2-disubstituted alkenes with excellent selectivity" .^
A partial synthesis of vitamin D2 was achieved employing fragments derived from a new 
improved degradation procedure. Condensation of the sodium derivative of BT sulfone 230 
with aldehyde 198 yielded 70% of vitamin D2 (163,1E:Z = 72:28) after deprotection.
(a) NaHMDS, EtaO 
-78°C, 1 h
SO2
TBSO,. 
198
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-100°C ^  rt, 0/N  
(0) T B A F -3 H 2 0  
THF, rt, 0/N
HO'
vitamin D2  (163) 
70%, 7 E;Z= 72:28
The first total synthesis of the polyketide herboxidiene (233) was completed in 22 linear steps 
from cyclohexanone^. Both BT and FT one-pot Julia methodologies were used at pivotal 
junctures in the synthesis. The new FT variant was employed to access a simple 1,2- 
disubstituted olefin (327) prior to subsequent Sharpless asymmetric dihydroxylation. The 
established BT technology was used to conjoin two late stage intermediates, 332 and 238, to 
yield 81% of the protected herboxidiene derivative 394 with \OE:Z =91:9.
MeO
PCBO
332
PCB = 4-chlorobenzoyl
(a) LDA,THF,-78°C, 15min 
238
CO2 AII
-78°C ^ -2 0 °C , 1.5 h 
, deprotection
MeO
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394, R = PCB, R' = All 
81%, 10E;Z=91:9 
herboxidiene (233), R = R' = H
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4-methyl-1,2,4-triazol-3-yl
1. The One-pot Julia Olefination
The organic chemist now has a vast array of reactions in his/her arsenal^, but unfortunately still 
relatively few procedures which are at once both mild and selective enough to effect the linkage 
of complex multi-functional fragments. Of those at our disposal, connective olefination 
processes^’^  are amongst the most powerful, provided that chemo-, regio- and stereoselection 
can all be under complete control.
Until the advent of the Wittig reaction^ 'in  the early 1950's, alkenes were typically prepared 
via classical elimination methods. Under the relatively harsh conditions required for such 
reactions, double bond formation is frequently under thermodynamic control and thus doomed 
to yield Saytzeff-type products^^ The following example provided by Inhoffen*^ exemplifies 
some of the problems facing chemists in the pre-Wittig era (Scheme 1). Ionic elimination of 
water from diene 2 not surprisingly failed to yield the desired vitamin D model triene 1, but 
instead yielded the higher substituted endocyclic olefin 3.
OH
1 2
Schem e 1
3
The Wittig reaction offered for the first time a mild connective olefination method which not 
only enabled precise positioning of the newly formed double bond but often also gave an 
enormous degree of stereocontrol. A large variety of the olefination methods available today 
employ the same basic paradigm laid down by Georg Wittig over 45 years ago: condensation 
of a carbanion (or ylide) stabilised by an adjacent third row heteroatom (Si, P or S) with a 
carbonyl group initiates a cascade of reactions ultimately leading to the formation of an alkene. 
Olefination procedures belonging to this general class include: the phosphorus-based Wittig^’^ ®, 
Homer-Wittig^^’^ '^  and Homer-Wadsworth-Emmons (HWE)^^’^  ^reactions (all three have been 
comprehensively reviewed by Maryanoff and Reitz*^); the silicon-based Peterson** reaction and 
the sulfur-based Johnson*^ and classical Julia^ ** reactions. The aforementioned processes all 
rely on the variable valency of the key stabilising heteroatom and many are thermodynamically 
driven by the formation of a strong heteroatom oxygen bond. A new variant of the classical 
Julia reaction, the one-pot Julia olefination^, is the main focus of this PhD thesis.
1.1. Phosphorus hased olefination methods: the W ittig, Horner-Wittig and 
Horner-W ads worth-Emmons reactions
1.1.1. The Wittig reaction
The very well known Wittig reaction involves the addition of a phosphonium ylide 5 
(phosphorane) to a carbonyl compound 4, resulting in the formation of an olefin 8 (always at 
the site of the original carbonyl group) and a phosphine oxide 9 (Scheme 2)* ’^^ *, Although 
zwitterionic betaines were originally thought to be intermediates in the reaction, it is now the 
accepted view (certainly in the case of unstabilised ylides^^) that the reaction occurs via 
diastereomeric oxaphosphetane entities (6 and 7). Their formation is thought to be the result of 
a [2+2] cycloaddition between the ylide and carbonyl; a syn cycloreversion process can then 
either return the starting materials or yield the products irreversibly.
Schem e 2
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Although regiochemistry is precisely controlled, the stereochemical outcome of the Wittig 
reaction depends upon several factors, being particularly sensitive to the type of ylide used. 
Generally, stabilised ylides yield predominately E-olefins whereas the contrary is true of 
unstabilised ylides. Indeed, in the absence of soluble lithium salts (so called 'salt-free' 
conditions) extremely high Z-selectivity can result from the use of unstabilised ylides^^.
Due to the high degree of stereochemical predictability and the large number of functional 
groups with which the Wittig reaction is compatible, it has found wide spread use in the field 
of target directed synthesis^ "*-^ .^ One of the few detractions of the process lies with the difficulty 
of preparation and purification of certain phosphonium salts (the precursors to phosphonium 
ylides). Also, being neutral species phosphoranes are poor nucleophiles and on rare occasions 
Wittig reactions fail because the carbonyl component is reasonably sterically hindered or of low 
electrophilicity.
Many variants of the Wittig reaction have appeared^ most notable being the Horner- 
W ads worth-Emmons * ^  and the Homer-Wittig*^’*"*’^  ^reactions. Both processes differ from the 
original Wittig reaction in that phosphoryl stabilised carbanions rather than phosphoranes are
employed as nucleophiles. The former are extremely potent nucleophiles when compared to 
neutral ylide species and have many other advantages besides.
1.1.2. The Horner-Wadsworth-Emmons reaction
The Horner-Wads worth-Emmons reaction employs carbanions derived from phosphonates. 
Scheme 3 outlines the basic reaction: an a-metallated phosphonate ester 11 (R' is typically a 
stabilising group such as carboxyl, vinyl, sulfide, amine etc) is condensed with an aldehyde or 
ketone to yield a mixture of j9-alkoxyphosphonates 12. Following intramolecular alkoxide 
trapping to give the heterocyclic intermediates 13, syn elimination then occurs to form the 
alkene products 14 and a phosphate salt 15. Overall the reaction from the alkoxyphosphonates 
12 is stereospecific; the anti diastereomer yielding a cis olefin and likewise the 
syn diastereomer yielding a trans olefin. Thus the stereoselectivity of the HWE reaction is 
dependent on the initial ratio between the syn and anti alkoxyphosphonates 12 and their 
ability to equilibrate. The phosphate by-product 15 is water soluble and so easily removed 
during aqueous work-up, unlike the phosphine oxide remnant from the classical Wittig reaction 
which must be removed by chromatography. As with the Wittig reaction conditions can be 
subtly altered to effect the desired stereocontroE.
10
o
I I
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R" * H
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More remarkably, stereoselectivity in HWE reactions can be tuned by variation in the 
phosphonate ester group, R. Since this group is separate from the intrinsic make-up of the bulk 
of the nucleophilic partner 11, a degree of substrate independent stereoselectivity is possible. 
The intermediate j3-alkoxyphosphates 12 are able to equilibrate via retro-addition: bulky R 
groups {eg isopropyl) hinder the cyclisation step, 12 to 13, and promote equilibration to 
favour the syn form of 12 (and so yield predominantly E-olefins). In contrast, small R groups 
{eg methyl) or strongly electron-withdrawing groups (R = 2,2,2-trifluoroethyl), inhibit 
equilibration by promoting rapid forward reaction, and favour the anti form of 12 (and so 
yield predominantly Z-olefins)^. The use of bis(trifluoroethyl)phosphonoesters {eg 17) was 
introduced by Still and Gennari^^ and represents an important modification of the HWE 
providing as it does a method for synthesising cis a,j8-unsaturated esters with good 
geometrical purity (see Scheme 4 overleaf). Such ideas concerning the ability of 'spectator' 
substituents to exert a controlling influence on double bond geometry shall be returned to much 
later in the discussion of our l//-tetrazole based variant of the one-pot Julia olefination {vide 
infra).
10
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Schem e 4
1.1.3. The Horner-Wittig reaction
The Homer-Wittig reaction is very similar to the Homer-Wads worth-Emmons reaction and 
only differs in that a phosphine oxide rather than a phosphonate is used to stabilise the 
carbanion. A stabilising group a  to the phosphine oxide is not required and if a lithiated 
phosphine oxide is employed the intermediate hydroxyphosphine oxides can be isolated^"  ^and 
the diastereoisomers separated. Further treatment of a diastereomerically pure 
hydroxyphosphine oxide with a sodium base can then yield the corresponding isomerically 
pure alkene^*. The Homer-Wittig variant was used to great effect by Lythgoe^^ to complete the 
first direct total synthesis of vitamin Dg (21) (Scheme 5). Indeed, the analogous Wittig reaction 
was tried initially for the same fragment linkage and found to be ineffectual, the low 
nucleophilicity of the appropriate phosphorane being the primal cause of failure. Using the 
Horner-Wittig procedure the coupling went in good yield, forming the required IE  double 
bond geometry and preserving the stereochemical integrity of the 5Z double bond.
(a) -40°C
19
Schem e 5
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1.2. Sulfur based olefination methods: the classical and the one-pot Julia 
olefinations
1.2.1. The classical Julia olefination
In 1973 Julia and Paris published a short paper outlining a new connective olefination 
procedure utilising the reductive elimination of /3-hydroxysulfones^^. Herein referred to as the 
classical Julia olefination, this mild selective method has found pivotal use in the synthesis of 
many natural products (for example see^ ®'^ )^. The initial proliferation of the Julia reaction was 
hindered by the relatively cumbersome nature of the four steps required for coupling (Scheme 
6): metallation of an aryl alkyl sulfone 22, condensation with an aldehyde to yield a p-
11
alkoxysulfone 24, alkoxide acylation and finally reductive elimination with sodium amalgam to 
afford the alkene products (for reviews see KellyJulia^^ and Kocienski^"^). All four steps can 
be carried out in a single reaction vessel although in practice the overall yield of the process is 
found to benefit from isolation of the intermediate j8-hydroxysulfone and functionalisation of 
the hydroxyl group in a separate step.
S02Ph r'chO 
R M
22, M = H  1 BuLi, THF
R
S02Ph 
R'
OLi
BzCI
S02Ph 
R'
OBz
Na (Hg)
THF-MeOH
-20°C
23, M = Li
l
— I -78°C
24 25 26
Schem e 6
The greatest attribute of the classical Julia olefination is the high trans selectivity of the 
reductive elimination stage. During their vitamin D synthetic studies, Kocienski and Lythgoe 
investigated and developed the fledgling Julia reaction before applying modified conditions to 
achieve the first total synthesis of vitamin 04 ®^ (see Chapter 3). Kocienski discovered that 
increased chain branching on the coupling partners resulted in a higher E:Z ratio of the product 
alkenes^^ (Figure 1).
CeHia C5H1
27
E:Z= 60:20
28
E;Z= 90:10 E:Z> 99:1
increasing chain branching
Figure 1
Furthermore, the geometry of the alkene product was completely independent of the relative 
stereochemistry of the j3-acyloxysulfone^^’^ .^ Taken together these key observations suggested 
that reductive removal of the arylsulfonyl group led to the formation of a relatively long-lived 
radical or anionic intermediate (31 or 32) which achieves a low energy trans configuration 
before final loss of the acylate anion yields the olefin (see Scheme 7 overleaf). Of course, 
increased branching at the site of elimination should increase the trans selectivity for steric 
reasons.
Problems can potentially occur with any of the four steps essential for the Julia olefination^" .^ 
Although the metallated sulfones are competent nucleophiles, their generation with n-butyl 
lithium can be inhibited if bulky Of-substituents are present. Also it has been known for 
deprotonation to occur on the aryl ring rather than at an a  site on the alkyl moiety. Such
12
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35 36
problems can usually be circumvented by the use of alternative bases such as LDA, or 
transmetallation with MgBr2 to magnesiated derivatives.
The addition of metallated sulfones to carbonyl compounds can be reversible, this is likely if 
either of the components is very bulky or if the sulfone carbanion is well stabilised. Such 
'retroaldolisation' reactions were thought to severely limit the use of the Julia reaction for the 
synthesis of tri- and tetrasubstituted alkenes from ketones, although a recent report by Hart 
suggests otherwise^®. Hart and co-workers advocate 1,2-dimethoxyethane (DME) rather than 
THF as the solvent of choice for conducting metallated sulfone-carbonyl addition reactions. 
Acylation of the intermediate hydroxysulfone remains an important device for inhibiting 
retroaldolisation during the inherently basic reductive elimination step.
More recent developments have seen the use of alternative reductants to the ever unpopular 
sodium amalgam. Although expensive Sml2 seems particularly advantageous in demanding 
cases^^ and has also been advocated for the preparation of trisubstituted alkenes from 
ketones"^ .^ The samarium based system does, however, require the use of an additional co­
solvent such as hexamethylphosphoramide (HMPA) or dimethylpropylene urea (DMPU) to 
promote electron transfer to phenylsulfones. Kende has demonstrated that in the case of N- 
methylimidazol-2-yl (IM) sulfones such additives are unnecessary. IM sulfones are superior 
one-electron acceptors to phenylsulfones and the derived )3-hydroxysulfones are readily 
reduced by Sml2"^ \ The most convenient system discovered to date involves the reduction of 
j3-acetoxyphenylsulfones by magnesium metal under HgCl2 catalysis in ethanol"^ ,^ the general 
scope of this methodology is yet to be determined.
Based on deuterium labelling studies, Keck^^ has suggested an alternative mechanism for the 
reduction of /3-acetoxyphenylsulfones by Na/Hg (Scheme 8): methoxide generated from Na/Hg
13
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and MeOH initiates the elimination of acetate to yield a vinyl sulfone 38. Subsequent reductive 
removal of the sulfone moiety and a further electron transfer then yields a vinyl anion 41; a 
proton quench then yields the product olefin 42. Equilibration of the incipient vinyl radical 40 
is proposed to account for the inherent trans selectivity. Use of MeOH-J^ led to >90% 
deuterium incorporation in the product; the traditionally accepted mechanism given above 
(Scheme 7) does not account for any label incorporation. The analogous experiment conducted 
with Sml2 gave products with no deuterium incorporation, indicating that the samarium 
mediated process probably proceeds solely via the previously accepted mechanism. The Na/Hg 
and Sml2 reduction systems do not give products with identical E:Z ratios.
Finally, a sulfoxide version of the Julia reaction has been reported by Satoh and co-workers"^ .^ 
Following the addition of an a-sulfinyl metallate to an aldehyde subsequent trapping with 
mesyl chloride yields a j8-mesyloxysulfoxide 44 (Scheme 9). The latter is treated with butyl 
lithium resulting in an exchange of sulfoxide ligands to yield the transient carbanion 45. Before 
further ligand exchange can occur the highly reactive intermediate 45 eliminates mesylate to 
afford an alkene product. Stereoselectivity is typically poor and likely reflects meagre 
diastereoselective bias in the initial addition event. However, the use of aromatic aldehydes
Ph'
,9 (a) LDA, R'CHO O QMS
43
(b) MsGI, EtaN, CH2 CI2
OMs
0 | ^ R '
R
45
PK  ^  'R* 
R
44
BuLi, THF
-78°C, 5 mln
r ^ ^ R '
46
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yields pure trans olefins directly upon mesylation. The authors implicate the intermediacy of a 
benzylic cation to explain this phenomenon"^ .^
1.2.2. The one-pot Julia olefination
Eighteen years after the original disclosure of the classical Julia olefination by Marc Julia^®, 
Sylvestre Julia reported a significant modification of his brother's earlier discovery^ In 
common with the classical reaction, the new variant begins with the lithiation of an aryl alkyl 
sulfone and its subsequent condensation with a carbonyl compound. However, rather than 
simple phenyl sulfones, the new procedure employs benzothiazol-2-yl sulfones, hereafter 
denoted as BT sulfones (Scheme 10). The presence of an electrophilic site within the 
heterocyclic moiety allows reaction to continue beyond the jS-alkoxysulfone 48; the alkoxide 
intramolecularly attacks the C=N bond of the benzothiazole moiety forming the putative 
spirocyclic intermediate 49. Breakdown of the spirocycle can then occur with transfer of the 
heterocycle from sulfur to oxygen to yield 50; the overall process 48 to 50 is then analogous 
to the Smiles rearrangement"^"^. Adduct 50 then loses sulfur dioxide with concomitant 
elimination of the lithium derivative of benzothiazolone (52) to form the olefin. We refer to the 
aforementioned procedure as the one-pot Julia olefination for obvious reasons.
N
s V l:
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47
R'CHO 
THF, -78°G
SO2BT 
R'
OLi
48
R '- ^ O  N 
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52
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In subsequent investigations Julia found that pyridine and pyrimidine heterocyclic systems 
could also mediate the olefination process^’^ . Although both new heterocyclic mediators were 
generally inferior, work with the pyridine series provided rewarding mechanistic insight. The 
2-pyridyl j8-hydroxysulfone intermediates were found to be generally stable and could be 
isolated in many instances from the reaction mixtures. Only on rare occasions was it found 
possible to isolate such intermediates in the BT series. The addition of lithiated 2- 
pyridylsulfones to saturated or aromatic aldehydes was found to be essentially non- 
diastereoselective and the product syn /J-hydroxysulfones were converted far more rapidly to 
alkene products than the corresponding anti adducts^. Diastereomerically pure j3- 
hydroxysulfones (both BT and pyridyl) were next prepared via the base mediated opening of
15
stereodefined epoxides by heterocyclic thiols followed by sulfur oxidation. The data from the 
examples studied suggested that the final elimination step was entirely antiperiplanar only for 
those alkoxides bearing saturated aliphatic chains R and R'. In such cases anti p- 
hydroxysulfones yield E-olefins and likewise syn j3-hydroxysulfones yield Z-olefins. Where 
'stereochemical drift' was noted, equilibration between the hydroxysulfones (via retroaddition) 
was proposed to be the cause^.
With some idea of a possible mechanism developing, Julia and co-workers embarked on an 
extensive study of the stereochemical outcome of over 100 representative coupling reactions 
encompassing a variety of different types of substrate^. During the investigation some basic 
limitations of the BT-mediated olefination process were revealed.
acceptor
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N
53
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N Li 53
Ll. N
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MeS02
55
—MeS02LI
— N
N
56 Schem e 11
The success of the one-pot Julia reaction hinges on the electrophilicity of the benzothiazolyl 
moiety; for this reason, a non-nucleophilic base must be used for the deprotonation step to 
prevent premature nucleophilic attack upon the heterocycle and expulsion of a sulfinic acid salt 
(Julia favoured the use of LDA in THF at -78°C^). However, if simple BT sulfones are 
metallated in the absence of an aldehyde, their donor-acceptor nature can lead to self­
condensation (Scheme 11). 'Dimeric' species such as 56 have been isolated from Julia 
coupling experiments and their formation is, of course, detrimental to the olefination process. 
A reverse addition protocol does not prevent self-condensation; adding the sulfone to the base 
also results in formation of the bisheterocyclic adducts. To overcome the problem of low yields 
arising from self-condensation, Julia and co-workers adopted so-called Barbier' conditions for 
the vast majority of their coupling experiments. Rather than 'pre-metallate' the sulfone and then 
subsequently add the aldehyde (a more usual protocol for many reactions), the base was added 
to a mixture of the sulfone and aldehyde. Thus addition of the in situ metallated sulfone to the 
aldehyde competes more than adequately against a self-condensation mechanism. Employing 
Barbier conditions, yields were typically 10-40% higher in the case of 'simple' (ie small and 
non-sterically hindered) sulfones. Of course it is to be expected that complex multifunctional 
aldehyde substrates would not tolerate such conditions.
16
The coupling studies of Julia revealed an important relationship between substrate pairings and 
stereoselectivity^. Three distinct situations were investigated: (a) condensation of saturated BT 
sulfones with saturated aldehydes (simple steric effects), (b) condensation of stabilised BT 
sulfones with saturated aldehydes (nucleophile electronic effects), and (c) condensation of 
saturated BT sulfones with Of,j3-unsaturated aldehydes (electrophile electronic effects). Scheme 
12 illustrates some actual results which crudely encompass all three variations^.
h-CsH-itCHO 
B T S O g ^ /^  ---------------► CgHi/
LDA, -78°C^rt
(a)
Schem e 12
48%, E:Z= 49:51
nucleophile electrophile
(sulfone) (aldehyde)
(a) saturated saturated
(b) stabilised saturated
(c) saturated unsaturated
BTSO2
n-CgH^yCHO 
LDA, -78°C->rt
(b)
CgHi7
80%, E:Z= 23:77
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CHO
BTSO2
LDA, -78°C->rt ^
R Yield% E:Z
OMe 95 99:1
H 68 94:6
Cl 51 77:23
(C)
The above results display some interesting trends and the stereoselectivies shown here were 
echoed faithfully for other examples of the same general 'type'. Points to note are: little or no 
selectivity was observed for type (a) couplings; a slight Z-preference was generally displayed 
for type (b) couplings, and a significant E-preference noted for type (c). Notice in the type (c) 
example illustrated, as the benzaldehydes became more electron rich, trans selectivity 
increased.
On the basis of the evidence summarised above Julia suggested the somewhat convoluted 
mechanism illustrated in Scheme 13. The provisional mechanism provides a very good 
working model for the prediction of stereoselectivity for most types of simple substrates, the 
ideas are ingenious and initially very attractive.
The two possible diastereoisomers of the initial )3-alkoxysulfone adduct, 57 (anti) and 63 
(syn), are proposed to be in equilibrium with the syn form being thermodynamically favoured 
due to the staggered nature of R and R'. Evidence from the pyridyl series already suggested the 
more facile reaction of syn j9-hydroxysulfones. Equilibration is promoted if R is unsaturated
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since the resultant stabilisation offered to the original a-metallated sulfone encourages 
reversibility of the addition step. In such cases it is often found that the product alkene is 
formed with high Z-selectivity due to initial equilibration to 63 followed by the direct route 
from 64 to alkene 66 (c/type (b) couplings). Cases where R and R' are saturated generally 
exhibit a complete lack of stereocontrol due to the associated inhibition of equihbration between 
57 and 63 and the observed lack of addition diastereoselectivity (c/type (a) couplings). High 
^-selectivity is observed when R' is an electron donating group (c/type (c) couplings). The 
selectivity is proposed to arise from the possibility of both the syn adduct 63 and the anti 
adduct 57 being directly converted to an E  alkene 60. The route from 63 to 60 is postulated to 
proceed via direct loss of lithium benzothiazolone from the spirocycle 64 to yield the 
zwitterionic intermediate 62. The betaine then loses sulfur dioxide from the lowest energy 
conformation to yield an E-alkene. R' electron donating groups are best able to stabilise the 
positive charge site of the zwitteiion and so facilitate the unusual reaction pathway.
Due to its immaturity, the one-pot Julia olefination has found relatively few applications; 
however, the successes achieved to date suggest the reaction may become a standard tool for 
the synthesis of complex natural products. Several groups have discovered that the 
stereochemical outcome of the reaction can be subtly altered by variations in both base and 
solvent {vide infra).
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Kocienski's synthesis of a C10-C26 fragment of rapamycin (69) employed the Julia 
olefination to construct an all trans conjugated triene m o i e t y T h e  coupling was attempted in 
two different senses (Scheme 14): either unsaturated sulfone 68 was condensed with the enal 
67 or the saturated sulfone 71 was condensed with the dienal 70. As could be predicted from 
the above discussion, the latter strategy was far more successful in securing the all trans 
olefinic system. The reactions illustrated were initiated with hexamethyldisilazide bases and of 
particular interest was the dependency of stereoselectivity upon the base counter cation. 
Kocienski and co-workers have also used the one-pot Julia reaction to construct the diene 
segment of herboxidiene (see Chapter 5).
Charette's application of the one-pot Julia olefination toward the synthesis of the skipped 
hexakiscyclopropane natural product (-k)-U-106305"^^  (75), provides an example of an unusual 
type (a) coupling (Scheme 15). A number of unspecified connective olefination methods (one 
can only assume including common Wittig variants) were surveyed in attempts to forge the 
non-conjugated 1,2-disubstituted double bond of the natural product. All failed until the one- 
pot Julia reaction was finally tested as a last resort. To generate and then maintain a carbanion 
Of to a cyclopropane moiety, sufficient stabilisation must be at hand to prevent ring opening: BT 
sulfones are apparently equal to the task. As illustrated in Scheme 15, the one-pot Julia reaction 
between sulfone 73 and aldehyde 72 operating under Barbier conditions, yielded after 
deprotection the olefin 74 in excellent yield with good stereoselectivity.
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The optimised reaction conditions employed by Charette were arrived at via an interesting 
model s tudy(Table  1). The coupling between the simplified aldehyde 76 and sulfone 73 was 
investigated in a number of solvents of differing polarity and Lewis basicity. The base counter 
cation had little effect on the stereochemical outcome in contrast to Kocienski's findings above 
(compare entries 1 and 7, 4 and 8), however, solvent had a profound effect. Non-polar 
solvents gave excellent Z-selectivities, as polarity and Lewis basicity increased the E-olefin was 
favoured (entries 1 through to 6). Of particular note is the success of the reaction in both CH- 
2CI2 and DMF, very untraditional solvents for carbanion chemistry. Ironically, the one solvent 
that gave the worst stereoselectivity here, THF, was the only solvent employed during Julia's 
extensive studies^.
U-106305 model studies
TIPSa
MN(SIMe3 )2  TiPSOv
O
73
TIPSO H 77
76 Table 1
entry M solvent E:Z
(77:78)
entry M solvent E:Z
(77:78)
1 Na PhMe 9:91 5 Na DME 71:29
2 Na CH2 CI2 9:91 6 Na DMF 78:22
3 Na Et20 11:89 7 K PhMe 21:79
4 Na THF 52:48 8 K THF 55:45
® All reactions conducted at -78°C  except those in DMF and DME which were run at -60°C . '^ Aii yields >90%.
Following Kocienski's lead"^  ^"^ ,^ the McCarthy group have also employed the one-pot Julia 
reaction to synthesise a conjugated olefin"^ * (Scheme 16). To secure the requisite E,E-diene 81 
rather illogically the stabilised BT sulfone metallate 79 was condensed with the carboxylactam 
80. The umpoled approach here would probably have given far superior selectivity without 
competing )3-lactam opening ( E I c b )- I n  any event use of potassium hexamethyldisilazide as 
base was found to give the optimum yield albeit with slightly compromised stereoselectivity
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{E:Z = 75:25). The greatest selectivity was achieved with NaHMDS {E:Z = 80:20) although the 
yield was then a disappointing 25%. Perhaps more importantly the analogous coupling was 
also attempted using two phosphorous based olefination methods and both were found 
wanting. A Wittig reaction between the appropriate phosphorane and aldehyde 80 yielded only 
25% of the lactam 81 with no stereochemical bias. A Homer-Wittig reaction gave solely the 
desired E-isomer but in a yield of only 15%. The lactam product of interest, 81, is a donor of 
the j3-amino acid ADDA and has been used to synthesise conjugates such as the protected 
glycine-ADD A dipeptide 82"^ .^
MeO SO2BT
Ph
79
TBS.
OHC
(a) THF, -78°C
(b) KF
MeO
Boc.
80
NH O
MeO HN
Ph
E:ZM81
C02Me
Li — 66:34
Na 25% 80:20
K 45% 75:25
82 Schem e 16
Pattenden and co-workers have also employed the one-pot Julia olefination to construct an all 
trans conjugated diene segmenf^^ (Scheme 17). The diene 85 was realised most efficiently by 
the condensation of enal 84 and sulfone 83. As expected for such a sensible disconnection, the 
trans selectivity of the reaction was excellent as was the yield. The diene 85 was subsequently 
elaborated to a C31-C46 fragment of the marine natural product phorboxazole A.
TMS OMe
SO2BT OHC
OMe OMe
OMe
83 84
TMS OMe OMe OMeNaHMDS
OMe
THF, -78°C
85, 74%, E:Z> 95:5
Schem e 17
Lastly, the Burke group have revealed their future intent to employ the one-pot Juha reaction by 
disclosing the synthesis of sulfone 87^ ® (Figure 2). The enoate encompasses the C1-C9 region 
of the natural product rhizoxin 86. The C12-C26 triene 88 has also been realised^^ (the C20-
21
C21 double was installed via HWE methodology) and it shall be interesting to observe whether 
the completion of the total synthesis employs a standard macrolactonisation procedure or an 
innovative one-pot Julia macrocyclisation.
rhizoxin (86) Of 
HO,. '
OMe
Figure 2
B T S O g ^  , . 0 ^ 0
MeO. '
.OPMB
OMe
88
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2. Development of the One-pot Julia Olefination
At the outset of the work described herein, our basic goal was to further develop the one-pot 
Julia olefination with a view to improving the applicability, operational simplicity, 
stereoselectivity and overall efficacy of the process. Beyond basic methodology development, 
our intention was to apply the olefination procedure in its various guises to some complex 
synthetic problems: the partial synthesis of vitamin D (see Chapters 3 and 4) and the total 
synthesis of herboxidiene (see Chapters 5 and 6).
To seek improvement in the existing one-pot Julia technology one must first identify its 
limitations. Detractions of the benzothiazole mediated process include the tendency for 
sterically unencumbered sulfones to self-condense under pre-metallation conditions, and 
general lack of stereoselectivity for the synthesis of non-conjugated 1,2-disubstituted olefins. 
Certainly the latter problem could be solved if it were possible to promote irreversible 
diastereoselective addition of a sulfone nucleophile to an aldehyde.
The key to both improved stereocontrol and increased nucleophile stability is likely to lie with 
the heterocyclic nucleus employed to mediate the olefination process. Our development strategy 
was thus to first identify a promising alternative to the benzothiazole moiety and then to 
optimise reaction conditions for the new system.
2.1. Screening of novel heterocyclic olefination mediators
Julia's own group had already additionally demonstrated the feasibility of pyridine (PYR) and 
pyrimidine (PYM) heterocycles as successful mediators for the one-pot olefination process^. 
We re-investigated the BT, PYR and PYM sulfone systems and went on to extend our 
screening programme to include other heterocyclic systems also in possession of appropriate 
electrophilic C=N bonds. Figure 3 outlines the range of surveyed heterocycles: central to the
BT =
-N
i.
benzothiazol-2-yl
PYR =
pyridin-2-yl
PYM = I II 
N '
pyrimidin-2-yl
IQ = N
/soquinolin-1-yl
IM = NJ .
Me
1-methyl-
imidazol-2-yl
TZ =
-
Me
4-methyl-1,2,4- 
triazol-3-yl
PT =
N —  N
-
Ph
1-phenyl-
tetrazol-5-yl
Figure 3
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choice of the novel scaffolds was the ease of availability of the corresponding thiol compounds 
[all but wothiocarbostyriP^ (IQSH) were commercially available] and the presence of a free 
valence site in close proximity to the electrophilic centre. The latter attribute allows for the 
introduction of a bulky substituent which may offer some steric shielding to the electrophilic 
centre and so reduce the propensity for self-condensation. Fine tuning of such substituents may 
also affect the diastereoselectivity of addition.
A small range of sulfones was synthesised from the chosen set of heterocyclic thiol compounds 
which incorporated either a simple straight aliphatic chain or a j9-branched aliphatic chain 
(Table 2). The thiols were first elaborated via simple alkylation with the appropriate alkyl 
bromide or via thioetherification of an alcohol under standard Mitsunobu conditions'^. 
Oxidation of the resultant sulfides to the requisite sulfones was typically effected by the action 
of 3-chloroperoxybenzoic acid (m-CPBA).
(A) KOH, EtOH, RBr, A
or
HetSH --------------------------► HetSR
(B) ROM, DIAD, PPha 
THF, OX rt
m-CPBA, NaHCOa
CH2CI2, OX -> rt
HetS02R 
Table 2
Het alkylation
method
sulfide %yield sulfone %yleld
BT A 89 81 101 51
PYR A 90 100 102 70
PYM A 91 90 103 68
IM A 92 89 104 67
TZ A 93 74 105 53
IQ A 94 76 106 77
BT A 95 71 107 100
PT A 96 90 108 65
BT B 97 89 109 68
TZ A 98 100 110 73
IQ B 99 47 111 65
PT B 100 89 112 71
In our initial studies the above sulfones (with the exception of 107 and 108) were condensed 
with a selection of aldehydes and ketones (dodecanal, benzaldehyde, acetophenone, 2-octanone 
and its isomer 2-methylheptanal) under Julia's original Barbier conditions^, employing LDA as 
base and THF as solvent. The set of coupling partners chosen allowed us to observe not only 
the effect of heterocyclic mediator, but also in a more limited way, the effects of chain 
branching and component reversal on the olefination reaction. Our primary objective here was 
to identify a promising heterocyclic system for further optimisation with particular regard to the 
synthesis of non-conjugated 1,2-disubstituted olefins. The results are outlined in Table 3: each
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S02Het
O R LDA, THF, -78°C ^  rt
sulfone . carbonyl 'isolated 
t determined by 
GC analysis
T
R' R' Table 3
olefin entry Met sulfone %yleld olefin* E:Z^
1 BT 101 47 46:54
5 5
2
3
4
PYR
PYM
IM
102
103
104
46
5
12
35:65
55:45
3:97
113 5 TZ 105 34 43:57
6 IQ 106 54 44:56
5
7
8 
9
BT
IM
TZ
101
104
105
30
<1
44
79:21
54:46
38:62
114 10 IQ 106 40 74:26
/ \  1
11 BT 101 46 53:47
12 IM 104 <1 49:51
13 TZ 105 5 6:94
115 14 IQ 106 32 6:94
1 N 15 BT 101 60 34:67
16 IM 104 4 31:69
17 TZ 105 15 22:785
116 18 IQ 106 56 47:53
19 BT 101 58 43:57
20 IM 104 17 2:98
21 TZ 105 36 28:72
117 22 IQ 106 44 55:45
(cent, overleaf)
mixture of product olefins was isolated by flash chromatography and then NMR spectroscopy 
used to determine which geometrical isomer predominated. GC analysis of the product mixture 
was then employed to accurately measure the E:Z ratio (see Experimental Section for full 
details).
Immediately from the somewhat bewildering array of results it becomes clear that, as 
suspected, the heterocyclic mediator can have a profound effect on the yield and 
stereoselectvity of olefin formation. Obvious trends to highlight from Table 3 are;
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sulfone
SOaHet
J  O R  LDA, THF, -78°C ^  rt
R" ^  +  Y   •
R'
r
R'
carbonyl
R
‘isolated 
 ^determined by 
GC analysis
TablG 3 (cent.)
olefin entry Net sulfone %yield olefin* E:Z^
/s. Jl 23 BT 109 58 54:46
24 TZ 110 43 47:53
\  117
5 25 PT 112 69 65:25
26 BT 109 39 >99:1
"Ph
27
28
TZ
IQ
110
111
39
39
62:38
96:4
\  118 29 PT 112 90 >99:1
30 BT 109 23 14:86
"Ph 31 TZ 110 <1 6:94
\  119
32 PT 112 11 25:75
33 BT 109 33 25:75
34 TZ 110 3 14:86
\  120
35 PT 112 9 46:54
36 BT 109 28 75:25
37 TZ 110 29 6:94
\  121
38 PT 112 48 39:61
(a) Efficiency o f olefination: BT and IQ sulfones were generally the highest yielding systems, 
performing well when condensed with both aldehydes and ketones. PYM and IM sulfones 
were always low yielding and in general all of the five-membered nitrogenous heterocycles: 
IM, TZ and FT performed poorly with ketones. However, FT sulfones were superior when 
condensed with aldehydes (compare entries 26 to 28 with entry 29).
(b) Effect o f heterocycle on stereoselectivity: All of the BT couplings concerning aldehydes 
typically displayed the same trends in stereoselectivity previously observed by Julia^ [ie little 
control in the formation of non-conjugated 1,2-disubstituted olefins (see entries 1,19, 23) and 
moderate to high trans selectivity when benzaldehyde was employed (entries 7 and 26)]. IQ 
sulfones gave very similar results to BT sulfones in such cases. Of greater interest was the 
tendency for IM sulfones (and to a lesser extent TZ sulfones) to yield cis 1,2-disubstituted 
olefins (entries 4, 16 and 20) with a high degree of control. Indeed, IM sulfone 104 was the 
only compound that yielded a 12-tetracosene (113) product with any great stereocontrol. In all
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of Julia's investigations there were no examples of the use of unsymmetrical ketones and so 
little was known about stereoselectivity in the formation of trisubstituted double bonds. With 
regard to the synthesis of the trisubstituted olefins 115, 116, 119 and 120, a general Z- 
preference was noted for all heterocycles tested with TZ sulfones being the most selective 
(entries 13, 17, 31 and 34).
(c) Effect o f chain branching on stereoselectivity: Firstly, in the case of non-conjugated 1,2- 
disubstituted olefins, chain branching had little effect on stereocontrol in the BT series when 
present in either the sulfone or aldehyde component (compare entry 1 with entries 19 and 23). 
However, when present on both sides, a slight trans selectivity was noted (entry 36). For the 
TZ series branching on the sulfone had little influence (compare entries 5 and 24), although 
when present in the aldehyde an increased Z-preference was observed (entries 21 and 37). The 
reverse effect of increased chain branching on stereoselectivity for BT and TZ systems is 
noteworthy (compare entries 36 and 37). When sulfones were condensed with benzaldehyde, 
the presence of branching increased trans selectivity for BT, TZ and IQ systems [compare 
entries 7 and 26 (BT), 9 and 27 (TZ), 10 and 28 (IQ)]. Such behaviour is to be anticipated 
from Julia's explanation for general trans selectivity when conjugated aldehydes are utilised; 
the presence of branching will increase the energy difference between zwitterionic intermediates 
61 and 62 (see Scheme 13, Chapter 1). In the case of acetophenone the reverse effect is noted 
in the BT series (ie the presence of branching increases Z-selectivity, compare entries 11 and 
30) although possibly for the same reason; this time Me being more sterically demanding than 
Ph. However, such an argument does not explain why an increased Z-preference was noted 
when 2-octanone was employed [compare entries 15 and 33 (BT), 17 and 34 (TZ)].
Despite the interesting and complimentary behaviour of TZ sulfones when compared to their 
BT counterparts we did not pursue their development due to associated poor coupling yields. 
More promising we felt was the PT system which was eventually chosen as a candidate for 
further investigation. Although no great differences in stereoselectivity were yet noted between 
BT and PT sulfones, the latter gave by far the highest yields when condensed with aldehydes. 
The tetrazole nucleus is probably the most electrophilic of all the heterocycles tested above and 
so most suited to promoting rapid irreversible reactions. In addition, 1-phenyl-177-tetrazole-5- 
thiol is commercially available and analogues can be easily synthesised via the condensation of 
wothiocyanates with sodium azide^ .^
As an aside, it is interesting to note the limited success of l-methylimidazol-2-yl (IM) sulfones 
to mediate the one-pot Julia olefination. ^-Hydroxy-IM-sulfones had been employed 
previously by Kende"^  ^as readily reducible substrates for the classical Julia reaction before the 
discovery of the one-pot Julia olefination (see Chapter 1). The possibility of a one-pot 
olefination reaction was over-looked at that time.
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2.2. Comparison of BT and PT heterocyclic mediators: the effects of solvent 
and hase on the one-pot Julia olefination
As already discovered by both Charette"^  ^ and Kocienski'^^ the stereochemical outcome of the 
one-pot Julia olefination is particularly sensitive to base and solvent effects. We conducted a 
systematic study of the aforementioned variables whilst concurrently providing direct 
comparison between the BT and PT systems. At the outset our study was limited to examine 
the synthesis of three classes of 'simple' 1,2-disubstituted olefins, encompassing: non- 
conjugated monoenes, conjugated dienes and masked allylic alcohols. We hoped the 
information accumulated would provide a set of optimised reaction conditions for general use 
in the appropriate instance.
Figure 4 illustrates the full range of variables covered; total saturation of all possible 
permutations leads to 192 unique experiments all of which were eventually realised. A pre- 
metallation protocol was adopted throughout since we felt that such an operational mode would 
prove more suitable to generalisation (particularly for complex aldehydes) than Julia's original 
Barbier conditions. Choice of base was restricted to the hexamethyldisilazide family; lithium, 
sodium and potassium variants are all commercially available and thus enabled the sole effect of 
base counter-cation to be elucidated. The four solvents chosen for the study ranged from a 
lipophilic non-coordinating solvent (toluene) to a Lewis basic polar solvent (1,2- 
dimethoxyethane). As before the effects of chain branching would also be examined.
PhMe EtgO
THF DME
sol
BnO
(a) MN(SiMG3 )2 , sol 
HetS02R -----------------------►
(b) R'CHO
total number of experiments 
= 2 x 2 x 3 x 4 x 4  = 192
Figure 4
Due to the greater scope of the second study, GC analysis was used throughout to assess both 
the yield and stereoselectivity of each coupling. Such an approach obviated the need for a 
complex work-up/chromatography procedure after each reaction and so increased efficiency. 
An all GC method does, however, necessitate the independent synthesis and calibration of
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standards for all possible products. The Schlosser variant of the Wiitg reaction^^ was employed 
to procure each targeted olefin in predominantly cis form suitable for GC analysis and 
subsequent calibration against an inert internal standard (dodecane). The Experimental Section 
contains full details concerning the setting-up and mnning of the study.
2.2.1. Synthesis of non-conjugated 1,2-disubstituted olefinic hydrocarbons
Tables 4.1 to 4.4 (pages 30 and 31) illustrate the results obtained for the first olefin class 
examined. Dramatic clear trends are immediately obvious;
(a) Chain branching effects: Coupling yields for the unbranched BT sulfone 107 (Tables 4.1 
and 4.2) were typically much lower compared to those for the analogous PT sulfone 108. The 
presence of branching on BT sulfone 109 (Tables 4.3 and 4.4) led to comparable yields to the 
PT sulfone 112 and to greatly increased yields compared to analogous couplings with 107 
(Tables 4.1 and 4.2). These observations suggest that the BT sulfone 107 is unstable with 
regard to self-condensation; the presence of a chain branching element as exhibited by 109 
increases steric bulk and thus reduces the propensity for self-condensation with the expected 
increase in yield. For the PT sulfones, however, the presence, or otherwise, of chain 
branching was of little consequence; analogous experiments for 107 (unbranched) and 112 
(branched) gave very similar excellent yields. Thus PT sulfones apparently satisfy one of our 
early objectives and give rise to more stable metallated derivatives than their BT cousins. The 
effect of j3-branching on stereoselectivity was very slight for the BT series, although in the 
analogous PT series slight increases in trans selectivity were noted which may be attributable to 
chain branching on the aldehyde component.
Table 4.2 best illustrates the following trends for solvent and base effects, however, they are 
also exhibited in Tables 4.1, 4.3 and 4.4.
(b) Solvent effects: For both heterocyclic systems, as the polarity/coordinating ability of the 
solvent was increased (PhMe —> Et20 THE —> DME) the trans selectivity of the reaction 
was heightened.
(c) Base effects: In the BT series a change in the base counter cation typically had very little 
effect on stereoselectivity and a quite unpredictable effect on yield {nb many of the more 
anomalous results presented in Tables 4 to 6 were repeated with comparable results). 
However, for the PT series a trend emerged: as the alkali metal series was traversed (Li Na
K) the trans selectivity of the olefination process markedly increased. Regrettably, 
associated with the observed increase in selectivity was a decrease in yield.
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The last two effects highlighted above for the new PT system act cooperatively. Thus 
condensation of the potassium derivative of a PT sulfone with a non-conjugated aldehyde in 
DME provides an efficient trans olefin synthesis. The reduction in yield associated with the use 
of a potassium base is presumably due to the increased reactivity of the metallated sulfone and 
so its greater ability to self-condense (see Chapter 6 for a pertinent example with a potential 
solution).
To demonstrate the practical value of the PT system for the preparation of simple non- 
conjugated trans olefins, (E)-1 -cyclohexyl-1 -hexene (1250 was synthesised on a 10 mmol 
scale (Scheme 18). Under essentially identical conditions to those employed for the small scale 
GC experiments, the olefin 125  ^was realised in 71% yield as a single isomer.
(a) KHMDS, DME, -55°C, 70 min
108,10 mmol
(b) / ^ C H O  124
- 5 5 ° C r t ,  O/N 125f, 71%, E;Z>98:2
Schem e 18
2.2.2. Synthesis of conjugated 1,2-disubstituted olefinic hydrocarbons
Tables 5.1 and 5.2 (page 32) illustrate the results acquired for simple diene synthesis 
employing the a,/J-unsaturated aldehyde cyclohexenecarboxaldehyde^"^ (128). As expected 
from our own earlier work (Table 3) and Julia's results^, the presence of additional 
unsaturation had a profound effect upon stereoselectivity.
. (a) Chain branching effects: As before (Section 2.2.1) the presence of chain branching on the 
BT sulfone was essential for a respectable yield (compare any analogous results from Tables 
5.1 and 5.2) and again unnecessary for the PT system. However, for the latter, the presence of 
chain branching on the sulfone increased trans selectivity when a lithium or sodium base was 
employed. Less of a stereochemical effect was typically observed for the BT system in this 
regard.
(b) Solvent effects: For both BT and PT sulfones the type of solvent employed had very little 
effect on stereoselectivity when either lithium or sodium bases were utilised. However, in the 
case of KHMDS, the use of DME as solvent gave a lower trans selectivity in the BT series and 
curiously a higher trans selectivity in the PT series. A temperature effect may be in operation 
here since to prevent freezing the experiments in DME were conducted at higher temperatures 
{ca +20°C) than the other examples.
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(c) Base effects: Again the type of base used had relatively little effect on the stereochemical 
outcome of the BT mediated reactions; a lithium base was found to be optimal for the expected 
excellent trans selectivity. For the PT mediated couplings a complete reversal of the trend noted 
in Tables 4.1 to 4.4 was observed; ie as the series Li —> Na ^  K was transversed trans 
selectivity was progressively decreased. In common with the earlier results, a drop-off in yield 
was noted in conjunction with use of a potassium base for the PT system presumably for 
similar reasons.
The results given in Tables 5.1 and 5.2 reveal that the BT mediated reaction manifold remains 
the optimum system for the synthesis of trans diene systems (disconnected so as to employ an 
a,^-unsaturated aldehyde). Indeed the best conditions mirror those already utilised by the 
Kocienski group for their work towards the synthesis of rapamycin"^  ^(see Scheme 14, Chapter 
1), ie use of a lithium base in THF solvent. Such conditions were subsequently used for the 
total synthesis of herboxidiene (see Chapter 6).
2.2.3. Synthesis of non-conjugated allylic ethers
Tables 6.1 and 6.2 (page 33) illustrate the range of results obtained for the synthesis of the last 
class of olefin examined. Two simple allylic ethers 132 and 133 were realised with either the 
BT or PT methodology. The lactate derived aldehyde 131^  ^employed enabled the effect of an 
additional chelating atom to be studied; the products from such couplings provide a potential 
source of allylic alcohols, intermediates of value to target-directed synthesis^ "^ *^ .^
The allylic ether results present some peculiar anomalies but generally show the same trends 
previously discussed for Tables 4.1 to 4.4 (Section 2.2.1). However, the extreme trans 
selectivity noted before in the PT series was reduced to E:Z = 80:20 at best.
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HetS02'
Met = BT, 107 
PT, 108
(a) MN(SiMe3 )2  (1 .1  eq)
122 (1.5 eq) 123
Table 4.1
solvent* entry M Met = 
%yield'l’
BT
E.Zt
Met = 
%yield‘l'
PT
PhMe 1 Li 5 40:60 55 57:43
2 Na 29 51:49 80 59:41
3 K 15 47:53 13 64:36
Et2 0 4 Li 7 43:57 76 73:27
5 Na 17 53:47 90 57:43
6 K 6 8 51:49 30 72:28
THF 7 Li 42 60:40 97 75:25
8 Na 0 -- 89 76:24
9 K 24 55:45 71 86:14
DME 1 0 Li 3 55:45 95 77:23
1 1 Na 27 77:23 92 86:14
1 2 K 6 75:25 71 94:6
all reactions run at -78°C  except those In DME which were run at -60°C . ^determined by GC analysis 
(a) MN(SiM0 3 ) 2  (1 .1  eq)
HetS02'
Het= BT, 107 
PT, 108
(b)
124 (1.5 eq) 125
Table 4.2
solvent* entry M Het = 
%yield'l’
BT
E.Z^
Het = 
%yield'l'
PT
E'Z^
PhMe 1 Li 1 50:50 90 51:49
2 Na 2 0 54:46 51 65:35
3 K 13 54:46 2 2 77:23
Et2 0 4 Li 2 49:51 6 6 61:39
5 Na 17 50:50 83 65:35
6 K 57 51:49 46 89:11
THF 7 Li 6 66:34 90 69:31
8 Na 19 62:38 92 73:27
9 K 27 54:46 71 97:3
DME 1 0 Li 2 70:30 94 72:28
1 1 Na 32 75:25 95 89:11
1 2 K 4 76:24 81 99:1
all reactions run at -78°C  except those in DME which were run at -60°C . ‘•’determined by GC analysis
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HetSOg
Het = BT, 109 
PT, 112
(a) MN(SiM0 3 ) 2  (1 .1  eq)
122 (1.5 eq) 126
Table 4.3
solvent* entry M Het = 
%yield^
BT Het = 
%yield'l^
PT
E;Zt
PhMe 1 Li 8 6 54:46 96 43:57
2 Na 78 57:43 65 38:62
3 K 31 26:74 25 62:38
Et2 0 4 Li 74 60:40 61 48:52
5 Na 84 58:42 98 32:68
6 K 56 36:64 2 0 37:63
THF 7 Li 98 57:43 1 0 0 67:33
8 Na 89 39:61 8 8 32:68
9 K 6 8 25:75 23 76:24
DME 1 0 Li 1 0 0 44:56 1 0 0 60:40
1 1 Na 87 64:36 1 0 0 78:22
1 2 K 63 46:54 2 2 96:4
’all reactions run at -78°C  except those in DME which were run at -60°C . ^determined by GC analysis
(a) MN(SiMe3 )2  (1 .1  eq)
HetS02
Het= BT, 109 
PT, 112
(b)
124 (1.5 eq) 127
Table 4.4
solvent* entry M Het = 
%yield'l'
BT
E;Zt
Het = 
%yield‘*'
PT
E Z t
PhMe 1 Li 8 8 70:30 85 39:61
2 Na 6 6 86:14 83 67:33
3 K 48 76:24 6 8 98:2
Et2 0 4 Li 70 67:33 74 41:59
5 Na 75 87:13 98 53:47
6 K 6 8 78:22 28 92:8
THF 7 Li 87 72:28 90 53:47
8 Na 84 67:33 71 48:52
9 K 85 40:60 58 97:3
DME 1 0 Li 83 58:42 1 0 0 40:60
1 1 Na 96 55:45 1 0 0 84:16
1 2 K 1 0 0 36:64 59 99:1
ail reactions run at -78°C  except those in DME which were run at -60°C . ’•'determined by GC analysis
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HetS02"
Het = BT, 107 
PT. 108
(a) MN{SiM0 3 ) 2  (1 .1  eq)
(b)
1 ^ ^  128 (1.5 eq) 129
Table 5.1
solvent* entry M Het = 
%yield'l’
 BT
E;Z+
Het = 
%yield^
PT
E;Z+
PhMe 1 Li 15 95:5 74 8 8 : 1 2
2 Na 43 97:3 81 80:20
3 K 17 >95:5 41 61:39
Et2 0 4 LI 24 99:1 95 89:11
5 Na 48 97:3 82 75:25
6 K 60 94:6 69 58:42
THF 7 Li 35 96:4 91 67:33
8 Na 13 86:14 99 75:25
9 K 39 79:21 93 66:34
DME 1 0 Li 2 ——— 84 84:16
1 1 Na 26 77:23 1 0 0 8 8 : 1 2
1 2 K 35 55:45 64 85:15
‘all reactions run at -78°C
H e tS 0 2 ^ ^ r ^ ^ ^
Het= BT, 109 
PT, 112
except those in DME which were run at -60°C .
(a) MN(SiMe3 )2  (1 .1  eq)
(b) / " ^ C H O
128 (1.5 eq)
^determined by GC analysis 
130
Table 5.2
solvent* entry M Het :
%yield'*’
= BT
E:Z^
Het = 
%yield'l'
PT
E Z t
PhMe 1 Li 69 98:2 71 94:6
2 Na 98 97:3 90 82:18
3 K 70 97:3 27 55:45
Et2 Û 4 Li 16 97:3 79 95:5
5 Na 89 97:3 85 79:21
6 K 8 8 96:4 31 50:50
THF 7 Li 96 >99:1 1 0 0 98:2
8 Na 96 94:6 78 85:15
9 K 76 86:14 44 58:42
DME 1 0 Li 93 >99:1 83 99:1
1 1 Na 1 0 0 91:9 48 92:8
1 2 K 94 72:28 38 81:19
‘all reactions run at -78°C  except those in DME which were run at -60°C . ^determined by GC analysis
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HetS02^
Het = BT, 107 
PT, 108
(a) MN(SiM0 3 ) 2  (1 .1  eq)
(b) \ / C H O
BnO 131 (1.5 eq)
132 OBn
Table 6.1
solvent* entry M Het : 
%yield^
= BT
E;Z+
Het = 
%yield'*’
PT
E.Z+
PhMe 1 Li 2 50:50 54 31:69
2 Na 5 52:48 1 0 0 49:51
3 K 8 63:37 47 58:42
Et2 0 4 Li 1 55:45 31 35:65
5 Na 5 52:48 82 44:56
6 K 1 0 76:24 78 59:41
THF 7 Li 23 74:26 91 64:36
8 Na 32 64:36 1 0 0 65:35
9 K 44 61:39 1 0 0 72:28
DME 1 0 Li < 1 ——— 8 8 59:41
1 1 Na 25 64:36 96 68:32
1 2 K 5 58:42 94 79:21
'all reactions run at -78°C
Het= BT, 109 
PT, 112
except those in DME which were run at -60°C .
(a) MN(SiMe3 )2  (1 .1  eq)
(b) ^ C H O  "
BnO 131 (I.Seq)
‘•‘determined by GC analysis 
133
Table 6.2
solvent* entry M Het
%yield'l'
= BT Het = 
%yield'l’
PT
E Z t
PhMe 1 Li 1 0 0 47:53 43:57
2 Na 72 61:39 79 30:70
3 K 98 61:39 71 64:36
Et2 0 4 Li 85 48:52 1 0 0 42:58
5 Na 34 42:58 1 0 0 28:72
6 K 8 8 41:59 48 34:66
THF 7 Li 89 54:46 87 44:56
8 Na 84 50:50 99 19:81
9 K 95 34:66 6 6 45:55
DME 1 0 Li 55 68:32 90 45:55
1 1 Na 94 57:43 93 50:50
1 2 K 8 6 40:60 37 80:20
all reactions run at -78°C  except those in DME which were run at -60°C . ‘•‘determined by GC analysis
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2.3. Mechanistic studies
The base/solvent study exposed the enormous potential of PT sulfones to access non- 
conjugated 1,2-disubstituted olefins with excellent stereoselectivity (Tables 4.1 to 4.4). It 
is likely that the origin of olefin stereocontrol in this instance is a direct consequence of kinetic 
diastereoselectivity in the initial addition event. To prove such a postulate it is necessary and 
sufficient to demonstrate that under the appropriate reaction conditions /3-alkoxysulfone 
intermediates breakdown stereospecifically and that they cannot interconvert. Julia and co­
workers have already demonstrated for simple BT sulfones that the base induced breakdown of 
^-hydroxysulfone intermediates is stereospecific^ (see Chapter 1). It remained to demonstrate 
this finding for the PT system (Scheme 19).
KHMDS, DME
-60°C -> rt, 1.5 h
135, 91%, E;Z> 98:2
TESO
136
TBAF, DME 
-60°C rt, 3 h
Schem e 19
137, 95%, Z'E >98:2
Diastereomerically pure syn and anti j3-hydroxy PT sulfides were synthesised via the opening 
of stereodefined epoxides by PTSH (see Experimental Section). Following sulfur oxidation, 
the anti derivative 134 was accessed without incident. Unfortunately a direct oxidation route to 
the syn analogue was not possible; upon oxidation spontaneous elimination of SO2 and PTOH 
occurred to yield the olefin. The more facile elimination from such syn derivatives has already 
been noted by Julia in the BT series^. Protecting the carbinol as a silyl ether prior to sulfur 
oxidation enabled the masked syn j8-hydroxysulfone 136 to be realised. Base treatment of the 
anti isomer 134 under the previously optimised reaction conditions for E-olefin synthesis 
(KHMDS, DME, -60°C) yielded the expected trans alkene 135 as a single observable isomer. 
Likewise fluoride induced elimination from syn 136 yielded the Z-olefin 137 as a single 
isomer.
Interconversion between jS-alkoxysulfone intermediates 138 and 142 is only possible via a 
retro-addition/addition mechanism (Scheme 20). The formation of the initial retro-addition 
product, 140, can be indirectly detected if an additional trapping reagent is present. If the base- 
induced elimination of a j8-hydroxysulfone is conducted in the presence of R^CHO the
R'
R'
O©
R
S02Het
138
O0
S02Het
142
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R
139
R'CHO
R ^ S 0 2 H e t R^CHO 
0  140 R
141
R'CHO
R'
143
Schem e 20
formation of any of the cross-over product 141 is proof of the existence of 140 and thus the 
possibility of equilibration between 138 and 142. The experiments outlined in Scheme 19 
were both repeated in the presence of 4-nitrobenzaldehyde; in each case a comparable result 
was obtained and no cross-over adduct was found. Taken together the above observations 
prove that high levels of ^-selectivity found for the one-pot Julia reaction between non­
stabilised PT sulfones and saturated aliphatic aldehydes are a direct consequence of the 
selective formation of an anti j3-alkoxysulfone intermediate.
To demonstrate that the 4-nitrobenzaldehyde trapping experiment was a valid method to detect 
/3-alkoxysulfone equilibration an additional system was examined. The stilbene derivatives 
144 and 145 (Scheme 21) were synthesised in an analogous manner to 134 commencing 
from trans stilbene oxide. Retro-addition from the alkoxides of such compounds would yield 
highly stabilised benzylic sulfone anions and so it was expected that equilibration would be a 
facile process. Indeed, Julia has already invoked /3-alkoxysulfone equilibration to explain high 
Z-selectivities in the one-pot Julia olefination reaction of stabilised BT sulfones (see Chapter 
1). Treatment of either sulfone with LDA in THF at -78°C in the presence of 4- 
nitrobenzaldehyde resulted in the formation of the expected stilbene 146 together with large 
quantities of the cross-over product 4-nitrostilbene (147). Thus in favourable cases
p-N02PhCH0, LDA
S02Het
144, Het = BT
145, Het = PT
THF, -78°C rt
Schem e 21
146
Het %yield E;Z
BT 40% >98:2
PT 35% 87:13
O2 N ^  147
Het %yield E:Z
BT 60% 92:8
PT 60% 69:31
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equilibration between ^-alkoxysulfones is a viable mechanistic pathway and our trapping 
experiments have a sound basis.
Further insight can be gleaned from a careful examination of the respective yields and 
selectivities found for the two products 146 and 147. For both BT and PT systems the cross­
over product 147 was formed with lower E-selectivity than stilbene (146). Two reasons may 
account for such an observation: (a) the initial anti adduct is already predisposed to yield a trans 
product if intramolecular alkoxide trapping occurs before retro-addition, and (b) due to the 
electronic effects suggested by Julia (see Scheme 12, Chapter 1) an electron deficient 
unsaturated aldehyde would be expected to yield a product with lower trans selectivity than an 
electron rich one. The PT sulfone 145 yielded stilbene products with lower E-selectivity than 
its BT counterpart 144; the results of Tables 5.1 and 5.2 already suggested the inferiority of 
the PT system for the synthesis of conjugated olefins. Lastly, it is significant that both sulfones 
gave the same proportion of 147 to 146, it may therefore be incorrect to assume that the 
tetrazole nucleus is better able than benzothiazole to trap a tethered alkoxide. The 
electrophihcity of both heterocyclic mediators appears equivalent in this regard.
2.4. Origin of diastereoselectivity in the heterocyclic sulfone 'aldol' reaction
The above observations taken together with those of Julia^ establish that stereocontrol in the 
one-pot Julia olefin synthesis is a direct consequence of diastereoselective sulfone addition only 
in 'simple' cases {ie non-stabilised sulfones and saturated aldehydes). The results of Tables 4.1 
to 4.4 thus represent a study of diastereocontrol in the sulfone analogue of the aldol reaction; 
the anti:syn ratio of the intermediate j8-alkoxysulfone corresponds to the observed E.Z ratio of 
the isolated olefin. Such studies are somewhat rare in the literature in contrast to analogous 
sulfoxide chemistry^^. Sulfone moieties are typically removed immediately after their activating 
properties have been utilised and so the isomer distribution of the intermediate p- 
hydroxysulfones is of little consequence and seldom determined. Where isomer ratios have 
been assigned and documented the selectivity is typically poor^^ (1:1 < dr < 3:1).
The structural nature of metallated sulfones has received much attention, however, different 
sources still provide varying models accompanied by their own experimental justification. Ab 
initio calculations for the hypothetical metallate HS02CH2Li (148, R = R' = H, M = Li, 
Figure 5) suggest that the carbanion is intermediate between sp^ and sp^ hybridised and that an 
asymmetric chelated structure is adopted^^’^ .^ Theoretical studies for the anion of dimethyl 
sulfone also support this modeF^. However, direct probing of several stabilised sulfone 
metallates via X-ray crystallography supports a different view^®’^ ^ The metal cation associates 
with the sulfone oxygen atoms and the carbanion is sp^ hybridised with the p-orbital lying 
gauche to both oxygen atoms. Gais has established with ^Li-^H heteronuclear nOe experiments
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R' 148 149 R j p
M M
/  \  /  \
^  ^  nc->C7*S-R- n
150 H R 151
Figure 5
that it is likely such a structure is also adopted by a lithiated benzylic triflone»TMEDA complex 
in solution^^. The general consensus now is that the latter model 150 (Figure 5) is the most 
acceptable with the a-carbon being pyramidal except in those cases where the anion receives 
resonance stabilisation from
Sulfones do not stabilise adjacent negative charge by resonance effects (c/carbonyl chemistry) 
but rather by a combination of induction and negative hyperconjugation (nc —> o*s-R', see
151 the no bond' canonical form of 150). The latter effect provides a significant energy 
barrier to rotation about the CcrS bond and so enables lithiosulfones to have chiral anions even 
when their a-carbon atom (bearing different groups) is coordinated in a planar rather than 
tetrahedral fashion. Metallated sulfones are thus fundamentally different from enolates, 
however, in developing models for the heterocyclic sulfone aldol reaction, analogy with 
carbonyl enolate chemistry may yield valuable insight. Here we seek basic concepts to explain 
the two strong trends displayed in Tables 4.1 to 4.4, namely: (a) the rise in 
anti diastereoselectivity for both BT and PT sulfones as solvent coordinating ability increases, 
and (b) the dependency of syn:anti ratio on counter cation for the PT sulfone metallates only.
In lipophilic non-coordinating solvents polar transition states experience compression and 
closed systems with anionic and cationic species in close association are favoured. For sulfone- 
aldehyde addition reactions occurring in such media we suggest the Zimmerman-Traxler^^'^^ 
like six-membered chair transition states 152 and 154 illustrated below (Figure 6, analogous 
transition states have been proposed for the addition of sulfinyl stabilised carbanions to 
aldehydes^^ and also for the addition of metallated phenyl sulfones to acyl silanes^^). Upon 
approach of the aldehyde the metal cation (previously associated with both sulfone oxygen 
atoms, cf 150 Figure 5) exchanges one sulfone oxygen atom ligand for the carbonyl oxygen 
atom. Reorganisation of the resultant assembly then occurs to yield either of the chairlike forms
152 or 154. Note that the aldehyde side-chain adopts an equatorial orientation to avoid 
destabilising 1,3-diaxial interactions, and that in both transition states the stereoelectronic
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closed transition 
states
low selectivity
Het
O 152
r:
S02Het
OM
SOpHet
Figure 6
R'
S02Het
Y ^ R  
OM 153
R
154
S02Het».
O
155
open transition 
states
high selectivity
156
requirement for sulfone a-carbanion stabilisation is fulfilled. Which sulfone oxygen ligand the 
metal gave up (O* or Q t) determines whether the R  group is equatorially or axially disposed; 
the same metallated sulfone can thus behave equally well as either an E-enolate' (154) or a Z- 
enolate' (152) equivalent in the transition state. Such reactivity duality together with the lack of 
an obvious destabilising interaction with which to discriminate between 152 and 154 would 
suggest a general lack of selectivity when reaction proceeds via a closed transition state. Such 
is the case for the addition of metallated BT sulfones (Li, Na or K) and lithiated PT sulfones to 
aldehydes in toluene.
As the solvent is exchanged for progressively more Lewis basic media the metal cation will 
experience additional solvation. Under such conditions the cation will become less tightly 
associated with the sulfone leading to the possibility of reaction via a looser, or even totally 
open transition state. Arrays 155 and 157 represent such an extreme and are based on 
analogous open transition states suggested for the aldol reaction^^. With the illustrated favoured 
approach of the aldehyde, transition state 155 lacks the repulsive gauche interaction present in 
157 and so will be favoured. Thus in polar coordinating solvents competition from open 
transition states would lead to a general preference for the anti product. The above model 
accounts for the observed solvent effect, however, many other reasonable arguments {eg 
competition from closed boatlike transition states, change in aggregation state of metallate etc) 
could no doubt also be brought forward.
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The dependency of diastereoselectivity on base counter-cation for the PT sulfone series and the 
associated independence of cation for the corresponding BT sulfones is harder to rationalise. 
Regarding the model presented above, we would suggest that traversing the series Li —> Na ^  
K encourages PT sulfone addition reactions to proceed via open transition states 155 and 157; 
the solvent and cation effects are then naturally cooperative. The fact that no cation effect is 
observed for the BT series suggests that this phenomena is linked with the very different 
shapes associated with the two heterocycles. The BT moiety has no substituents with which to 
directly affect the choice of reaction pathway. In contrast the phenyl ring of the PT moiety is 
appended to the tetrazole nucleus in close proximity to the sulfone and so is likely to play an 
important role in transition state selection. The cation effect in the PT series may be due to the 
variable interaction of different alkali metals with the phenyl substituent. Alkali metals readily 
form intercalation compounds with graphite^^ and arene complexes of potassium cations are 
known^^'^\ For example, Caulton has reported the crystal structure of a cubic tetrameric 
complex between KOSiMe2Ph and benzene of stoichiometry [(C6H6)KOSiMe2Ph]4; each 
potassium ion within the tetramer is associated with three oxygen atoms and the coordination 
environment supplemented by an additional T?^-benzene ligand^^ The rj^ coordination of 
potassium ions to arenes is believed to be the result of an induced dipole interaction^^.
I
" "-r<
158 159 160
Figure 7
As a sulfone metallate counter-cation is varied from Li -> Na —> K the ionic radius of the metal 
increases and the sulfone O-M bond lengthens accordingly. We suggest that in the case of a PT 
sulfone potassium metallate 160, the metal cation is strongly bound by both sulfone oxygen 
atoms and appropriately positioned to receive additional 7]^  coordination from the phenyl ligand 
appended to the tetrazole nucleus (Figure 7). The stable 'claw-like' chelate structure 
immobilises the metal ion and makes a closed transition state for aldehyde addition virtually 
inaccessible. The reactions of PT sulfone potassium metallates with aldehydes are thus forced 
to proceed via predominantly open transition states and are typically highly stereoselective.
In contrast, lithium ions are smaller and less polarisable than potassium ions and so their 
susceptibility to an induced dipole is substantially reduced. The coordination of a lithium cation 
to an arene is thus intrinsically weak^^. In addition the shorter sulfone O-M bond for a lithiated 
PT sulfone would make an analogous chelate structure to that discussed above for potassium
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highly unstable. The lithium derivatives of PT sulfones 158 therefore react similarly to BT 
sulfone metallates and their addition reactions are typically unselective unless carried out in 
highly coordinating solvents. Sodium represents an intermediate case with reaction via an open 
transition state being promoted but with closed transition states still accessible and able to 
compete.
The absence of a cation stereochemical effect for BT sulfone reactions can then be attributed to 
its lack of substitution. Within the closed transition states, traversing the series Li ^  Na —> K 
would obviously still result in a lengthening of the O-M bond. However, such a distortion 
would not lead to greater discrimination between 152 and 154.
Our hypothesis concerning the 'claw-like' mode of PT sulfone metal chelation could of course 
be easily probed by varying the tetrazole substituent (eg to include electron rich and electron 
deficient phenyl rings and simple groups such as methyl, wopropyl, tert-butyl etc). Some initial 
work has been conducted involving the l-r^rr-butyl-li/-tetrazol-5-yl (TBT) mediator^^; as 
expected the trans selectivity obtained by reaction of a simple TBT sulfone potassium metallate 
with a saturated aldehyde was less than the corresponding result with a PT sulfone (see 
Chapter 7). However, the selectivity of the TBT sulfone (E:Z = 89:11) was not reduced to the 
level anticipated for the analogous BT sulfone (E:Z « 75:25).
In the above discussion the influence of metal chelation to the 'imine-like' nitrogen atom of 
both the heterocyclic systems was neglected. Certainly in the case of hthium metallates such an 
effect may be important; Julia and co-workers invoked chelation to the nitrogen atom of the 
benzothiazole moiety in their discussion of transition state selection for the alkoxide addition 
step of the one-pot olefination process^. Of course for both PT and BT scaffolds such chelation 
can occur, in the PT case this would have a dramatic effect on the positioning of the phenyl 
substituent relative to the reactive centres. Simple models also suggest the possibility of a 
closed transition state in which the metal is simultaneously coordinated to the aldehyde, a 
sulfone oxygen atom and the heterocycle 'imine' nitrogen. Such a transition state does not, 
however, satisfy the stereoelectronic requirement for sulfone carbanion stabilisation.
Lastly, it would be reasonable to assume that the selectivities exhibited in Tables 6 are also a 
consequence of diastereocontrolled sulfone addition. The trends displayed are identical to those 
found in Tables 4 but stereoselectivity is reduced suggesting that the oxygenated side-chain of 
the aldehyde component provided an additional control element. The results of Tables 5 are not 
solely the effect of sulfone aldol diastereoselectivity due to additional electronic effects (see 
Chapter 1). It is not surprising then that the solvent and base effects are significantly perturbed, 
nevertheless, the reverse cation effect for the PT sulfone series is intriguing.
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3. Vitamin D Fragment Linkage Strategies
The D vitamins form part of a family of compounds of steroidal origin known as seco-steroids', 
they possess the A, C and D rings common to steroids but lack ring B. There are three distinct 
vitamin D congeners: D2, D3 and D4 (see Scheme 22). Vitamin D3 and vitamin D% are derived 
from cholesterol and ergosterol respectively and both have recognised biological function. The 
biological activity of the closely related vitamin D4 seems doubtful. Curiously vitamin D% is not 
a single compound but rather a 1:1 complex of lumisterol and vitamin D2.
Natural vitamin D3 {calciferol, 21) is formed in the skin of man by the action of ultraviolet light 
on 7-dehydrocholesterol (161, R = R3). The ensuing conrotatory electrocyclic ring opening 
yields the so-called previtamin (162) which can then undergo a thermally allowed [l,7]a- 
sigmatropic hydrogen shift to form the vitamin itself^. The hormonally active metabolite of the 
vitamin, la,25-dihydroxyvitamin D3 {calcitriol, 166), is then obtained by two successive 
enzymatic hydroxylations, the first at C25 in the liver followed by hydroxylation at Cl in the 
kidney (Scheme 22).
A,[1,7]a H-shift
R
skin
HO HO
provitamin D (161)
OH
liver
seco-B-ring ^ ^ 3 kidney
H0"3 H O ' OH
vitamin D2  (163), R = R2  
vitamin D3  (21), R = R3  
vitamin D4  (164), R = R4
165
Schem e 22
calcitriol (166)
(1 a,25-dihydroxyvitamin D3 )
Rp = Rp = R4  =
As is suggested by the above biosynthetic route to vitamin D3, the substance is not technically a 
vitamin but rather belongs to a class of steroidal hormones. Long known to be essential for 
normal bone calcification, the hormonally active metabolite 166 regulates calcium and
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phosphorus metabolism within the body. As such the vitamin D family of steroidal molecules 
have been extensively used in the past as curative agents for rickets and similar diseases^^. 
However, it has come to light that this more classical role is supplemented by other far more 
significant activities. In particular, calcitriol is implicated in the promotion of cell differentiation 
and inhibition of cell proliferation^"^. Unfortunately, the use of la,25-dihydroxyvitamin Dg 
(166) as a drug for the treatment of cancer is limited due to serious hypercalcémie side-effects 
at useful dose levels. The current resurgence of interest in the chemistry of vitamin D 
compounds is mainly due to the need to find analogues of calicitriol which retain anticancer 
activity but which do not affect calcium mobilisation and deposition. New efficient synthetic 
procedures which enable the rapid assembly of vitamin D type systems are clearly highly 
desirable.
The synthesis of vitamin D and related compounds has a long and well established history, 
beginning with the pioneering and exhaustive work of Lythgoe^^ at Leeds and Inhoffen^^ at 
Braunschweig. An excellent recent review article by Okamura^^ surveys the subsequent 40 
years of vitamin D synthetic chemistry, and so rather than give an in-depth analysis of 
particular total syntheses, it is intended here to illustrate some of the more important strategies 
employed for final fragment linkage.
3 .1 . Direct coupling of A-ring and CD-ring fragm ents via  connective 
olefination
Typically vitamin D syntheses are convergent and terminate with the coupling of an A-ring 
fragment with a CD-ring fragment followed in some cases by a subsequent rearrangement^^. 
Lythgoe was the first to successfully synthesise vitamin Dg via such a direct approach in 1978, 
and at that time employed a Homer-Wittig^'^^ reaction to forge the C7-C8 double-bond^^ (see 
Scheme 5, Chapter 1). Fragment linkage via the connective construction of the IE  olefin has 
since become the most commonly adopted strategy for the synthesis of vitamin D type 
molecules. Indeed, the first total synthesis of calcitriol by a Hoffmann-La Roche group^^ 
utilised an analogous approach to Lythgoe for final fragment linkage (Scheme 23).
(a) BuLi, THF, -78°C  
--------------------------► calcitriol (166)
OTMS
TBSO" OTBS
167 168
(b) deprotection
Schem e 23
Lythgoe and co-workers were also intrigued by the notion of reversing the sense of their earlier 
coupling; ie employing an A-ring electrophile and a CD-ring nucleophile. Initial attempts to 
synthesise a CD-ring C8 phosphorane (with regard to later using the Wittig olefin synthesis)
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were unsuccessful, highlighting the difficulty of introducing a PPhg group into a sterically 
congested environment. Instead the C8 CD-ring phenylsulfone (173) was realised in 6 steps 
from des-AB-ergost-8-ene (169) (Scheme 24) and the classical Julia olefination^®’^ "^ (see 
Section 1.3.1) applied for the first time since its discovery to a complex synthetic problem; the 
synthesis of vitamin 04 ®^.
BzO""
Ph02S
R4  (a) m-CPBA , CH2 CI2  
0°C, 1.5 h
(b) PhSNa, EtOH ^0"  
A, 16 h, 77%
Schem e 24
f-BuOK
PhS
(a) BzCI, pyridine
(b) m-CPBA, CH2 CI2  
rt, 2  h, 8 8 %
170
THF, rt, 3 h
R4
H2 , 10% Pd/C
EtOAc, rt, 92%
Ph02S Ph02S
H
171 172 173
Condensation of the lithium derivative of a-sulfone 173 with the unstable dienal 174 was 
followed by subsequent silylation with trimethylsilylchloride to proffer the /3-siloxysulfone 
175 (Scheme 25). The crude compound was then treated with 6% lithium amalgam in a 
mixture of THF and MeOH to yield 45% of vitamin D4 (from sulfone 173) after saponification 
as a single isomer. Interestingly, reductive elimination from the /3-benzoyloxysulfone 
analogous to 175 not only yielded vitamin D4 (36%) but also 20% of (5E, 7£)-vitamin D4. 
The trans selectivity of the classical Julia reaction for the vitamin D coupling is unsurpassed 
and others have also investigated its use. Fukumoto has described a total synthesis of the CD- 
ring 8 (%-phenylsulfone necessary for the construction of vitamin D3 {ie compound 173 with R3 
sidechain). Subsequent condensation of the lithiated (LDA) sulfone with the TBS protected A- 
ring dienal, followed by acétylation, reductive elimination with 5% sodium amalgam and final 
silylether deprotection yielded 51% of vitamin D3 as a single isomer^^.
173
(a) BuLi, THF, -70°C, 30 min 
174 0 , 1 5  min
(c) TM SCI,-70°C^rt, 16h
BzO"
OTMS
Ph02S
Schem e 25
(a) 6 % Li (Hg), MeOH 
THF, -20°C, 3.5 h
(b) KOH, H2 O
HO"
175 vitamin D4  (164)
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3.2. Palladium catalysed cross-coupling approaches
Scheme 26 illustrates an interesting cross-coupling strategy towards calcitriol devised by 
Castedo and Mourino which borrows a transformation from nature's biosynthetic sequence. A 
Stille coupling between the A-ring alkynylstannane 177 and the CD-ring fragment enol triflate 
176 yielded the acetylene 178 in excellent yield^^. Lindlar reduction of the central triple bond 
produced the previtamin D type triene 179. As for previtamin Dg itself, the system is 
predisposed towards a [1,7] sigmatropic H-shift and subsequently rearranged to yield the 
vitamin D triene system. Minor modifications of the resulting substrate then yielded la,25- 
dihydroxy vitamin Dg (166).
TBSO"' OTBS TBSO"
TBSO
H2  (1  atm)
Lindlar cat. TBSO
179
177
OTBS
178
Schem e 26
(a) A [1,71a H-shift
(b) sidechain modification
(c) deprotection 
 — calcitriol (166)
The above procedure builds on earlier work also by Lythgoe^® which predates the advent of 
palladium catalysed cross-coupling reactions. The original route to a pre vitamin structure 
employed the condensation of the lithium derivative of an A-ring enyne analogous to 177 with 
either Grundmann's ketone or its 9-chloro derivative. Elimination of the resulting alcohol or 
vicinal chlorohydrin respectively yielded the required dienyne intermediate.
The following approach developed by Trost differs from all other common strategies in that the 
A-ring is created from an acyclic unit during the coupling reaction^\ Scheme 27 (overleaf) 
outlines the basic concept: after Pd(0) oxidatively inserts into the labile C-Br bond of CD-ring 
vinyl bromide 180, subsequent carbopalladation across the alkyne of the acyclic seco-A-ring 
fragment 181 yields intermediate 183. A further carbopalladation reaction closes the A-ring 
and is followed by ^^-elimination of HPdBr from 184 leaving the exocyclic terminal methylene 
moiety in place and frees the protected product. In a final step the active Pd(0) catalytic species 
is regenerated by reductive elimination of HBr from HPdBr assisted by triethylamine and the 
cycle recommences.
The vinyl bromide 180 can be realised by Wittig reaction of (bromomethylene)- 
triphenylphosphorane with a Grundmann's ketone derivative, unusually high ^-selectivity is
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obtained. The acyclic fragment 181 can be synthesised in homochiral form by a simple eight 
step sequence in 20% overall yield^^
(a) (dba)3 Pd2 *CHCl3
Ph3 P, Et3 N, PhMe
180
PdBr
TBDPSO'' OTBS
184
BrPd
PdBr182
TBDPSO'' OTBS TBDPSO'" OTBS
183181
Et3N
-HPdBr Pd° + EtsN-HBr Schem e 27
R =calcitriol (166) OH
3.3. Vinylallene rearrangement approach
Okamura has taken advantage of known vitamin D rearrangement chemistry to introduce a 
conceptually new synthetic approach. Upon irradiation of vitamin D3 (21) two diastereomeric 
vinylallenes 185 are formed as minor products^^; the result of a [1,5] hydrogen shift of the 
circled atom (Figure 8). Thermolysis of the vinylallenes reverses the shift to regenerate the 
vitamin D triene segment. Okamura has developed routes to vitamin D analogues via the 
intermediacy of such vinylallenes^^, however, under the heat-induced rearrangement protocol 
both allene diastereoisomers yield not 
only the natural 5Z ,1 E  olefin 
stereochemistry but also the unnatural 
5Z,7Z configuration. Unfortunately at the 
high temperatures required for the 
thermally induced reaction the 5Z,7Z 
isomer once formed undergoes further 
[1,7] H-shifts (commencing from H14 to 
C l9) to generate a triad of equilibrating 
secondary and tertiary products.
HO""
calciferol (2 1 )
hv, 1 1 %
A 
[1,5]
Figure 8
OH
185
The aforementioned pitfall of the thermal rearrangement vinylallene route lead Okamura and co­
workers to investigate and develop a practical chromium(O) mediated isomérisation route of 
vinylallene intermediates to calcitriol*"  ^(see Scheme 28). Following the addition of an A-ring
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alkynyllithium to a Grundmann's ketone derivative, the benzoate 186 was easily realised. 
Reduction of the propargyl benzoate with a Pd(0)-Sm(II) reagent system followed by silylether 
deprotection, lead to the formation of the requisite vinylallene 187 with excellent 
stereoselectivity (the 6S major isomer is illustrated). Rearrangement of either vinylallene (6S or 
6R) mediated by a (naphthalene)tricarbonylchromium catalyst yielded (7Z)-calcitriol (188) in 
excellent yield and stereoselectivity. Under the relatively mild reaction conditions further [1,7]- 
hydrogen shifts of the labile 5Z,7Z system were not promoted. By employing the long known 
(5Z —> 5E) isomérisation of vitamin D trienes via the cheleotropic addition-extrusion of 
sulfur dioxide*^’^ ,^ together with a new efficient photoisomerisation of the bond (7Z —> 
the Okamura group were able to synthesise every double bond isomer of calcitriol from 
the 5Z,7Z material 188.
OTMS OHR =
BzO (a) Pd(PPh3 )4 , Sml2  
/-PrOH OH
H"
(b) TBAF
TBSO'' OHOTBS
186
hv, sensitiser
HO' "OH 
(7Z)-calcitriol (188) 
80%, dr > 98:2
Schem e 28
HO" ^  "OH 
calcitriol (166)
HO' "OH 
(5E)-calcitriol (190)
HO ^  "OH 
(5E,72)-calcitriol (189)
A = (a) SO2 , -15°G, 2.5 h; (b) 78°C, 1.5 h 
cheleotropic addition-extrusion of SO2
3.4. Cyclovitamin D solvolysis approach
The last approach to be introduced here also exploits natural vitamin D rearrangement 
chemistry. In efforts to protect the delicate triene system of vitamin D3 prior to subsequent 
functionalisation, Mazur discovered an intriguing interconversion between the vitamin and its i- 
steroid form, 3,5-cyclovitamin Treatment of the tosylate of vitamin D3 (191) with
sodium acetate in methanol-acetone yielded 55% of the cyclopropane 192 and its C6 epimer 
(dr = 82:18) together with 10% of 30-methyl vitamin Dg (Scheme 29). Acid catalysed
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hydrolysis of the major cyclopropane epimer 192 regenerated vitamin D3 in 80% yield with 
excellent selectivity {5Z:E =93:7).
R3
TsO*
NaOAc
MeOH-Me2CO
(4:1)
MeO.,,
cat. p-TsOH
dioxane-H20
(3:1)
191 192, 55%, dr (C6 ) = 82:18
Schem e 29
HO'
21,80%, 5Z;E=93:7
Several groups have employed Mazur's discovery to achieve the synthesis of vitamin D 
systems via the coupling of appropriate bicyclo[3.1.0]hexane A-ring precursors to CD-ring 
fragments*^’^ .^ Wilson has devised a particularly useful vitamin D synthesis which utilises the 
solvolytic rearrangement of vinylogons cyclopropane 194^ ® (Scheme 30): the latter behaves 
similarly to Mazur's system, the solvolysis presumably involving an identical allyl cation 
intermediate. Condensation of a lithium derivative of a bicyclo[3.1.0]hexane A-ring alkyne 
with a Grundmann's ketone analogue yielded the propargylic alcohol 193. Reduction with 
lithium aluminium hydride modified by sodium methoxide gave the requisite trans allylic 
carbinol 194 as a single isomer. An extremely efficient acid catalysed hydrolysis then 
generated the and double bonds with solely the natural stereochemistry and 
concomitantly removed the two silylether protecting groups to yield calcitriol (166) directly in 
64% yield.
OTMS OTMS OH
HO UAIH4 , NaOMe HO cat. p-TsOH
dioxane-H20 (1:1) 
64%
HO'"
89%
OTBSOTBS
OH
193
Schem e 30
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4. Partial Synthesis o f Vitamin D
Construction of the conjugated triene segment of vitamin D has provided major stimulus to the 
development of many connective olefination processes. Indeed, application of the classical 
Julia reaction to the synthesis of vitamin D4 by Lythgoe and Kocienski^^ was key to its 
development and popularisation as a powerful synthetic tool. To draw a fitting historical 
parallel between classical and one-pot Julia olefination variants, we desired to apply the latter to 
the vitamin D problem in an analogous fashion to Lythgoe (see Scheme 25, Chapter 3). Rather 
than produce yet another total synthesis, we focused our studies towards formation of the 
crucial 7,8-olefinic bond. Not only would this work extend our knowledge of the applicability 
of the new Julia variant but it would also provide a further method for the synthesis of a very 
valuable class of natural products.
4.1. Retrosynthetic analysis
The 7,8-double bond of vitamin D (197, R = R%, R3 or R4, see Scheme 22, Chapter 3) is 
potentially accessible via two Julia olefination strategies: (I) a metallated A-ring sulfone 196 is 
condensed with a CD-ring ketone 195 or, (II) a metallated CD-ring sulfone 199 is condensed 
with the A-ring aldehyde 198 (Scheme 31). Advanced starting materials for the speedy 
construction of such precursor compounds are readily available from the appropriate vitamin 
via degradation protocols {vide infra). A priori from the earlier discussions of stereocontrol in 
the one-pot Julia olefination (see Chapters 1 and 2) one would anticipate that the latter approach 
(II) employing Het = BT should be the most successful coupling protocol for securing the 
trans alkene geometry.
195
TBSO"
196
CHO
HO'' TBSO""
198
H
HetS02
199
Schem e 31
4.2. Approach I: A-ring nucleophile, CD-ring electrophile
A simple degradation sequence for vitamin D3 developed by Okamura^^ provided A-ring 
alcohol 200. Mitsunobu thioetherification of 200 with 2-mercaptobenzothiazole (BTSH) 
under standard conditions provided the heterocyclic sulfide 201 in excellent yield (Scheme 
32). Treatment of the thioether with hydrogen peroxide in the presence of an ammonium
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SBTOH BTSH, DIAD, PPha
THF, rt, 12h  
89% TBSO'"TBSO'"
201200
SO2BT
TBSO'"
202 , 21%
+
TBSO"'
204, 13%
(N H 4)6M 07024, H2O 2
Eton, 0°C rt, 6  h
TBSO'
203, 54%, dr =1:1
Schem e 32
molybdate catalyst resulted in only 21% of the requisite sulfone 202 together with significant 
quantities of the rearranged sulfoxide 203 and corresponding sulfone 204. Evidently the 
initially formed sulfoxide 205 undergoes two consecutive [2,3]-sigmatropic rearrangements 
resulting in the thermodynamically favoured double bond topology (see Scheme 33).
All initial coupling experiments were singularly unsuccessful: treatment of sulfone 202 with 
sodium hexamethyldisilazide (NaHMDS) in THF at -78°C followed by the subsequent addition 
of Grundmann's ketone (19) failed to yield any vitamin product. Rather, only decomposition 
of the sulfone and épimérisation of the ketone was observed^^. Faced with such dual jeopardy, 
approach I was abandoned in hope of better fortune with the reversed strategy.
[2.3] [2,3]
205 206 203
Schem e 33
4.3. Approach II; A-ring electrophile, CD-ring nucleophile
All attempts to substitute the hindered axial hydroxyl group of the CD-ring alcohol 213 (also 
obtained via Okamura's procedure^^) with BTSH using a standard Mitsunobu reaction failed 
(Scheme 35). Starting material was recovered together with 18% of an elimination product. 
Reasoning that the less sterically encumbered a-alcohol 210 would make a better substrate for 
the Mitsunobu reaction, we sought an efficient means for its preparation from Grundmann's 
ketone (19) (existing routes to the seldom reported a-alcohol are circuitous^^’^ "^ ). Metal hydride 
type reductions of Grundmann's ketone are well known to occur from the unhindered cc-face 
and return only the axial alcohol 213^^’^ .^ However, conventional Bouveault-Blanc reduction^^ 
of the bicyclic carbinone should, in theory, return the desired alcohol (see Scheme 34). Initial
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electron transfer to Grundmann's ketone (19) followed by proton abstraction would yield ketyl 
208. The expected equatorial preference for the hydroxyl group of the ketyl is reinforced by 
stereoelectronic effects of the surrounding carbocyclic framework. Rehybridisation of the 
SOMO occurs, mixing s and p orbitals appropriately so as to obtain maximum orbital 
stabilisation. The radical centre is thus partially pyramidalised with orbital extension to the j3- 
face ensuring maximal hyperconjugative stabilisation from the adjacent axial methyl 
substituent. Overlap between cTc-c and the carbon radical is more effective than between the 
SOMO and any appropriately positioned cTc-h orbitals^^. Subsequent electron/proton transfer to 
the /Tface then yields the desired a-alcohol 210.
Schem e 34
hyperconjugative
Na / EtOH
+e"
+H'
stabilisation
c-c
SOMO
HO H
+e"
207
+H+
208 209 210
In practice significant épimérisation of the sensitive ketone occurred under the inherently basic 
reaction conditions. Gratifyingly, when the reduction was carried out in the presence of dried 
Amberlite® IR118 acidic exchange resin, the pure a-alcohol 210 was obtained in nearly 
quantitative yield. Table 7 illustrates the product distributions of two such Bouveault-Blanc 
reductions, one conducted with, and one without, the benefit of the buffering acidic resin; both 
were quenched at approximately their half-way stage. The effect of the resin is quite remarkable 
and its compatibility with metallic sodium is noteworthy. Alternative grades of acidic resin 
investigated proved ineffectual in preventing ketone épimérisation.
Na (15 eq)
Et20:Et0H 
(5:1), 0°C HO HO
210 211 19 212
no additive 2 2 %
Amberlite® IR118 >38%
16%
<1%
4%
• 54%
38%
<2%
Table 7
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"H" "
Amberlite® IR 118 
Na (11 eq)
Et20-EtOH, 0°C, 2.5 h 
96% HO
213 19 210
HetSH, DIAD, PPha 
THF, 0 °C->rt, 12h
m-CPBA, NaHCOa
HetS
214
H
HetS02
217, Het = BT, 95%
218, Het = PT, 81%
CH2 CI2 , A, 15 h
HetS
215, Het = BT, 6 8 %
216, Het = PT,71%
Schem e 35
As predicted Mitsunobu reaction of the product equatorial alcohol 210 with BTSH occurred in 
good yield to afford the corresponding /3-thioether 215 and subsequent oxidation with m- 
CPBA provided the requisite sulfone 217. Related 1-phenyl-l//-tetrazol-5-yl (PT) compounds 
216 and 218 were similarly prepared.
Initial attempts to link sulfone 217 and aldehyde 198 (prepared from 200 by Dess-Martin 
oxidation, vide infra) under Julia's standard Barbier conditions^ employing a variety of bases 
(LDA, LiHMDS, NaHMDS, KHMDS) gave no coupling products whatsoever. Similarly, pre- 
metallation of the sulfone with LDA, LiHMDS or KHMDS followed by addition of the
H
HetS02
R3  (a) NaHMDS (1.1 eq) 
(b) additive (1.15 eq)
«=>(1.5eq)
217, Het = BT
218,Het = PT
TBSO'
+ E H 
HetS02
OTBS
221, Het = BT
222, Het = PT
198 219 2 2 0 Table 8
entry Het solvent temp.
e c )
additive %yield®
(219+220)
E:Z^
(219:220)
%yield^
a-sulfone
1 BT THF -60 none 38 67:33 42
2 BT Et2 0 -60 none 25 83:17 54
3 BT PhMe —60 none 28 80:20 45
4 BT Et2 0 -78 MgBr2 *OEt2 52 73:27 26
5 PT Et2 0 -78 MgBr2 *OEt2 54 45:55 . . . c
6 PT THF -78 MgBr2 *OEt2 42 35:65 ...C
‘isolated yield after column chromatography.  ^ determined by NMR analysis. not determined
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aldehyde failed to return any of the desired triene. However, a pre-metallation protocol using 
NaHMDS in THF (Table 8, entry 1) gave a 38% yield of vitamin D3 adducts 219 and 220 
(1E:Z = 2:1) together with 42% of the epimerised sulfone 221 Varying the solvent had a 
beneficial effect on stereoselectivity: in Et20 or toluene the E:Z ratio improved to 5:1 (entries 2 
and 3) but at the expense of a decrease in yield. Transmetallation of the sodiated sulfone to the 
magnesium derivative increased the yield of the coupling adducts (entry 4). As may be 
predicted from our earlier methodology results (Chapter 2), use of the PT sulfone 218 was not 
advantageous for the synthesis of a conjugated trans olefin (entries 5 and 6). However, the 
predominance of the (5Z,7Z)-vitamin D system here is of some interest; analogues of vitamin D 
with such a configuration have seldom been reported in the literature nor has their biological 
activity been examined. The parent systems (7Z)-vitamin D2 and (7Z)-vitamin D3 have never 
been reported.
Further attempts to improve on the modest yields achieved above led us to re-investigate our 
protocol for the production of the unstable aldehyde 198. Variations in the quality of the labile 
carbonyl compound were found ultimately to lie with Okamura's vitamin D degradation 
procedure^* (Scheme 36). Following regioselective dihydroxylation of vitamin D3 and 
subsequent protection of the C3 hydroxyl group, the diol 223 is oxidatively cleaved by the 
action of lead tetraacetate. Due to instability of the resulting dienal 198, the mixture of the 
aldehyde and Grundmann's ketone (19) is immediately reduced in situ to yield the carbinol 
200 and axial CD-ring alcohol 213. However, in our hands the action of Red-Al on 198 
resulted in a degree of over reduction to the enol 224; a compound virtually inseparable from 
200 by chromatography and indistinguishable from it by simple TLC analysis. In certain
CHO
"OH +
PhH, rt
TBSO""
198 19
TBSO''
223
variable (5-30%)
CHO
OH OH
DMP
TBSO"" TBSO"" TBSO"’ HO
225 224 200 213
Schem e 36
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instances the aldehyde 198 used in our Julia coupling studies was contaminated by the enal 
225 derived from concomitant oxidation of 224 and 200. Aldehyde 225 does not appear to 
act as an electrophile since no coupling adducts incorporating the appropriate A-ring motif were 
ever observed. However, due to its presumably high enol content, it may act as a ready proton 
source thence reducing yields.
We sought an improved degradation procedure which could consistently furnish pure dienol 
200 and so aid our preparation of aldehyde 198. At this juncture we were forced to turn our 
attention to vitamin D2 due to a regrettable supply problem with vitamin D3. Degradation 
studies commenced from the known vitamin D2 triol 226^^ (Scheme 37): following silyl 
protection at 03, the vicinal diol was oxidatively cleaved as before by lead tetraacetate. A Luche 
reduction^* then secured pure A-ring dienol 200 in excellent yield and returned the Windaus- 
Grundmann C19 ketone 228 relatively unscathed. No trace of the enol 224 was found and 
13% of the appropriate CD-ring j8-alcohol was also recovered. The new degradation sequence 
was ideally suited to our needs, yielding the stable A-ring dienal precursor 200 and the 
requisite ketone for our modified Bouveault-Blanc reduction.
(a) Pb(OAc)4 , pyridine (3 eq) 
CH2 CI2 , 0°CHO' I H 
OH
226, R = H
227, R = TBS
(b) CeCl3*7H20, NaBH4
MeOH, 0°C TBSO'’
2 0 0 , 81% 228, 83%
TBSCI, DMAP 
imidazole 
CH2 CI2 , rt, 89%
Schem e 37 TBSO''
DMP, CH2 CI2  
rt, 30 min, 89%
TBSO'
after reaction 
at equilibrium
The instability of aldehyde 198 necessitated its rapid preparation and dispensation, thus slow 
chromatographic purification was avoided. As such it was of paramount importance that the 
precursor 200 was of a high purity and that the oxidation method employed was both fast and 
clean. Oxidation by Dess-Martin periodinane^^ (DMP) suited our needs perfectly (Scheme 37). 
It should be noted that dienal 198 exists in dynamic equilibrium with its cyclic tautomer 229; 
complete separation of these components is impossible (due to subsequent interconversion) and 
pointless, the 277-pyran merely acts as a latent aldehyde equivalent.
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Finally, the vitamin D2 CD-ring sulfone 230 was synthesised from 228 in analogy with the 
corresponding vitamin D3 fragments 217 and 218 (see Experimental Section for details). 
Adopting the previously optimised reaction conditions, metallation of the sulfone 230 with 
NaHMDS in Et20 was followed by addition of the freshly prepared 'aldehyde' 198 (Scheme 
38). Subsequent deprotection yielded 70% (2 steps) of the separable vitamin D2 isomers, 163 
(natural) and 231 (unnatural), with moderate stereoselectivity {1E:Z = 72:28). Our synthetic 
vitamin D2 exhibited identical physical and spectroscopic characteristics to those previously 
reported^°°'^°^. The unnatural isomer 231 exhibited only limited stability and its 
stereochemistry was assigned by comparison of NMR data with that reported for other (7Z)- 
vitamin D derivatives^"^’
(a) NaHMDS, Et2 0  
-78°C, 1 h
230
Schem e 38
%  O ^ C H O
-100°C rt, 0/N  
(0) TBAF-3H20 
THF, rt, O/N
HO"
70% 
E:Z= 72:28
232, 18%
vitamin D2  (163) (72)-vitamin D2  (231)
After the initial coupling event some epimeric a-sulfone 232 was recovered as before (c/221, 
Table 8); the isomer arose from configurational instability of the metallated jS-sulfone 230. 
Treatment of 230 with NaHMDS in Et20 at -78°C followed by subsequent low temperature 
protonolysis (MeOH) yielded 92% of the epimeric sulfones 230 and 232 in the ratio 15:85 
respectively.
Curiously, conducting the vitamin D2 coupling experiment via the intermediacy of the 
magnesiated derivative of 230 (formed by transmetallation of the sodium metallate with 
MgBr2*OEt2) gave only 63% of TBS protected vitamin D2 isomers in the ratio 1E:Z = 69:31. 
The higher yields associated with the use of MgBr2*OEt2 previously for the vitamin D3 series 
(Table 8, entries 4 to 6) were in cases where the contaminating enal 225 was present.
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5. The Herbicîdal Polyketide Herboxidiene
In 1992 the Monsanto company reported the isolation of a secondary metabolite produced by a 
fermentation broth of Streptomyces sp. A7847 (ATCC 49982)^®" .^ The agent exhibited 
exceptional phytotoxicity towards several broadleaf annual weed species: oilseed rape {Brassica 
napus), wild buckwheat {Polygonum convolvulus), morning glory {Ipomoea sp.) and hemp 
sesbania {Sesbania exaltata) all had their growth inhibited by >90% when treated with 35 g 
acre-1 of the metabolite. Indeed, good inhibition (75%) was retained at a dosing of just 7 g 
acre-1. More importantly, when the above weed species were co-planted with wheat {Triticum 
aestivum), the agent was able to selectively control growth of the pest plants whilst exhibiting 
no phytotoxicity toward the cash crop.
Extensive NMR studies by the Monsanto group enabled 
elucidation of the gross structure of the active compound. Named 
herboxidiene (233) to reflect its biological activity and structural 
features, the agent was an essentially linear polyketide possessing 
epoxide and tetrahydropyran ring systems linked by a conjugated 
diene s e g m e n t ^ A t  the conclusion of these studies the absolute 
stereochemistry and the relative configuration at C12 and C16- 
C18 remained ambiguous.
herboxidiene (233)
Some synthetic modifications of herboxidiene were undertaken to determine if the structure 
could be simplified whilst phytotoxic properties were retained^^. Derivatives which decreased 
the polarity, such as the Cl methyl ester and the 018 acetylated adduct were slightly more 
active. Interestingly, if the C l carboxyl group was reduced to a primary alcohol, activity was 
also retained indicating the relative unimportance of an acid group masked or otherwise. 
However, the presence of the epoxide moiety was essential for biological activity as was the 
presence of the C18 hydroxyl function at that oxidation level (the C18 ketone was completely 
inactive). The latter two structural features also account for the inherent instability of 
herboxidiene under both acidic and basic conditions (Scheme 39). Unfortunately, any 
significant skeletal simplifications resulted in compounds devoid of all herbicidal activity.
MeO OH . , . ^  MeO H
pg, (a) AcgO, pyridine V - o  ^ NaOMe
MeO
15 i
OH
OAO ' ' ' 1 1 MeO
234 Schem e 39 233 235
At this juncture Kocienski's Southampton group"^  ^ and the Banwell group in Canberra^® '^^^  ^
both instigated independent synthetic studies toward certain arbitrary herboxidiene
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diastereoisomers. Of course with the relative configuration of four stereogenic centres and the 
absolute stereochemistry yet to be determined there was only a slim chance that either group 
would target the true structure first time around. This has subsequently been borne out, neither 
camp sighted compounds of the correct natural configuration (vide infra).
5.1. Kocienski's total synthesis of (+)-herboxidiene A
In 1996 Kocienski reported the total synthesis of (+)-herboxidiene (236), a notional target 
chosen to best demonstrate certain synthetic methodologies, among them the original BT 
variant of the one-pot Julia olefination^'^ and the Hoppe homoaldol reaction^^*'^^®. Comparison 
of iR and NMR data for the synthetic material 236 with the previously published data for 
natural herboxidiene^^, revealed several discrepancies suggesting the two were diastereomeric.
Scheme 40 outlines the original basic retrosynthetic analysis: the BT mediated Julia olefination 
is used to conjoin two late stage intermediates, sulfone 237 and the aldehyde 238, forming the 
ClO-Cl 1 double bond stereoselectively. The validity of such an approach had been previously 
demonstrated both in Julia's methodology work^ and Kocienski's rapamycin studies Each 
of the fragments can in turn be derived from the vinyl carbamate 239 since, by design, they 
share the same relative and absolute configurations.
CO2H
MeO H
OH : 
(+)-herboxidiene A (236)
SO2BT
MeO
TBSO
Schem e 40237
CHO
238
OH
TBSO
239
O y O
N(/-Pr)2
CO2 AII OH 
240
Synthesis of the pivotal intermediate 239 commenced with the E-crotyl carbamate 241: 
metallation with butyl lithium in the presence (-)-sparteine resulted in the precipitation of a 
single diastereomeric complex via a dynamic resolution process. Transmetallation with 
Ti(/-PrO)4 proceeded with inversion of c on f igu ra t i on an d  was followed by reaction with 
aldehyde 244 to yield the vinyl carbamate 239 with good stereocontrol (see Scheme 41). After
58
méthylation of the C l7 hydroxyl, elaboration toward 237 continued with stereoselective 
synthesis of the requisite trisubtituted olefin via a 1,2-metallate rearrangement sequence^ 
Addition of vinyl stannane 246 to a 1:1 mixture of cuprate 247 and its alkyl lithium precursor 
resulted in transmetallation to a putative higher-order mixed cuprate. Upon slow warming a 
1,2-metallate rearrangement occurred, the resultant lower-order vinyl cuprate was then 
alkylated with methyl iodide to afford olefin 248 together with 12% of the terminal acetylene 
resulting from Fritsch Buttenburg Wiechell (FEW) r e a r r a n g e m e n t ^ o f  the lithiated enol 
carbamate. Standard synthetic steps then yielded the sulfone 237.
N(APr)p
CHO 
ÔTBS
V "  244
TBSO 0 ^ 0
239, R = R' = H N(/-Pr)2
r  .........  I i v i  —  ■ I l ^ i i  ■
® I— ► 243. M   Tif/-PrOU ^ '— ►
A I , IVI -  M D I
242, M= — Li'sparteine 245, R = Me, R' = H
, ( )3 ’  246, R = Me, R' = SnMeg
" G \~ ~
TESO^ ^  ICuLi F OMe ^  249, R = OH
248, R = OTES
^ 250, R = SBT
247 TBSO I * I— ► 237, R = SO2 BT
Schem e 41. Reagents and conditions:
A i  BuLi, (-)-sparteine, cyclohexane-pentane, 80°C, 3 h
B i  Ti(APrO)4 , pentane,-80°C, 20 min
0  63% 244, -80°C rt, 2.5 h, dr {anti) = 7:1
D 70% 4-Me-2,6-dl-f-Bu-pyrldine, MeOTf, PhMe, 70°C, 10 h
E 95% (a) f-BuLI, THF, -85°G, 50 min; (b) MeaSnCI, -85°C rt, 80 min
F 64% (a) 246, Et2 0 -pentane, -35°C 0°C; (b) Mel, HMPA-THF, -20°C, E Z =  88:12
G 93% HF*pyridine, pyridine-THF, 0°C -> rt, 1 h
H 94% BTSH, PhgP, DEAD, THF, rt, 30 min
1 84% Mo(VI), H2 O2 , Et0 H-H2 0 , 0°C -> rt, 24 h
Synthesis of the dienal fragment 238 began with PMB protection of the C l hydroxyl of 239 
followed by a synthetically useful FEW rearrangement of the derived lithiated enol carbamate 
to yield alkyne 252 (see Scheme 42). Homologation of the terminal acetylene with methyl 
chloroformate followed by hydrogenation and DIEAL-H reduction afforded the masked 
dihydroxy aldehyde 255. A Homer-Wadsworth-Emmons olefination of the aldehyde followed 
by selective deprotection of the C l hydroxyl yielded the trans 5-hydroxyenoate 257, a suitable 
cyclisation precursor to the tetrahydropyran ring system. Intramolecular conjugate addition of 
the tethered 0 -nucleophile to the proximal a,/?-unsaturated ester resulted in selective formation 
of the thermodynamically most stable cis oxane 258 (all substituents equatorial). The authors 
claim tetrahydropyran 258 is both the thermodynamic and kinetic product of the cyclisation"^ .^
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However, investigations from BanwelP^^ and our own results here {vide infra) suggest that the
trans oxane is actually the kinetic product. Following silyl ether deprotection the heterocyclic
hydroxy ester 240 was elaborated to the completed dienal 238 in four standard steps.
O
OR
B
TBSO 0 ^ 0
239, R = H N(APr) 2  
251, R = PMB[%
MeOC
PMBO
PMBOOTBS
OTBS
252 253
D
R
PMBO'
OTBS
254, R = COgMe
255, R = CHO
H
^ R O '
CO2 AII OTBS 
256, R = PMB
257, R = H
CO2 AII OR 
258, R = TBSc:240, R = H
M
259
CO2 AII
CHO
238
Schem e 42. Reagents and conditions:
A 6 6 % PMB0-C(=NH)-CCl3, TMSOTf, Et20 
B 81% f-BuLi, Et2 0 ,-20°C
C 95% (a) BuLi, THF, -80°C; (b) CIC0 2 Me
D 84% H2  (1 atm), Pd/C, EtOAc, rt
E 85% DIBAL-H, CH2 CI2 , -80°C
F 96% (Et0 )2 P(=0 )CH2 C0 2 AII, NaH, THF
G 93% DDQ, CH2 CI2 -H2 O, rt
CO2R
260, R = t-Bu
261, R = H
H 99% f-BuOK, THF, -65°C
I 84% TBAF, 4Â MS, THF, rt
J 89% PCC, 4Â MS, CH2 CI2 , rt
K 81% (Et0 )2 P(=0 )CH2 C0 2 B^u, NaH, THF 
L 96% TFA, PhSMe, CH2 CI2
M — (a) [Me2 N=CHCI]CI, THF-MeCN;
78% (b) LiAIH(0 teu) 3
The synthetic studies were completed as shown in Scheme 43. The one-pot Julia olefination 
performed admirably in its role, linking together the advanced intermediates 237 and 238 via a 
standard premetallation protocol; the (E,E)-diene 262 was obtained in 65% yield together with 
a further 6% of a 1:1 mixture of two isomeric dienes. Following TBS-deprotection the 
bishomoallyic C l8 hydroxy of triene 263 served to direct the epoxidation of the C14-C15 
trisubstituted olefin. Although a single diastereoisomeric epoxide was obtained and a model 
presented to account for the illustrated facial selectivity, no direct proof of stereochemistry was 
obtained. Following allyl ester deprotection, herboxidiene A (236) was obtained in twenty 
linear steps from (5)-ethyl lactate. As already noted, comparison of NMR data revealed that 
herboxidiene A was a diastereoisomer of the natural product.
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MeO
TBSO
MeO
OR237
262, R = TBS
263, R = H
Schem e 43. Reagents and conditions:
A — (a) LDA, THF,-80°C; 0  52%
65% (b) aldehyde 2 3 8 ,-8 0 °C -> rt D 67%
B 77% HF*pyridine, THF-pyrldine, rt
MeO
OH
264, R = All 
236, R = H
V0 (acac)2 , TBHP, CH2 CI2 , 0°C 
Pd(PPh3 )4 , morpholine, THF, rt
5.2. Banwell's synthetic studies towards the herboxidiene skeleton
In common with Kocienski's work, Banwell chose a strategy involving late stage connective 
olefination of two major fragments followed by hydroxyl directed epoxidation and final 
deprotection. The two fragments the Canberra group have synthesised to date, phosphine oxide 
265 and aldehyde 269, are illustrated in Scheme 44. A Homer-Wittig reaction has been 
selected to forge the ClO-Cl 1 double bond, model studies have already illustrated the validity 
of such an approach.
C02Me
M©02C
PPh2
C02Me OH 
266
OAc
MeO
TBSO
269
Schem e 44
MeO O
OH
268
TBSO
For the synthesis of the Cl 1-C l9 aldehyde fragment 269, a rather ambitious strategy was 
adopted^®^. All four of the contiguous stereogenic centres in the Claisen rearrangement 
precursor 270 were to be derived directly from commercially available methyl (/?)-3-hydroxy- 
2-methylpropionate (271) via stereocontrolled nucleophilic addition to chiral aldehydes (1,2- 
asymmetric induction). Scheme 45 illustrates the execution of the plan; the somewhat laborious 
route toward 270 was not without its pitfalls. The first addition, to aldehyde 273, was
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RO
OR OBn
271, R = H, R' = C02Me
272, R = Bn, R' = COaMe
273, R = Bn, R‘ = CHO
274, R = H, X = CHz
275, R = Me, X = CH2
276, R = Me, X = O
277, R = H, R' = Bn
278, R = TBS, R' = Bn
279, R = TBS, R' = H 
O
MeO
TBSO
270
TBSO N [ Z
282, R = CO2 H
283, R = CH2 OH 
269, R = CHO
Schem e 45. Reagents and conditions:
A 73% BnOC(=NH)CCl3 , TfOH, CH2 CI2 , rt 1 -- (a) (COCI)2 , DMSO, CH2 CI2 , -60°C;
B -- (a) UAIH4 , Et2 0 , 0 °C; (b) (COCI)2 , 98% (b) EtaN, -eO°C
6 8 % DMSO, CH2 CI2 , -60°C: (c) EtaN, -60°C J 83% [H2 C=C(Me)]2 CuLI, Et2 0 , -78°C, dr >95:5
C 70% H2 C=CHMgBr, THF, -78°C, dr= 1:1 K 82% (EtC0 )2 0 , DMAP, pyridine, rt
D 94% Mel, KH, THF, 0°C rt L -- (a) KHMDS, HMPA-THF, -78°C;
E 92% (a) O3 , CH2 CI2 , -78°C; (b) PhaP 80% (b) TMSCI, EtaN; (c) 45°C, dr > 95:5
F 96% MeMgCI, THF, -78°C, dr = 4:1 M 83% LIAIH4 , Et2 0 , 0°C
G 93% TBSCI, Imidazole, DMF, 60°C N -- (a) (COCI)2 . DMSO, CH2 CI2 , -60°C;
H 77% H2  (1 atm), Pd/C, EtOH 94% (b) EtaN, -60°C
completely non-diastereoselective and yielded only 70% of the product allylic alcohols. 
Subsequent additions fared better: reaction of méthylmagnésium chloride with aldehyde 276 
yielded 96% of masked triol 277 with a 4:1 diastereoselectivity. The addition of wopropenyl 
cuprate to aldehyde 280 was most successful, yielding alcohol 281 as a single isomer in 83% 
yield. An X-ray structure of the derived silyl-deprotected crystalline diol confirmed relative 
stereochemistry at this stage. The Ireland-Claisen rearrangement^ of the Z-silyl ketene acetal 
derived from 270 occurred without incident and furnished the E-trisubstituted olefin 282 and 
thence the aldehyde 269 by standard steps.
In contrast to the lengthy route to the Cl 1-C19 fragment, Banwell's route to the oxane portion 
of herboxidiene, 265, was succinct (Scheme 46)^ (^ ^T07 Commencing with nerol (268),
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Sharpless asymmetric epoxidation^ afforded the epoxy alcohol 284 in good yield but with 
poor enantioselectivity (50% ee). Regioselective reduction of the epoxide with NaCNBHg / 
Bp3*OEt2 followed by acétylation yielded diacetate 286. Ozonolytic cleavage of the olefin 
extremity to give aldehyde 287 was followed by a Still-Gennari^^ modified HWE reaction to 
yield the Z-enoate 267.
OH
268
OH
284
B OR
285, R = H
286, R = Ac
O OAc OAc
OAc ,OAc
CO2M©
287 267
C02Me OH 
266
Schem e
A 76%
B 73%
C 96%
D 97%
E 78%
F 8 8 %
 46. Reagents and conditions:
(-)-DET, Ti(APrO)4 , TBHP, CH2 CI2 , -20°C, er = 75:25 
NaCNBHg, Bp3 »OEt2  
AC2 O, DMAP, pyridine, rt 
(a) O3 , CH2 CI2 , -60°C; (b) Ph3 P, -30°C-4 rt
(CF3 CH2 0 )2 P(=0 )CH2 C0 2 Me, 18-crown-6«MeCN, KHMDS, THF, -78°C
(a) K2 CO3 , MeOH, rt; (b) H2 SO4 , MeOH
Model studies by Banwell and co-workers have shown that under non-equilibrating conditions 
the stereochemistry of tetrahydropyrans formed via the intramolecular Michael addition of O- 
nucleophiles to tethered acrylates is governed by the geometry of the enoate^^^ (see Scheme 
47). Thus, Z-enoates 288 yield cis oxanes 290 selectively due to the proposed intermediacy of 
the chair-like transition state 289 in which tight chelation of the participating metal ion to both 
the carbinol and ester oxygen atoms is possible. Reaction of the E-enoate 291 is suggested to 
proceed via the boat-like transition state 292 leading to trans oxanes 293 with only moderate 
selectivity. Metal binding in 292 may be looser than in 289 and stereochemical leakage via an 
alternative chair-like transition state is proposed to account for the poorer control. A change in 
the alkali metal base counter cation (Li, Na and K) had little effect on these findings. As 
predicted by Banwell's model, cyclisation of Z-enoate 267 by treatment with excess potassium 
carbonate in methanol afforded cis oxane 266 as a single detectable diastereoisomer. 
Saponification of all the ester groups occurred under the reaction conditions and the product 
carboxylic acid was immediately re-esterified.
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Me02C.
MH (M = Li, Na, K)
OH
THF, -78°C ^  rt
288
Schem e 47
Me
289
OMe
Me02Cv
290, 98%, dr = 97:3 
(M = Na)
,C02Me 
I  MH (M = Li, Na, K)
r  OHI T THF, -78°C ^  rt
291
OMe
M©Me
292
Me02C.
a
293,98%, dr = 3:1 
(M = Na)
Completion of the synthesis of phosphine oxide 265 and the attachment of a model side-chain 
are depicted in Scheme 48. Clumsy elaboration of the alcohol 266 afforded the ketoester 296, 
a known degradation product of herboxidiene^®' ,^ produced via ozonolysis of its methyl ester. 
Comparison of the sign of optical rotation for the synthetic material with the degraded 
material^*® revealed a match thus confirming the absolute stereochemical assignment of the 
tetrahydropyran sub-unit of herboxidiene.
266
CO2MG
294, R = CHO
295, R = CH(0H)CH3
296, R = C(=0)CH3
OH
297
GO2M6
298, R = Br
265, R = P(=0)Ph2
Schem e 48. Reagents and conditions:
G
C02Me
299
A 51% PCC, NaOAc, CH2 CI2 , rt
B 77% MeMgCI, THF, -60°C 0°C
0 51% PCC, NaOAc, CH2 CI2 , rt
D 37% H2 C=CHMgBr, THF, -78°C 0°C
E 91% PBr3 , Et20, 0°C
F 84% Ph2 POEt, THF, A
G -- (a) nonanai, NaH, THF, 45°C;
94% (b) H2 SO4 , MeOH, rt, E;Z= 85:15
Addition of a vinyl Grignard reagent to ketone 296 yielded 37% of isomeric alcohols 297 
together with a significant quantity of vinyl ketone adducts (31%), the result of nucleophilic 
addition to both the ketone and ester moieties present in 296. Treatment of 297 with PBrg 
yielded the geometrically pure rearranged E-allylic bromide 298; a standard Michaelis-Arbuzov 
reaction then gave the desired second fragment, phosphine oxide 265, as a crystalline solid.
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To ascertain the selectivity of the projected Homer-Wittig olefination, nonanai was selected as a 
simplified model for fragment 269. Under the illustrated conditions, olefination with 
phosphine oxide 265 resulted in concomitant ester hydrolysis. The product mixture was re- 
esterified to aid purification and yielded the herboxidiene model compound 299 in 94% yield 
(from 265) with E:Z =85:15 about the newly formed olefin. The above summary concludes 
Banwell's published studies on herboxidiene to date.
5.3. Determ ination of the absolute configuration of herboxidiene 
degradation and synthetic studies
To aid synthetic chemistry programs towards herboxidiene, a Swiss 
group in collaboration with the late Professor Oppolzer, set out to 
elucidate the absolute configuration of the natural product via 
unambiguous independent asymmetric synthesis of certain 
degradation fragments**^. Their efforts were facilitated by an X-ray 
analysis of crystals of herboxidiene which yielded the complete 
relative stereochemist ryUlt imately,  the Swiss study not only 
succeeded in determining the stmcture of herboxidiene as 233, but 
also provided a wealth of information concerning its stability under a 
variety of conditions.
by
OH
herboxidiene (233)
Ozonolysis of herboxidiene afforded the acid 300 (subsequently esterified to ease purification) 
and the unstable aldehyde 301 (Scheme 49). The latter compound was immediately reduced to 
yield an alcohol which spontaneously cyclised to the tetrahydrofuran 302. Fragment 302 was 
regarded as useless for the preparation of semi-synthetic derivatives and so a new degradation 
procedure was developed (see Scheme 50).
233
(a) O3 , CH2 CI2 , -78°C
(b) Me2 S, -78°C rt
300, R = H, 78%- 
296, R = M e - ^  
[ah = -92.5°
HCi, MeOH 
A, 96%
NaBH4
MeOH-THF 
rt, 94%
MeO
Schem e 49 301, 92% 302
Following estérification of herboxidiene, the methyl ester 303 was treated with anhydrous HCI 
to yield the tetrahydrofuran adduct 304. Issac and c o - w o r k e r s r e p o r t e d  the same 
transformation catalysed under basic conditions (c/ Scheme 39). Osmium(VIII)-catalysed 
dihydroxylation of the diene selectively oxidised the less hindered ClO-Cll  olefin to afford 
diol 305 as a mixture of diastereoisomers. Standard oxidative cleavage produced bicyclic lactol
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OH
OH
MeO
MeOMeO
OHOH
305304233, R = H 
303, R = Me
+OH
MeOORMeO
OH
308, 77%309, R = H
310, R = TBDPS
306, R = CHO, 74%
O
18
M e O  17 : 16
311,97% 
[ah  = +29.9°
12 ,
O
OTBDPS
312, 84%
Schem e 50. Reagents and conditions:
A 92% K2 CO3 , (Me0)2S02, DMF, 90°C
B 60% HCI, MeOH, rt
C 94% OSO4 , NMO, acetone-H2 0
D -- Nal0 4 , H2 O-THF, rt
E 97% NaBH4 , THF-MeOH, 0°C
F 8 8 % TBDPSCI, DMAP, imidazole, DMF
G -- PCC, 4Â MS, CH2 CI2 , A
308 and dienal 306. The latter compound is very closely related to the dienal 238 used by 
Kocienski et al in their first total synthesis of the herboxidiene skeleton"^ .^ Both of these 
compounds were subsequently reduced to the corresponding alcohols. Selective mono­
protection of diol 309 was followed by a further oxidative fragmentation: treatment of the 
hydroxy tetrahydrofuran with PCC yielded lactone 311 and ketone 312. At this stage 
tetrahydropyran 296 and the 7-lactone 311 were chosen as targets for independent asymmetric 
synthesis.
The lactone 311 was totally synthesised stereospecifically in short order via the boron 
mediated aldol reaction between (/?)-lactate derived aldehyde 314 and the propionyl saccharin 
based sultam 313 Although the auxiliary and aldehyde comprised a mis-matched pair the all 
syn aldol adduct 315 was obtained with greater than 95% diastereoselectivity. Méthylation was 
followed by silyl ether deprotection with 5% HF which resulted in concomitant lactonisation 
(Scheme 51). Spectroscopic and optical rotation data for the synthetic material matched that 
obtained previously for the herboxidiene degradation fragment.
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O
N
O2S
313
v^CHO TBSÔ
ÔTBS 
314
O
MeO O
315, R = H
316, R = Me
311
[a]o = +29.2=
Schem e 51 . Reagents and conditions:
A — (a) Et2 B0 Tf, /-Pr2 NEt, CH2 CI2 , -5°C; B 98% Me3 0 BF4 , proton sponge®, CH2 CI2 , rt
72% (b) aldehyde 02 , -78°C C 75% 5% HF, MeCN, rt
Synthesis of the oxane degradation fragment 296 was achieved via a very different strategy to 
the similar line adopted by both Kocienski and Banwell (see Schemes 42 and 46 respectively). 
Rather than employ a conjugate addition reaction to form the requisite heterocycle, the Swiss 
group utilised the stereodefined reductive ring opening of a bicyclic ketal to access the 
cis tetrahydropyran (Scheme 52).
Commencing with diastereoselective alkylation of (S')-dimethyl malate 317, standard steps 
yielded the ketodioxolane 324. Intramolecular transacétalisation afforded the bicyclic ketal
OH
MGO2C
317
MGO2C
OR
318, R = H
319, R = THP
H
320, R = THP
321, R = H
O O
F,G
MGO2C
322, R = OH
323, R = I
324
COpMG CO2MG o
^ I 266, R = CH2 OH
^  294, R = CHO
Schem e 52. Reagents and conditions:
296
[«Id = -9 4 . T
A -- (a) LDA, THF, -78°C; H 74% mGthyl acGtoacGtatG, LDA,
6 6 % (b) MgI ,-78°C, dr = 91:9 THF-HMPA, 0°C
B 4 TsOH, DHP, CH2 CI2 , rt 1 87% TsOH, CH2 CI2 , A
0 4 LIA!H4 , Et20, 0°C J 71% EtaSiH, TiCU, CH2 CI2 , -78°C ^ -2 5 °C
D 4 AmbGrlitG IR120, MgOH, rt K (a) (0 0 0 1 )2 , DMSO, OH2 OI2 , -78°0;
E 56% TsOH, Et2 C0 -THF, A 87% (b) EtaN, -7 8 °0  -+ rt
F 87% TsCI, pyridinG, 0°C rt L -- (a) MGMgBr, EtaO, -7 8 °0  ^  -40°0;
G 92% Nal, acGtonG, A 64% (b) OrOa, H2 SO4 , acGtonG, rt
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325; the reduction method of Kotsuki^^* then gave the cis oxane 266 as a single 
diastereoisomer. Final transformation to the degradation fragment 296 was then achieved in 
three steps reminiscent of Banwell's end-game (see Scheme 48). Again it was found that the 
synthetic and degraded fragments had identical spectroscopic and optical rotational properties.
The studies presented above conclusively prove the absolute stereochemistry of herboxidiene 
as: 3R, 6S, IS, 12S, 14R, 15R, 16R, HR, 18/?.
Recent reports suggest that the biology of herboxidiene is not restricted to mere herbicidal 
activity. The polyketide has been found to up-regulate the gene expression of low density 
lipoprotein receptors^^^ and also block the cell-cycle at the G2 phase in human tumour cells^^ .^ 
Such findings taken together with the now definite structural assignment further validate new 
synthetic endeavours towards herboxidiene.
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6. Total Synthesis of Herboxidiene
To fully assess the scope of any new methodology, it must be applied in ever more complex 
situations. Herein we present the first total synthesis of herboxidiene (233), a particularly valid 
target molecule (see Chapter 5), and an excellent vehicle for demonstrating the utility of the 
one-pot Julia olefination to solve demanding synthetic problems.
6.1. Retrosynthetic analysis
Our initial synthetic plan to construct herboxidiene is laid bare below (Scheme 53). A one year 
time constraint for the synthesis necessitated a fairly conservative approach which built in part 
on the previous Kocienski group synthesis of herboxidiene and also borrowed ideas from 
Banwell^^.
HWEBT Julia ref 46
HO
 ^ CO2H CO2 AII OHCHO
238 326
1319
PT JuliaADHO
CHO
herboxidiene (233)
327 328
SO2 BT
Mao 329MeO
alkylationTBSOPO 330332 333
O
Claisen
[3,31-0
MeO O
MeO
CHO
aldol
TBSO
TBSO
334 335
V
TBSO
244
CHO
331
Schem e 53
In common with the synthesis of herboxidiene A by Smith and Kocienski"*  ^a BT mediated one- 
pot Julia olefination reaction was chosen as a device for advanced fragment linkage to forge the 
lOE double bond. However, here we desired to increase the scope of the coupling and to
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further demonstrate its mildness by employing a sulfone fragment 332 already replete with the 
C14-C15 oxirane ring. Following the alkenation reaction, deprotection of the masked Cl acid 
and C l8 hydroxyl function would then furnish herboxidiene directly. Aldehyde 238 is the 
same coupling partner used previously and so its competency as an electrophile for the Julia 
olefination was not in any doubt. The chemistry already developed to synthesise 238 from 
alcohol 240 was to be taken verbatim from KocienskT^ .^
A linch-pin in the herboxidiene A synthesis was the use of vinyl carbamate 239 as a synthon 
for both Cl 1-C l9 sulfone 237 and dienal 238. However, the stereochemistry inherent in 239 
is not appropriate for direct elaboration to sulfone 332, and now could only be used efficiently 
to make aldehyde 238 via the route previously described (Scheme 42). For this reason, and to 
add originality to our synthesis, a completely new route to 240 was devised. A tandem 
Horner-Wads worth-Emmons (HWE) - conjugate addition sequence was to furnish 240 
directly from hydroxy lactol 326; it was hoped that protection of the C8 hydroxyl would be 
superfluous. Lactol 326 could be derived in turn from the Sharpless asymmetric 
dihydroxylation (AD)^ "^^  of trans olefin 327. Herein lies an excellent opportunity to road-test 
our own PT modification of the one-pot Julia reaction; it was anticipated from earlier precedent 
(see Chapter 2) that condensation of the potassium metallate of PTS02Et (347) with aldehyde 
328 would yield alkene 327 with excellent stereoselectivity. Standard steps commencing with 
the asymmetric alkylation of acyl sultam 331 with homoallyl iodide (330) would yield 328.
For the synthesis of sulfone 332 a fusion of chemical ideas from KocienskT^^, BanwelF®^ and 
Oppolzer^ were harvested. A series of oxidation level changes and standard manipulations of 
acid 333 (a diastereoisomer of Banwell group intermediate 282) would yield 332. A key step 
in the void 333 to 332 would be a C l8 hydroxyl directed epoxidation of the trisubstituted 
olefin (c/Kocienski, Scheme 43, Chapter 5). To gain the necessary stereocontrol an unnatural 
configuration of the C l8 hydroxyl function was implicit {vide infra) obviously requiring 
subsequent correction. Chemistry reminiscent of Banwell's herboxidiene work would be 
adapted to procure acid 333 from aldehyde 335. Here it was anticipated that a [3,3] 
sigmatropic rearrangement of the Z-silyl ketene acetal derived from propionate 334 would 
yield 333 in a predictable manner. Finally, some Oppolzer chemistry would be employed to 
synthesise 335 via a boron-mediated aldol reaction between aldehyde 244 and sultam 331 (a 
common intermediate to both 332 and 238). The aldehyde 244 is itself honed from cheap 
ethyl (5)-lactate"^  ^and comprises a 'matched' pair with sultam 331, thus aldol stereoselectivity 
was expected to be excellent.
6.2. Synthesis of alcohol 240
Our synthesis of the tetrahydropyran 240 experienced its first problems early on. Alkylation of 
(2E)-A-propanoylbomane-10,2-sultam (331) with homoallyl iodide (330) under the standard
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conditions developed by Op p ol ze r ^ p r o v e d  disappointing (Scheme 54). Although 
diastereoselectivity appeared to be good, low yields were a constant problem and the product 
was difficult to separate from the highly crystalline starting material 331. In addition, 
homoallyl iodide is not commercially available and had to be synthesised from the expensive 
chloride via a standard Finkelstein reaction^^ .^
331
(a) NaHMDS, THF 
-78°C, 1 h
(b) ' 330
HMPA, -78°C rt
O
329, 24%
Xq
Mel
337
Schem e 54
Oppolzer has disclosed that homoallyl halides do not react smoothly with acyl sultam 
enolates^^^ despite the fact that other non-activated halides pose no problem. Rather than dwell 
on such a minor set-back we elected to change the sense of the alkylation; employing the 
antipodean auxiliary Xc'H with a 5-hexenoyl substituent (ie acyl sultam 337) and the highly 
reactive methyl iodide as electrophile.
Derivatives of 5-hexenoic acid are not commercially available and so we turned to an interesting 
synthesis of the parent acid (342) developed by Rust^^  ^(Scheme 55). The process relies on the 
oxidation and reduction of free radicals by metal salts. A ketone hydroperoxide (339), formed 
by the action of hydrogen peroxide on cyclohexanone (338), is first reduced by an Fe(U) salt.
HO O-OH
Cu+ 4- H+ + Fe(OHr+
HO O
342
340
Cu2++Fe2++H20
E /V
Fe3++e"^Fe2+ +0.77
Cu2++e“ -+Cu+ +0.16
Schem e 55
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The resulting oxygen centred radical 340 rapidly ring-opens to afford carbon radical 341. 
Oxidation of the latter species by Cu(II) then yields 5-hexenoic acid (342). The Cu(I) and 
Fe(in) salts formed comprise a redox pair and the Fe(II) and Cu(II) species needed to effect the 
overall conversion are regenerated. In practice, optimum yields of 5-hexenoic acid (342) are 
not obtainable when working with catalytic quantities of the metal salts; however, the aqueous 
metal ion solution can be recycled many times.
With a ready source of 5-hexenoic acid to hand good progress was made (Scheme 56). Sultam 
337 was synthesised by standard methodology and alkylation of its lithium Z-enolate with 
methyl iodide suffered from none of the previously encountered set-backs. In common with a 
recent synthesis of Ibuprofen^^^, we found dimethyl propylene urea (DMPU) a sufficiently 
powerful co-solvent to effect the alkylation. Slow addition of the base (BuLi) to 337 
via syringe pump was advantageous; a fast addition lead to some deprotonation a  to the 
sulfone of the chiral auxiliary. The stereoselectivity of 
the alkylation can be easily predicted via the standard 
model presented in Figure 9125,129 ^  six-membered 
lithium chelate between the enolate oxygen atom and 
an auxiliary sulfone oxygen atom locks the 
conformation; approach of the electrophile then occurs 
from the face not shielded by Me*.
«face unhindered
Figure 9
Me approach from j5 face 
343 blocked by Me*
338 342, R = OH 
344, R = Cl 
337, R = Xc'
Xc
345
O
Xc
336
346, R = CH2 OH 
328, R = CHOSchem e 56. Reagents and conditions:
A 37% (a) H2 0 2 (aq), 35°C ^  -5°C, 40 min; (b) CUSO4 , FeS0 4 , H2 S0 4 (aq> 0°C ^  rt, 5 h
B 75% SOCI2 , 80°C, 30 min
C 94% (a) (2S)-bornane-10,2-sultam, NaH, PhMe, rt, 1 h; (b) acid chloride 344, O/N
D 80% (a) BuLi, THF, -80°C, 2  h; (b) Mel, DMPU, -80°C -4 . rt, O/N, dr > 98:2 (recrys.)
E — (a) O3 , MeOH-CH2 Cl2  (1:3), -78°C, 2 h; (b) Me2 S, -78°C -4 rt, O/N;
72% (c) 2,2-dimethylpropane-1,3-diol, pTsOH, PhMe, A (-H2 O), O/N (recrys.)
F 93% LIAIH4 , Et2 0 , rt, O/N
G 96% SOg'pyridine, EtaN, DMSO, rt, 30 min
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The crystalline alkylated product 336 was formed with excellent stereoselectivity. A simple 
recrystallisation yielded analytically pure material with no detectable isomeric contaminants in 
80% yield. Ozonolysis of 336 in MeOH-CH2Cl2 (1:3) yielded a mixture of the corresponding 
aldehyde (minor) and dimethyl acetal (major) after reductive work-up. The mixture was 
immediately taken up in toluene and acetalised/transacetalised to the 1,3-dioxane 345. The 
dioxane protecting acetal was chosen to lend increased weight to olefin 327, an otherwise 
potentially volatile intermediate. 345 was also a solid and again only needed recrystallisation to 
yield pure compound in 72% overall yield from 336. Reductive removal of the chiral auxiliary 
followed by oxidation of the resulting alcohol 346 yielded aldehyde 328 in excellent yield. It 
is worth commenting that alcohol 346 turned out to be one of the most sensitive intermediates 
of the entire synthesis; under mildly acidic conditions {eg dissolution in unbuffered CDCI3) the 
1,3-dioxane ring was opened by the distal hydroxyl to afford the corresponding oxane.
Initial attempts to condense aldehyde 328 with the potassium metallate of PT sulfone 347 
proved disheartening (Scheme 57). Under the pre-metallation protocol which had previously 
been so successful in the PT series (see Chapter 2), at most a 15% yield of 327 was obtained 
albeit with excellent E:Z selectivity (>9:1). Unreacted aldehyde was typically recovered from 
these failed experiments. The low yields were rationalised as the result of self-condensation of 
the potassium metallate of the sterically unencumbered 347. Although the isolation of 
bisheterocyclic adduct 348 (the expected product of self-condensation) was not vigorously 
pursued here, in a separate study it has been prepared under identical metallation conditions'^.
N —  N
N...A
(a) KHMDS, PME, -60°C
L g A  CHO
3 4 7  328 • 327, <15%, EZ>9:1 348
Schem e 57
Again it is likely that an 'umpoled' approach could save the day; a metallated PT sulfone 
derived from alcohol 346 would be too bulky to self-condense. However, a reversal in the 
coupling sense adds one extra step to the linear sequence of the synthesis and would involve 
the use of acetaldehyde, a compound notoriously difficult to purify and dry for small scale 
work. An alternative was to apply Barbier conditions to the current system of 328 and 347, 
although then racémisation of the aldehyde was a possibility. Such fears proved unfounded; 
addition of potassium hexamethyldisilazide to a mixture of 328 and 347 in DME at -60°C 
yielded 93% of the olefin 327 with E:Z = 93:7 (Scheme 58). The product was degraded back 
to alcohol 346 and the derived mandelate ester analysed by NMR; no detectable racémisation 
was found (see Experimental Section for details). Despite aldehyde 328 being 
thermodynamically more acidic than the PT sulfone 347, the kinetic acidity of the latter is 
obviously higher.
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Rs = H, Rm = Mg OH
OH
349, 83%, dr ~ 93:7
Schem e 58
rrart5- l ,2-Disubstituted olefins comprise one of the optimum classes of substrate for the 
Sharpless asymmetric dihydroxylation*^"^ and alkene 327 proved no exception. Under the most 
standard reported reaction conditions*^** commercially available AD-mix a  was chosen to 
oxidise 327 based on the illustrated mnemonic device. Two diastereoisomers of 349 were 
formed in 83% yield in a distribution which reflected the E:Z ratio of the starting material (dr ~ 
93:7). A total of four isomers should be formed, the other two isomers were presumably too 
insignificant to be detected by simple NMR experiments.
As commented by Nicolaou, use of the pre-formulated AD-mixes has 
reduced the 'commonly perceived "black art" of organic synthesis to a 
nearly embarrassing level of s i m p l i c i t y T h e  commercially available 
AD-mixes contain: a catalytic quantity of an involatile source of OSO4 
(K20s02(0 H)4), a chiral cinchona alkaloid derived ligand (AD-mix a  
contains the (DHQ)2-PHAL ligand), a stoichiometric oxidant 
(K3Fe(CN)6), and K2CO3 to maintain the correct pH level. The reaction 
is carried out in a two-phase system of r-BuOH and H2O, the gross 
reaction manifold is illustrated below (Scheme 59). For all but terminal 
olefins hydrolysis of the osmate ester 351 becomes rate-limiting. In such 
cases the addition of an organic sulfonamide assists in the saponification, 
freeing the product 352 and ligand L and returning the Os(VI) by­
product to the catalytic cycle. The presence of MeS02NH2 can accelerate 
an AD reaction by up to 50 times.
OMe
O
OMe
(DHQ)2-PHAL
74
???
350
351 OH
R' + L
OH 352organic
phase
aqueous
phase
2-2-
HO " .OH OSL 
HO " OH
Schem e 59
20H-
2Fe(CN)e3-
ZHgO
2Fe(CN)6‘^
The precise mechanism for the crucial oxidation step (350 to 351) has been the subject of 
great controversy in the recent literature. For many years Sharpless held with the notion that a 
stepwise [2+2] mechanism involving the formation of an osmaoxetane was followed by ligand 
assisted ring expansion to form the osmium glycolate ligand complex 351^ "^^  (see Scheme 60, 
path A). Corey and Noe have always supported the direct [3+2] mechanism originally 
proposed by Criegee^^^ (path B) and have produced a critical analysis of the two pathways^^^. 
Remarkably a recent report by Sharpless comparing experimental and theoretical kinetic isotope 
effects, actually supports a rate-limiting [3+2] cycloaddition^^^. At which exact stage the ligand 
becomes involved is still under debate.
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Whatever the exact nature of the oxidation step, key to asymmetric induction is that oxidation 
of the olefin with OSO4 alone is very slow compared to reaction of the olefin with a complex of 
OSO4 and the chiral ligand (the principle of ligand accelerated catalysis^^^). Coordination of the 
chiral tertiary amine ligand (DHQ)2-PHAL to OSO4 greatly enhances its reactivity towards 
olefins. A substrate molecule is therefore within a chiral environment when oxidised, ensuring 
asymmetry. The mnemonic given in Scheme 58 is a crude representation of the shape of the 
binding pocket within an "OSO4+L" complex: the SE quadrant is extremely sterically 
demanding and can normally only admit a hydrogen atom, the NW comer is moderately 
demanding whilst conversely the SW quadrant represents an area particularly attractive to 
aromatic or long aliphatic substituents There is thus an intrinsic shape incompatibility with 
c/5- l,2-disubstituted olefins; the highest recorded enantioselectivities observed in such cases 
are only 80% ee and require a special indoline based ligand. The use of our PT sulfone 
mediated Julia reaction to generate 327 with high trans selectivity was thus of great 
importance and makes it a natural partner to the AD process.
With the diol 349 in hand we attempted the seemingly trivial task of acetal hydrolysis. As 
outlined below (Scheme 61) a variety of conditions were screened for the hydrolysis; far from 
being a facile process, only the most aggressive of conditions tested (IM HCl(aq), THF, reflux) 
succeeded in freeing the substrate from the 1,3-dioxane acetal. However, rather than liberate 
the desired hydroxylactol 326, a subsequent dehydration yielded the odoriferous bicyclic acetal 
354. The stmcture of 354 could only confirmed by LRMS due to its extreme volatility. In an 
attempt to remove the cyclic acetal under milder conditions, the deprotection procedure of
Schem e 61
CBr4  (25 mol%) 
MeCN-HaO (1:2) 
A, 3h
TFA (cat.) 
THF-H2 O (4:1) 
rt, 18 h
X
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THF, rt, 2 h
PPha (25 mol%) 
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86%
PPTS (cat.) 
damp THF 
rt, 18 h
1M HCI(aq) 
THF (1:9)
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damp THF 
rt, 18 h
TsOH (3 eq) 
dioxane-H20 (9:1) 
60°C, 2 h
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Kerr^^^ was employed unsuccessfully: upon treating dioxane 349 with PPhg and CBr^ in 
acetone, the acetonide 353 was produced in 86% yield. In a final attempt to procure lactol 
326, dioxane 349 was transacetalised with ethylene glycol to yield the corresponding 1,3- 
dioxolane. Exposure of the labile dioxolane to Kerr's process also resulted in the formation of 
bicycle 354. It was concluded that hydroxylactol 326 was not a viable intermediate in our 
synthesis, spontaneously dehydrating under particularly mild conditions.
To prevent the dehydration of lactol 326, the C8 hydroxyl group must be provided with a 
suitable acid stable protecting group. Acid catalysed methanolysis of 349 provided methyl 
acetal 355 as a mixture of diastereoisomers in favour of the a  anomer (a:p =3:1, Scheme 62). 
Selective PMB protection of the free C8 carbinol was then possible in 93% yield by treatment 
of the potassium alkoxide with PMB Cl in the presence of tetrabutylammonium iodide (TBAI). 
Careful hydrolysis of the resulting ether 356 with aqueous acetic acid then yielded an 
alternative lactol 357 suitable for our planned tandem HWE-Michael sequence. The acetal 
hydrolysis had to be carefully monitored, excessive reaction time lead to PMB removal and 
formation of bicycle 354 again became a problem. Terminating the reaction before completion 
enabled 357 to be isolated in 74% yield {a :p  = 1.4:1) together with 18% of recovered starting 
material.
HO
OH349
RO
OR' COpAII
c e :
355, R = Me, R' = H
356, R = Me, R' = PMB
357, R = H, R' = PMB
358cf, R = PMB 
358c, R = PMB 
240, R = H
Schem e 62. Reagents and conditions:
A 73% TsOH, MeOH, rt, 3 d, a p  = 3:1
B 93% (a) KHMDS, THF, 0°C, 20 min; (b) PMBCI, TBAI, 0°C rt, 24 h
0  74% ACOH-THF-H2 O (3:2:2), 65°G, 2 h, a p  = 1.4:1
D 82% ally! diethyiphosphonoacetate, CS2 CO3 , THF, A, 18 h, cisitrans = 4:6
E 89% f-BuOK, THF, -65°C, 1 0  min, pure cis isomer 
F 95% DDQ, H2 O-CH2 CI2  (1:15), rt, 30 min
Treatment of the lactol 357 with allyl diethyiphosphonoacetate in the presence of CS2CO3 in 
refluxing THE lead to the formation of a mixture of cis (358c, desired) and trans (358f, 
undesired) oxane products (82%) in the ratio 4:6 respectively. The initial HWE reaction would 
yield a trans enoate intermediate with high stereoselectivity^^^, and the subsequent in situ 
Michael addition is essentially irreversible since protracted heating of the reaction mixture led to 
no change in the ratio of products. The distribution of products therefore reflects the kinetic 
selectivity of an intramolecular conjugate addition of a 5-hydroxyl group to a tethered E-enoate
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and is in accord with the model proposed by Banwell^^^ (see Scheme 47, Chapter 5). To obtain 
the cis oxane 358c selectively as the kinetic product would require an intermediate Z-enoate 
and thus an expensive Still-Gennari phosphonate^^; this tack was employed by the Ban well 
group in their synthesis of herboxidiene tetrahydropyran fragment 266^°^ (see Scheme 46, 
Chapter 5).
It is known from Maurer's synthesis of methyl (cw-6-methyloxan-2-yl)acetate^^^ (a derivative 
of civet (Viverra civetta) extract), and Kocienski's synthesis of herboxidiene that alkoxide 
bases can promote the equilibration of our tetrahydropyranyl system to the all equatorial cis 
isomer. Treatment of the mixture of oxanes 358c^ (cis:trans = 4:6) with r-BuOK in THF at 
-78°C resulted in rapid equilibration to 358c which was isolated in 89% yield. Careful 
examination of the proton NMR spectrum of 358c enabled complete assignment of the relative 
stereochemistry around the ring. Diagnostic axial-axial /-couplings were discernible for both 
H3 and H7 (Figure 10). The relative stereochemistry of the stereogenic centre at C8 is thus also 
fixed since it was derived from the same dihydroxylation event which determined the 
configuration at C7. Finally, oxidative removal of the PMB ether moiety from 358c was 
effected by DDQ in aqueous CH2CI2 and yielded the target alcohol 240 in 95% yield. The free 
alcohol was identical in all respects to that synthesised previously by Kocienski and Smith" .^
4ax
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Me
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Figure 10
6.3. Synthesis of sulfone 332
Construction of sulfone 332 began simply enough with a standard boron-mediated aldol 
reaction between propionyl sultam 331 and aldehyde 244 (Scheme 63)^^ .^ Pre-complexation 
of sultam 331 with diethylboron triflate (generated in situ from triethylborane and triflic acid) 
facilitates a highly selective deprotonation by Hiinig's base to form the (Z)-boron enolate^^^’^ ^^ . 
Subsequent addition of aldehyde 244 initiates an aldol reaction which proceeds via the 
Zimmerman-Traxler^ transition state illustrated in Figure 11. The natural Felkin preference of 
244 for attack from its re face is matched by the intrinsic bias of the camphor sultam chiral 
auxiliary, here oriented to minimise dipole-dipole repulsion. The crystalline syn aldol 359 was 
thus produced with excellent diastereoselectivity and subsequent recrystallisation furnished 
75% of the adduct as a single isomer.
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To effect méthylation of the aldol 359 a combination of proton sponge® (1,8- 
bis(dimethylamino)naphthalene) and methyl triflate was employed. The conditions were 
derived as a cheap hybrid formulation of two other costly mild méthylation procedures 
popularised by Evans "^^®: (a) methyl triflate (inexpensive) with 1,6-di-fgrr-butyl-4- 
methylpyridine (DTBMP, very expensive) and, (b) trioxonium tetrafluoroborate (Meerwein's 
salt, expensive) with proton sponge® (inexpensive). Methyl triflate and proton sponge® 
proved to be compatible partners and produced the methylated adduct 360 in 90% yield with 
no trace of retroaldolisation. Following reductive removal of the chiral auxiliary the alcohol 
361 was oxidised with Dess-Martin reagent to afford aldehyde 335 in excellent yield.
After the non-stereoselective addition of wopropenyl magnesium bromide to aldehyde 335, the 
resulting mixture of enols {syn:anti = 57:43) was immediately oxidised to the corresponding 
enone in 80% overall yield. Methodology developed by Mori^^  ^ for the directed reduction of p- 
alkoxyketones to yield masked 5y«-l,3-diols was then employed. A solution of the enone 362
331
\^C H O
OTBS
244
MeO
TBSO TBSO
359, R = H
360, R = Me
361.R = CH20H
335, R = OHO 
O
MeO OH H
TBSO RO
(363)
TBSO
362 363, R = TBS 
365, R = H
364
Schem e 63. Reagents and conditions:
A 75% (a) Et2B0Tf, CH2 CI2 , -5°C; (b) APr2 NEt, 30 min; (c) 244, -78°C, 3 h. dr > 98:2 (recrys.) 
B 90% MeOTf, proton sponge®, PhMe, 80°C, 24 h
0  99% LiAIH4 , Et20, 0°C, 15 min
D 91% Dess-Martin reagent (DMP), CH2 CI2 , 0 ° C r t ,  2 h
E 80% (a) CH2 =C(Me)MgBr, Et20, 0°C, 1 h, dr (anti) = 43:57; (b) DMP, CH2 CI2 , rt, 4 h
F 75% LiA!H4 , Lil, Et20, -100°C, 1 h, dr {anti) = 85:15, > 98:2 (recrys.)
G 72% TBAF*3H20,THF, rt, 15min
H 97% (EtC0)20, DMAP, pyridine, rt, 16 h
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in ether was treated with anhydrous lithium iodide at -30°C; after further cooling to -100°C the 
supposedly chelated ketone was reduced with lithium aluminum hydride to yield, rather 
unexpectedly, the anti alcohol 363 with 70% de. Unambiguous determination of the 
stereochemistry was provided by single crystal X-ray diffraction studies on the derived diol 
365 (see appendix for details).
half-chair chelates
R'
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Me
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R O Me
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Hydride addition to the possible half-chair lithium chelates of 362 (see conformers 366 and 
367 above, Figure 12) is unlikely to occur from the observed a-face due to severe steric 
hindrance. Rather the reduction appears to be under Felkin-type controF^^, with an open chain 
model (368) correctly predicting the observed outcome. Why chelation control does not appear 
to operate here is unclear; however, all of the substrates examined by Mori lacked a- 
substituents and acetonide ether oxygen atoms were used to direct the reduction^^^F In any 
event, recrystallisation of the solid product 363 followed by careful chromatography of the 
resulting mother liquor residues gave a combined yield of 75% of isomerically homogeneous 
material. Estérification of the pure alcohol 363 under standard conditions then afforded the 
Ireland-Claisen precursor 364 in near quantitative yield.
For the [3,3]-sigmatropic rearrangement of a silyl ketene acetal 369 (the Ireland-Claisen 
rearrangement^^^, see Table 9) to yield a product with predictable stereochemistry it is vital that 
three variables are determined absolutely: (a) the configuration of the stereogenic centre at C4 
of the starting material (the R group will be equatorially/pseudoequatorially oriented in chairlike 
or boatlike transition states), (b) the geometry of the silyl ketene acetal, and (c) the transition 
state (chairlike C, or boatlike B) through which the rearrangement proceeds. It is clear that 
misassignment of any of the three factors (a) to (c) leads to a reversal in the configuration of the 
Cl stereogenic centre in the product 370. The extent to which the variables are controlled 
affects the selectivity of the process; poor 1,4-chirality transfer in Claisen ester enolate 
rearrangements is typically due to associated problems with selective énolisation but can also be 
caused by competition between chair- and boatlike transition states.
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(a) 0 4  configuration in 369
(b) geometry of enolate
(c) transition state type
(d) 01 configuration in 370
Table 9
(a) (b) (c) (d) (a) (b) (c) (d)
a Z C P P Z C a
a Z B a P Z B P
a E C a P E C P
a E B P P E B a
It is well precedented for simple acyclic substrates that Ireland-Claisen rearrangments occur via 
chairlike transition s t a t e s W e  were therefore required to form an E-silyl ketene acetal of 364 
to yield acid 333 with the natural ^^-configuration at the newly formed stereogenic centre (ie 
set (a) = p, (c) = C and (d) = p in  the above chart).
Ireland and co-workers have extensively investigated the factors controlling ester 
é n o l i s a t i o n At low temperatures ester enolates are formed irreversibly and so the 
geometry of the adduct is under kinetic control. Ireland discovered that E-silyl ketene acetals 
can be formed with high stereoselectivity (E:Z = 94:6) by the treatment of esters with lithium 
diwopropylamide (LDA) in THF at -78°C followed by silylation. Conversely, in the presence 
of an additional dipolar co-solvent {eg HMPA or DMPU) under essentially the same conditions 
Z-silyl ketene acetals could be formed with even greater selectivity (Z:E > 98:2)^" .^
H P ' v
OR'
Li
371 Figure 13 372
To explain the origin of the remarkable kinetic selectivity observed, Ireland proposed that in the 
absence of a dipolar co-solvent, deprotonation by LDA occurs via a tight 6-membered 
transition state (Figure 13). Two conformations are stereoelectronically permitted for 
deprotonation, 371 and 372. The dominant steric interaction occurs in 372 which exhibits 
severe 1,3-diaxial strain between the A-wopropyl group and the R group. Deprotonation in
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THF alone thus occurs preferentially from conformer 371 and leads to the Z-lithium enolate 
(and thence to the E-silyl ketene acetal). In the presence of a dipolar co-solvent, the lithium 
cation experiences greater solvation, weakening the Li+-carbonyl oxygen bond and leading to a 
looser (or even open) transition state. The repulsive interaction in 372 is thus significantly 
diminished whilst the destabilising interaction in 371 between R and OR' remains constant. 
Therefore in the presence of HMPA or DMPU deprotonation occurs preferentially from 372 
and leads to the E-lithium enolate (and thence to the Z-silyl ketene acetal).
TBSO
(a) LDA, THF 
-76°C, 30 min
(b) TBSCI, DMPU
TBSO -78°C -^A , 1 h
[3.3]
364 373
TBSO MCI
HOgC.
(aq)
374
TBSO 
333,68%, dr = 86:14
Schem e 64
MeO
R =
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Adopting standard conditions for the generation of a Z-lithium enolate, the propionate 364 was 
exposed to the action of LDA in THF at -78°C (Scheme 64). Following silylation with tert- 
butyldimethylsilyl chloride (TBSCI) in DMPU, rearrangement of the resulting E-silyl ketene 
acetal 373 to the corresponding silyl ester 374 was effected by heating. The dipolar co-solvent 
is required to assist silylation at low temperatures and does not affect enolate geometry when 
added after the énolisation event^" .^ Hydrolysis of the labile silyl ester with dilute mineral acid 
yielded the desired carboxylic acid 333 in good yield with moderate diastereoselectivity (dr = 
86:14).
Reduction of acid 333 yielded the alcohol 375 in good yield (Scheme 65), it was possible at 
this stage to remove the minor diastereoisomer resulting from the Ireland-Claisen reaction via 
simple flash chromatography. A standard Mitsunobu thioetherification then installed the
HO2C.
TBSO
333
Schem e 65. Reagents and conditions:
A 90% UAIH4 , Et2 0 ,0°C, 10 min C
B 99% BTSH, PPha, DIAD, THF, 0°C ^  rt, 2 h D
B 375, R = TBS, R' = OH
376, R = TBS, R' = SBTc :
^ 3 7 7 , R = H, R' = SBT
D 378, R = H, R' = SO2 BT
98% TBAF-3 H2 0 , THF, rt, 32 h 
8 8 % Mo(VI), H2 O2 , H2 0 -Et0 H, rt, 24 h
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requisite BT sulfide moiety in quantitative yield. Oxidation of the resulting thioether 376 to the 
corresponding sulfone by Mo(VI) catalysis proved sluggish requiring over 48 h for complete 
conversion. Furthermore, attempted silyl ether deprotection of the resulting sulfone with 
TB AF«3H20 lead to complete decomposition; only benzothiazolone was isolated in 86% yield. 
Evidently the BT sulfone was not stable to the basic conditions of the deprotection protocol. 
Simply reversing the order of the aforementioned steps solved both problems. Deprotection of 
the sulfide 376 with TBAF»3H20  occurred in excellent yield with no detectable 
decomposition of substrate. The sulfide moiety of the resulting alcohol 377 was then rapidly 
converted to the sulfone 378 via treatment with a Mo(VI) catalyst and H202(aq) in EtOH. The 
absence of the TBS ether presumably reduced the lipophilicity of the sulfide, increasing its 
solubility in the reaction medium and thus facilitated oxidation.
The directed epoxidation reaction used by Kocienski for the synthesis of herboxidiene was 
next re-investigated for the oxidation of olefin 378 (Scheme 66). The reactivity of an olefinic 
alcohol towards VO(acac)2 catalysed epoxidation depends on the proximity of the hydroxyl 
group to the alkene^"^ .^ As a consequence the oxidation of bishomoallylic alcohol 378 was 
extremely slow at sub-ambient temperatures and low catalyst loadings. Unfortunately, at higher 
temperatures or catalyst loadings the formation of unwanted by-products became significant. 
Specifically, conducting the epoxidation in toluene at 60°C (3 mol% V0 (acac)2, 1.5 eq TBHP) 
resulting in sole formation of the tetrahydrofuran 380 in 63% yield; the product of 
intramolecular attack of the free hydroxyl on the virgin epoxide. Alternatively the reaction could 
be hurried at 0°C if repeated portions of catalyst (40 mol%) were added, but then acetates of the 
product 379 and starting material 378 were formed. The only potential source of acetate in the 
reaction manifold was the acetylacetonate ligand and the mechanism for acetate formation 
remains unclear.
378
R =
VO(acac)2 , TBHP
CH2 CI2 , -8°C, 72 h
MeO H
SO2 BT
MeO
381
379, 69%, dr >98:2 
— ► 46%, dr = 85:15
m-CRBA, NaHCOa
CH2 CI2 , rt, 20 h
Schem e 66
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After careful optimisation of the reaction, patience was found to pay dividends: at a fixed 
catalyst loading of just 1 mol% a cold (-8°C) solution of the olefin 378 in CH2CI2 was treated 
with three equivalents of TBHP via a syringe pump delivery system over 48 h. After the 
complete addition, the oxidation was allowed a further 24 h of reaction time. Such a protocol 
yielded 69% of 379 as a single diastereoisomer, together with a small quantity of the THF- 
adduct 380 and 26% of recovered starting material 378. The illustrated facial selectivity of the 
reaction was rationalised by transition state 381 in analogy with that suggested by KocienskT^  ^
for the epoxidation of 263 (see Scheme 43, Chapter 5). The derivation of the model was based 
on earlier work by Sharpless^"^  ^ and Mihelich '^^^ and has been discussed at great length by 
Smith "^^ *. Key points to note are: (a) the trigonal bipyrimidal co-ordination geometry of the 
V(V) ternary complex, (b) the pseudo-chair conformation adopted by the substrate, (c) 
interactions between substituents along the carbon skeleton and vanadium ligands are 
minimised, and (d) breakage of the peroxide bond occurs from the backside along the 0 -0  
bond axis"^ .^ The inherent stereochemistry found in 378 allows for the all pseudo-equatorial 
disposition of substituents within 381 and presumably accounts for the high level of 
stereocontrol observed.
Epoxidation was also achieved with m-CPBA commencing from the corresponding sulfide 
377. Concomitant oxidation of the sulfide and olefin occurred to yield 46% (unoptimised) of 
the epoxysulfone 379 directly with good diastereoselectivity (dr = 85:15).
To complete the synthesis of the nucleophilic coupling partner 332, all that remained was to 
invert the stereogenic centre at C l8 and to protect the resultant hydroxyl group. Reasoning that 
an ester function would be a sufficiently robust protecting group for the imminent Julia 
olefination, a Mitsunobu reaction was the logical choice for the inversion opera t ionIn i t i a l  
experiments employed the most standard of Mitsunobu conditions: viz, a mixture of the alcohol 
379, triphenylphosphine and 4-chlorobenzoic acid (PCBOH) in THE at 0°C was treated with 
either diethyl azodicarboxylate (DEAD) or diwopropyl azodicarboxylate (DIAD) and allowed to 
warm^^. Although these simple experiments afforded the product ester 332, yields were low to 
moderate (23-66%) and more infuriatingly the product proved very difficult to separate from 
the appropriate hydrazodicarboxylate by-product. To solve the purification problem the 
azodicarboxylate component was changed to the rarely used dimethyl congener (DMAD^^°) 
which has a water soluble hydrazine derivative. The increased reactivity of DMAD produced 
difficulties of a different nature (Scheme 67). Under standard conditions (equal quantities of 
the three reagents) significant quantities of acylated hydrazine adducts (382 and 383) were 
formed and the yield of the product ester 332 was disappointing (30%).
An explanation for these findings and a potential remedy can be gleaned from consideration of 
the mechanism for the Mitsunobu process (Scheme 68)^ "^ .^ The formation of adduct 382 is a
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382, R = FOB, R' = H, 23%
383, R = R' = PCB, 24%
Schem e 67
PCB = 4-chlorobenzoyl
consequence of direct attack of the carboxylate 388 on the azaphosphonium adduct 387 
followed by displacement of triphenyl phosphine oxide by 390. An extension of such a 
reaction path can lead to the double acylated hydrazine derivative 383. The enhanced reactivity 
of the DMAD adduct 387 toward weak nucleophile 388, and the expected low rate of steps B 
and C (due to steric hindrance of 379) account for competition from the undesired reaction 
path.
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A potential solution to the problem is to employ an excess of the acid component {ie a ratio of 
PCBOHiPPhgiDMAD = 2:1:1)^ "^ ;^ herein the PCBOH/PCBO“ ratio is increased. The excess 
acid form solvates the carboxylate thus reducing its nucleophilicity and so stabilising the 
complex 387+388. Such conditions were tested on our system (Scheme 67). No product 
formation (or 382 and 383) occurred and the starting material was recovered in 72% yield. 
The problem arises because accompanying the reduction in carboxylate nucleophilicity is a 
reduction in its basicity; thus, step B is retarded and so too the rate of oxyphosphonium ion 
391 formation.
To circumvent all of the aforementioned difficulties a different approach was adopted. 
Preforming the betaine adduct between triphenyl phosphine and DMAD in THF at 0°C, the 
alcohol 379 was added followed by the slow portionwise addition of the acid PCBOH 
(Scheme 69). Thus the concentration of the carboxylate 388 is kept low whilst its 
nucleophilicity and basicity are uncompromised. Under the new protocol ester 332 was 
produced rapidly in good yield (74%) and proved easy to purify. The hydrazine 392 was 
removed by aqueous work-up.
(a) PPhg, DMAD, THF, 0°CMeO
HO
379
(b) PCBOH, 0 ° C r t ,  3 h 
PCB = 4-chlorobenzoyl
Schem e 69
MeO
PCBO
332, 74%
6.4. Completion of synthesis - union of sulfone 332 and aldehyde 238
After the various problems encountered in realising alcohol 240 and sulfone 332, the 
synthesis was easily completed (Scheme 70). Aldehyde 238 was prepared from 240 as 
previously disclosed by KocienskT^^ (see Scheme 42, Chapter 5). The one-pot Julia reaction 
between sulfone 332 and 238 employing standard pre-metallation conditions yielded 81% of 
the protected herboxidiene derivative 394 with excellent selectivity (lOE.Z = 91:9). Some 
minor points are worth noting: (a) the presence of any excess base resulted in the énolisation of 
the aldehyde 238 thus inhibiting its role as electrophile, the most successful conditions 
employed sulfone (1.2 eq), base (1.1 eq) and aldehyde (1 eq); (b) quenching of the reaction at 
-78°C yielded only 60% of 394 with E:Z = 80:20. The reduced selectivity and yield were 
probably due to the moderate stabihty of an anti j3-alkoxysulfone intermediate which required a 
longer reaction time and/or higher temperature than the corresponding syn adduct to undergo
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spirocyclisation (see Chapter 1). Allowing some warming of the reaction mixture to -20°C 
before quenching thus raised both yield and selectivity.
SO2BT
MeO
PCBO
332
A
CO2 AII OHO
MeO
RO
238
Schem e 70. Reagents and conditions:
A — (a) LDA, THF, -78°C, 15 min;
81% (b) 238, -78°C ^ -2 0 °C , 1.5 h, E:Z= 91:9 
B 72% K2 CO3 , MeOH, A, 2 h
394, R = PCB, R' = All 
303, R = H, R' = Me 
233, R = R' = H
C
D
84%
93%
K2 CO3 , H2 0 -Me0 H (1:4), A, 1 h 
K2 CO3 , H2 0 -Me0 H (1:4), A, 2 h
Although direct double deprotection of 394 was possible by simple saponification (step D 
above), we favoured a two step deprotection protocol (B+C) via the previously reported methyl 
ester of herboxidiene 303^ ®"^ . Separation of minor impurities and the lOZ isomer from 394 by 
chromatography proved very difficult, as was direct purification of herboxidiene 233 itself. 
The natural product was not separable from 4-chlorobenzoic acid or its minor lOZ isomer by 
simple flash chromatography. Gratifyingly, purification of the methyl ester 303 (produced via 
transestérification of 394) proved relatively straightforward and our synthetic material matched 
that reported by I s a a c i n  all respects. Subsequent deprotection of pure ester 303 then 
enabled the production of a high quality sample of herboxidiene 233 in excellent yield.
Comparison of and NMR data for our synthetic herboxidiene (233) and the natural
material reported by Isaac revealed significant discrepancies in the C1-C3 region (see Tables
10 and 11). Variation in the geminal coupling constant between the C2 protons suggested a 
difference in the ionisation state for natural and synthetic samples. The sodium salt of our 
synthetic material (prepared by treatment with Na2C03 in CD3OD) provided and NMR 
data in complete agreement with Isaac^ "^^ . The data reported in the literature therefore likely 
pertains to a carboxylate derivative rather than the free acid of herboxidiene and the integrity of 
our synthesis is without doubt.
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NMR data for herboxidiene (233) Table 10
natural herboxidiene synthetic herboxidiene^
position 8 multiplicity J(Hz) 8 multiplicity J{Hz)
H2a 2.45 dd 14.1, 6 . 6 2.46 dd 15.6, 7.2
H2 b 2.25 dd 14.1,7.5 2.38 dd 15.3, 5.7
H3 3.76 m -- 3.80-3.70 m --
H4a 1 .8 6 -1 . 6 8 m -- 1.90-1.82 m --
H4b 1.30 m -- 1.40-1.22 m --
H5a 1 .8 6 -1 . 6 8 m -- 1.74-1.65 m --
H5b 1.26-1.12 m -- 1.40-1.22 m --
H6 1.55 m -- 1.60-1.43 m --
C6 -Me 0 . 6 6 d 6 . 6 0 . 6 8 d 6 . 6
H7 3.34 d 9.9 3.34 d 9.9
C8 -Me 1 . 6 8 s -- 1.69 s --
H9 5.90 d 1 1 . 1 5.92 d 1 0 . 8
H10 6.29 dd 15.0, 1 0 . 8 6.30 dd 15.0, 10.8
H11 5.45 dd 15.0, 9.0 5.47 dd 15.0, 9.1
H12 2.44 m 2.50-2.38 m --
C12-Me 1.03 d 6 . 6 1.04 d 6.7
H 1 3 a 1.91 dd 13.1,4.3 1.92 dd 13.4, 4.3
H 1 3 b 1.26-1.12 m — 1.18 dd 13.0, 11.2
C14-Me 1.27 s — 1.28 s
H15 2.65 d 9.6 2.65 d 9.4
H16 1.45 m — 1.60-1.43 m
C16-Me 0.83 d 6.9 0.83 d 6.9
H17 2.96 dd 6.0, 4.5 2.97 dd 6.1. 4.3
H18 3.78 dq 6 .6 , 6.3 3.78 quintet 6.4
H19 1 . 1 1 d 6 . 6 1 . 1 0 d 6.4
OMe 3.52 s -- 3.52 s
‘recorded from CD3 OD at 300MHz, reported by Isaac frecorded from CD3 OD at 360 MHz
NMR data for herboxidiene (233) Table 11
natural synthetic^ natural synthetic^
position 8 8 A8 position 8 8 A8
C1 179.8 175.3 -4 .5 Cl 2 36.5 36.6 +0.1
C2 46.4 42.3 -4.1 C12-Me 22.7 22.7 0.0
C3 77.0 75.5 -1 .5 013 48.1 48.1 0.0
C4 33.1 32.8 -0 .3 014 62.6 62.6 0 . 0
C5 33.7 33.4 -0 .3 014-Me 16.8 16.8 0 . 0
C6 33.5 33.4 —0 . 1 015 67.8 67.9 +0.1
C6 -Me 18.2 18.1 - 0 . 1 016 36.4 36.4 0.0
C7 92.2 92.2 0 . 0 016-Me 11.7 11.5 -0.2
C8 136.5 136.2 -0 .3 017 8 8 . 6 88.5 -0.1
C8 -Me 1 2 .1 1 2 .1 0 . 0 018 69.8 69.9 +0.1
C9 129.5 129.6 +0 .1 019 19.9 19.8 -0.1
C10 126.6 126.5 - 0 .1 OMe 61.9 61.9 0.0
C11 140.5 140.7 +0 . 2
'recorded from CD3 OD at 75MHz, reported by Isaac etal^ ^^ . frecorded from CD3 OD at 90 MHz
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7. Summary of Results and Conclusion
The 1-phenyl-l//-tetrazol-5-yl (PT) variant of the one-pot Julia olefination reaction has 
emerged as a powerful synthetic tool for the synthesis of non-conjugated 1,2-disubstituted 
trans alkenes (see Chapter 2). The new variant was found to complement the existing 
benzothiazol-2-yl (BT) system introduced by Julia^ which remains optimum for the 
constmction of trans conjugated dienes. In contrast to the classical Julia olefination, trans 
selectivity in the PT variant of the one-pot reaction shows little dependence on the degree of 
chain branching about the point of connection (Figure 14). Indeed, the new system is able to 
access simple non-branched E-alkenes {eg 123) with much greater selectivity than the classical 
Julia reaction {eg 27).
CeHia C5H11.
27
E;Z= 80:20
28
E:Z= 90:10
29
classical
reaction^^
E;Z> 99:1
increasing chain branching
C4 H9 C3 H7
123
E;Z= 94:6
125
E.Z= 99:1 E.Z= 99:1
Figure 14
127
PT one-pot 
variant
Further to the discovery of an alternative class of heterocyclic mediator for the one-pot Julia 
olefination, we also demonstrated the efficacy of both variants (BT and PT) toward target 
directed synthesis. Vitamin D% and herboxidiene were both successfully synthesised by 
employing one-pot Julia technology at pivotal junctures.
The ability to synthesise vitamin D derivatives convergently by joining complex A- and CD- 
ring fragments enables the rapid assembly of analogues with potentially beneficial biological 
properties. The BT variant of the one-pot Julia reaction proved equal to the task of forging the 
crucial 7,8-double bond of vitamin D from such fragments with reasonable selectivity and in 
good yield (see Chapter 4). Drawing a parallel with the original Julia olefination, it is important 
to note that, although the classical reaction is completely stereoselective for the formation of the 
7E-double bond, yields seldom exceed 50%^®’^ *. Furthermore, with the advent of new 
photoisomerisation protocols for the conversion of 7Z vitamin D trienes into the natural IE  
state^ "^ , the onus is now on methods to be higher yielding. The one-pot Julia olefination method
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presented here is both more convenient and higher yielding than the classical reaction for the
linkage of A-ring and CD-ring vitamin D fragments (Scheme 71).
R4
classical Julia^° j —
174
HO'
Schem e 71
164, 45%
one-pot Julia j —
HO''
163, 50%
OH 
231,20%
The first total synthesis of herboxidiene (233) was achieved in a total of 36 steps from 
cyclohexanone with a longest linear sequence of 22 steps (see Chapter 6). The high level of 
convergency achieved was in part due to the ability of the one-pot Julia olefination to conjoin 
two complex late stage intermediates, sulfone 332 and aldehyde 238 (Scheme 72). Of 
particular note was the presence of both epoxide and ester functionalities in the sulfone 
component. The compatibility of the one-pot Julia reaction with such groups bodes well for its 
wider scope and future potential in more demanding applications.
(a) LDA, THF, -78°C, 15 min CO2 AII
MeO H
SO2 BT
MeO
PCBO
332
238
OHO
PCB = 4-chlorobenzoyl
CO2 AII 
-78°C ^ -2 0 °C , 1.5 h 
Schem e 72
PCBO 
394, 81%, E;Z= 91:9
Equally important was the role of our PT variant of the reaction to achieve a two carbon 
extension of the aldehyde 328 to access trans olefin 327, an excellent substrate for a 
subsequent asymmetric dihydroxylation (Scheme 73). Although metallated PT sulfones were 
generally more resistant than their BT counterparts towards self-condensation, sulfone 347 
was incompatible with a premetallation protocol. However, despite employing Barbier
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conditions for the requisite coupling, no racémisation of the «-branched chiral aldehyde was 
observed.
328
PTS02Et (347), KHMDS - 4 ^ P  
CHO -------------------------------- --
□ME, -60°C, 45 min 
Schem e 73
327, 93%, E;Z= 93:7
The only chiral pool material used to construct the carbon skeleton of herboxidiene was cheap 
ethyl (5)-lactate from which the aldehyde 244 was derived"^ .^ All other stereogenic centres 
were manufactured via asymmetric synthesis employing both chiral auxiliary and chiral catalyst 
methods. The remaining achiral carbon sources were generally cheap bulk chemicals {eg 
cyclohexanone, propionic anhydride, methyl iodide etc) and the two phosphonate esters 
employed for HWE reactions were the most costly materials (Figure 15). Antipodes of 
Oppolzer's camphor sultam auxiliary^^^ (Xc and Xc', see Scheme 54, Chapter 6) were derived 
from the appropriate enantiomer of camphorsulfonic acid^^  ^ and were recycled many times 
during the course of the synthesis. The low material cost and the operational simplicity of the 
experimental procedures employed make the herboxidiene synthesis presented herein 
particularly efficient and amenable to scale-up.
Figure 15
oII
(EtO)2^^'^2
^COaAII
Mel
O
total synthesis of herboxidiene (233) 
summary information and carbon sources
linear sequences =  2
length of sequences = 22 (0.94%) 
(overall yield) 17 (4.63%)
total number of steps = 36
MeO H
1 7 : 1 5 Î
HO
233
SO2PT
(EtO)2>
347
P'II
O
C02^ Bu
10
o o 
11
12
19
V
TBSO
244
13
331
To conclude this thesis it would be pertinent to briefly survey an extension of the tetrazole 
olefination technology recently developed in the Kocienski group^^. Replacement of the N- 
phenyl moiety in a PT sulfone with an N-tert-buty\ substituent yields a one-pot Julia system 
exhibiting even greater stability toward premetallation. Such sulfones (denoted TBT; l-tert- 
butyl-1 J7-tetrazol-5-yl) are available via analogous methods to the PT sulfones commencing
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from the known compound 1 -^grf-butyl-17f-tetrazole-5 -thiol ^ . An illustration of the increased 
stability of the TBT system over the PT variant was provided by a repeat of the two carbon 
extension of aldehyde 328 (Scheme 74).
-N
A
(a) KHMDS, DME, -60°C, 10 min
02 (b)
347, R = Ph 
395, R = f-Bu
CHO
328
327
R = Ph, 6 %, E;Z> 95:5 
R = f-Bu, 85%, E;Z= 89:11
Schem e 74
Under a premetallation protocol the TBT sulfone 395 was condensed with aldehyde 328 to 
yield the olefin 327 in excellent yield (85%) albeit with a slightly reduced trans selectivity {E:Z 
= 89:11) when compared to the analogous result with the PT sulfone 347 {E:Z > 95:5)^^. 
However, the low yield in the latter case is of little preparative value and was no doubt due to 
self-condensation of metallated sulfone 347.
The additional steric shielding of the electrophilic centre provided by the sterically demanding 
tert-hvXy\ group is presumably responsible for the heightened stability of TBT metallated 
sulfones. Of course the bulky group would also retard intramolecular nucleophilic attack upon 
the C=N bond and thus inhibit spirocyclisation of the initially formed j9-alkoxysulfones. In the
case of stabilised sulfones, such an
aldehyde sulfone aldehyde sulfone
Het
396
%yield Z.E Het
397
%yield Z.E
BT 80 77:23 BT 78 68:32
PT 70 71:29 PT 39 33:67
TBT 95 99:1 TBT 60 96:4
Figure 16
effect would facilitate equilibration 
b e tw een  syn and a n t i  p -  
alkoxysulfones and lead to a 
preference for the cis olefin product 
(see Chapter 1). Indeed, reaction of 
benzylic or allylic TBT sulfones with 
saturated aldehydes yielded olefins 
with excellent Z-selectivity at a level 
which exceeded that of the analogous 
BT or PT sulfones^^ (Figure 16).
The ability of a substituent on the tetrazole scaffold to tune the reactivity of a metallated 
sulfone, and so affect product olefin geometry, provides great scope for further optimisation. It 
may be possible in future for the selectivity of a one-pot Julia olefination reaction to become 
completely independent of substrate class by use of the appropriate heterocycle substituents. In 
this regard the tetrazole variant of the one-pot Julia reaction in some ways mirrors the HWE
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reaction (Chapter 1), in which variation in phosphonate ester groups can control equilibration 
between ^alkoxyphosphonates and ultimately the product olefin geometry.
Finally, Table 12 provides a guide to the currently accepted optimum choice of heterocyclic 
sulfone for the synthesis of a range of 1,2-disubstituted olefin systems via the one-pot Julia 
olefination.
Table 12
olefin class sulfone aldehyde base solvent
' ' ^ S O j P T  0 ^ . KHMDS DME
Isolated trans
i i 
! !
' ' ^ S O a B T LiHMDS THF 
(LDA)
conjugated trans
' : . 1 .
i
y X ^ S O z T B T
! !
-  unoptimised -
conjugated cis
reactions should first be attempted employing a premetallation protocol and Barbier conditions adopted if low yields are 
experienced
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8. Experimental Section
All reactions requiring anhydrous conditions were conducted in flame-dried glass apparatus 
under a static atmosphere of nitrogen. 1,2-Dimethoxyethane (DME), tetrahydrofuran (THF) 
and diethyl ether were freshly distilled from sodium benzophenone ketyl prior to use. N,N- 
Dimethylformamide (DMF) and dimethyl sulfoxide (DMSO) were distilled from CaH2 at sub­
ambient pressure (ca 15 mmHg, water aspirator). Dichloromethane was freshly distilled from 
CaH2 and toluene was distilled from molten sodium. Where required anhydrous methanol and 
ethanol were obtained by distillation from their respective magnesium alkoxides and stored 
over activated 4Â molecular sieves (MS). Preparative chromatographic separations were 
performed on Macherey-Nagel silica gel 60 (230-400 mesh) and reactions were followed by 
TLC analysis using Macherey-Nagel silica gel 60 plates with fluorescent indicator (254 nm) 
and visualised with UV or phosphomolybdic acid. All commercially available reagents were 
purchased from Aldrich and were typically used as supplied.
Melting points were recorded using open capillary tubes on a Griffin melting point apparatus 
and are uncorrected. Specific optical rotations ( [ o : ] d )  were measured at ambient temperature 
(24±3°C) from CHCI3 solutions on an Optical Activity polAAr 2000 polarimeter using a 5 mL 
cell with 1 dm path length. Infra-red (IR) spectra were recorded on a Nicolet Impact 410 FT-IR 
spectrometer using a thin film supported between NaCl plates or KBr discs where stated. 
Details are reported as Vmax in cm~i, followed by an intensity descriptor: s = strong, m = 
medium, w = weak or br = broad. ^H and nuclear magnetic resonance (NMR) spectra 
were recorded in Fourier transform mode at the field strength specified either on a Bruker 
AM360 or a Jeol Gx-270 spectrometer. All spectra were obtained in CDCI3 solution in 5 mm 
diameter tubes, and the chemical shift in ppm is quoted relative to the residual signals of 
chloroform (5h = 7.27 ppm or 6c = 77.2 ppm). Multiplicities in the ^H NMR spectra are 
described as: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet and br = broad. 
Coupling constants (J) are reported in Hz. Numbers in parentheses following the chemical shift 
in the NMR spectra refer to the number of attached hydrogens as revealed by the DEPT 
spectral editing technique employing secondary pulses at 90° and 135°. Low (LRMS) and high 
(HRMS) resolution mass spectra were run on a Jeol JMS700 spectrometer. Ion mass/charge 
(m/z) ratios are reported as values in atomic mass units followed, in parentheses, by the peak 
intensity relative to the base peak (100%).
Where given, assignment of NMR spectral data is notional and based only on standard 
reference sources^ "^^ '*^ .^ Any assignment of the complex NMR signals of vitamin D derivatives 
was made by analogy to the work of Mizhiritskii et and likewise NMR signal assignment 
of herboxidiene derivatives was made by analogy to the work of Isaac^^ and KocienskT^ .^
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-SECTION 2.1-
Scheme 75 outlines the synthesis of racemic 2-methylheptanal (401), 2-methyl-1-heptanol 
(402) and l-bromo-2-methylheptane (403); commercially unavailable materials required to 
synthesise many of the compounds in Tables 2 and 3 (Chapter 2).
MeO OMe
COaMe)
398
399, n = 2
400, n = 1
CHO
401
Schem e 75. Reagents and conditions: 
A 70% (a) NaH, THF, 0°C; (b) CgHnBr 
71% NaCI, H2 O, DMSO, A 
86% DIBAL-H, CH2 CI2 , -78°C  
84% LÎAIH4, EÎ20, 0°C A 
68% PBra, 100°C
D
402 403
Dimethyl methylpentylmalonate (399):
To a stirred suspension of sodium hydride (9.0 g, 60 wt.% dispersion in mineral oil 
subsequently washed with dry hexanes 3x10 mL, 225 mmol) in anhydrous THF (200 mL) 
under N2(g) at 0°C was added dropwise dimethyl methylmalonate (398, 27.3 mL, p  =1.098,
30.0 g, 205 mmol) over 30 min (CARE! H2(g) evolution). After 1 h the mixture was an 
homogeneous yellow solution of the sodium enolate. 1-Bromopentane (28.0 mL, p =1.22,
34.2 g, 226 mmol) in anhydrous THE (30 mL) was then added dropwise and the mixture 
heated to reflux and stirred 0/N  (a white precipitate of NaBr was observed to form). The 
mixture was then allowed to cool and the solvent removed in vacuo. The residue was 
partitioned between H2O (150 mL) and Et20 (100 mL). The layers were then separated and the 
aqueous phase extracted (2x50 mL Et20). The combined organic extracts were washed with 
brine (50 mL), dried (MgSO^) and then concentrated in vacuo to yield 45 g of a crude yellow 
oil. The oil was further purified via distillation under reduced pressure to yield dimethyl 
methylpentylmalonate (399, 30.9 g, 143 mmol, 70%) as a clear oil: bp 116°C, 20 mmHg. 
(CAS No. 98061-04-2).
iH and ^^C NMR in complete agreement with that previously reported^^^.
(±)-Methyl 2-methylheptanoate (400):
Decarbalkoxylation was effected via the method of Krapcho^^^: A suspension of dimethyl 
methylpentylmalonate (399, 30.9 g, 143 mmol), sodium chloride (17.0 g, 291 mmol) and 
water (3 mL, 3.0 g, 167 mmol) in DMSO (150 mL) was stirred vigorously at reflux for 48 h. 
The mixture was then allowed to cool to rt and partitioned between H2O (300 mL) and Et20
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(100 mL). The layers were separated and the aqueous phase extracted (4x75 mL Et20). The 
combined organic extracts were washed successively with H2O (4x75 mL), brine (75 mL), 
dried (MgSO^) and then concentrated in vacuo to yield 16.9 g of a light brown oil. Further 
purification was effected by distillation under reduced pressure to yield (±)-methyl 2- 
methylheptanoate (400, 14.4 g, 101 mmol, 71%) as a clear oil: bp 86-88°C, 20 nrniHg. (lit.^^  ^
bp 78-80°C, 21 mmHg. CAS No. 51209-78-0).
13C NMR (67.5 MHz, CDCI3): 5=  177.4 (0), 51.47 (3), 39.6 (1), 33.9 (2), 31.8 (2), 27.0
(2), 22.6 (2), 17.1 (3), 14.1 (3) ppm.
(±)-2-Methylheptanal (401):
A stirred solution of (±)-methyl 2-methylheptanoate (400, 1.03 g, 6.0 mmol) in anhydrous 
CH2CI2 (25 mL) under N2(g) at -78°C was treated dropwise with diwobutylaluminium hydride 
(DIBAL-H, 4.1 mL, 1.5 M in PhMe, 6.15 mmol) over 5 min . After stirring for 2 h, sat. 
NH4Cl(aq) (10 mL) was added and the mixture allowed to warm slowly to rt. The resultant 
jellified biphasic system was then poured into an aqueous solution of potassium sodium tartrate 
(5 g in 30 mL H2O) and stirred vigorously for 30 min. Et20 (30 mL) was then added and the 
layers shaken and separated. The aqueous phase was extracted (3x10 mL Et20) and the 
combined organic extracts washed with brine (10 mL), dried (MgS04) and then concentrated in 
vacuo. The residue was further purified via column chromatography (eluting with 5% Et20 in 
hexanes) to yield (±)-2-methylheptanal (401, 0.66 g, 5.2 mmol, 86%) as a clear oil. (CAS 
No. 16630-91-4).
IR (film): v = 2931 (s), 2860 (m), 1729 (s), 1462 (m), 1378 (w), 1241 (w), 1108 (w), 926 
(w) cm-i.
^H NMR in agreement with that previously reported^
(±)-2-M ethyl-l-heptanoI (402):
To a stirred suspension of lithium aluminium hydride (3.9 g, 103 mmol) in anhydrous Et20 
(150 mL) under N2(g) at 0°C was added dropwise (±)-methyl 2-methylheptanoate (400, 14.4 
g, 101 mmol) in anhydrous Et20 (75 mL) at such a rate as to maintain a gentle reflux (CARE! 
total addition complete after 30 min). The reaction mixture was then stirred at rt 0/N  before 
being cooled to 0°C and the excess reductant quenched by dropwise addition of EtOAc (25 mL, 
CARE!). Sat. NH4Cl(aq) (100 mL) was then added cautiously and mixture stirred vigorously 
for 15 min. The resultant precipitate was then removed by filtration through a celite pad and the 
residue washed well with Et20 (2x100 mL) and H2O (100 mL). The layers of the biphasic 
filtrate were separated and the aqueous phase extracted (2x50 mL Et20). Combined organic 
extracts were washed with brine (150 mL), dried (MgSÛ4) and then concentrated in vacuo .
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The residue (11.8 g) was further purified via distillation under reduced pressure to yield (±)-2- 
methyl-1-heptanol (402, 11.1 g, 85 mmol, 84%) as a clear oil: bp 94-100°C, 20 mmHg. 
(lit.161 bp 184-185°C, 760 mmHg. CAS No. 60435-70-3).
IR (film): v = 3336 (s, br), 2927 (s), 1466 (m), 1379 (w), 1033 (m), 987 (w) cm-i.
iH NMR (270 MHz, CDCI3): 5 =  3.51 (IH, dd, J = 10.4, 5.8 Hz), 3.41 (IH, dd, J  = 10.4,
6.6 Hz), 1.67-1.47 (IH, m), 1.47-1.17 (7H, m), 1.17-1.02 (IH, m), 0.91 (3H, d, 7 = 6.6 
Hz), 0.89 (3H, t, 7 = 6.8 Hz) ppm.
13C NMR (67.5 MHz, CDCI3): 5 =  68.3 (2), 35.8 (1), 33.3 (2), 32.3 (2), 26.8 (2), 22.8 (2),
16.7 (3), 14.2 (3) ppm.
(±)-l-Brom o-2-m ethylheptane (403):
To stirred (±)-2-methyl-1-heptanol (402, 6.5 g, 50 mmol) under N2(g) at 0°C was added 
dropwise phosphorous tribromide (2.4 mL, p  =2.85, 6.8 g, 25 mmol) and the mixture stirred 
at 80°C for 2 h. TLC analysis then indicated complete loss of starting material. The reaction 
mixture was then cooled to 0°C and ice (3 g) added (CARE! HBr evolved). After gas evolution 
had ceased the aftermath was partitioned between Et20 (20 mL), H2O (20 mL) and the layers 
separated. The aqueous phase was extracted (3x10 mL Et20) and the combined organic 
extracts washed with H2O (2x10 mL), brine (10 mL), dried (MgSO^) and then concentrated in 
vacuo. The residue (9.0 g) was distilled under reduced pressure to yield only 3.9 g of the title 
bromide: bp 48-49°C, 20 mmHg (lit.^^  ^72°C, 11 mmHg). The residue was treated with further 
phosphorous tribromide (5 mL, 52 mmol) as above and then heated at 100°C for 1 h. After an 
identical work-up procedure the crude product was combined with the original distillate (not 
completely pure) and further purified via column chromatography (eluting with 5% Et20 in 
hexanes) to yield (±)-1 -bromo-2-methylheptane (403, 6.5 g, 34 mmol, 68%) as a clear oil. 
(CAS No. 72279-59-5).
IH NMR (270 MHz): 8 = 3.40 (IH, dd, 7 = 9.7, 5.0 Hz), 3.32 (IH, dd, 7 = 9.9, 6.0 Hz), 
1.90-1.75 (IH, m), 1.55-1.15 (8H, m), 1.01 (3H, d, 7 = 6.6 Hz), 0.89 (3H, t, 7 = 6.6 Hz) 
ppm.
13C NMR (67.5 MHz): 8 = 41.7 (2), 35.4 (1), 35.0 (2), 32.1 (2), 26.7 (2), 22.8 (2), 19.0
(3), 14.2 (3) ppm.
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Thiol alkylation method A (Table 2):
In a typical experiment a stirred solution/suspension of the heterocyclic thiol (5 mmol) in EtOH 
(50 mL) under N2(g) was treated with finely powdered potassium hydroxide (0.3 g, 5.4 mmol) 
and the mixture stirred at reflux for 2 h. The neat alkyl bromide (5.7 mmol) was then added 
dropwise and the reaction mixture stirred at reflux O/N. After allowing the resultant suspension 
to cool the solvent was then removed in vacuo. The residue was then partitioned between H2O 
(30 mL) and CH2CI2 (30 mL) and the layers separated. The aqueous layer was extracted (2x20 
mL CH2CI2) and the combined organic extracts washed with brine (20 mL), dried (MgSO^) 
and then concentrated in vacuo. The residue was then purified via column chromatography.
Thiol alkylation method B (Table 2):
In a typical experiment a stirred solution of the heterocyclic thiol (3.8 mmol), 
triphenylphosphine (1.13 g, 4.3 mmol) and the alcohol (3.6 mmol) in anhydrous THE under 
N2 at -5°C was treated dropwise with neat diwopropylazodicarboxylate (DIAD, 0.85 mL, p = 
1.027, 0.87 g, 4.3 mmol). The mixture was stirred for 1 h then allowed to warm to rt and 
stirred O/N. The solvent was then removed in vacuo and the residue further purified via 
column chromatography.
2-(Dodecylthio)henzothiazole (89):
2-Mercaptobenzothiazole (1.70 g, 10.0 mmol) was alkylated with 1-bromododecane (2.5 mL, 
11 mmol) via method A to afford 2-(dodecylthio)benzothiazole (89, 2.71 g, 8.1 mmol, 81%) 
as a clear oil.
IR (film): v= 2922 (s), 2852 (s), 1462 (s), 1428 (s), 1309 (m), 1275 (w), 1239 (m), 1125 
(w), 1077 (w), 995 (s), 754 (s), 725 (s) cm-i.
>H NMR (300 MHz); 5 = 7.88 (IH, dm, J = 7.4 Hz), 7.75 (IH, dm, 7 = 8.1 Hz), 7.42 (IH, 
td, J  = 7.7, 1.5 Hz), 7.32-7.25 (IH, m), 3.35 (2H,t, J  = 7.4 Hz), 1.83 (2H, quintet, J  = 7.5 
Hz), 1.54-1.42 (2H, m), 1.36-1.24 (16H, m), 0.91 (3H, t, 7 = 7.0 Hz) ppm.
>3C NMR (75 MHz): 5 =  167.6 (0), 153.5 (0), 135.3 (0), 126.1 (1), 124.2 (1), 121.6 (1),
121.0 (1), 33.8 (2), 32.1 (2), 29.8 (2), 29.8 (2), 29.7 (2), 29.5 (2), 29.4 (2), 29.3 (2), 29.0 
(2), 22.9 (2), 14.3 (3) ppm.
LRMS (electrospray); m/z = 336 (M+H)+.
2-(Dodecylthio)pyridine (90):
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2-Mercaptopyridine (1.1 Ig, 10.0 mmol) was alkylated with 1-bromododecane (2.5 mL, 11 
mmol) via method A to afford 2-(dodecylthio)pyridine (90, 2.79 g, 10.0 mmol, 100%) as a 
clear oil.
IR ( f i l m ) :  V = 2922 (s), 2853 (s), 1579 (s), 1556 ( m ) ,  1454 ( m ) ,  1414 ( m ) ,  1281 ( w ) ,  1125 
(s), 1043 ( w ) ,  985 ( w ) ,  756 ( m ) ,  724 ( w )  c m - i .
iR NMR (300 MHz): 5 =  8.42 (IH, dd, /  = 5.5, 2.6 Hz), 7.45 (IH, td, J  = 7.7, 2.2 Hz), 
7.16 (IH, d, 7 = 8.1 Hz), 6.97-6.92 (IH, m), 3.16 (2H, t, 7 = 7.4 Hz), 1.71 (2H, quintet, 7 
= 7.4 Hz), 1.48-1.39 (2H, m), 1.33-1.24 (16H, m), 0.88 (3H, t, 7 =  6.6 Hz) ppm.
13C NMR (75 MHz): 8=  159.8 (0), 149.6 (1), 135.9 (1), 122.2 (1), 119.2 (1), 32.1 (2),
30.3 (2), 29.8 (2), 29.7 (2), 29.5 (2), 29.4 (2), 29.1 (2), 28.9 (2), 22.9 (2), 14.3 (3) ppm.
LRMS (electrospray): m/z = 280 (M+H)+.
2>(Dodecylthio)pyrimidine (91):
2-Mercaptopyrimidine (1.12g, 10.0 mmol) was alkylated with 1-bromododecane (2.5 mL, 11 
mmol) via method A to afford 2-(dodecylthio)pyrimidine (91, 2.52 g, 9.0 mmol, 90%) as a 
crystalline solid: mp 29-31°C.
IR (film): v = 2923 (s), 2853 (s), 1566 (s), 1547 (s), 1466 (w), 1382 (s), 1205 (m), 795 (w), 
774 (w), 750 (w) cm-T
iR NMR (300 MHz): 8=  8.48 (2H, d, 7 = 4.4 Hz), 6.92 (IH, t, 7 = 4.8 Hz), 3.12 (2H, t, 7 =
7.4 Hz), 1.71 (2H, quintet, 7 = 7.4 Hz), 1.50-1.36 (2H, m), 1.35-1.10 (16H, m), 0.86 (3H, 
t, 7 =  6.6 Hz) ppm.
13C NMR (75 MHz): 8=  173.0 (0), 157.2 (1), 116.3 (1), 32.1 (2), 31.0 (2), 29.8 (2), 29.8 
(2), 29.7 (2), 29.5 (2), 29.3 (2), 29.2 (2), 29.1 (2), 22.8 (2), 14.3 (3) ppm.
LRMS (electrospray): m/z = 281 (M+H)+.
2-(Dodecylthio)-l-m ethylim idazole (92):
2-Mercapto-1 -methylimidazole (1.14g, 10 mmol) was alkylated with 1-bromododecane (2.5 
mL, 11 mmol) via method A to afford 2-(dodecylthio)-l-methylimidazole (92, 2.52 g, 8.9 
mmol, 89%) as a clear oil.
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IR ( f i l m ) :  V = 2919 (s), 2851 (s), 1509 ( w ) ,  1463 ( m ) ,  1417 ( w ) ,  1376 ( w ) ,  1278 ( m ) ,  1125 
( w ) ,  1079 ( w ) ,  913 ( w ) ,  721 ( m ) ,  681 ( m )  c m - f
IH NMR (300 MHz): ô = 7.01 (IH, d, /  = 1.5 Hz), 6.87 (IH, d, 7 =  1.5 Hz), 3.57 (3H, s),
3.01 (2H, t, 7 = 7.4 Hz), 1.62 (2H, quintet, 7 = 7.4 Hz), 1.42-1.30 (2H, m), 1.28-1.18 
(16H, m), 0.85 (3H, t, 7 = 6.6 Hz) ppm.
13C NMR (75 MHz): 0=  142.2 (0), 129.3 (1), 122.1 (1), 34.5 (2), 33.3 (3), 32.0 (2), 29.9 
(2), 29.8 (2), 29.7 (2), 29.6 (2), 29.5 (2), 29.3 (2), 28.8 (2), 22.8 (2), 14.2 (3) ppm.
LRMS (electrospray): m/z = 283 (M+H)+.
3-(D odecylthio)-4-m ethyl-l,2,4-triazole (93):
3-Mercapto-4-methyl-1,2,4-triazole (1.15g, 10.0 mmol) was alkylated with 1-bromododecane 
(2.5 mL, 11 mmol) via method A to afford 3-(dodecylthio)-4-methyl-1,2,4-triazole (93, 2.09 
g, 7.4 mmol, 74%) as a white solid: mp 68-69°C.
IR (film): v =  2931 (s), 1519 (m), 1463 (m), 1417 (m), 1381 (m), 1218 (m), 1162 (w), 1058 
(w), 998 (w), 958 (w), 885 (w), 754 (w), 723 (m), 693 (m), 648 (m) cm -f
IH NMR (300 MHz): Ô = 8.06 (IH, s), 3.50 (IH, s), 3.13 (2H, t, 7 = 8.1 Hz), 1.65 (2H,
quintet, 7 = 7.4 Hz), 1.40-1.28 (2H, m), 1.28-1.12 (16H, m), 0.78 (3H, t, 7 = 6.6 Hz) ppm.
13C NMR (75 MHz): 0=  151.1 (0), 145.1 (1), 33.3 (2), 32.0 (2), 31.0 (3), 29.7 (2), 29.6
(2), 29.6 (2), 29.4 (2), 29.2 (2), 28.7 (2), 22.8 (2), 14.2 (3) ppm.
LRMS (electrospray): m/z = 284 (M+H)+, 306 (M+Na)+, 567 (2M+H)+, 872 (3M+Na)+.
l-(DodecyIthio)/soquinoIine (94):
l-Mercaptowoquinoline (1.61g, 10.0 mmol)^^ was alkylated with 1-bromododecane (2.5 mL, 
11 mmol) via method A to afford l-(dodecylthio)woquinoline (94, 2.50 g, 7.6 mmol, 76%) as 
a clear oil.
IR (film): v = 3051 (m), 2921 (s), 2852 (2), 1620 (w), 1584 (m), 1552 (s), 1494 (m), 1466 
(m), 1337 (s), 1301 (s), 1261 (m), 1183 (w), 1148 (m), 990 (s), 813 (s), 743 (s), 676 (m) 
cm“L
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IH NMR (270 MHz): 8 = 8.32 (IH, d, 7 =  5.6 Hz), 8.23 (IH, dm, 7 = 7.7 Hz), 7.76 (IH, 
dm, 7 = 7.7 Hz), 7.66 (IH, td, 7 = 7.4, 1.4 Hz), 7.56 (IH, ddd, 7 = 7.5, 7.5, 1.4 Hz), 7.33 
(IH, d, 7 = 5.8 Hz), 3.38 (2H, t 7 = 7.3 Hz), 1.80 (2H, quintet, 7 = 7.4 Hz), 1.54-1.46 (2H, 
m), 1.40-1.15 (16H, m), 0.90 (3H, t, 7 = 6.6 Hz) ppm.
13C NMR (75 MHz): 8 = 160.0 (0), 141.9 (1), 135.4 (0), 130.2 (1), 127.2 (0), 127.1 (1),
126.9 (1), 124.7 (1), 117.0 (1), 31.9 (2), 29.8 (2), 29.7 (2), 29.6 (2), 29.6 (2), 29.4 (2),
29.3 (2), 29.2 (2), 29.1 (2), 22.7 (2), 14.2 (3) ppm.
LRMS (electrospray): m/z = 330 (M+H)+.
2-(Pentylthio)benzothiazole (95):
2-Mercaptobenzothiazole (5.0 g, 30 mmol) was alkylated with 1-bromopentane (4.1 mL, 33 
mmol) via method A to afford 2-(pentylthio)benzothiazole (95, 5.07 g, 21 mmol, 71%) as a 
clear oil.
IR (film): v =  2955 (s), 2858 (m), 1460 (s), 1428 (s), 1109 (m), 995 (s), 755 (m) cm -f
IH NMR (360 MHz, CDCI3): 8 = 7.87 (IH, dm, 7 =  8.2 Hz), 7.74 (IH, dm, 7 = 8.0 Hz),
7.40 (IH, ddd, 7 =  8.4, 7.3, 1.3 Hz), 7.27 (IH, ddd, 7 = 8.3, 7.3, 1.2 Hz), 3.34 (2H, t, 7 =
7.4 Hz), 1.82 (2H, quintet, 7 = 7.1 Hz), 1.51-1.32 (4H, m), 0.92 (3H, t, 7 = 7.2 Hz) ppm.
13C NMR (90 MHz, CDCI3): 8=  167.5 (0), 153.5 (0), 135.3 (0), 126.1 (1), 124.2 (1), 121.6
(1), 121.0 (1), 33.7 (2), 31.1 (2), 29.0 (2), 22.3 (2), 14.1 (3) ppm.
LRMS (EI+ mode): m/z = 237 (31%), 190 (37), 181 (17), 167 (100), 108 (16).
5-(Pentylthio)-l-phenyI-17f -tetrazole (96):
1-Phenyl-1/7-tetrazole-5-thiol (6.6 g, 37 mmol) was alkylated with 1-bromopentane (5.0 mL, 
40 mmol) via method A to afford 5-(pentylthio)-1 -phenyl-177 -tetrazole (96, 8.3 g, 33.5 
mmol, 90%) as a clear oil.
IR (film): v = 2957 (m), 2930 (m), 2859 (m), 1597 (m), 1500 (s), 1463 (m), 1411 (s), 1386 
(s), 1298 (w), 1277 (m), 1242 (m), 1108 (s), 1055 (m), 1015 (m), 980 (w), 761 (s), 694 (m), 
617 (w) cm -f
IH NMR (200 MHz, CDCI3): 8 = 7.63-7.50 (5H, m), 3.38 (2H, t, 7 = 7.2 Hz), 1.81 (2H, 
quintet, 7 =  7.3 Hz), 1.52-1.23 (4H, m), 0.89 (3H, t, 7 =  7.0 Hz) ppm.
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13C NMR (50 MHz, CDCI3): ô=  154.6 (0), 133.8 (0), 130.2 (1), 129.9 (1), 123.9 (1), 33.4
(2), 30.9 (2), 28.9 (2), 22.2 (2), 14.0 (3) ppm.
LRMS (EI+ mode): v =  248 (8%), 220 (7), 163 (7), 150 (17), 135 (6), 118 (100), 91 (19), 77 
(34).
(±)-2-(2-M ethylheptylthio)benzothiazole (97):
2-Mercaptobenzothiazole (0.64 g, 3.8 mmol) was alkylated with (±)-2-methyl-1 -heptanol 
(402, 0.47 g, 3.6 mmol) via the Mitsunobu conditions of method B to yield (±)-2-(2- 
methylheptylthio)benzothiazole (97, 0.90 g, 3.2 mmol, 89%) as a clear oil.
IR (film): v = 2927 (s), 2870 (s), 1461 (s), 1428 (s), 1377 (m), 1309 (m), 1239 (m), 1125 
(w), 1077 (m), 995 (s), 755 (s), 726 (s) cm"L
IH NMR (270 MHz): ô = 7.87 (IH, d, 7 = 8.1 Hz), 7.74 (IH, d, 7 = 7.9 Hz), 7.41 (IH, t, 7 
= 7.7 Hz), 7.27 (IH, t, 7 = 8.1 Hz), 3.41 (IH, dd, 7 = 13.3, 5.6 Hz), 3.20 (IH, dd, 7 = 
14.0, 7.5 Hz), 2.05-1.80 (IH, m), 1.60-1.20 (8H, m), 1.08 (3H, d, 7 = 6.8 Hz), 0.91 (3H, 
t, 7 = 6.3 Hz) ppm.
13C NMR (67.5 MHz): 5=  167.8 (0), 153.4 (0), 135.3 (0), 126.0 (1), 124.1 (1), 121.5 (1),
121.0 (1), 40.8 (2), 36.2 (2), 33.3 (1), 32.0 (2), 26.7 (2), 22.7 (2), 19.5 (3), 14.2 (3) ppm.
LRMS (electrospray): m/z = 280 (M+H)+.
(±)-4-M ethyl-3-(2-m ethyIheptylthio)-l,2,4-triazole (98):
3-Mercapto-4-methyl-1,2,4-triazole (0.58 g, 5.0 mmol) was alkylated with (±)-l-bromo-2- 
methylheptane (403, 1.10 g, 5.7 mmol) via method A to afford (±)-4-methyl-3-(2- 
methylheptylthio)-1,2,4-triazole (98, 1.14 g, 5.0 nunol, 100%) as a clear oil.
IR (film): v =  3412 (hr, s), 3110 (m), 2921 (s), 1514 (s), 1463 (s), 1422 (s), 1378 (m), 1199 
(s), 1161 (m), 1065 (w), 954 (w), 725 (w), 690 (m) cm -f
iH NMR (270 MHz):8 = 8.04 (IH, s), 3.50 (3H, s), 3.18 (IH, dd, 7 = 12.6, 5.8 Hz), 3.00 
(IH, dd, 7 = 12.4, 7.5 Hz), 1.84-1.65 (IH, m), 1.45-1.05 (8H, m), 0.93 (3H, d, 7 = 6.6 
Hz), 0.77 (3H, t, 7 = 6.8 Hz) ppm.
13C NMR (270 MHz): 8=  151.3 (0), 144.9 (1), 40.4 (2), 35.8 (2), 33.1 (1), 31.9 (2), 30.8
(3), 26.4 (2), 22.5 (2), 19.0 (3), 13.9 (3) ppm.
102
LRMS (electrospray): m/z = 455 (2M+H)+, 477 (2M+Na)+, 493 (2M+K)+. 
(±)-l-(2-M ethylheptylthio)/soquinoline (99);
1-Mercaptowoquinoline (0.45 g, 2.8 mmol)^^ was alkylated with (±)-2-methyl-l-heptanol 
(402, 0.36 g, 2.8 mmol) via the Mitsunobu conditions of method B to yield (±)-l-(2- 
methyIheptyIthio)ijoquinoline (99, 0.36 g, 1.3 mmol, 47%) as a clear oil.
IR (film): v = 2925 (s), 1620 (w), 1584 (m), 1551 (m), 1494 (m), 1456 (m), 1375 (w), 1337 
(m), 1314 (m), 1261 (m), 1183 (w), 1148 (m), 990 (s), 814 (s), 743 (m), 676 (m), 648 (m) 
cm~L
IH NMR (270 MHz): Ô = 8.32 (IH, d, 7 = 5.6 Hz), 8.28 (IH, d, 7 =  8.3 Hz), 7.74 (IH, d, 7 
= 7.9 Hz), 7.65 (IH, t, 7 = 7.3 Hz), 7.55 (IH, t, 7 = 7.9 Hz), 7.32 (IH, d, 7 =  5.6 Hz), 3.49 
(IH, dd, 7 =  12.6, 5.6 Hz), 3.25 (IH, dd, 7 =  12.7, 7.5 Hz), 2.00-1.80 (IH, m), 1.65-1.20 
(8H, m), 1.11 (3H, d, 7 = 6.6 Hz), 0.92 (3H, t, 7 = 6.8 Hz) ppm.
13C NMR (67.5 MHz): 5=  160.3 (0), 142.9 (1), 135.5 (0), 130.3 (1), 127.4 (0), 127.2 (1),
127.0 (1), 124.9 (1), 117.1 (1), 37.0 (2), 36.7 (2), 33.3 (1), 32.2 (2), 26.9 (2), 22.8 (2),
19.8 (3), 14.3 (3) ppm.
LRMS (electrospray): m/z = 274 (M+H)+, 
(±)-5-(2-M ethylheptylthio)-l-phenyl-lH -tetrazole (100):
1-Phenyl-lH-tetrazole-5-thiol (0.68 g, 3.8 mmol) was alkylated with (±)-2-methyl-l-heptanol 
(402, 0.47 g, 3.6 mmol) via the Mitsunobu conditions of method B to yield (±)-5-(2- 
methy Ihepty Ithio)-1 -phenyl-1 H-tetrazole (100, 0.93 g, 3.2 mmol, 89%) as a clear oil.
IR (film): v = 2926 (s), 2856 (s), 1598 (m), 1501 (s), 1462 (m), 1410 (m), 1386 (s), 1279 
(w), 1241 (m), 1088 (m), 1015 (m), 761 (s), 695 (s) cm~L
iH NMR (270 MHz): 5=  7.60-7.50 (5H, m), 3.44 (IH, dd, 7 = 13.8, 5.8 Hz), 3.23 (IH, dd, 
7 = 12.6, 7.3 Hz), 2.00-1.75 (IH, m), 1.60-1.15 (8H, m), 1.01 (3H, d, 7 = 6.6 Hz), 0.85 
(3H, t, 7 = 6.5 Hz) ppm.
13C NMR (67.5 MHz): 154.8 (0), 133.9 (0), 130.1 (1), 129.8 (1), 123.9 (1), 40.6 (2),
35.9 (2), 33.0 (1), 32.0 (2), 26.5 (2), 22.6 (2), 19.2 (3), 14.1 (3) ppm.
LRMS (electrospray): m/z = 291 (M+H)+, 581 (2M+H)+.
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Sulfide oxidation method (Table 2):
In a typical experiment a stirred suspension of the heterocyclic sulfide (10 mmol) and 
NaHC0 3 (s) (4.2 g, 50 mmol) in CH2CI2 (50 mL) at 0°C was treated portionwise with 3- 
chloroperoxybenzoic acid (m-CPBA, 8.7 g, 50 wt.%, 25 mmol). The mixture was stirred for 2 
h and then allowed to warm to rt and stirred O/N. After this time the mixture was poured into 
sat. Na2S203/N aH C0 3 (aq) (80 mL), stirred vigorously for 30 min and then the layers 
separated. The aqueous phase was extracted (2x30 mL CH2CI2) and the combined organic 
extracts washed successively with sat. NaHC03(aq) (30 mL), brine (30 mL), dried (MgS04) 
and then concentrated in vacuo. The residue was then further purified via column 
chromatography.
2 -(Dodecylsulfonyl)benzothiazole (1 0 1 ):
2-(Dodecylthio)benzothiazole (89, 2.71 g, 8.1 mmol) was oxidised via the above procedure to 
yield 2-(dodecylsulfonyl)benzothiazole (101, 1.52 g, 4.1 mmol, 51%) as a white solid: mp 
58-60°C.
IR (CHCI3): V = 2928 (s), 2856 ( m ) ,  1472 ( m ) ,  1333 (s), 1220 (s), 1147 (s) c m - f
iH NMR (270 MHz, CDCI3): ô = 8.22 (IH, dm, J  = 7.3 Hz), 8.02 (IH, dm, J  = 6.8 Hz), 
7.64 (IH, td, J  = 7.2, 1.6 Hz), 7.59 (IH, td, J  = 7.1, 2.1 Hz), 3.55-3.46 (2H, m), 1.94-1.76 
(2H, m), 1.46-1.38 (2H, m), 1.32-1.18 (16H, m), 0.87 (3H, t, 7 =  6.6 Hz) ppm.
13C NMR (75 MHz, CDCI3): <5= 166.1 (0), 152.9 (0), 136.9 (0), 128.2 (1), 127.8 (1), 125.6
(1), 122.5 (1), 54.9 (2), 32.0 (2), 29.7 (2), 29.6 (2), 29.5 (2), 29.3 (2), 29.1 (2), 28.4 (2),
22.8 (2), 22.4 (2), 14.3 (3) ppm.
LRMS (electrospray): m/z = 757 (2M+Na)+.
Anal. Calcd. for C19H29NO2S2 (M = 367): C, 62.08; H, 7.95; N, 3.81; S, 17.45. Found: C, 
62.32; H, 8.26; N, 3.70; S, 16.18.
2-(DodecyIsuIfonyl)pyridine (102):
2-(Dodecylthio)pyridine (90, 2.79 g, 10.0 mmol) was oxidised via the above procedure to 
yield 2-(dodecylsulfonyl)pyridine (102, 2.18 g, 7.0 mmol, 70%) as a white solid: mp 39- 
42«C.
IR (film): v = 2854 (s), 1579 (m), 1455 (m), 1428 (m), 1317 (s), 1164 (s), 1114 (m), 1083 
(m), 992 (m), 776 (m) cm"L
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iH NMR (270 MHz, CDCI3): ô = 8.70 (IH, ddd, J  = 5.5, 1.8, 1.1 Hz), 8.04 (IH, dt, /  = 
7.7, 1.1 Hz), 7.93 (IH, td, J  = 7.7, 1.7 Hz), 7.52 (IH, ddd, J  = 7.5, 4.8, 1.4 Hz), 3.36- 
3.28 (2H, m), 1.73-1.60 (2H, m), 1.39-1.26 (2H, m), 1.22-1.14 (16H, m), 0.81 (3H, t, 7 = 
6.7 Hz) ppm.
13C NMR (75 MHz, CDCI3): 0=  157.3 (0), 150.4 (1), 138.4 (1), 127.5 (1), 122.3 (1), 52.0 
(2), 32.0 (2), 29.7 (2), 29.6 (2), 29.4 (2), 29.3 (2), 29.1 (2), 28.4 (2). 22.8 (2), 22.2 (2),
14.2 (3) ppm.
LRMS (electrospray): m/z = 312 (M+H)+, 623 (2M+H)+, 645 (2M+Na)+, 956 (3M+Na)+.
Anal. Calcd. for C17H29NO2S (M = 311): C, 65.55; H, 9.38; N, 4.50; S, 10.29. Found: C, 
65.80; H, 9.93; N, 4.53; S, 9.06.
2-(Dodecylsulfonyl)pyrim idine (103):
2-(Dodecylthio)pyrimidine (91, 2.52 g, 9.0 mmol) was oxidised via the above procedure to 
yield 2-(dodecylsulfonyl)pyrimidine (103, 1.90 g, 6.1 mmol, 68%) as a white solid: mp 65- 
680C.
IR (CHCI3): V = 2923 (s), 2856 (s), 1566 (s), 1466 (m), 1389 (s), 1325 (s), 1235 (m), 1125 
(s) cm -f
iH NMR (270 MHz): Ô = 8.93 (2H, d, 7 = 4.8 Hz), 7.58 (IH, t, 7 = 4.7 Hz), 3.52-3.44 (2H, 
m), 1.87-1.73 (2H, m), 1.45-1.30 (2H, m), 1.25-1.17 (16H, m), 0.83 (3H, t, 7 = 6.6 Hz) 
ppm.
13C NMR (75 MHz): 0=  165.9 (0), 158.9 (1), 124.1 (1), 51.5 (2), 32.0 (2), 29.7 (2), 29.6 
(2), 29.4 (2), 29.3 (2), 29.1 (2), 28.5 (2), 22.8 (2), 22.1 (2), 14.2 (3) ppm.
LRMS (electrospray): m/z = 313 (M+H)+, 647 (2M+Na)+, 959 (3M+Na)+.
Anal. Calcd. for C16H28N2O2S (M = 312): C, 61.50; H, 9.03; N, 8.97; S, 10.26. Found: C, 
61.71; H, 9.36; N, 8.96; S, 10.15.
2-(DodecyIsuIfonyl)-l-methyIim idazole (104):
2-(DodecyIthio)-1 -methylimidazole (92, 2.52 g, 8.9 mmol) was oxidised via the above 
procedure to yield 2-(dodecylsulfonyl)-l-methylimidazole (104, 1.88 g, 6.0 mmol, 67%) as a 
white solid: mp 45-48°C.
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IR (film): v =  2920 (s), 2852 (s), 1469 (s), 1320 (s), 1279 (m), 1182 (w), 1125 (s), 915 (w), 
782 (m), 720 (w), 680 (w), 632 (w) cm~’.
'H  NMR (270 MHz): J  = 7.10 (IH, d, 7 = 1.0 Hz), 6.99 (IH, d, 7 = 0.8 Hz), 3.96 (3H, s), 
3.45-3.36 (2H, m), 1.85-1.72 (2H, m), 1.40-1.30 (2H, m), 1.25-1.20 (16H, m), 0.85 (3H, 
t, 7 = 6.7 Hz) ppm.
1% NMR (75 MHz): S=  142.1 (0), 129.2 (1), 125.6 (1), 55.2 (2), 35.2 (3), 32.0 (2), 29.7
(2), 29.6 (2), 29.4 (2), 29.4 (2), 29.1 (2), 28.3 (2), 22.8 (2), 22.2 (2), 14.2 (3) ppm.
LRMS (electrospray): m/z = 315 (M-tH)+, 629 (2M-tH)+, 651 (2M-t-Na)+.
Anal. Calcd. for C16H30N2O2S (M = 314): C, 61.11; H, 9.62; N, 8.91; S, 10.20. Found: C, 
61.91; H, 10.12; N, 8.96; S, 9.56.
3-(D odecylsulfonyl)-4-m ethyl-l,2,4-triazole (105):
3-(Dodecylthio)-4-methyl-1,2,4-triazole (93, 2.09 g, 7.4 mmol) was oxidised via the above 
procedure to yield 3-(dodecylsulfonyl)-4-methyl-1,2,4-triazole (105, 1.24 g, 3.9 mmol, 53%) 
as a white solid: mp 77-80°C.
IR (CHCI3): v = 2927 (s), 2856 (s), 1511 (m), 1467 (m), 1329 (s), 1198 (m), 1139 (s) cm-i.
>H NMR (270 MHz): 5 =  8.21 (IH, s), 3.95 (3H, s), 3.63-3.52 (2H, m), 1.95-1.80 (2H, m), 
1.50-1.30 (2H, m), 1.30-1.05 (16H, m), 0.84 (3H, t, 7 = 6.5 Hz) ppm.
NMR (75 MHz): S = 151.6 (0), 146.7 (1), 55.3 (2), 33.0 (3), 32.0 (2), 29.7 (2), 29.6
(2), 29.4 (2), 29.4 (2), 29.1 (2), 28.3 (2), 22.8 (2), 22.1 (2), 14.2 (3) ppm.
LRMS (electrospray): m/z = 316 (M-tH)+, 631 (2M+H)+, 653 (2M+Na)+.
I-(D odecylsulfonyl)isoquinoline (106):
l-(Dodecylthio)(Soquinoline (94, 2.38 g, 7.2 mmol) was oxidised via the above procedure to 
yield l-(dodecylsulfonyl)isoquinoline (106, 2.0 g, 5.5 mmol, 77%) as a white solid: mp 59- 
60“C.
IR (film): v =  2908 (s), 1583 (w), 1467 (m), 1371 (w), 1302 (s), 1130 (s), 833 (m), 750 (m)
cm-1
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iR NMR (270 MHz): 8 = 9.02 (IH, dm, J = 8.5 Hz), 8.48 (IH, d, J = 5.4 Hz), 7.91 (IH, 
dm, J = 7.2 Hz), 7.84 (IH, d, J = 5.6 Hz), 7.78 (IH, ddd, J = 6.8, 6.8, 1.5 Hz), 7.72 (IH, 
ddd, J  = 6.8, 6.8, 1.4 Hz), 3.73-3.67 (2H, m), 2.03-1.87 (2H, m), 1.56-1.40 (2H, m), 1.40-
1.20 (16 H, m), 0.87 (3H, t, 7 = 6.6 Hz) ppm.
13C NMR (75 MHZ): 8=  156.3 (0), 140.1 (1), 137.7 (0), 131.3 (1), 129.2 (1), 127.5 (1),
125.1 (1), 125.1 (1), 124.0 (0), 52.3 (2), 31.9 (2), 29.6 (2), 29.5 (2), 29.3 (2), 29.3 (2),
29.1 (2), 28.5 (2), 22.7 (2), 22.2 (2), 14.1 (3) ppm.
LRMS (electrospray): m/z = 362 (M+H)+, 384 (M+Na)+, 426, 745 (2M+Na)+.
Anal. Calcd. for C21H31NO2S (M = 361): C, 69.76; H, 8.64; N, 3.87; S, 8.87. Found: C, 
69.98; H, 8.89; N, 3.70; S, 8.32.
2-(Pentylsulfonyl)benzothiazole (107):
2-(Pentylthio)benzothiazole (95, 4.9 g, 21 mmol) was oxidised via the above procedure to 
yield 2-(pentylsulfonyl)benzothiazole (107, 5.65 g, 21 mmol, 100%) as a white solid: 48- 
49°C. (CAS No. 19094-29-2).
IR (film): V = 2932 (w), 2872 (w), 1472 (m), 1458 (w), 1329 (s), 1146 (s), 1126 (w), 1108 
(w), 1087 (w), 1025 (w), 853 (w), 763 (m), 628 (w), 592 (w), 424 (w), 404 (w) cm -f
iR NMR (200 MHz, CDCI3): 8 = 8.21 (IH, dm, 7 =  8.0 Hz), 8.02 (IH, dm, 7 =  7.0 Hz), 
7.69-7.53 (2H, m), 3.54-3.45 (2H, m), 1.97-1.79 (2H, m), 1.50-1.22 (4H, m), 0.86 (3H, t, 
J = 1.0 Hz) ppm.
13c NMR (50 MHz, CDCI3): 8=  165.9 (0), 152.8 (0), 136.8 (0), 128.1 (1), 127.7 (1), 125.5
(1), 122.5 (1), 54.8 (2), 30.3 (2), 22.1 (2), 22.0 (2), 13.8 (3) ppm.
LRMS (EI+ mode): m/z = 269 (7%), 177 (39), 162 (62), 135 (100), 108 (12), 90 (10).
5-(PentyIsulfonyI)-l-phenyI-17f-tetrazole (108):
5-(Pentylthio)-l-phenyl-l//-tetrazole (96, 2.19 g, 8.8 mmol) was oxidised via the above 
procedure to yield 5-(pentylsulfonyl)-l-phenyl-l//-tetrazole (108, 1.60 g, 5.7 mmol, 65%) as 
a white solid: mp 38-40°C (f-PrOH).
IR (film): v=  2959 (w), 2933 (w), 2874 (w), 1498 (w), 1464 (w), 1384 (w), 1340 (m), 1229 
(w), 1151 (m), 1107 (s), 1048 (m), 764 (w), 618 (m), 519 (w) cm“L
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m  NMR (200 MHz, CDCI3): d = 7.75-7.54 (5H, m), 3.78-3.68 (2H, m), 2.02-1.87 (2H, 
m), 1.57-1.32 (4H, m), 0.92 (3H, t, 7 =  7.0 Hz) ppm.
13C NMR (50 MHz, CDCI3): ô=  153.6 (0), 133.2 (0), 131.6 (1), 129.8 (1), 125.2 (1), 56.1
(2), 30.3 (2), 22.2 (2), 21.8 (2), 13.8 (3) ppm.
LRMS (CI+ mode, wobutane): m/z = 578 (13), 561 (50), 337 (35), 298 (26), 281 (100).
Anal. Calcd. for C12H 16N4O2S (M = 280): C, 51.41; H, 5.75; N, 19.98. Found C, 51.44; H, 
5.82; N, 20.01.
(±)-2-(2-M ethyIheptylsulfonyl)benzothiazole (109):
(±)-2-(2-Methylheptylthio)benzothiazole (97, 0.90 g, 3.2 mmol) was oxidised via the above 
procedure to yield (±)-2-(2-methylheptylsulfonyl)benzothiazole (109, 0.68 g, 2.2 mmol, 
68%) as a clear oil.
IR (film): v = 2929 (s), 2857 (m), 1472 (m), 1324 (s), 1147 (s), 1086 (w), 1024 (w), 853 
(m), 762 (s), 730 (m), 689 (w), 631 (m) cm -f
IH NMR (270 MHz, CDCI3): 5 = 8.18 (IH, d, 7 = 7.5 Hz), 7.99 (IH, d, 7 = 7.3 Hz), 7.62 
(IH, t, 7 = 6.4 Hz), 7.56 (IH, t, 7 = 7.3 Hz), 3.55 (IH, dd, 7 = 14.3, 4.6 Hz), 3.33 (IH, dd, 
7 = 14.3, 7.9 Hz), 2.40-2.15 (IH, m), 1.55-1.10 (8H, m), 1.12 (3H, d, 7 = 6.8 Hz), 0.81 
(3H, t, 6.8 Hz) ppm.
13C NMR (67.5 MHz, CDCI3): ô = 166.8 (0), 152.7 (0), 136.8 (0), 128.1 (1), 127.7 (1),
125.4 (1), 122.4 (1), 60.8 (2), 36.6 (2), 31.6 (2), 28.6 (1), 26.0 (2), 22.5 (2), 19.9 (3), 14.0
(3) ppm.
LRMS (electrospray): m/z = 312 (M+H)+, 623 (2M+H)+, 645 (2M+Na)+, 956 (3M+Na)+. 
HRMS (CI+ mode, NH3): Found (M+H)+% 312.1072. C15H21NO2S2+H requires 312.1092.
(±)-4-M ethyI-3-(2-m ethylheptyIsuIfonyl)-l,2,4-triazoIe (110):
(±)-4-Methyl-3-(2-methylheptylthio)-1,2,4-triazole (98, 1.36 g, 6.0 mmol) was oxidised via 
the above procedure to yield (±)-4-methyl-3-(2-methylheptylsulfonyl)-1,2,4-triazole (110, 
1.13 g, 4.4 mmol, 73%) as a white solid: mp 58-60°C.
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IR (film): v = 2926 (s), 2860 (m), 1510 (m), 1463 (m), 1415 (w), 1323 (s), 1177 (m), 1131 
(s), 770 (w) cm-i.
IH NMR (270 MHz): ô = 8.21 (IH, s), 3.95 (3H, s), 3.64 (IH, dd, J  = 14.3, 4.6 Hz), 3.42 
(IH, dd, J  = 14.3, 7.9 Hz), 2.40-2.15 (2H, m), 1.55-1.40 (IH, m), 1.40-1.16 (7H, m), 1.11 
(3H, d, 7 = 6.8 Hz), 0.84 (3H, t, 7 = 6.7 Hz) ppm.
13C NMR (67.5 MHz): 8=  152.2 (0), 146.7 (1), 61.1 (2), 36.6 (2), 33.0 (1), 31.7 (2), 28.2
(3), 26.0 (2), 22.5 (2), 19.8 (3), 14.0 (3) ppm.
LRMS (electrospray): m/z = 260 (M+H)+, 519 (2M+H)+, 541 (2M+Na)+.
Anal. Calcd. for C11H21N3O2S (M = 259): C, 50.94; H, 8.16; N, 16.20; S, 12.36. Found: C, 
50.95; H, 8.56; N, 16.38; S, 11.78.
(±)-l-(2-M ethylheptyIsuIfonyl)woquinoIine (111):
(±)-l-(2-Methylheptylthio)/5oquinoline (99, 0.36 g, 1.32 mmol) was oxidised via the above 
procedure to yield (±)-l-(2-methylheptylsulfonyl)z5oquinoline (111, 0.26 g, 0.85 mmol, 
65%) as a yellow oil.
IR (film): v = 2928 (s), 1770 (w), 1583 (m), 1456 (m), 1370 (m), 1300 (s), 1216 (w), 1130 
(s), 1021 (w), 843 (m), 750 (m) cm f
IH NMR (270 MHz): 8 = 9.04 (IH, d, 7 = 8.1 Hz), 8.48 (IH, d, 7 = 5.4 Hz), 7.91 (IH, d, 7 
= 7.5 Hz), 7.83 (IH, d, 7 = 5.4 Hz), 7.77 (IH, t, 7 = 7.0 Hz), 7.72 (IH, t, 7 =  7.9 Hz), 3.77 
(IH, dd, 7 = 14.3, 4.5 Hz), 3.51 (IH, dd, 7 = 14.3, 7.7 Hz), 2.45-2.20 (IH, m), 1.62-1.45 
(IH, m), 1.40-1.15 (7H, m), 1.17 (3H, d, 7 = 6.8 Hz), 0.86 (3H, t, 7 = 6.8 Hz) ppm.
13C NMR (67.5 MHz): 8=  156.9 (0), 140.1 (1), 137.8 (0), 131.4 (1), 129.3 (1), 127.6 (1),
125.2 (1), 124.1 (0), 58.1 (2), 37.0 (2), 31.8 (2), 28.3 (1), 26.2 (2), 22.7 (2), 20.2 (3), 14.1
(3) ppm.
LRMS (electrospray): m/z = 306 (M+H)+, 611 (2M+H)+, 633 (2M+Na)+, 938 (3M+Na)+.
(±)-5-(2-M ethyIheptyIsuIfonyl)-l-phenyI-lH-tetrazoIe (112):
(±)-5-(2-Methylheptylthio)-l-phenyl-IH-tetrazole (100, 0.93 g, 3.2 mmol) was oxidised via 
the above procedure to yield (±)-5-(2-methyIheptyIsulfonyl)-1 -phenyl-1 H-tetrazole (112,0.74 
g, 2.3 mmol, 71%) as a clear oil.
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IR ( f i l m ) :  V = 2930 ( s ) ,  2859 ( s ) ,  1770 ( w ) ,  1596 ( m ) ,  1498 ( s ) ,  1463 ( m ) ,  1339 ( s ) ,  1153
( s ) ,  1076 ( w ) ,  1044 ( w ) ,  1015 ( w ) ,  919 ( w ) ,  824 ( w ) ,  763 ( s ) ,  688 ( s )  cm~K
iH NMR (270 MHz, CDCI3): ô = 7.70-7.54 (5H, m), 3.81 (IH, dd, J  = 14.5, 4.6 Hz), 3.58 
(IH, dd, J = 14.5, 7.9 Hz), 2.40-2.24 (IH, m), 1.60-1.20 (8H, m), 1.15 (3H, d, 7 = 6.8 
Hz), 0.88 (3H, t, 7 = 6.6 Hz) ppm.
13C NMR (67.5 MHz, CDCI3): S=  154.2 (0), 133.2 (0), 131.5 (1), 129.8 (1), 125.3 (1),
62.0 (2), 36.6 (2), 31.7 (2), 28.4 (1), 26.1 (2), 22.6 (2), 19.8 (3), 14.1 (3) ppm.
LRMS (electrospray): m/z = 361 (M+K)+, 667 (2M+Na)+.
HRMS (CI+ mode, NH3): Found (M+H)+*, 323.1538. C15H22N4O2S+H requires 323.1542. 
Julia olefination under Barbier conditions (Table 3):
In a typical procedure a stirred solution of the heterocyclic sulfone (0.5 mmol) and carbonyl 
compound (0.55 mmol) in anhydrous THF (5 mL) under N2(g) at -78°C was treated dropwise 
with LDA (1 mL, 0.6 M in THF, 0.6 mmol) over 1 min. The resultant coloured solution was 
stirred for 1 h and then allowed to warm to rt and stirred for a further 3 h. H2O (5 mL), Et20 
(5 mL) and a little brine (1 mL) were added and the layers shaken and then separated. The 
aqueous phase was then extracted (2x5 mL Et2Û) and the combined organic extracts dried 
(MgSÛ4). Silica (0.4 g) was then added to the ethereal solution and the solvent removed in 
vacuo. The silica adsorbed residue was then loaded onto a packed column (02  cm, 3 cm depth, 
silica) and eluted with hexanes. The pure hydrocarbon alkene products were completely 
contained within the first six 5 mL fractions.
Alkenes 113 to 121 were obtained as isomeric mixtures from the above procedure when the 
appropriate sulfone and carbonyl compounds were coupled. Yields and stereoselectivities are 
listed in Table 3. The spectroscopic data which follows for individual alkene isomers was 
typically extracted from spectra containing a mixture of all possible isomers, as such some 
spectra are incomplete and none constitute characterisation data for the compounds (isomers 
were not separable by the simple purification procedure detailed above). The following 
discussion illustrates how a given stereochemistry was assigned to a particular major isomer.
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stereochemical assignment of alkenes 113 to 121: /-gauche effects in 
NMR spectroscopy
For the majority of the alkenes given in Table 3, NMR spectra were ineffectual for the 
assignment of stereochemistry. Infact, only for the two unsymmetric disubstituted alkenes 114 
and 118 were proton spectra useful, here vicinal vinyl couplings were evident (typically for the 
trans isomer J  = 15-18 Hz, and for the cis isomer J  = 10-12 For the other alkenes so-
called /-gauche effects^^"^’^ ^^ *^ ^^  in NMR spectroscopy were used to determine the 
stereochemistry of the major isomer in a mixture.
A hydrogen bearing carbon atom which is conformationally fixed /-gauche or /-eclipsed with 
respect to another such carbon atom experiences a significant upfield shift. The effect is 
believed to be due to the forced overlap of Gc-h bonding orbitals which results in a shift of 
electron density towards the carbon nuclei thus shielding them^^ .^ Obviously such an effect can 
be used to discriminate between the two isomers of an alkene within a mixture. Figure 17 
illustrates the effect for olefin 115; when presented with the NMR spectrum containing a 
mixture of both alkenes, DEPT experiments (90° and 135°) are used to identify the two allylic 
methyl carbon resonances. The further upfield signal can be attributed to the E  isomer, here the 
allylic methyl group is sterically compressed by the adjacent chain. Providing there is a 
significant difference in the relative quantities of the two isomers present in the mixture, most, 
if not all of the peaks within the carbon spectrum can be assigned to a particular geometrical 
isomer.
5c=  25.8 ppm8c=  15.9 ppm
Figure 17
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In the following NMR assignments chemical shifts in bold signify the diagnostic resonance(s) 
for geometrical isomer assignment.
(E)-12-Tetracosene (113^): (Z)-12-Tetracosene (113c):
NMR in agreement with that 
previously reported^^" .^ (CAS No. 76665- 
54-8).
NMR in agreement with that 
previously reported^^" .^ (CAS No. 77428- 
46-7).
I l l
(£)-l-P henyl-l-tridecene (114()i (Z )-l-Phenyl-l-tridecene (114c)
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x4
iH NMR (270 MHz, CDCI3): ô = 7.50-
7.10 (5H, m, At), 6.40 (IH, d, 7 = 15.8 
Hz, HI), 6.25 (IH, dt, J  = 15.8, 6.7 Hz, 
H2), 2.23 (2H, q, J  = 7.0 Hz, H3), 1.60-
1.40 (2H, m, H4), 1.40-1.15 (16H, m), 
0.95 (3H, t, 7 = 6.7 Hz, H I3) ppm. (CAS 
No. 42036-74-8).
iH NMR (270 MHz, CDCI3): 5 = 7.50-
7.10 (5H, m, Ar), 6.43 (IH, d, 7 = 11.4 
Hz, HI), 5.70 (IH, dt, 7 = 11.6, 7.3 Hz, 
H2), 2.35 (2H, q, 7 = 7.0 Hz, H3), 1.60-
1.40 (2H, m, H4), 1.40-1.15 (16H, m), 
0.95 (3H, t, 7 = 6.7 Hz, H13) ppm. (CAS 
No. 83897-71-6).
lit.'^^ 'H  NMR (100 MHz, CDCI3, isomer mixture): S = 7.5-7.0 (5H, m), 6.55-6.00 (IHz + 
2He, m), 5.62 (IHz, dt, 7 = 12, 7 Hz), 2.4-2.2 (2H, m), 1.5-1.3 (18H, m), 0.96 (3H, m) 
ppm.
(£)-2-Phenyl-2-tetradecene (1151): (Z)-2-Phenyl-2-tetradecene (115c) :
'x7
IH NMR (270 MHz, CDCI3): S = 7.35-
7.10 (5H, m, Ar), 5.74 (IH, t, 7 = 7.3 Hz, 
H3), 2.14 (2H, q, 7 = 7.0 Hz, H4), 1.97 
(3H, s, H I), 1.45-1.10 (18H, m), 0.83 
(3H, t, 7 = 6.6 Hz, H14) ppm.
" C  NMR (67.5 MHz, CDCI3): S = 144.3 
(0, C2), 134.6 (0, Ar), 129.0 (1, Ar),
128.3 (2C, 1, Ar), 126.6 (1, C3), 125.8 
(2C, 1, Ar), 32.1 (2, C12), 29.8 (intense, 
2), 29.6 (2), 29.6 (2), 29.0 (2), 22.9 (2, 
C13), 15.9 (3, C l), 14.3 (3, C14) ppm.
14
IH NMR (270 MHz, CDCI3): S = 7.35-
7.10 (5H, m, Ar), 5.41 (IH, t, 7 = 7.3 Hz, 
H3), 1.97 (3H, s, H I), 1.91 (2H, q, 7 =
7.1 Hz, H4), 1.45-1.10 (18H, m), 0.83 
(3H, t, 7 = 6.6 Hz, H14) ppm.
" C  NMR (67.5 MHz, CDCI3): S=  142.5 
(0, C2), 136.1 (0, Ar), 128.2 (intense, 1, 
Ar), 126.5 (1, C3), 32.1 (2, C12), 30.4 
(2, C4), 29.8 (intense, 2), 29.7 (2), 29.6
(2), 29.5 (2), 29.3 (2), 25,8 (3, C l), 22.9 
(2, C l3), 14.3 (3, C14) ppm.
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(E)-7-M ethyl-7-nonadecene (116/); (Z)-7-M ethyl-7-nonadecene (116c);
iR NMR (270 MHz, CDCI3): <5 = 5.13 
(IH, t, 7 = 7.3 Hz, H8), 2.10-1.90 (4H, 
m, H6, H9), 1.59 (3H, s, C7-Me), 1.35-
1.20 (26H, m), 0.90 (6H, m, HI, H19) 
ppm.
13C NMR (67.5 MHz, CDCI3): ô=  135.3 
(0, C7), 124.8 (1, C8), 40.0  (2, C6),
32.1 (2C, 2, C3, C17), 30.2 (2, C9), 29.9 
(intense, 2), 29.6 (2), 29.2 (2), 28.2 (2),
28.1 (2), 22.9 (2C, 2, C2, C18), 16.1 (3, 
C7-Me), 14.3 (2C, 3, C l, C19) ppm.
iR  NMR (270 MHz, CDCI3): 5 = 5.13 
(IH, t, J  = 7.3 Hz, H8), 2.10-1.90 (4H, 
m, H6, H9), 1.69 (3H, s, C7-Me), 1.35-
1.20 (26H, m), 0.90 (6H, m, H I, H19) 
ppm.
13C NMR (67.5 MHz, CDCI3): ô=  135.6 
(0, Cl), 125.5 (1, C8), 32.2 (2C, 2, C3, 
C17), 32.0 (2, C6), 30.4 (2, C9), 29.9 
(intense, 2), 29.6 (2), 28.3 (2), 28.0 (2),
23.6 (3, C7-Me), 22.9 (2C, 2, C2, C18),
14.3 (2C, 3, C l, C19) ppm.
(E)-6-M ethyl-7-nonadecene (117/) : (Z)-6-M ethyl-7-nonadecene (117c) :
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13C NMR (67.5 MHz, CDCI3): 0=  136.7 
(1, C l), 128.7 (1, C8), 37.5 (2, C5),
3 6 .9  (1, C6), 32.8 (2, C17), 29.9 
(intense, 2), 29.8 (2), 29.6 (2), 29.4 (2),
27.3 (2), 22.9 (2C, 2, C2, C18), 21.2 (3, 
C6-Me), 14.3 (2C, 3, C l, C19) ppm.
13C NMR (67.5 MHz, CDCI3): 5=  136.6 
(1, Cl), 128.6 (1, C8), 37.8 (2, C5), 32.3 
(2, C3), 32.2 (2, C17), 31.9 (1, C6),
30.2 (2, C9), 29.9 (intense, 2), 29.8 (2),
29.6 (2), 27.7 (2), 27.4 (2), 22.9 (2C, 2, 
C2, C18), 21.6 (3, C6-Me), 14.3 (2C, 3, 
C l, C19) ppm.
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(£^)-3-M ethyl-l-phenyl-l-octene
(118/):
IH NMR (270 MHz, CDCI3): 5 = 7.45-
7.15 (5H, m, Ar), 6.37 (IH, d, 7 = 15.8 
Hz, HI), 6.13 (IH, dd, 7 = 15.8, 7.8 Hz, 
H2), 2.40-2.20 (IH , m, H3), 1.45-1.20 
(8H, m), 1.11 (3H, d, 7 = 6.8 Hz, C3- 
Me), 0.92 (3H, t, 7 = 5.5 Hz, H8) ppm.
13C NMR (67.5 MHz, CDCI3): 0=  138.2 
(0, Ar), 137.3 (1, C l), 128.6 (2C, 1, Ar),
128.1 (1, Ar), 126.9 (1, C2), 126.2 (2C, 
1, Ar), 37.5 (1, C3), 37.3 (2, C4), 32.2 
(2, C6), 27.3 (2, C5), 22.8 (2, Cl), 20.9 
(3, C3-Me), 14.3 (3, C8) ppm.
(Z )-3-M ethyl-l-phenyl-l-octene
(118c):
IH NMR (300 MHz, CDCI3): Ô = 7.45-
7.15 (5H, m, Ar), 6.40 (IH, d, 7 = 11.8 
Hz, H I), 5.46 (IH, dd, 7 = 11.8, 10.3 
Hz, H2), 2.83-2.70 (IH , m, H3), 1.45-
1.20 (8H, m), 1.07 (3H, d, 7 = 6.6 Hz, 
C3-Me), 0.88 (3H, t, 7 = 7.4 Hz, H8) 
ppm.
13C NMR (75 MHz, CDCI3): 8= 139.8 (1, 
C l), 128.8 (2C, 1, Ar), 128.3 (2C, 1, Ar),
127.5 (1, Ar), 126.5 (1, C2), 37.8 (2, 
C4), 32.3 (1, C3), 32.2 (2, C6), 27.2 (2, 
C5), 22.8 (2, Cl), 21.2 (3, C3-Me), 14.2 
(3, C8) ppm.
(Z)-4-M ethyl-2-phenyl-2-nonene
(119c):
13C NMR (67.5 MHz, CDCI3): 8 =  134.5 
(1, C3), 128.2 (2C, 1, Ar), 128.1 (2C, 1, 
Ar), 126.4 (1, Ar), 37.8 (2, C5), 33.1 (1, 
C4), 32.1 (2, C7), 27.2 (2, C6), 26.0 (3, 
Cl), 22.8 (2, C8), 21.7 (3, C4-Me), 14.3 
(3, C9) ppm.
(Z)-6,8-Dim ethyl-7-tetradecene
(1 2 0 c):
13C NMR (67.5 MHz, CDCI3): 8=  133.9 
(0, C8), 132.3 (1, C l), 38.1 (2, C5), 32.3 
(1, C6), 32.1 (2C, 2, C3, C12), 29.6 (2, 
C9), 28.5 (2, C ll) ,  27.5 (2, C4), 23.6  
(3, C8-Me), 22.9 (2C, 2, C2, C13), 21.8 
(3, C6-Me), 14.3 (2C, 3, C l, C14) ppm.
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(± & mcso,jE)-6,9-Dim ethyl-7-tetra- 
decene (1 2 1 /);
13c NMR (75 MHz, CDCI3): 0= 134.8 (1, 
Cl), 134.7 (1, C7), 37.4 (both isomers, 2, 
C5), 37.0 (1, C6), 36.8 (1, C6), 32.2 
(both isomers, 2, C3), 27.2 (2, C4), 27.1 
(2, C4), 22.7 (both isomers, C2), 21.3 (3, 
C 6-M e), 21.2 (3, C6-M el. 14.2 (both 
isomers. C l) ppm. (dr = 50:50)
(± & /wcso,Z)-6,9-Dim ethyl-7-tetra- 
decene (1 2 1 c):
13c NMR (75 MHz, CDCI3): 8= 135.1 (1, 
Cl), 134.9 (1, Cl), 37.8 (2, C5), 37.7 (2, 
C5), 32.2 (both isomers, 2, C3), 32.2 (1, 
C6), 32.1 (1, C6), 27.5 (2, C4), 27.4 (2, 
C4), 22.7 (both isomers, 2, C2), 21.9 (3, 
C6-M e), 21.8 (3, C6-M e), 14.2 (both 
isomers, 3, C l) ppm. (dr = 50:50)
To confirm the above stereochemical assignment the phosphorane derived from the 
triphenylphosphonium salt of (±)- l-bromo-2-methylheptane (403) was oxidatively 
homocoupled via the method of Poulain^^^ to yield an authentic sample of a 1:1 mixture of (±, 
Z)-6,9-dimethy 1-7-tetradecene and {meso, Z)-6,9-dimethyl-7-tetradecene. 13C NMR data for 
the mixture of cis olefins matches that given above.
Gas chromatography conditions for the analysis of Table 3 olefins
The following gas chromatography was carried out using a Hewlett Packard GC system fitted 
with a flame ionisation detector. Separations were effected using a HP5 capillary column (5% 
phenyl methyl silicone, dimensions 30m x 0.32 mm x 0.25 //m) at the indicated constant oven 
temperature with a helium carrier gas flow rate of 2 mL mim^.
olefin oven temp. retention time (min)
(°Q Z E
12-tetracosene (113) 200 17.0 17.6
1 -phenyl-1 -tridecene (114) 240 2.3 2.6
2-phenyl-2-tetradecene (115) 240 2.3 2.8
7-methyl-7-nonadecene (116) 200 4.6 4.9
6-methy 1-7 -nonadecene (117) 200 4.2 4.3
3-methyl-1 -phenyl-1 -octene (118) 150 4.7 6.6
4-methyl-2-phenyl-2-nonene (119) 200 1.9 2.3
6,8-dimethyl-7-tetradecene (120) 150 4.3 4.6
6,9-dimethyl-7-tetradecene (121) 130 6.9, 7.4 7.5, 7.8
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-SECTION 2.2- 
Synthesis of alkene standards from Tables 4 to 6
Each of the product olefins illustrated in Tables 4 to 6 were synthesised as described below in 
predominantly cis formvia the Schlosser modification of the Wittig reaction^^ (so-called 'salt- 
free' conditions). For general methods for the preparation of phosphonium salts see 
L aw ren cean d  references therein.
Pentyltriphenylphosphonium bromide:
To a solution of triphenylphosphine (5.5 g, 21 mmol) in benzene (20 mL) at rt under N2(g) was 
added 1-bromopentane (2.50 mL, p = 1.22, 3.1 g, 20 mmol) and the resultant solution stirred 
at reflux for 24 h. A fine white precipitate of the product salt was observed to form. The 
mixture was then allowed to cool and filtered to yield pentyltriphenylphosphonium bromide 
(3.11 g, 7.5 mmol, 38%) as a white solid: mp 158-169°C.
(±)-(2-M ethyl-l-heptyl)triphenylphosphonium bromide:
A stirred solution of triphenylphosphine (1.4 g, 5.3 mmol) in benzene (5 mL) at rt under N2(g) 
was treated with (±)-1 -bromo-2-methylheptane (403, 1.0 g, 5.2 mmol) in benzene (2 mL) and 
the resultant mixture stirred at reflux for 42 h. No precipitate was observed to form during this 
time. The solvent was then removed in vacuo. The residue {ca 2.3 g) was heated to 150°C and 
the resultant melt stirred O/N under N2(g). After this time the mixture was allowed to cool and 
the crude oil triturated' with ether (to remove soluble bromide and PPhg) to yield presumably 
(±)-(2-methyl-1 -heptyl)triphenylphosphonium bromide (1.37 g, 3.0 mmol, 58%) as a clear oil. 
It proved impossible to crystallise the salt which was later used without analysis or further 
purification.
Wittig olefination under 'salt-free' conditions'^:
To a stirred solution/suspension of phosphonium salt (1.0 mmol) in anhydrous THE (2 mL) at 
rt under N2(g) was added dropwise sodium hexamethyldisilazide (1.1 mL, 0.93 M in THE, 1.0 
mmol) and the resultant solution of ylide stirred for 5 min. The mixture was then cooled to 
-78°C and treated with the neat aldehyde (2.0 mmol). After 5 min the reaction was allowed to 
warm to rt and stirred for a further 20 min. H2O (5 mL) was then added followed by Et20 (5 
mL) and the layers separated. The aqueous phase was then extracted (5 mL Et20) and the 
combined organic extracts washed with brine (5 mL), dried (MgS04) and then concentrated in 
vacuo. The residue was then further purified via column chromatography (eluting with 
hexanes). For branched alkenes extended reaction times were employed.
(Z)-Undec-5-ene (123c):
The title alkene was prepared via the above method utilising (1-pentyltriphenylphosphonium 
bromide (420 mg, 1.02 mmol) and «-hexanal (245 /xL, p  = 0.834, 204 mg, 2.0 mmol) as
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substrates. The procedure yielded (Z)-undec-5-ene (123c, 132 mg, 0.86 mmol, 84%, Z:E > 
95:5 by NMR analysis) as a clear oil. (CAS No. 764-96-5).
13c NMR data in agreement with that previously reportedi^^.
IR (film): v = 2958 (s), 1466 (m), 1378 (w), 1104 (w), 966 (w), 908 (w), 736 (m) cm l
IH NMR (200 MHz, CDCI3): 5 = 5.44-5.29 (2H, m), 2.10-1.94 (4H, m), 1.40-1.22 (lOH, 
m), 0.90 (3H, t, 7 = 6.8 Hz), 0.89 (3H, t, 7 =  6.6 Hz) ppm.
LRMS (EI+ mode): m/z = 154 (23%), 97 (17), 84 (19), 83 (24), 70 (46), 69 (68), 67 (13), 57 
(24), 56 (60), 55 (100), 54 (17), 43 (27), 41 (54).
(Z )-l-C yclohexyl-l-hexene (125c):
The title alkene was prepared via the above method utilising pentyltriphenylphosphonium 
bromide (420 mg, 1.02 mmol) and cyclohexanecarboxaldehyde (245 /xL, p  = 0.926, 227 mg,
2.0 mmol) as substrates. The procedure yielded (Z)-1 -cyclohexyl-1 -hexene (125c, 141 mg, 
0.85 mmol, 83%, Z:E = 98:2 by GC analysis) as a clear oil. (CAS No. 17301-35-8).
iH and l3c NMR data in agreement with that previously reported*^*.
IR (film): v =  2956 (s), 1448 (m), 1406 (w), 1378 (w), 944 (w), 890 (w), 728 (m) cm-i.
LRMS (EI+ mode): m/z = 166 (43%), 109 (62), 96 (66), 81 (83), 67 (100), 55 (34), 41 (41).
(±,Z)-8 -M ethyltridec-6 -ene (126c) :
The title alkene was prepared via  the above method utilising (±)-(2-m ethyl-l- 
heptyl)triphenylphosphonium bromide (615 mg, 1.35 mmol) and «-hexanal (325 pL, p = 
0.834, 271 mg, 2.7 mmol) as substrates. The reaction was allowed 40 min for the initial ylide 
formation and left to stir at rt O/N before quenching. The procedure yielded (±,Z)-8- 
methyltridec-6-ene (126c, 56 mg, 0.29 mmol, 21%, Z:E = 94:6 by GC analysis) as a clear oil.
IR (film): v=  2928 (s), 1458 (m), 1378 (m), 1106 (w), 966 (w), 742 (m) cm-i.
m  NMR (200 MHz, CDCI3): <5 = 5.30 (IH, dt, 7 = 11.0, 7.3 Hz), 5.11 (IH, dd, 7 = 10.8,
9.6 Hz), 2.47-2.30 (IH, m), 2.08-1.93 (2H, m), 1.40-1.14 (14H, m), 0.98-0.84 (9H, m) 
ppm.
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13C NMR (90 MHz, CDCI3): ô=  136.6 (1), 128.5 (1), 37.8 (2), 32.2 (2), 31.8 (1), 31.7 (2),
29.8 (2), 27.6 (2), 27.4 (2), 22.9 (2), 22.8 (2), 21.6 (3), 14.3 (3), 14.2 (3) ppm.
LRMS (EI+ mode): m/z = 196 (9%), 125 (13), 112 (10), 97 (17), 83 (43), 69 (100), 55 (76), 
41 (39).
(± ,Z )-l-C yclohexyl-3-m ethyl-l-octene (127c):
The title alkene was prepared via  tha above method utilising (±)-(2-m ethyl-l- 
heptyl)triphenylphosphonium bromide (520 mg, 1.14 mmol) and cyclohexanecarboxaldehyde 
(275 pL, p = 0.926, 254 mg, 2.26 mmol) as substrates. The reaction was given 40 min for the 
initial ylide formation and left to stir at rt O/N before quenching. The procedure yielded (±,Z)- 
1 -cyclohexyl-3-methyl-1 -octene (127c, 74 mg, 0.36 mmol, 31%, Z:E  = 89:11 by GC 
analysis) as a clear oil.
IR (film): v = 2958 (s), 1448 (m), 1372 (w), 1270 (w), 958 (w), 890 (m), 842 (w), 746 (m) 
cm'i.
IH NMR (200 MHz, CDCI3): 5 =  5.14 (IH, dd, J  = 10.9, 8.9 Hz), 5.00 (IH, dd, 7 =  10.8,
9.7 Hz), 2.46-2.12 (2H, m), 1.78-1.52 (6H, m), 1.33-0.97 (12H, m), 0.93 (3H, d, 7 = 6.6 
Hz), 0.89 (3H, t, 7 = 7.0 Hz) ppm.
13C NMR (90 MHz, CDCI3): <5= 134.7 (1), 134.6 (1), 37.8 (2), 36.9 (1), 34.0 (2), 33.7 (2),
32.2 (2), 32.2 (1), 27.4 (2), 26.3 (2), 26.2 (2) x2, 22.9 (2), 22.0 (3), 14.3 (3) ppm.
LRMS (EI+ mode): m/z = 208 (20), 137 (12), 109 (47), 96 (82), 81 (100), 67 (74), 55 (89), 
41 (57).
(Z)-l-C ycIohexenyl-l-hexene (129c):
The title alkene was synthesised via the above method utilising pentyltriphenylphosphonium 
bromide (413 mg, 1.0 mmol) and cyclohexenecarboxaldehyde^"^ (7, 170 pL, p = 0.966, 164 
mg, 1.5 mmol) as substrates. The procedure yielded (Z)-1 -cyclohexenyl-1 -hexene (129c, 123 
mg, 0.75 mmol, 75%, Z:E  = 92:8 by GC analysis) as a clear oil. (CAS No. 85437-90-7, 
137097-94-0).
iH and NMR data in agreement with that previously reported^^^.
IR (film): v = 2928 (s), 1640 (w), 1436 (m), 1378 (w), 1340 (w), 1268 (w), 1134 (w), 1078 
(w), 962 (w), 918 (m), 852 (m), 804 (w) cm"L
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LRMS (EI+ mode): m/z = 164 (42%), 135 (31), 121 (29), 107 (31), 93 (52), 79 (100), 77 
(29), 67 (45).
(±, Z )-l-C yclohexenyl-3-m ethyl-l-octene (130c):
The title alkene was synthesised via the above method utilising (±)-(2-methyl-l- 
heptyl)triphenylphosphonium bromide (500 mg, 1.0 mmol) and cyclohexenecarboxaldehyde^'^ 
(7, 170 pL, p = 0.966, 164 mg, 1.5 mmol) as substrates. The procedure yielded (±, Z)-l- 
cyclohexeny 1-3-methyl-1 -octene (130c, 81 mg, 0.39 mmol, 39%, Z:E = 92:8 by GC analysis) 
as a clear oil.
IR (film): v = 2848 (s), 1456 (s), 1372 (w), 1340 (w), 1268 (w), 1134 (w), 1078 (w), 964 
(w), 920 (m), 854 (m), 806 (m), 762 (w), 742 (m) cm~i.
iR NMR (360 MHz, CDCI3): 5 =  5.70 (IH, d, 7 =  11.8 Hz), 5.61 (IH, m), 5.03 (IH, dd, 7 
= 11.0, 11.0 Hz), 2.75-2.65 (IH, m), 2.17-2.06 (4H, m), 1.68-1.55 (4H, m), 1.36-1.18 
(8H, m), 0.96 (3H, d, 7=  6.6 Hz), 0.89 (3H, t, 7 = 6.9 Hz) ppm.
13C NMR (90 MHz, CDCI3): 8=  136.5 (1), 135.8 (0), 130.4 (1), 126.8 (1), 38.1 (2), 32.7
(1), 32.2 (2), 29.2 (2), 27.4 (2), 25.8 (2), 23.1 (2), 22.9 (2), 22.4 (2), 21.9 (3), 14.3 (3) 
ppm.
LRMS (EH- mode): m/z = 206 (48%), 163 (3), 149 (27), 135 (100), 121 (11), 107 (37), 93 
(63), 79 (69).
(±, Z)-(l-M ethylhept-2-enyloxym ethyl)benzene (132c):
The title alkene was synthesised via the above method utilising pentyltriphenylphosphonium 
bromide (413 mg, 1.0 mmol) and 2-(benzyloxy)propanal^^ (8, 235 pL, p  = 1.048, 246 mg,
1.5 mmol) as substrates. The procedure yielded (±, Z )-(  1-m e th y lh e p t-2 -  
enyloxymethyl)benzene (132c, 184 mg, 0.84 mmol, 84%, Z:E  = 99:1 by GC analysis) as a 
clear oil.
IR (film): v = 2930 (s), 1496 (w), 1454 (m), 1368 (m), 1306 (w), 1202 (w), 1094 (s), 1068 
(s), 1028 (m), 910 (w) cm-i.
iR NMR (200 MHz, CDCI3): 8 = 7.37-7.25 (5H, m), 5.58 (IH, dt, 7 =  5.38 (IH, dd, 7 = 
10.9, 8.9 Hz), 4.59 (IH, d, 7 =  11.9 Hz), 4.37 (IH, d, 7 = 11.8 Hz), 4.31 (IH, dq, 7 = 8.8,
6.3 Hz), 2.10-1.97 (2H, m), 1.43-1.28 (4H, m), 1.27 (3H, d, 7 =  6.4 Hz), 0.91 (3H, t, 7 =
6.8 Hz) ppm.
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13C NMR (50 MHz, CDCI3): ô=  139.1 (0), 132.7 (1), 132.1 (2C, 1), 128.4 (2C, 1), 127.9
(I), 127.5 (1), 70.2 (1), 69.9 (2), 32.0 (2), 27.5 (2), 22.5 (2), 21.8 (3), 14.1 (3) ppm.
LRMS (EI+ mode): m/z = 218 (2%), 203 (1), 160 (6), 127 (3), 112 (6), 107 (6), 91 (100), 69
( I I ).
(Z)-(l,4-Dim ethylnon-2-enyloxym ethyl)benzene (133c):
The title alkene was synthesised via the above method utilising (±)-(2-methyl-l- 
heptyl)triphenylphosphonium bromide (500 mg, 1.0 mmol) and 2-(benzyloxy)propanal^^ (8, 
156 pL, p = 1.048, 163 mg, 1.0 mmol) as substrates. The procedure yielded a diastereomeric 
mixture of (Z)-(l,4-dimethylnon-2-enyloxymethyl)benzene (133c, 111 mg, 0.43 mmol, 43%, 
Z:E = 86:14 by GC analysis) as a clear oil.
IR (film): v = 2926 (s), 1496 (w), 1454 (m), 1370 (m), 1306 (w), 1202 (w), 1098 (s), 1070 
(s), 1028 (m), 734 (s), 696 (s) cm-^.
iH NMR (200 MHz, CDCI3): Ô = 7.40-7.20 (5H, m), 5.40-5.22 (2H, m), 4.61 (IH, d, 7 =
11.9 Hz, major isomer), 4.37 (IH, d, 7 =  12.1 Hz, major isomer), 4.40-4.20 (IH, m), 2.45- 
2.26 (IH, m), 1.45-1.10 (IIH , m), 1.05-0.80 (6H, m) ppm.
13C NMR (50 MHz, CDCI3, major isomer): Ô = 139.2 (0), 130.4 (1), 128.5 (1, 2C), 127.8
(1), 127.7 (1, 2C), 127.5 (1), 70.8 (1), 70.0 (2), 37.7 (2), 32.5 (1), 32.2 (2), 27.5 (2), 22.8
(2), 22.3 (3), 21.7 (3), 14.3 (3) ppm.
LRMS {EI+ mode): m/z = 260 (1%), 245 (1), 202 (1), 169 (2), 152 (14), 131 (2), 112 (3), 95 
(7), 91 (100), 69 (14).
Gas chromatography conditions for the analysis of olefins from Tables 4 to 6
With the exception of undec-5-ene (123) GC separations were effected with a Hewlett-Packard 
6890 instrument equipped with a SGE HT5 capilliary column (5% phenyl equivalent 
polysiloxane-carborane, 12 m x 0.22 mm x 0.1 pm) and flame ionisation detector (FID) 
interfaced to a HP 3395 integrator. The injector was operated in split mode (75:l)*and the 
helium carrier gas and make-up flow rates were 1.4 mL min~l and 25 mL min-i respectively. 
The injection port and detector temperatures were 255°C and 300°C respectively. [For undec-5- 
ene (123) GC separations were effected with identical hardware equipped with a DB-225 
fused silica capilliary column (50% cyanopropylphenylsilicone, 30 m x 0.32 mm x 0.25 pm). 
The injector was operated in split mode (300:1) and the helium carrier gas and make-up flow 
rates were 1.5 mL min~l and 25 mL min~l respectively. The injection port and detector
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temperatures were both set at 200°C]. All analyses were carried out by Dr W. J. Cole of the 
University of Glasgow. Alkene samples rich in cis isomer (synthesised as described above) 
were employed to calibrate the gas chromatographs against an internal dodecane standard 
[retention times are listed relative to dodecane=l; temperature programming (TP): X°C (hold 
time/min), Y ramp rate °C min~l —> Z°C (hold time/min)].
i,a_ -
ks  ^= calibration factor for standard (s), analyte (a) 
na = amount of analyte, ng = amount of standard 
Aa = area of analyte GC peak 
Ag = area of standard GC peak
olefin TP relative retention time 
Z E
^dodecane
undec-5-ene (123) 50 (2), 3 ^  90 (1) 0.80 0.78 1.090
1-cyclohexyl-1-hexene (125) 60 (2), 5 ^  90 (1), 
10 190 (5)
1.02 1.11 0.996
8-methyltridec-6-ene (126) 60 (2), 5 100 (1), 
1 0 ^  190 (5)
1.36 1.39 0.890
1 -cyclohexy 1-3-methyl-1 -octene 
(127)
70 (2), 5 120 (1), 
10 190 (5)
1.77 1.92 0.877
1-cyclohexenyl-1-hexene (129) 60 (2), 5 -4  90 (1), 
10 -4  190 (5)
1.27 1.54 1.040
1 -cyclohexeny 1-3-methyl-1 - 
octene (130)
70 (2), 5 -4 120 (1), 
10 190 (5)
2.20 2.68 0.942
( 1 -methylhept-2-enyloxy- 
methyl)benzene (132)
80 (2), 5 -4  140 (1), 
10-» 210 (5)
3.05 3.13 0.917
( 1,4-dimethylnon-2- 
enyloxymethyl)benzene (133)
80 (2), 5 -4  160 (1),
10 -4- 230 (5)
4.18
4.26
4.29
4.35
0.834
The identity of olefin peaks for each of the standard samples was verified by gas 
chromatography-mass spectrometry (GCMS). Analyses were carried out on a Hewlett-Packard 
5971 mass selective detector interfaced to a 5890 series II gas chromatograph and computer 
(Vectra QS/16S). Separations were effected with a HPl fused silica capilliary column (12.5 m 
X 0.2 mm x 0.33 pm). Injection and temperature programming conditions were identical to 
those given for GC above. Retention times from the total ion current (TIC) traces practically
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matched those of the FID chromatograms. Mass spectra (70 eV) were recorded in continuous 
scanning mode over the range m/z 40 to m/z 600 and are given above along with other 
characterisation data.
Julia olefination under pre-metallation conditions (Tables 4 to 6 ):
To a stirred solution of the sulfone (0.2 mmol) and dodecane (23 pL, p = 0.749, 17 mg, 0.1 
mmol, internal standard) in anhydrous reaction solvent (1 mL) at -78°C (-60°C in case of 
DME) under N2(g) was added dropwise the base (0.22 mmol of a ca 0.5 M solution). The 
mixture was then stirred for 30 min before being treated with the neat aldehyde (0.3 mmol). 
After stirring for a further 2 h at -78°C the reaction mixture was allowed to warm slowly to rt 
and stirred O/N. H2O (1 mL) and Et20 (2 mL) were then added and the mixture shaken well. 
The organic layer was then separated and dried (MgSO^). An aliquot of the dry organic extract 
was then diluted by a factor of 5 with further Et20 and the resultant sample subjected to GC 
analysis. The absolute quantity of alkene produced by the reaction (n^) could then be assessed 
by using the appropriate calibration factor and setting n^  = 0.1 mmol in the above relation.
Solvent preparation: Et20, THE and DME were all freshly distilled from Na / benzophenone 
directly before use. PhMe was dried by distillation from molten sodium and stored over 
activated 4Â molecular sieves under an atmosphere of N2(g). Stock solutions of lithium 
hexamethyldisilazide (LiHMDS, 0.45 M in hexanes), NaHMDS (0.54 M in PhMe) and 
KHMDS (0.44 M in PhMe) were dispensed.
Preparation of (E)-l-cyclobexyl-l-bexene (125/):
N N (a) KHMDS (199)
" if DME,-55°C, 70 min
 ^ (b) ^
Ph 108 (112) 124 125/
C1 2 H1 6 N4 O2 S (280.35) -55°C -> rt, O/N C1 2 H2 2  (166.30)
To a stirred solution of 5-(pentylsulfonyl)-l-phenyl-1//-tetrazole (108, 2.80 g, 10 mmol) in 
anhydrous DME (40 mL) under N2(g) at -55°C was added dropwise via cannular a similarly 
cooled solution of potassium hexamethyldisilazide (KHMDS, 2.74 g, 80 wt.%, 11 mmol) in 
anhydrous DME (20 mL) over 10 min. The initially yellow/orange solution darkened to a deep 
brown over the subsequent 70 min. After this time neat cyclohexanecarboxaldehyde (124,
1.80 mL, p = 0.926, 1.67 g, 15 mmol) was added dropwise over 5 min. During the following 
20 min the colour dramatically lightened to a pale yellow and TLC analysis indicated complete 
consumption of the sulfone. The reaction mixture was then allowed to stir for 1 h at -55°C 
before being allowed to warm slowly to rt O/N. The resulting orange suspension was then 
quenched by the addition of H2O (5 mL) and stirred for 1 h leaving a pale yellow 
homogeneous solution. The mixture was then diluted with Et20 (150 mL) and H2O (200 mL)
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and the layers well shaken and then separated. The aqueous phase was then extracted (3x30 
mL Et20) and the combined organic extracts washed successively with H2O (3x50 mL), brine 
(50 mL), dried (MgS04) and then concentrated in vacuo to yield 2.74 g of a crude yellow oil. 
The residue was then further purified via column chromatography (eluting with hexanes) to 
yield 1.32 g of a clear non-polar oil. Subsequent kugelrohr distillation (oven temperature 
180°C, 15 mmHg) yielded (E)-1 -cyclohexyl-1 -hexene (125/, 1.18 g, 7.1 mmol, 71%) as a 
clear oil. NMR analysis indicated the presence of only the desired trans isomer.
IR (film): V = 2926 (s), 1448 (m), 1378 (w), 1258 (w), 1044 (w), 966 (s), 892 (w), 842 (w)
cm-1
iR NMR (360 MHz, CDCI3): 8 = 5.43-5.30 (2H, m), 2.03-1.94 (2H, m), 1.94-1.84 (IH, 
m), 1.76-1.60 (5H, m), 1.37-0.99 (9H, m), 0.90 (3H, t, 7 = 6.9 Hz) ppm.
13c NMR (90 MHz, CDCI3): 8=  136.6 (1), 127.9 (1), 41.0 (1), 33.5 (2, 2C), 32.6 (2), 32.1 
(2), 26.5 (2), 26.4 (2, 2C), 22.4 (2), 14.2 (3) ppm.
(lit. 7^0 IR (film): v = 2880, 1450, 970 cm~l; iR  NMR (60 MHz, CDCI3): 8 = 5.38 (2H, m), 
2.2-0.8 (20H, m) ppm; l^C NMR (15 MHz, CDCI3): 8=  136.6, 127.8, 33.5, 32.5, 32.1, 
26.4, 22.3, 14.0 ppm).
-SECTION 2.3-
PTSH (178), EtgN (101)
CuHgéO (212.37)
MeOH, 0°C ^  rt, 7 d
m-CPBA (172.5)
NaHCOg (84)
CH2 CI2 , rt, 6  d
SOnPT
404, n = 0, C2 iHg4N4 0 S (390.59) 
134, n = 2, C2 iHg4N4 0 gS (422.59)
5-[(lJR *,2S*)-l-H exyl-2-hydroxyoctyI]thio-l-phenyl-17/-tetrazoIe (404).
To a stirred solution of 1-phenyl-l//-tetrazole-5-thiol (PTSH, 4.0 g, 22.5 mmol) and (E)-7- 
tetradecene oxide^ (1.18 g, 5.56 mmol) in MeOH (50 mL) at 0°C was added triethylamine (3.1 
mL, p  = 0.726, 2.25 g, 22.3 mmol). The resultant mixture was allowed to warm to rt and 
stirred for 7 d. After this time the solvent was removed in vacuo and the residue partitioned 
between CH2CI2 (75 mL) and sat. K2C03(aq) (75 mL). The layers were well shaken and then 
separated. The organic phase was then washed successively with sat. K2C03(aq) (3x50 mL), 
IM HCl(aq) (4x50 mL), brine (25 mL), dried (MgSO^) and then concentrated in vacuo. The 
resulting residue was then further purified via column chromatography (eluting with 5-15% 
Et20 in hexanes) to yield recovered oxirane (0.39 g, 1.84 mmol, 33%) and the sulfide 404 
(1.26 g, 3.23 mmol, 58%) as a clear oil.
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IR (film): v = 3416 (s, br), 2926 (s), 1598 (w), 1500 (m), 1464 (m), 1386 (m), 1316 (w), 
1280 (w), 1240 (w), 1074 (w), 1016 (w), 912 (w), 760 (m), 734 (m), 694 (m) 554 (w) cm~i.
IH NMR (360 MHz, CDCI3): Ô = 7.62-7.52 (5H, m), 4.10-4.04 (2H, m), 3.10-2.78 (IH, 
broad s), 1.83-1.73 (IH, m), 1.67-1.47 (5H, m), 1.43-1.20 (14H, m), 0.87 (3H, t, 7 = 6.6 
Hz), 0.85 (3H, t, 7 = 7.1 Hz) ppm.
13C NMR (90 MHz, CDCI3): 5=  154.8 (0), 133.8 (0), 130.3 (1), 129.9 (2C, 1), 124.2 (2C, 
1), 74.2 (1), 56.9 (1), 33.6 (2), 31.9 (2), 31.7 (2), 29.4 (2C, 2), 29.1 (2), 27.7 (2), 26.2 (2),
22.7 (2), 22.7 (2), 14.2 (3), 14.2 (3) ppm.
LRMS {C1+ mode, NH3): m/z = 391 (100%), 230 (9), 164 (8), 136 (16).
5-[(l/î* ,2S*)-l-H exyl-2-hydroxyoctyl]su lfonyl-l-phenyl-17/-tetrazole (134):
A stirred suspension of the sulfide 404 (900 mg, 2.30 mmol) and sodium hydrogencarbonate 
(1.0 g, 11.9 mmol) in CH2CI2 (40 mL) at rt was treated with 3-chloroperoxybenzoic acid (m- 
CPBA, 4.4 g, 50 wt.%, 12.8 mmol) and stirred vigorously for 6 d. After this time the resultant 
gel was poured into sat. Na2S203-NaHC03(aq) (50 mL) and stirred vigorously for 3 h. The 
layers were separated and the aqueous phase extracted (3x10 mL CH2CI2). The combined 
organic extracts were then washed with sat. NaHC03(aq) (2x10 mL), brine (10 mL), dried 
(MgS0 4 ) and then concentrated in vacuo. The residue was further purified via column 
chromatography (eluting with 15-20% Et20 in hexanes) to yield the sulfone 134 (486 mg,
1.15 mmol, 50%) as a white solid: mp 68-69°C (cyclohexane).
IR (film): v = 3458 (br, m), 2930 (s), 2856 (s), 1594 (w), 1500 (m), 1460 (w), 1332 (s), 
1154 (s), 1068 (m), 770 (m), 692 (m), 620 (m), 572 (w), 540 (w) cm~i.
iH NMR (360 MHz, CDCI3): 5 = 7.70-7.57 (5H, m), 4.34 (IH, dd, 7 = 8.8, 3.4 Hz), 3.76 
(IH, t, 7 = 5.6 Hz), 2.93 (IH, br s), 2.01-1.92 (2H, m), 1.75-1.65 (IH, m), 1.64-1.42 (4H, 
m), 1.37-1.23 (13H, m), 0.90 (3H, t, 7 =  6.4 Hz), 0.88 (3H, t, 7 = 6.9 Hz) ppm.
13C NMR (90 MHz, CDCI3): 5=  153.4 (0), 133.2 (0), 131.7 (1), 129.8 (2C, 1), 125.6 (2C, 
1), 70.8 (1), 69.0 (1), 34.8 (2), 31.8 (2), 31.5 (2), 29.2 (2), 29.1 (2), 28.8 (2), 26.1 (2),
22.7 (2), 22.7 (2), 22.4 (2), 14.2 (3), 14.2 (3) ppm.
LRMS (Cl4- mode, wobutane): m/z = 423 (20%), 230 (28), 147 (100).
124
Anal. Calcd. for C21H34N4O3S (M = 422): C, 59.69; H, 8.11; N, 13.26. Found C, 59.77; H, 
8.16; N, 13.27.
Base induced elimination of anti-)3-hydroxy$ulfone 134 (Scheme 19):
HO
KHMDS, DME
-60°C ^  rt, 1 .5 h
135134
C2 1 H3 4 N4 O3 S (422.59) C 1 4 H2 8  (196.37)
To a stirred solution of the )3-hydroxysulfone 134 (100 mg, 0.24 mmol) in anhydrous DME (2 
mL) at -60°C under N2(g) was added dropwise potassium hexamethyldisilazide (0.69 mL, 0.45 
M in DME, 0.31 nunol). The resultant mixture was stirred for 30 min and then allowed to 
warm slowly to it over 1 h. The reaction was then diluted with Et2Û (10 mL) and H2O (5 mL) 
and the layers shaken then separated. The aqueous phase was extracted (2x5 mL Et2Û) and the 
combined organic extracts washed with H2O (2x5 mL), brine (5 mL), dried (MgSO^) and then 
concentrated in vacuo. The residue was then further purified via column chromatography 
(eluting with hexanes) to afford (E)-7-tetradecene (135, 43 mg, 0.22 mmol, 91%) as a clear 
oil (CAS No. 41446-60-0). A single isomer was observable by NMR analysis.
iR and NMR data was in complete agreement with that previously reported^^.
IR (film): v=  2958 (s), 1466 (m), 1378 (w), 966 (m), 724 (w) cm“L
LRMS (EI+ mode): m/z = 196 (43%), 111 (27), 97 (50), 83 (72), 55 (100).
O
PTSH (178), Et3 N (101)
MeOH, rt, 5 d SOnPT
C 1 4 H 2 8 P
(212.37) TESCI (150.7), imidazole (6 8 )
DMAP (1 2 2 ), CH2 CI2 , rt,4h 
m-CPBA (172.5), NaHC03 (84)
CH2 CI2 , rt, 6  d
405, R = H, n = 0, C2 1 H3 4 N4OS (390.59)
406, R = TES, n = 0, C2 7 H4 8 N4 0 SSi (504.85) 
136, R = TES, n = 2, C2 7 H4 8 N4 0 3 SSi (536.85)
5-[(lR *,2R *)-l-H exyI-2-hydroxyoctyl]th io-l-phenyl-lfl^-tetrazole (405):
To a stirred solution of 1-phenyl-l//-tetrazole-5-thiol (PTSH, 4.94 g, 27.8 mmol) and (Z)-7- 
tetradecene oxide^ (1.47 g, 6.92 mmol) in MeOH (50 mL) at rt was added triethylamine (3.9 
mL, p  = 0.726, 2.83 g, 28.0 mmol) and the resultant mixture stirred for 5 d. After this time the
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solvent was removed in vacuo and the residue dissolved in CH2CI2 (75 mL). The organic 
phase was then washed successively with sat. K2C03(aq) (4x20 mL), IM HCl(aq) (20 mL), 
brine (20 mL), dried (MgS04) and then concentrated in vacuo. The residue was further 
purified via column chromatography (eluting with 10% Et20 in hexanes) to afford the sulfide
405 (1.83 g, 4.69 mmol, 68%) as a clear oil.
IR (film): V = 3430 (s, hr), 2858 (s), 1598 (w), 1500 (s), 1464 (m), 1386 (m), 1280 (w),
1240 (w), 1074 (w), 1018 (w), 912 (w), 760 (s), 730 (w), 694 (m) cm'L
IH NMR (360 MHz, CDCI3): ô = 7.62-7.50 (5H, m), 4.01 (IH, ddd, J  = 8.9, 5.6, 3.3 Hz), 
3.93 (IH, ddd, J  = 7.9, 4.4, 4.4 Hz), 3.12 (IH, s br), 1.97-1.88 (IH, m), 1.80-1.68 (IH, 
m), 1.65-1.55 (2H, m), 1.53-1.40 (3H, m), 1.32-1.19 (13H, m), 0.85 (3H, t, 7 = 7.1 Hz), 
0.84 (3H, t, 7 = 6.9 Hz) ppm.
13C NMR (90 MHz, CDCI3): 8=  154.8 (0), 133.8 (0), 130.2 (1), 130.2 (2C, 1), 124.1 (2C, 
1), 73.2 (1), 56.6 (1), 34.9 (2), 32.3 (2), 31.8 (2), 31.7 (2), 29.3 (2), 29.1 (2) 27.4 (2), 26.0
(2), 22.7 (2), 22.6 (2), 14.2 (3), 14.1 (3) ppm.
LRMS (CI+ mode, NH3): m/z = 391 (100%), 230 (8), 164 (7), 136 (11).
5-[(lR *,2R *)-l-H exyl-2-[(triethylsilyI)oxy]octy l]su lfonyl-l-phenyl-17f-  
tetrazole (136):
A stirred solution of the hydroxysulfide 405 (730 mg, 1.87 mmol), imidazole (380 mg, 5.59 
mmol) and 4-(dimethylamino)pyridine (DMAP, 20 mg, 0.16 mmol) in anhydrous CH2CI2 (10 
mL) at rt under N2(g) was treated with triethylsilylchloride (TESCI, 0.47 mL, p = 0.898, 422 
mg, 2.80 mmol). After 4 h the mixture was diluted with Et2Û (20 mL) and H2O (20 mL) and 
the layers shaken then separated. The aqueous phase was then extracted (2x10 mL Et20) and 
the combined organic extracts washed with brine (10 mL), dried (MgSO^) and concentrated in 
vacuo. The residue was then further purified via column chromatography (eluting with 10% 
Et20 in hexanes) to yield 5-[( IR*,2R *)-1 -hexyl-2-[(triethylsilyl)oxy]octyl]thio-1 -phenyl- 17f- 
tetrazole (406, ca 920 mg, 90 wt.% contaminated by TES OH, 1.64 mmol, 88%). A 
suspension of the silyl ether 406 {ca 920 mg, 90 wt.%, 1.64 mmol) and sodium 
hydrogencarbonate (800 mg, 9.5 mmol) in CH2CI2 (20 mL) at rt was treated with 3- 
chloroperoxybenzoic acid (m-CPBA, 3.20 g, 50 wt.%, 9.3 mmol) and stirred for 2 d. After 
this time the mixture was worked-up as for sulfone 134 above and further purified via column 
chromatography (eluting with 5% Et20 in hexanes) to yield the sulfone 136 [407 mg, 0.76 
mmol, 41% from 405 (2 steps)] as a clear oil.
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IR (film): v = 2929 (s), 2875 (s), 1498 (m), 1462 (m), 1414 (w), 1341 (s), 1238 (w), 1153 
(s), 1127 (w), 1073 (m), 1005 (m), 729 (m), 688 (m) 636 (w) cm-i.
iH NMR (360 MHz, CDCI3): 5 = 7.67-7.56 (5H, m), 4.38 (IH, dt, J = 7.6, 4.0 Hz), 4.05 
(IH, td, J = 6.1, 4.0 Hz), 2.04-1.80 (2H, m), 1.71-1.50 (2H, m), 1.48-1.15 (16H, m), 0.94 
(9H, t , J =  8.1 Hz), 0.88 (3H, t, J  = 7.1 Hz), 0.88 (3H, t, 7 = 7.0 Hz), 0.61-0.53 (6H, m) 
ppm.
13C NMR (90 MHz, CDCI3): 5=  154.6 (0), 133.4 (0), 131.5 (1), 129.7 (2C, 1), 125.7 (2C, 
1), 70.2 (1), 69.4 (1), 34.0 (2), 31.9 (2), 31.5 (2), 29.4 (2), 29.4 (2), 27.5 (2), 25.4 (2),
25.0 (2), 22.7 (2), 22.7 (2), 14.2 (3), 14.2 (3), 7.0 (3C, 3), 5.0 (3C, 2) ppm.
LRMS (CI+ mode, wobutane): m/z = 593 (19%), 537 (100), 507 (10).
HRMS (CI+ mode, /^obutane): Found (M+H)+, 537.3297. C27H49N 403SSi requires 
537.3295.
Fluoride induced elimination of sy n-P-si\o\ysulfone  136 (Scheme 19):
TBAF, DME
TESO
SO2PT
136
-60°C ^  rt, 3 h
137
C27H48N403SSi (536.85) C 1 4 H2 8  (196.37)
To a stirred solution of the )3-siloxysulfone 136 (100 mg, 0.19 mmol) in anhydrous DME (2 
mL) at -60°C under N2(g) was added dropwise anhydrous tetra-n-butylammonium fluoride 
(TBAF, 1.9 mL, 1.0 M in DME, solvated water removed by activated 4Â MS). The resulting 
solution was then allowd to warm slowly to rt over 3 h. After this time the mixture was diluted 
with Et20 (5 mL) and H2O (5 mL) and the layers shaken and then separated. The aqueous 
phase was then extracted (2x5 mL Et20) and the combined organic extracts washed with brine 
(5 mL), dried (MgS04) and then concentrated in vacuo. The residue was then further purified 
via column chromatography (eluting with hexanes) to yield (Z)-7-tetradecene (137, 42 mg, 84 
wt.% contaminated by TESF, 0.18 mmol, 95%) as a clear oil (CAS No. 41446-63-3). A 
single isomer was observable by NMR analysis.
and NMR data was in complete agreement with that previously reported^^.
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C i4 H i^  (196.24)
PTSH (178), EtgN (101)
MeOH, rt, 5 d SOnPT
m-CPBA (172.5) |-------407, n = 0, C2 1 H18N4 OS (374.46)
CH2 CI2 , rt, 8  d 145, n = 2, C2 1 H18N4 O3 S (406.46)
5-[(lR *,2S*)-2-H ydroxy-l,2-d iphenylethyl]th io-l-phenyl-lF f-tetrazole (407).
A solution of trans-siilbQne oxide (1.50 g, 7.65 mmol) and 1-phenyl-li/-tetrazole-5-thiol 
(PTSH, 4.60 g, 25.8 mmol) in MeOH (50 mL) at rt under N2(g) was treated with triethylamine 
(4.30 mL, p = 0.726, 3.12 g, 30.9 mmol) and stirred for 5 d. After this time the solvent was 
removed in vacuo and the resulting residue partitioned between sat. K2C03(aq) (40 mL) and 
CH2CI2 (50 mL). The layers were well shaken and separated. The organic phase was then 
washed successively with sat. K2C03(aq) (3x40 mL), 2M HCl(aq) (3x40 mL), dried (MgS04) 
and then concentrated in vacuo. The resulting crude solid was then recrystallised from EtOAc 
(30 mL) to yield the sulfide 407 (1.02 g, 2.73 mmol, 36%) as a buff solid: mp 163-165°C.
IR (KBr): v = 3510 (br m), 1595 (w), 1499 (s), 1450 (m), 1419 (m), 1390 (s), 1295 (w), 
1174 (w), 1094 (w), 1054 (m), 1015 (w), 857 (w), 764 (s), 700 (s), 686 (m), 606 (w), 557 
(w), 520 (w) cm~k
IH NMR (360 MHz, CDCI3): Ô = 7.62-7.53 (5H, m), 7.32-7.24 (lOH, m), 5.53 (IH, t, 7 =
4.2 Hz), 5.43 (IH, d, 7 = 4.7 Hz), 2.86 (IH, d, 7 = 3.8 Hz) ppm.
13C NMR (90 MHz, CDCI3): 5=  153.7 (0), 140.1 (0), 135.7 (0), 133.6 (0), 130.3 (1), 129.9
(1), 129.4 (1), 128.4 (1), 128.4 (1), 126.7 (1), 124.2 (1), 76.2 (1), 59.3 (1) ppm.
LRMS (CU  mode, wobutane): m/z = 375 (100%), 357 (9), 268 (14), 197 (30), 181 (18), 167 
(5), 119 (21), 107(10).
HRMS (CI+ mode, wobutane): Found (M+H)+, 375.1277. C21H 19N4OS requires 375.1280.
Anal. Calcd. for C21H 18N4OS (M = 374): C, 67.36; H, 4.85; N, 14.96. Found C, 67.37; H, 
4.81; N, 14.86.
5-[(l/?* ,2S*)-2-H ydroxy-l,2-d iphenylethyl]su lfonyl-l-phenyl-17f-tetrazole
(145):
A stirred solution of the sulfide 407 (978 mg, 2.61 mmol) in CH2CI2 (50 mL) was treated 
with 3-chloroperoxybenzoic acid (m-CPBA, 2.25 g, 50 wt.%, 6.52 mmol) and stirred at rt for
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8 d. After this time the mixture was poured into sat. Na2S203-NaHC03(aq) (100 mL) and 
stirred vigorously for 1 h. The layers were then separated and the aqueous phase extracted 
(2x25 mL CH2CI2). The combined organic extracts were washed with sat. NaHC03(aq) (2x30 
mL), dried (MgS04) and concentrated in vacuo. The residue was further purified via column 
chromatography (eluting with 40% EtOAc in hexanes) to yield the sulfone 145 (809 mg, 1.99 
mmol, 76%) as a white solid: mp 138-140°C (50% EtOAc-hexanes).
IR (KBr): v = 3444 (br m), 1591 (w), 1494 (m), 1453 (m), 1342 (s), 1238 (w), 1153 (s), 
1061 (m), 1014 (w), 919 (w), 867 (w), 766 (s), 703 (s), 640 (s), 610 (m) cm~i.
iR  NMR (360 MHz, CDCI3): 5 = 7.64 (IH, tt, J = 7.5, 1.2 Hz), 7.58-7.51 (2H, m), 7.41 
(IH, tt, J  = 7.2, 1.4 Hz), 7.37-7.19 (IIH , m), 6.10, (IH, t, 7 = 3.4 Hz), 5.19 (IH, d, 7 = 
3.1 Hz), 3.11 (IH, d, 7 =  3.6 Hz) ppm.
13C NMR (90 MHz, CDCI3): 5=  153.1 (0), 138.8 (0), 132.8 (0), 132.1 (1), 131.5 (1), 129.9
(1), 129.4 (1), 128.7 (1), 128.5 (1), 126.4 (1), 126.2 (0), 125.7 (0) ppm.
LRMS (CI+ mode, wobutane): m/z = 301 (59%, PTS02Bn+H), 181 (7), 147 (16), 119 (21), 
107 (100%, PhCHO).
Anal. Calcd. for C21H 18N4O3S (M = 406): C, 62.05; H, 4.46; N, 13.78. Found C, 62.11; H, 
4.56; N, 13.83.
Cross over experiment (Scheme 21);
The following procedure employing 5-[(lR*,25*)-2-hydroxy-l,2-diphenylethyl]sulfonyl-l- 
phenyl- 177-tetrazole (145) is representative; an analogous experiment with the benzothiazole 
derivative 144 (prepared as previously described^) was conducted in a like manner.
p-N02PhCH0 (151)
LDA
S02Het THF, -78°C rt
146 147
144, Met = BT, C2 1 H17NO3 S2  (395.50)
145, Met = FT, C2 1 H1 7 M4 O3 S (406.46)
C 1 4 H12  (180.25) C1 4 H1 1 NO2  (225.24)
A stirred solution of 5-[(lR*,25*)-2-hydroxy-l,2-diphenylethyl]sulfonyl-l-phenyl-l//- 
tetrazole (145, 150 mg, 0.37 mmol) and 4-nitrobenzaldehyde (61 mg, 0.40 mmol) in 
anhydrous THE (5 mL) at -78°C under N2(g) was treated dropwise with freshly prepared 
lithium diwopropylamide (LDA, 0.5 mL, 0.82 M in THE, 0.41 mmol). The resulting deep 
purple mixture was stirred for 30 min and then allowed to warm to rt. After a further 15 min
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the reaction mixture was quenched with H2O (5 mL) and diluted with Et20 (10 mL). The 
layers were separated and the aqueous phase extracted (2x5 mL Et20). The combined organic 
extracts were then washed with brine (10 mL), dried (MgS04) and concentrated in vacuo. The 
residue was further purified via column chromatography (eluting with 3% Et20 in hexanes) to 
yield in order of elution: stilbene isomers (146, 23 mg, 0.13 mmol, 35%, E:Z =87:13) and 4- 
nitrostilbene isomers (147, 52 mg, 96 wt.% (contaminated by benzaldehyde), 0.22 mmol, 
60%, E:Z = 69:31) both as off-white powders. The analogous results for the BT system are 
given in Scheme 21.
Geometrical selectivities were determined by NMR (360 MHz, CDCI3) analysis as follows. 
For stilbene isomers (146), integration of the olefmic proton resonances: %  = 7.15 (2H, s), 
5z -  6.64 (2H, s) ppm. For 4-nitrostilbene isomers (147), integration of ortho nitro proton 
resonances: 8e=  8.29 (2H, d, 7 = 8.8 Hz), 8 z  = 8.14 (2H, d, 7 = 8.8 Hz) ppm. ^H NMR 
data was consistent with that previously reported for rraw5-stilbene^^^ (CAS No. 103-30-0), 
cfj-stilbene^^^ (CAS No. 645-49-8), rran5'-4-nitrostilbene^^^ (CAS No. 1694-20-8) and cis-A- 
nitrostilbene^^"^ (CAS No. 6624-53-9).
-  SECTION 4.2 -
(Z ,S)-2-[2-[5-[(l,l-Ilim ethyIethyl)d im ethylsilyI]oxy-2-m ethyIenecyclo- 
hexylidene]ethylthio]benzothiazole (201):
7
BTSH (167), DIAD (202)
PPha (262)
OH
TBSO''
200
SBT
TBSO"
201
THF, rt, 12 h
Ci sHzsO^Si (268.47) C2 2 H3 1 NOS2 S 1 (417.71 )
To a stirred solution of the A-ring dienol 200^  ^ (540 mg, 2.0 mmol), triphenylphosphine (630 
mg, 2.4 mmol) and 2-mercaptobenzothiazole (BTSH, 550 mg, 3.3 mmol) in anhydrous THE 
(10 mL) at rt under N2(g) was added dropwise neat diwopropyl azodicarboxylate (DIAD, 0.48 
g, 2.4 mmol). The resultant solution was stirred for 12 h and then concentrated in vacuo. The 
crude residue was further purified via column chromatography (eluting with 5% Et20 in 
hexanes) to yield the sulfide 201 (747 mg, 1.79 mmol, 89%) as a clear oil.
[œ]d = +36.9 (c = 1.04, CHCI3).
IR (film): v = 2934 (s), 2855 (s), 1460 (s), 1428 (s), 1252 (m), 1092 (s), 997 (s), 902 (m), 
869 (m), 836 (s), 774 (s), 755 (s), 726 (m) cm~L
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m  NMR (360 MHz, CDCI3): ô = 7.88 (IH, dm, J  = 8.2 Hz, BT), 7.76 (IH, dm, J  = 8.0 Hz, 
BT), 7.42 (IH, ddd, J = 8.4, 7.3, 1.2 Hz, BT), 7.30 (IH, ddd, J = 8.1, 7.0, 1.2 Hz, BT), 
5.51 (IH, tm, J = 7.8 Hz, H6), 5.06 (IH, br s, H19e), 4.87 (IH, br s, H19z), 4.19 (IH, dd, 
J = 12.8, 7.9 Hz, H7a), 4.11 (IH, ddd, J  = 12.8, 7.6, 1.1 Hz, H7b), 3.83 (IH, tt, J  = 8.2,
3.7 Hz, H3), 2.50-2.38 (2H, m, H4), 2.22 (IH, dd, J = 12.9, 8.1 Hz, H Ia), 2.11 (IH, 
dddm, J = 14.4, 8.4, 4.4 Hz, H lg), 1.90-1.82 (IH, m, H2a), 1.62 (IH, dddd, J = 12.9, 
9.8, 8.2, 4.6 Hz, H2b), 0.87 (9H, s, CMeg), 0.04 (6H, s, SiMei) ppm.
13C NMR (90 MHz, CDCI3): ô=  167.1 (0, BT), 153.5 (0, BT), 145.1 (0, CIO), 142.9 (0, 
C5), 135.5 (0, BT), 126.2 (1, BT), 124.3 (1, BT), 121.7 (1, BT), 121.1 (1, BT), 119.0 (1, 
C6), 112.1 (2, C19), 70.1 (1, C3), 46.3 (2, C4), 36.2 (2, C2), 32.6 (2, C7), 32.5 (2, Cl),
26.0 (3C, 3, CMes), 18.3 (0, ÇMeg), -4.5 (3, SiMei), -4.5 (3, SiMei) ppm.
LRMS (E1+ mode): m/z = 417 (37%), 370 (25), 285 (17), 252 (17), 224 (26), 193 (17), 149 
(18), 119 (100), 91 (52), 73 (64).
HRMS (El4- mode): Found M+\ 417.1619. C22H3iNOS2Si requires 417.1616.
(Z ,S)-2-[2-[5-[(l,l-D im ethylethyl)d im ethylsily l]oxy-2-m ethylenecyclo-  
hexylidene]ethylthio]benzothiazole (202):
(NH4)6Mo7024*4H20 (1235.8)
SBT
TBSO"
201
H2 O2  (34), EtOH, 0°C -> rt
C2 2 H3 iNOS2 Si (417.71)
TBSO'"
202
SOBT
+
TBSO"'
203
SO2 BT
+
TBSO''
204
C22H31 N0 3 %Si (449.70) C22H31N0 2 S2 SÎ (433.70) C22H31N0 3 S2 SÎ (449.70)
A stirred solution of the sulfide 201 (200 mg, 0.48 mmol) in EtOH (5 mL) at 0°C was treated 
with ammonium heptamolybdate tetrahydrate (150 mg, 0.12 mmol) in 30% H202(aq) (230 mg,
2.0 mmol). The resulting yellow suspension was allowed to stir for 2 h at 0°C and then for a 
further 4 h at rt. The mixture was then diluted with H2O (10 mL) and extracted (4x10 mL 
Et20). The combined organic extracts were then dried (MgSO^) and concentrated in vacuo. 
The residue was then further purified via column chromatography (eluting with 10-25% Et20 
in hexanes) to yield in order of elution: the sulfone 202 (44 mg, 0.10 mmol, 21%), the
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isomeric sulfone 204 (28 mg, 0.06 mmol, 13%) and its parent sulfoxides 203 (113 mg, 0.26 
mmol, 54%, dr = 1:1) all as clear oils.
( Z , 5 ) - 2 - [ 2 - [ 5 - [ ( l , l - D i m e t h y l e t h y l ) d i m e t h y l s i l y l ] o x y - 2 - m e t h y l e n e c y c l o h e x y l i d e n e ] -  
e t h y l t h i o ] b e n z o t h i a z o l e  ( 2 0 2 ) .
[a]o = +9.2 (c = 0.48, CHCI3).
IR (film): v = 2930 (s), 2856 (s), 1472 (m), 1332 (s), 1252 (m), 1149 (s), 1091 (s), 868 (m), 
837 (m), 763 (m) cm~L
iR NMR (360 MHz, CDCI3): S = 8.23 (IH, dm, J = 7.6 Hz, BT), 8.02 (IH, dm, J  = 7.6 Hz, 
BT), 7.65 (IH, ddd, J  = 7.2, 7.2, 1.4 Hz, BT), 7.60 (IH, ddd, J  = 7.3, 7.3, 1.3 Hz, BT), 
5.35 (IH, t, 7 = 7.6 Hz, H6), 4.99 (IH, br s, H19e), 4.83 (IH, m, H19z), 4.57 (IH, dd, J  =
14.2, 8.9 Hz, H7a), 4.28 (IH, ddd, J  = 13.0, 6.2, 1.2 Hz, H7b), 3.55 (IH, tt, J = 8.8, 3.8 
Hz, H3), 2.42 (IH, dd, J  = 12.9, 3.9 Hz, H4a), 2.25 (IH, dt, J  = 12.1, 4.4 Hz, H4b), 2.23-
2.16 (IH, m, H Ia), 1.77-1.67 (2H, m, HIb, H2a), 1.55-1.46 (IH, m, H2b), 0.84 (9H, s, 
CMeg), 0.00 (3H, s, SiMei), -0.01 (3H, s, SiMe2) ppm.
13C NMR (90 MHz, CDCI3): S=  166.0 (0, BT), 152.9 (0, BT), 149.0 (0, CIO), 144.5 (0, 
C5), 137.0 (0, BT), 128.2 (1, BT), 127.8 (1, BT), 125.6 (1, BT), 122.5 (1, BT), 112.8 (2, 
C19), 108.9 (1, C6), 70.3 (1, C3), 55.4 (2, C7), 46.8 (2, C4), 36.1 (2, C2), 32.3 (2, Cl),
26.0 (3C, 3, CMes), 18.3 (0, CMeg), -4.6 (3, SiMei), -4.6 (3, SiMei) ppm.
LRMS (CI+ mode, wobutane): m/z = 450 (100%), 136 (26).
HRMS (CI+ mode): Found (M+H)+, 450.1595. C22H32N03S2Si requires 450.1593.
(5)-4-[(Benzothiazol-2-yl)sulfoxy]methyl-l-[(l,l-dimethylethyl)dimethylsilyl]oxy-3- 
vinylcyclohex-3-ene (203).
IR (film): v=  2928 (s), 2856 (s), 1472 (m), 1427 (w), 1252 (s), 1007 (s), 1004 (m), 881 (m), 
836 (s), 774 (m), 760 (m), 729 (w) cm~L
iR NMR (360 MHz, CDCI3, isomeric mixture - * denotes a resolved signal arising from a 
single isomer): S = 8.06 (IH, dm, J  = 8.2 Hz, BT), 7.99 (IH, dm, 7 = 8.1 Hz, BT), 7.56 
(IH, ddd, 7 =  8.4, 7.3, 1.3 Hz, BT), 7.51-7.45 (IH, m, BT), 6.65 (IH, dd, 7 = 17.1, 11.0 
Hz, H6), 5.15 (IH, d, 7 =  17.1 Hz, H7z), 4.96 (IH, d, 7 =  11.0 Hz, H7e), 4.17 (IH*, d, 7 
= 13.1 Hz, H19a), 4.09 (IH*, d, 7 = 13.0 Hz, H19a), 4.03 (IH*, d, 7 = 13.1 Hz, H19b),
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3.96 (IH*, d, /  = 12.8 Hz, H19b), 3.99-3.90 (IH, m, H3), 2.52-2.20 (3H, m, H4a, H4b, 
H Ia). 2.19-2.08 (IH, m, HIb), 1.85-1.74 (IH, m, H2a), 1.68-1.56 (IH, m, H2b), 0.89 
(9H*, s, CMes), 0.88 (9H*, s, CMes), 0.07 (3H, s, SiMes), 0.07 (3H, s, SiMes) ppm.
13c NMR (90 MHz, CDCI3, isomeric mixture - 1 denotes signals common to both isomers): S 
= 177.61 (0, BT), 153.9+ (0, BT), 136.1 (0, BT), 136.0 (0, BT), 135.4 (0, C5), 135.4 (0, 
C5), 133.4 (1, BT), 133.3 (1, BT), 127.0+ (1, BT), 126.3+ (1, BT), 124.5 (0, CIO), 124.3 
(0, CIO), 124.1 (1, C6), 124.0 (1, C6), 122.4 (1, BT), 122.4 (1, BT), 114.4 (2, C7), 114.3 
(2, C7), 67.4 (1, C3), 67.2 (1, C3), 61.9 (2, C19), 61.8 (2, C l9), 35.1+ (2, C4), 31.6 (2, 
C2), 31.4 (2, C2), 31.0 (2, C l), 30.6 (2, C l), 26.0+ (3C, 3, CMes). 18.3+ (0, CMes), -4.5+ 
(3, SiMes), -4.5+ (3, SiMes) ppm.
LRMS (Cl-t- mode, ùobutane): m/z = 434 (100%), 251 (20), 184 (20), 119 (39).
(S)-4-[(Benzothiazol-2-yl)sulfonyl]methyl-l-[(l,l-dimethylethyl)-dimethylsilyl]oxy-3- 
vinylcyclohex-3-ene (204).
IR (film): V = 2929 (s), 2856 (s), 1472 (s), 1334 (s), 1252 (s), 1152 (s), 1097 (s), 1006 (m), 
882 (m), 837 (s), 763 (s), 729 (m) cm-'.
>H NMR (360 MHz, CDCI3): S = 8.23 (IH, dm, J=  7.9 Hz, BT), 7.99 (IH, dm, J  = 8.4 
Hz, BT), 7.64 (IH, ddd, 7 =  8.2, 7.2, 1.4 Hz, BT), 7.59 (IH, ddd, J  = 8.1, 7.2, 1.3 Hz, 
BT), 6.50 (IH, dd, J  = 17.1, 10.9 Hz, H6), 5.01 (IH, d, 7 =  16.4 Hz, H7z), 4.79 (IH, d, 7 
= 11.1 Hz, H7e), 4.42 (IH, d, 7 = 14.2 Hz, H19a), 4.33 (IH, d, 7 =  14.0 Hz, H19b), 3.97- 
3.90 (IH, m, H3), 2.59-2.34 (3H, m, H4a, H4b, H Ia), 2.07 (IH, ddm, 7 = 17.2, 7.0 Hz, 
HIb), 1.84-1.75 (IH, m, H2a), 1.68-1.58 (IH, m, H2b), 0.89 (9H, s, CMes), 0.07 (3H, s, 
SiMes), 0.06 (3H, s, SiMes) ppm.
13C NMR (90 MHz, CDCI3): S = 165.4 (0, BT), 153.0 (0, BT), 137.7 (0, BT), 136.7 (0, 
C5), 133.1 (1, C6), 128.1 (1, BT), 127.8 (1, BT), 125.6 (1, BT), 122.3 (1, BT), 121.9 (0, 
CIO), 114.8 (2, C7), 67.1 (1, C3), 58.8 (2, C19), 35.3 (2, C4), 31.5 (2, C2), 30.1 (2, Cl),
26.0 (3C, 3, CMes), 18.3 (0, CMes), -4.4 (3, SiMes), -4.5 (3, SiMez) ppm.
LRMS (CI mode, isobutane): m/z = 450 (100%), 136 (16).
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-  SECTION 4.3 -
Partial reduction of Grundmann's ketone (19) with and without Amherlite® 
IR118 resin additive (Tahle 7).
R3
Na (23)
o "
19
C is H a ^  (264.45)
Et20-Et0H 5:1), 0°C
13 17
211 212
C 18H34O (266.46) C 18H34O (266.46) C ig H g ^  (264.45)
Two reductions were performed in parallel, one reaction devoid of the buffering acidic resin 
and the other provided with 1.2 g of dried Amherlite® IR118 resin. Both adhered to the 
following protocol: a stirred solution of Grundmann's ketone (19, 100 mg, 0.38 mmol) in 
Et20-Et0 H (5 mL:l mL) at 0°C under N2(g) was treated portion wise with sodium metal (100 
mg, 4.3 mmol, ca 10 portions). H2O (5 mL) and Et20 (5 mL) were then added and mixture 
filtered if need be to remove resin beads. The layers of the filtrate were separated and the 
aqueous phase extracted (2x5 mL Et20). The combined organic extracts were then dried 
(MgSO^) and concentrated in vacuo. The resultant crude residue was further purified via 
column chromatography (eluting with 10-40% Et20 in hexanes) to afford in order of elution a 
mixture of ketone epimers (19 and 212) and a separate mixture of alcohol diastereoisomers 
(210 and 211) both as clear oils.
The reaction without resin yielded 38 mg of alcohol isomers (0.14 mmol, 38%, 210:211= 
59:41 by GC analysis) and 42 mg of ketone epimers (0.16 mmol, 42%, 19:212= 10:90 by 
NMR analysis). In contrast the reaction buffered by the resin yielded 39 mg of alcohol 
isomers (0.15 mmol, 38%, 210:211> 99:1 by GC analysis) and 54 mg of ketone epimers 
(0.20 mmol, 54%, predominantly 19 by TLC analysis). Ketone epimers could not be 
effectively analysed by GC due to the interconversion of 19 to 212 upon volatilisation.
( lR,3âRJaR)-1 -[( IR)-1,5-Dimethylhexyl]-7a-methyloctahydro- l//-inden-4-one 
(Grundmann's ketone, 19, CAS No. 66251-18-1).
and l^C NMR data was in complete agreement with that previously reported^^.
( lR,3a/?,4/?,7aR)-1-[( 1/?)-1,5-DimethyIhexy 1]-7a-methyloctahydro-17f-inden-4-ol (210).
IH NMR (360 MHz, CDCI3, selected): 5=  3.58 (IH, td, J  = 10.4, 4.6 Hz, H8) ppm.
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13c NMR (67.5 MHz, CDCI3, selected): 5= 12.2 (3, CIS) ppm.
Full characterisation data together with optimised preparation method for 210 are given below.
( lR,3a5,45',7a/?)-1-[( 1/?)-1,5-Dimethylhexyl]-7a-methyloctahydro-l//-inden-4-ol (211).
iH NMR (360 MHz, CDCI3, selected): 0 = 3 3 4  (IH, ddd, 7 = 11.2, 9.8, 4.5 Hz, H8) ppm.
13C NMR (67.5 MHz, CDCI3): S = 71.9 (1, C8), 58.1 (1, C17), 46.1 (1, C14), 45.8 (0, 
C13), 39.6 (2), 36.6 (2), 35.5 (1, C20), 35.4 (2), 35.3 (2), 28.2 (1, C25), 28.0 (2), 24.4 (2),
24.1 (2), 24.0 (3, CIS), 23.0 (3, C27), 22.7 (3, C26), 20.1 (2), 19.4 (3, C21) ppm.
( lR,3a5,7aR)-1 -[( IR)-1,5 -Dimethy Ihexy 1] -7 a-methy loctahy dro- l//-inden-4-one (212).
13C NMR (90 MHz, CDCI3): 5 = 213.9 (0, C8), 61.6 (1, C14), 50.6 (1, C17), 48.9 (0, 
C13), 40.3 (2), 39.6 (2), 36.6 (2), 35.9 (2), 34.5 (1, C20), 28.1 (1, C25), 27.9 (2), 24.3 (2),
23.2 (3, CIS), 23.0 (3, C27), 22.7 (3, C26), 21.4 (2), 21.0 (2), 19.3 (3, C21) ppm.
(lit.17513c NMR (CDCI3, selected): 0= 213.3 (0, C8), 19.0 (3, C21) ppm).
(lR ,3aR ,4R ,7aR )-l-[(lR )-l,5-D im ethylhexyl]-7a-m ethyloctahydro-liT -inden- 
4 -0 I (210):
To a stirred suspension of Grundmann's ketone (19, 1.64 g, 6.2 mmol), dried Amherlite® 
IR118 acidic ion-exchange resin (10.0 g, commercially supplied grade (Aldrich) dried at 0.1 
mmHg, 50°C, 5 h) and anhydrous EtOH (15 mL) in Et20 (60 mL) at 0°C under N%(g) was 
added portionwise sodium metal (2.3 g, 100 mmol, ca 20 portions) over 2.5 h. After this time 
H2O (15 mL) was added and the biphasic mixture filtered to remove the resin beads. The resin 
beads were then washed well (3x10 mL Et2Ü) into the filtrate and the layers separated. The 
aqueous phase was then extracted (2x10 mL Et20) and the combined organic extracts washed 
with brine (30 mL), dried (MgS04) and concentrated in vacuo. The residue was further 
purified via column chromatography (eluting with 25% Et20 in hexanes) to yield the vitamin 
D3 CD-ring a-alcohol 210 (1.59 g, 6.0 mmol, 96%) as a white solid: mp 53-60°C (hexanes). 
(BR No. 6799217).
[a]D = +17 (c = 0.45, CHCI3).
IR (film): V = 3343 (m), 2952 (s), 2931 (s), 1467 (w), 1376 (w), 1090 (s), 799 (w), 465 (m) 
c m -f
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LRMS (EI+ mode): m/z = 266 (12%), 251 (7), 249 (5), 163 (7), 152 (17), 135 (20), 125 
(20), 111 (100), 97 (25), 81 (25).
iH and NMR data was in complete agreement with that previously reported^" .^
BTSH (167) or PTSH (178) 
DIAD (202), PPhg (262)
0°C —>rt, 1 2 h y |_|
HetS
215, Het = BT, C2 5 H37NS2  (415.70)
C 1 8 H34D (266.46) 216, Het = PT, C2 sH3 ^ 4 S (426.66)
(l/2 ,3 a R ,4 S ,7 a R )-l-[(lR )-l,5 -D im eth y lh ex y l]-7 a -m eth y l-4 -(l-p h en y l-lH -  
tetrazol-5-yl)thiooctahydro-liï-indene (216):
To a stirred solution of the vitamin D3 CD-ring a-alcohol 210 (500 mg, 1.88 mmol), 1- 
phenyl- 177-tetrazole-5-thiol (PTSH, 400 mg, 2.3 mmol) and triphenylphosphine (690 mg, 2.6 
mmol) in anhydrous THF (10 mL) under N2(g) at 0°C was added dropwise diwopropyl 
azodicarboxylate (DIAD, 460 mg, 2.3 mmol) in anhydrous THF (3 mL). After 1 h the reaction 
was allowed to warm to rt and stirred for a further 24 h. The solvent was then removed in 
vacuo and the crude residue further purified via column chromatography (eluting with 10% 
Et20 in hexanes) to yield the )3-sulfide 216 (570 mg, 1.34 mmol, 71%) as a white solid: mp 
132-134°C (hexanes).
[a]D = +114 (c = 0.50, CHCI3).
IR (film): V = 2950 (s), 1597 (w), 1500 (m), 1464 (w), 1382 (m), 1273 (w), 1233 (w), 1086 
(w ), 1015 (w), 759 (s) cm  f
IH NMR (270 MHz, CDCI3): 5 =  7.70-7.50 (5H, m, PT), 4.78-4.56 (IH, m, H8), 2.25-1.00 
(20H, m), 0.89 (3H, d, 7 = 6.6 Hz, H21), 0.87 (3H, d, 7 =  6.6 Hz, H27), 0.86 (3H, d, 7 =
6.6 Hz, H26), 0.80 (3H, s, H18) ppm.
13C NMR (67.5 MHz, CDCI3): 5 =  155.5 (0, PT), 134.0 (0, PT), 130.1 (1, PT), 129.9 (2C, 
1, PT), 124.2 (2C, 1, PT), 56.5 (1, C17), 52.0 (1, C14), 49.3 (1, C8), 42.7 (0, C13), 40.0
(2), 39.6 (2), 36.0 (2), 35.6 (1, C20), 33.2 (2), 28.1 (1, C25), 27.2 (2), 24.4 (2), 23.8 (2),
23.0 (3, C27), 22.7 (3, C26), 18.7 (3, C21), 18.4 (2), 13.6 (3, C18) ppm.
LRMS (electrospray): m/z -  427 (M+H)+.
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Anal. Calcd. for C25H38N4S (M = 426): C, 70.38; H, 8.98; N, 13.13. Found C, 70.37; H, 
8.97; N, 12.92.
( l/î,3 a /î,4 S ,7 a /? )-4 -(B en zo th ia zo l-2 -y l)th io -l-[(l/î)-l,5 -d im eth y lh ex y l]-7 a -  
m ethyloctahydro-lH-indene (215):
The vitamin D3 CD-ring a-alcohol 210 (600 mg, 2.26 mmol) was reacted with 2- 
mercaptobenzothiazole (BTSH, 450 mg, 2.69 mmol) under the Mitsunobu conditions 
described above, to yield the ^sulfide 215 (639 mg, 1.54 mmol, 68%) as a white solid: mp = 
72-73°C (hexanes).
[a]D = +80.9 (c = 0.53, CHCI3).
IR (KBr): v = 2948 (s), 2864 (s), 1460 (s), 1427 (s), 1369 (w), 1238 (m), 1077 (m), 992 (s), 
757 (m), 726 (m) cmr^.
iR  NMR (360 MHz, CDCI3): ô = 7.85 (IH, d, 7 = 8.1 Hz, BT), 7.74 (IH, d, 7 = 8.3 Hz, 
BT), 7.40 (IH, tm, 7 = 7.7 Hz, BT), 7.27 (IH, tm, 7 = 7.6 Hz, BT), 4.57-4.53 (IH, m, H8), 
2.19 (IH, dm, 7 =  9.0), 2.02 (IH, dm, 7 = 12.6 Hz), 1.95-1.76 (4H, m), 1.73-1.47 (5H, 
m), 1.45-0.96 (lOH, m), 0.92 (3H, d, 7 = 6.5 Hz, H21), 0.90-0.85 (6H, m, H26, H27), 
0.89 (3H, s, H18) ppm.
i^C NMR (90 MHz, CDCI3): 8 = 168.7 (0, BT), 153.4 (0, BT), 135.2 (0, BT), 126.0 (1, 
BT), 124.2 (1, BT), 121.5 (1, BT), 121.0 (1, BT), 56.7 (1, C17), 52.4 (1, C14), 48.5 (1, 
C 8), 42.9 (0, C13), 40.3 (2), 39.7 (2), 36.1 (2), 35.7 (1, C20), 33.5 (2), 28.2 (1, C25), 27.3
(2), 24.5 (2), 24.0 (2), 23.0 (3, C27), 22.7 (3, C26), 18.7 (3, C21), 13.6 (3, C18) ppm.
LRMS (El mode): m/z = 415 (47%), 382 (100), 248 (12), 233 (19), 168 (72), 135 (60).
Anal. Calcd. for C25H37NS2 (M = 415): C, 72.23; H, 8.97; N, 3.37. Found C, 72.25; H, 
8.91; N, 3.47.
?3 R3
m-CPBA (172.5), NaHCOg (84)
CH2 CI2 , A,15h ^
HetS HetS0 2
215, Het = BT, C2 5 H37NS2  (415.70) 217, Het = BT, C2 5 H37NO2 S2  (447.70)
216, Het = PT, C2 5 H3 8N4 S (426.66) 218, Het = PT, C2 5 H3 7 M4 O2 S (458.66)
(l/f ,3 a R ,4S ,7a /? )-l-[(lR )-l,5 -D im eth y lh exyI]-7a -m eth yI-4 -(l-p h en y l-lH -  
tetrazol-5-yl)suIfonyloctahydro-lH -indene (218):
137
To a stirred suspension of the sulfide 216 (445 mg, 1.04 mmol) and NaHC03(s) (0.42 g, 5.0 
mmol) in CH2CI2 (20 mL) at 0°C was added 3-choroperoxybenzoic acid (m-CPBA, 0.90 g, 50 
wt.%, 2.61 mmol) and the mixture stirred for 1 h followed by 5 h at reflux. TLC analysis then 
indicated incomplete oxidation and only showed the presence of sulfoxide. Further m-CPBA 
(0.45 g, 50 wt.%, 1.30 mmol) was then added and the reaction heated to reflux and stirred 
0/N. The reaction mixture was then poured into sat. Na2S203-NaHC03(aq) (20 mL) and stirred 
vigorously for 1 h. The layers were then separated and the aqueous phase extracted (2x5 mL 
CH2CI2). The combined organic extracts were then washed with brine (20 mL), dried 
(MgS04) and concentrated in vacuo. The crude residue was then further purified via column 
chromatography (eluting with 5% Et20 in hexanes) to yield the sulfone 218 (384 mg, 0.84 
mmol, 81%) as a white solid: mp 98-100°C (hexanes).
[a]D = +61 (c = 0.64, CHCI3).
IR (film): V = 2952 (s), 1595 (w), 1497 (m), 1463 (w), 1338 (s), 1158 (m), 1136 (w), 1015 
(w), 762 (m), 692 (m) cm'i.
iH NMR (270 MHz, CDCI3): 8 = 7.75-7.54 (5H, m, PT), 4.67 (IH, tm, J=  5.7 Hz, H8), 
2.28-2.16 (IH, m), 2.14-1.04 (19H, m), 0.94 (3H, s, H18), 0.92 (3H, d, 7 = 6.6 Hz, H21),
0.87 (3H, d, 7 =  6.6 Hz, H27), 0.86 (3H, d, 7 =  6.6 Hz, H26) ppm.
13C NMR (67.5 MHz, CDCI3): 8=  154.9 (0, PT), 133.5 (0, PT), 131.5 (1, PT), 129.7 (2C,
1, PT), 125.6 (2C, 1, PT), 62.5 (1, C8), 56.0 (1, C17), 52.0 (1, C14), 41.2 (0, C13), 40.0
(2), 39.6 (2), 36.0 (1, C20), 36.0 (2), 28.2 (1, C25), 27.6 (2), 27.0 (2), 23.9 (2), 23.5 (2),
23.0 (3, C27), 22.7 (3, C26), 18.8 (3, C21), 18.4 (2), 12.7 (3, C18) ppm.
LRMS (electrospray): m/z = 459 (M+H)+, 934 (2M+NH4)+, 939 (2M+Na)+, 1397 (3M+Na)+.
Anal. Calcd. for C25H38N4O2S (M = 458): C, 65.47; H, 8.35; N, 12.22. Found C, 65.24; H, 
8.45; N, 11.97.
(lR ,3a /? ,4S ,7aR )-4-(B en zoth iazoI-2-y l)su Ifon yl-l-[(lR )-l,5 -d im eth ylh exyI]-  
7a-methyloctahydro-lfl^-indene (217):
The sulfide 215 (560 mg, 1.35 mmol) was oxidised with m-CPBA according to the above 
procedure to yield the corresponding sulfone 217 (576 mg, 1.29 mmol, 95%) as a white solid: 
mp 138-139°C.
[a]D = +31.1 (c = 0.28, CHCI3).
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IR (KBr): v =  3432 (m), 2954 (s), 1470 (m), 1379 (s), 1321 (m), 1087 (s), 763 (m), 466 (m) 
c m '.
'H  NMR (360 MHz, CDCI3): 5 = 8.19 (IH, dm, J  = 7.7 Hz, BT), 8.00 (IH, dm, J  = 7.6 
Hz, BT), 7.62 (IH, td, J = 7.3, 1.4 Hz, BT), 7.57 (IH, td, J  = 7.2, 1.3 Hz, BT), 4.25 (IH, 
tm, 7 =  5.6 Hz, H8), 2.36 (IH, dq, J = 18.1, 6.0 Hz), 2.22-2.06 (3H, m), 1.97-1.75 (3H, 
m), 1.60-1.25 (7H, m), 1.24-0.99 (6H, m), 1.12 (3H, s, H18), 0.94 (3H, A, J  = 6.5 Hz, 
H21), 0.88 (3H, d, 7 = 6.6 Hz, H27), 0.87 (3H, d, 7 = 6.6 Hz, H26) ppm.
'3C NMR (90MHz, CDCI3): S = 168.6 (0, BT), 152.9 (0, BT), 137.0 (0, BT), 127.9 (1, 
BT), 127.6 (1, BT), 125.4 (1, BT), 122.4 (1, BT), 61.2 (1, C8), 56.2 (1, C17), 52.0 (1, 
C14), 41.4 (0, C13), 40.3 (2), 39.6 (2), 36.0 (1, C20), 28.2 (1, C25), 27.1 (2), 27.0 (2),
23.9 (2), 23.9 (2), 23.0 (3, C27), 22.7 (3, C26), 18.8 (3, C21), 18.5 (2), 12.9 (3, C18) 
ppm.
LRMS (El mode): m/z = 448 (2%), 432 (2), 383 (90), 249 (44), 136 (72), 109 (100), 83 (86).
Anal. Calcd. for C25H37NO2S2 (M = 447): C, 67.07; H, 8.33; N, 3.13. Found C, 67.01; H, 
8.16; N, 3.16.
Unoptimsed vitamin D3 Julia coupling studies (Table 8):
R3  (a) NaHMDS(1.1 eq)
(b) MgBt2 *OEt2  (1.15 eq)
«=)(1.5eq)
217
C2sH37N02% TBSO''
(447.70) 198
TBSO' ■'
219:220
Ci5H260^Si (266.45) CaaHsgOSi (498.90)
H H 15
BTS0 2
221
C 2 5 H 3 7 N O 2 S 2
(447.70)
The following experiment (entry 4) is representative: To a stirred solution of sulfone 217 (100 
mg, 0.22 mmol) in anhydrous Et20 (2.5 mL) at -78°C under N2(g) was added dropwise 
sodium hexamethyldisilazide (NaHMDS, 0.26 mL, 0.93 M in THF, 0.24 mmol). The resultant 
yellow/orange solution was stirred for 50 min before a solution of freshly prepared magnesium 
bromide diethyl etherate (1.4 mL, 0.18 M in Et20, 0.25 mmol) was added dropwise. An 
immediate colour change to deep orange together with the appearance of a fine white precipitate 
was observed. The magnesiated sulfone was then stirred for 1 h at -78°C. A solution of freshly 
prepared dienal 198 (90 mg, 0.34 mmol) in anhydrous Et20 (1 mL) was then added dropwise.
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After only 3 min the colour of the reaction had lightened to yellow and TLC analysis indicated a 
very strong product spot. The reaction was allowed an additional 3 h before being quenched by 
the addition of MeOH (0.5 mL) and then allowed to warm to rt. The reaction mixture was then 
diluted with Et20 (5 mL), H2O (5 mL) added and the layers shaken and then separated. The 
aqueous phase was extracted with Et20 (5 mL) and the combined organic extracts washed with 
brine (5 mL), dried (MgSO^) and then concentrated in vacuo. The crude residue was then 
further purified via column chromatography (eluting with 1-10% Et20 in hexanes) to yield 68 
mg of inseparable non-polar material and the a-sulfone 221 (26 mg, 0.058 mmol, 26%) as a 
clear oil. ^H NMR (CDCI3, 200MHz) analysis of the non-polar material revealed the presence 
of 57 mg of O-rgrf-butyldimethylsilylvitamin D3 isomers (219:220 = 73:27, 0.114 mmol, 
52%) and 11 mg of the 2H-pyran 229.
0-[(l,l-Dimethylethyl)dimethylsilyl]vitamin D3 (219).
IH NMR (360 MHz, CDCI3, selected): 5 = 6.18 (IH, d, 7 = 11.3 Hz, H6), 6.03 (IH, d, 7 =
11.2 Hz, H7), 5.02 (IH, br s, H19e), 4.80 (IH, br s, H19z) ppm.
13C NMR (90 MHz, CDCI3): ô=  145.6 (0, CIO), 141.7 (0, C8), 136.4 (0, C5), 121.6 (1, 
C6), 118.0 (1, C7), 112.3 (2, C19), 70.8 (1, C3), 56.8 (1, C17), 56.5 (1, C14), 47.1 (2),
46.0 (0, C13), 40.8 (2), 39.7 (2), 36.6 (2), 36.4 (1, C20), 36.4 (2), 33.0 (2), 29.1 (2), 28.2 
(1, C25), 27.9 (2), 26.1 (3C, 3, CMeg), 24.1 (2), 23.7 (2), 23.0 (3, C27), 22.8 (3, C26), 
22.4 (2), 19.0 (3, C21), 18.4 (0, CMes), 12.3 (3, C18), -4.4 (2C, 3, SiMei) ppm.
(7Z)-0-[( 1,1-Dimethylethyl)dimethylsilyl]vitamin D3 (220).
IH NMR (360 MHz, CDCI3, selected): 5 = 6.31 (IH, d, 7 = 11.5 Hz, H6), 6.23 (IH, d, 7 =
11.6 Hz, H7), 5.06 (IH, br s, H19e), 4.83 (IH, br s, H19z) ppm.
13C NMR (90 MHz, CDCI3, selected): 8 = 145.0 (0, CIO), 141.2 (0, C8), 137.3 (0, C5),
122.8 (1, C6), 122.1 (1, C7), 112.9 (2, C19), 71.1 (1, C3), 56.3 (1, C17), 55.2 (1, C14),
47.3 (2), 46.9 (0, C13), 41.0 (2), 39.2 (2), 36.5 (2), 33.1 (2), 28.7 (2), 26.5 (2), 26.1 (3C, 
3, CMes), 24.3 (2), 24.1 (2), 19.3 (3, C21), 12.7 (3, C18), -4.4 (2C, 3, SiMea) ppm + other 
signals obscured by 219.
The stereochemistry of the olefinic linkage in 220 was assigned via analogy with other 7Z 
derivatives of vitamin D3 previously reported in the literature. Okamura et al^^ have reported 
NMR data for all four of the possible double bond isomers of calcitriol (166): ^H NMR data 
for the (5Z,7Z)-isomer most closely matched 220. Similarly data reported by Mourino^®3 for 
(5Z,7Z,9R)-30-[(l,l-dimethylethyl)dimethylsilyl]-9-hydroxyvitamin D3 closely matched that
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of 220 in the vinylic region, viv  NMR (250 MHz, CDCI3, selected): 5 = 6.42 (IH, d, 7 = 
12 Hz, H6), 6.27 (IH, d, 7 = 12 Hz, H7), 5.05 (IH, s, H19e), 4.78 (IH, s, H19z) ppm.
(lR,3a/?,4/?,7a/?)-4-(Benzothiazol-2-yl)sulfonyl-l-[(lR)-l,5-dimethylhexyl]-7a- 
methyloctahydro- 177-indene (221).
IH NMR (360 MHz, CDCI3): 8=  8.24 (IH, dm, 7 = 7.7 Hz, BT), 8.01 (IH, dm, 7 = 7.6 Hz, 
BT), 7.64 (IH, td, 7 = 7.2, 1.4 Hz, BT), 7.58 (IH, td, 7 =  7.3, 1.3 Hz, BT), 3.65 (IH, td, 7 
= 11.7, 3.5 Hz, H8), 2.01-1.00 (20H, m), 0.91 (3H, d, 7 = 6.5 Hz, H21), 0.86 (3H, d, 7 =
6.6 Hz, H27), 0.85 (3H, d, 7 = 6.6 Hz, H26), 0.74 (3H, s, H18) ppm.
13C NMR (90 MHz, CDCI3): 8 = 166.4 (0, BT), 153.0 (0, BT), 137.0 (0, BT), 128.0 (1, 
BT), 127.6 (1, BT), 125.6 (1, BT), 122.4 (1, BT), 63.9 (1, C8), 55.3 (1, C17), 48.1 (1, 
C14), 45.0 (0, C13), 39.5 (2), 38.9 (2), 36.2 (2), 35.7 (1, C20), 28.1 (1, C25), 28.0 (2),
26.6 (2), 25.1 (2), 23.9 (2), 22.9 (3, C27), 22.7 (3, C26), 21.2 (2), 18.9 (3, C21), 12.0 (3, 
C l8) ppm.
(3 j3 ,5Z ,7 /? ,8a ,22£)-3-[(l,l-D im eth yleth yl)d im eth ylsily l]oxy-9 ,10-seco-  
ergosta-5,10(19),22-triene-7,8-diol (227):
TBSCI (150.5), Im (6 8 ) 
DMAP (122)
"OH
HO''
226
CH2 CI2 , rt, 0/N
C28H4é03 (430.66)
TBSO'
227
C34H6oQ3Si (544.92)
To a stirred suspension of (3)3,5Z,7R,8a,22jE)-9,10-secoergosta-5,10(19),22-triene-3,7,8- 
triol (226 , 5.0 g, 11.6 mmol)^^’^ ,^ imidazole (Im, 2.4 g, 35.3 mmol) and 4- 
(dimethylamino)pyridine (DMAP, 20 mg, 0.16 mmol) in anhydrous CH2CI2 (50 mL) at rt 
under N2(g) was added dropwise over 30 min /grf-butylchlorodimethylsilane (TBSCI, 1.83 g,
12.2 mmol) in anhydrous CH2CI2 (50 mL) and the resultant mixture stirred 0/N. After this 
time the organic phase was washed successively with H2O (2x50 mL), brine (50 mL) and then 
dried (MgS04) and concentrated in vacuo. The crude residue was then further purified 
via column chromatography (eluting with 20% Et20 in hexanes) to yield the monosilylated 
product 227 (5.60 g, 10.3 mmol, 89%) as a white powder: mp 128-129°C (hexanes).
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[aJo = +76.6 (c = 0.50, CHCI3).
IR (KBr): v = 3421 (br), 2956 (s), 2860 (s), 1461 (m), 1371 (m), 1254 (m), 1096 (s), 1005 
(m), 870 (m), 837 (m), 775 (m) cm-i.
iH NMR (360 MHz, CDCI3): ô = 5.52 (IH, dm, J  = 9.8 Hz, H6), 5.21 (IH, dd, J = 15.2,
7.1 Hz, H22), 5.14 (IH, dd, J = 15.2, 7.4 Hz, H23), 4.98 (IH, br s, H19e), 4.92 (IH, d, J 
= 9.8 Hz, H7), 4.88 (IH, br s, H19z), 3.72 (IH, tt, J  = 9.7, 4.2 Hz, H8), 2.48-2.37 (2H, 
m), 2.19 (IH, ddd, J = 11.9, 10.0, 1.7 Hz), 2.05-1.90 (3H, m), 1.89-1.40 (lOH, m), 1.30-
1.08 (5H, m), 0.98 (3H, d, 7 = 6.6 Hz, H28), 0.91 (3H, d, 7 = 6.8 Hz, H21), 0.88 (9H, s, 
CMes), 0.86-0.80 (9H, m, H18, H26, H27), 0.07 (3H, s, SiMei), 0.06 (3H, s, SiMei) ppm.
13C NMR (90 MHz, CDCI3): ô=  145.9 (0, CIO), 141.8 (0, C5), 135.6 (1, C22), 132.2 (1, 
C23), 124.8 (1, C6), 111.1 (2, C19), 75.0 (0, C8), 71.4 (1, C7), 70.9 (1, C3), 59.8 (1, 
C17), 57.5 (1, C14), 47.2 (2), 44.2 (0, C13), 43.0 (1, C24), 40.2 (1, C20), 40.2 (2), 37.6
(2), 36.8 (2), 33.5 (2), 33.3 (1, C25), 27.9 (2), 26.0 (3C, 3, CMes), 22.0 (2), 20.8 (3, C28),
20.6 (2), 20.2 (3, C27), 19.8 (3, C26), 18.3 (0, ÇMes), 17.9 (3, C21), 13.2 (3, C18), -4.4 
(3, SiMe2), -4.5 (3, SiMe2) ppm.
LRMS (CI mode, NH3): m/z = 562 (15%), 527 (30), 509 (72), 377 (13), 294 (100), 267 
(57), 249 (51).
Anal. Calcd. for C34H6oOsSi (M = 544): C, 74.94; H, 11.10. Found C, 74.99; H, 10.9.
(Z ,S)-[5-[(l,l-D im ethylethyI)dim ethylsiIyl]oxy-2-m ethyIenecyclohexylidene]- 
ethanol (200) and ( l/ î ,3 a /î ,7 a /î)-7 a -m e th y l- l- [(£ ,l/? ,4 /? )- l,4 ,5 -tr im e th y l-2 -  
hexenyl]octahydro-17f-inden-4-one (228):
To a stirred solution of the diol 227 (3.0 g, 5.5 mmol) and pyridine (1.34 mL, p = 0.978, 
1.31 g, 16.6 mmol) in anhydrous CH2CI2 (25 mL) at 0°C under N2(g) was added portionwise 
lead(IV) acetate (2.93 g, 6.6 mmol) and the resultant suspension stirred vigorously for 10 min. 
The mixture was then filtered through a celite pad and the residue washed well (3x5 mL 
CH 2CI2). The filtrate and combined washings were then concentrated in vacuo and 
subsequently dissolved in a solution of cerium(III) chloride heptahydrate (4.11 g, 11.0 mmol) 
in MeOH (30 mL). The mixture was then cooled to 0°C, treated with sodium borohydride 
(0.26 g, 6.8 mmol) and stirred for 15 min. H2O (30 mL) and Et20 (30 mL) were then added 
and the layers shaken well and then separated. The aqueous phase was then further extracted 
(3x10 mL Et20) and the combined organic extracts washed with brine (15 mL), dried (MgS04) 
and then concentrated in vacuo. The crude residue was then further purified via column
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"OH
TBSO'"
227
C34H6o03Si (544.92)
(a) Pb(0Ac)4 (443.2) 
pyridine (79), CH2 CI2 , 0°C
---------------------------------- ► 4
(b) CeCl3«7H20 (372.6)
NaBH4 (37.8) TBSO'"
MeOH, 0°G 200
C l5 H 2 8 p 2 S i
(268.47)
C 1 9 H 3 2 P
(276.46)
chromatography (eluting with 10-15% Et20 in hexanes) to yield in order of elution: the 
Windaus-Grundmann C19 ketone (228, 1.26 g, 4.6 mmol, 83%)^^^, the corresponding over­
reduced j3-alcohol product (0.20 g, 0.72 mmol, 13%)^  ^and the A-ring dienol 200 (1.20 g, 4.5 
mmol, 81%)^' all as clear oils.
(Z,5)-[5-[( 1,1 -Dimethylethyl)dimethylsilyl]oxy-2-methylenecyclohexyhdene]ethanol (200). 
[aJo = +44.0 (c = 0.43, CHCI3).
IR (film): v = 3340 (m, br), 2986 (s), 1472 (w), 1254 (m), 1094 (s), 1006 (m), 836 (m), 774 
(m) cm-k
iR NMR (360 MHz, CDCI3): Ô = 5.45 (IH, tm, J = 7.0 Hz, H6), 4.97 (IH, br s, H19e), 
4.63 (IH, br s, H19z), 4.27 (IH, dd, J  = 12.5, 7.3 Hz, H7a), 4.19 (IH, ddd, /  = 12.4, 6.2,
1.8 Hz, H7b), 3.85 (IH, tt, 7 =  8.6, 4.0 Hz, H3), 2.45-2.35 (2H, m), 2.25-2.17 (IH, m), 
2.13-2.03 (IH, m), 1.92-1.84 (IH, m), 1.65-1.54 (IH, m), 0.89 (9H, s, CMes), 0.07 (3H, 
s, SiMe2), 0.06 (3H, s, SiMe2) ppm.
13C NMR (90 MHz, CDCI3): ô=  145.1 (0, CIO), 140.7 (0, C5), 125.1 (1, C6), 112.1 (2, 
C19), 70.3 (1, C5), 60.0 (2, C7), 46.2 (2, C4), 36.2 (2, C2), 32.5 (2, C l), 26.0 (3C, 3, 
CMes), 18.3 (0, ÇMes), -4.5 (3, SiMe2), -4.5 (3, SiMe2) ppm.
LRMS (CI mode, NH3): m/z = 286 (100%), 268 (37), 251 (16), 119 (16).
(l/?,3a/?,7aR)-7a-Methyl-l-[(E,lR,4R)-l,4,5-trimethyl-2-hexenyl]octahydro-l//-inden-4-one
(228).
[ a b  = -19.1 (c=  1.00, CHCI3).
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IR (film): v = 2958 (s), 1716 (s), 1460 (m), 1372 (m), 1306 (w), 1232 (w), 1056 (w), 972 
(m), 836 (w), 564 (w) cm-*.
*H NMR (360 MHz, CDCI3): S = 5.25 (IH, dd, J  = 15.3, 7.2 Hz, H22), 5.17 (IH, dd, J  = 
15.3, 7.9 Hz, H23), 2.46 (IH, ddm, J  = 11.0, 7.7 Hz), 2.33-2.17 (2H, m), 2.11-1.42 (14H, 
m), 1.35-1.30 (IH, m), 1.05 (3H, d, 7 = 6.7 Hz, H28), 0.92 (3H, d , J =  6.8 Hz, H21), 0.85 
(3H, d, 7 = 6.6 Hz, H27), 0.83 (3H, d, 7 = 6.7 Hz, H26), 0.66 (3H, s, H18) ppm.
13C NMR (90 MHz, CDCI3): S = 212.3 (0, C8), 135.1 (1, C22), 132.7 (1, C23), 62.3 (1, 
C14), 56.8 (1, C17), 50.0 (0, C l3), 43.0 (1, C24), 41.2 (2), 40.1 (1, €20), 39.1 (2), 33.2 
(1, €25), 27.9 (2), 24.3 (2), 21.2 (3, €28), 20.1 (3, €27), 19.8 (3, €26), 19.3 (2), 17.8 (3, 
€21), 12.9 (3, €18) ppm.
LRMS (EI+ mode): m/z = 276 (100%), 261 (6), 233 (32), 215 (41), 192 (13), 178 (34), 151 
(55), 133 (49), 109 (44).
(Z ,S)-[5-[(I,l-D lm ethylethyl)dim ethylsilyl]oxy-2-inethyIenecyclohexylidene] 
ethanal (198):
7 7
DMP (424) °
^ 1 9
OH
TBSO'"
200
TBSO'"
229
CH2 CI2 , rt, 30 min
T B S O '" ^ ^  1 
198
C1 5 H2 8 OSSI (268.47) Ci5H26Q2SI (266.45) C1 5 H2 6 P 2SI (266.45)
To a stirred solution of the A-ring dienol 200 (175 mg, 0.65 mmol) in anhydrous CH2CI2 (2 
mL) at rt under N2(g) was added Dess-Martin periodinane^^’^ ^^  (DMP, 305 mg, 0.72 mmol). 
The resultant mixture was then stirred for 30 min and subsequently diluted with Et20 (10 mL), 
poured into sat. Na2S203-NaHC03(aq) (15 mL) and stirred vigorously for a further 10 min. 
The layers were then separated and the aqueous phase extracted (2x5 mL Et20). The combined 
organic extracts were then washed with sat. NaHC03(aq) (10 mL), dried (MgS04) and 
concentrated in vacuo. The residue was then filtered through a short (4 cm) silica pad (eluting 
with 1% Et20 in hexanes) to yield a pure mixture of the aldehyde 198^^ and its tautomeric 
cyclic enol ether 229 (154 mg, 198:229 = 4:1, 0.58 mmol, 89%) as a clear oil. A dynamic 
equilibrium exists between the two isomers: chloroform solutions of the separated components 
both exhibit 198:229 = 7:3 after 36 h at rt.
(Z,5)-[5-[(l,l-Dimethylethyl)dimethylsilyl]oxy-2-methylenecyclohexylidene]ethanal (198).
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IH NMR (360 MHz, CDCI3): 5 = 9.81 (IH, d, J = 8.0 Hz, H7), 5.89 (IH, dm, J  = 8.0 Hz, 
H6), 5.21 (IH, m, H19e), 5.00 (IH, m, H19z), 4.06 (IH, tt, 7 =  6.8, 3.4 Hz, H3), 2.60- 
2.54 (2H, m), 2.42 (IH, dd, J =  13.3, 6.9 Hz), 2.25 (IH, ddd, J  = 12.4, 7.7, 4.6 Hz), 
1.95-1.86 (IH, m), 1.80-1.70 (IH, m), 0.87 (9H, s, CMes), 0.07 (6H, s, SiMc2) ppm.
13C NMR (90 MHz, CDCI3): Ô = 192.8 (0, C7), 163.2 (0, C5), 144.0 (0, CIO), 128.5 (1, 
C6), 116.8 (2, C19), 69.5 (1, C3), 46.3 (2, C4), 35.4 (2, C2), 31.5 (2, C l), 25.9 (3C, 3, 
CMes), 18.2 (0, ÇMes), -4.5 (3, SiMei), -4.6 (3, SiMei) ppm.
(5)-6-[( 1,1 -Dimethylethyl)dimethylsilyl]oxy-5,6,7,8-tetrahydrowochroman (229).
IH NMR (360 MHz, CDCI3, selected): Ô = 6.36 (IH, d, 7 = 5.5 Hz, H7), 5.02 (IH, d, 7 =
5.7 Hz, H6), 4.43 (2H, m, H19), 3.91 (IH, dddd, 7 = 11.2, 8.1, 5.1, 3.4 Hz, H3) ppm.
13C NMR (90 MHz, CDCI3): ô =  143.2 (1, C7), 123.0 (0, C5), 119.4 (0, CIO), 105.9 (1, 
C6), 68.3 (2, C19), 68.1 (1, C3), 36.8 (2, C4), 31.6 (2, C2), 26.1 (3C, 3, CMes), 25.3 (2, 
Cl), 18.4 (0, ÇMes), -4.5 (3, SiMei), -4.6 (3, SiMei) ppm.
(l/î,3a/?,4/?,7a/î)-7a-m ethyl-l-[(Æ ^,l^>4/?)-l,4 ,5-trim ethyl-2-hexenyl]octa- 
hydro-17T-indeii-4-ol (408):
R2 R2
Amberlite®IR118, Na(23) n
Et20-EtOH(4:1), 0°C ,2.5h ^
HO
228 408
C igH s^  (276.46) C 1 9 H34O (278.47)
The Windaus-Grundmann C19 ketone (228, 1.0 g, 3.62 mmol) was reduced via buffered 
Bouveault-Blanc reaction, in an analogous manner to Grundmann's ketone above, to yield the 
previously unreported vitamin D2 CD-ring cc-alcohol 408 (812 mg, 2.92 nunol, 81%) as a 
crystalline solid: mp 81-83°C (hexanes).
[a]D = -24.4 (c = 0.95, CHCI3).
IR (KBr): v = 3325 (br s), 2958 (s), 1459 (s), 1383 (w), 1368 (m), 1093 (m), 1068 (m), 
1031 (m), 1007 (m), 970 (s) cm“k
IH NMR (360 MHz, CDCI3): 5= 5.22  (IH, dd, 7 = 15.2, 7.1 Hz, H22), 5.16 (IH, dd, 7 =
15.3, 7.6 Hz, H23), 3.58 (IH, ddd, 7 = 10.4, 10.4, 4.3 Hz, H8), 2.07-1.94 (2H, m), 1.90-
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1.05 (14H, m), 1.01 (3H, d, J  = 6.6 Hz, H28), 0.92 (3H, d, 7 =  6.8 Hz, H21), 0.84 (3H, d, 
J = 6.7 Hz, H27), 0.82 (3H, d, 7 =  6.7 Hz, H26), 0.69 (3H, s, H 18) ppm.
13C NMR (90 MHz, CDCI3): 8 = 135.8 (1, C22), 132.1 (1, C23), 71.3 (1, C8), 57.5 (1, 
C14), 56.6 (1, C17), 44.8 (0, C13), 43.0 (1, C24), 40.0 (1, C20), 39.3 (2), 36.1 (2), 33.3 
(1, C25), 28.4 (2), 23.6 (2), 22.0 (2), 21.1 (3, C28), 20.1 (3, C27), 19.8 (3, C26), 17.8 (3, 
C21), 12.4 (3, C18) ppm.
LRMS (EI+ mode): m/z = 278 (22%), 260 (8), 217 (36), 180 (29), 151 (20), 135 (100), 109 
(31), 93 (35).
Anal. Calcd. for C19H34O (M = 278): C, 81.95; H, 12.31. Found C, 81.82; H, 12.22.
(lR ,3a /J ,4S ,7aR )-4-(B en zoth iazo l-2-y l)th io-7a-m eth yl-l-[(£^ ,lR ,4R )-l,4 ,5 -  
trim ethyl-2-hexenyl]octahydro-lH -indene (409):
R2 R2
BTSH (167), DIAD (202), PPhg (262) 11
H 15, THF, 0°C-^rt, 12 h ®
HÔ
408 409
C 1 9 H34D (278.47) C2 6 H3 7 NS2  (427.71)
The vitamin D2 CD-ring a-alcohol 408 (512 mg, 1.84 mmol) was reacted with 2- 
mercaptobenzothiazole (BTSH, 460 mg, 2.75 mmol) according to the Mitsunobu conditions 
given above for the preparation of 215 and 216, to yield the j3-sulfide 409 (562 mg, 1.32 
mmol, 72%) as a colourless solid: mp 68-70°C (hexanes).
[a]D = +36.1 (c = 0.40, CHCI3).
IR (film): v = 2954 (s), 1456 (s), 1428 (m), 1366 (w), 1308 (w), 1272 (w), 1238 (w), 992 
(s), 754 (s), 726 (m) cm-^.
IH NMR (360 MHz, CDCI3): 8 = 7.85 (IH, dm, 7 =  8.1 Hz, BT), 7.74 (IH, dm, 7 = 7.9 
Hz, BT), 7.34 (IH, ddd, 7 = 8.5, 7.3, 1.3 Hz, BT), 7.30-7.25 (IH, m, BT), 5.24 (IH, dd, 7 
= 15.3, 7.2 Hz, H22), 5.16 (IH, dd, 7 = 15.3, 8.0 Hz, H23), 4.56 (IH, br s, H8), 2.20 (IH, 
dm, 7 = 10.5 Hz), 2.05-1.95 (2H, m), 1.93-1.12 (12H, m), 1.02 (3H, d, 7 = 6.6 Hz, H28), 
0.93 (3H, d, 7 =  6.9 Hz, H21), 0.91 (3H, s, H18), 0.85 (3H, d, 7 = 6.7 Hz, H27), 0.84 
(3H, d, 7 = 6.8 Hz, H26) ppm.
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13C NMR (90 MHz, CDCI3): ô = 168.7 (0, BT), 153.4 (0, BT), 135.6 (1, C22), 135.2 (0, 
BT), 132.3 (1, C23), 126.1 (1, BT), 124.2 (1, BT), 121.5 (1, BT), 121.0 (1, BT), 56.5 (1, 
C17), 52.5 (1, C14), 48.5 (1, C8), 43.0 (1, C24), 42.8 (0, C13), 40.2 (2), 40.2 (1, C20),
33.5 (2), 33.3 (1, C25), 27.8 (2), 24.5 (2), 21.0 (3, C28), 20.1 (3, C27), 19.8 (3, C26),
18.7 (2), 17.8 (3, C21), 13.8 (3, C18) ppm.
LRMS (EI+ mode): m/z = 427 (45%), 394 (66), 384 (25), 260 (11), 168 (58), 125 (40).
Anal. Calcd. for C26H37NS2 (M = 427): C, 73.01; H, 8.72; N, 3.27. Found C, 72.97; H, 
8.73; N, 3.26.
(l/? ,3aR ,4S ,7aR )-4-(B enzoth iazol-2-yl)su lfonyl-7a-m ethyl-l-[(Æ ^,liî,4 /î)-
l,4 ,5-trim ethyl-2-hexenyl]octahydro-lH -indene (230):
R2 Y 2^
(NH4)6Mo7024*4H20 (1235.9) 11
------------------------------------------------------^  9'
H2 O2  (34), EtOH. rt, 10 d T H 15
BTSO2
409 230
C2 6 H3 7 NS2  (427.71 ) C2 6 H3 7 NO2 S2  (459.71 )
A stirred solution of the sulfide 409 (523 mg, 1.22 mmol) in EtOH (15 mL) at 0°C was treated 
with ammonium heptamolybdate tetrahydrate (150 mg, 0.12 nunol) in 30% H2Û2(aq) (680 mg,
6.0 mmol) and the resultant suspension allowed to warm to rt over 1 h. After subsequent 
stirring at rt for 2 d, TLC analysis indicated complete consumption of the sulfide and showed 
the formation of two diastereomeric sulfoxides. Further Mo catalyst (150 mg, 0.12 mmol) in 
30% H202(aq) (680 mg, 6.0 nunol) was then added and the mixture stirred at rt for a further 6 
d. Due to the sluggishness of oxidation of the sulfoxides to the sulfone, a further two portions 
of M0/H2O2 (as before) were added over the next 2 d during which time the reaction was 
continously sonicated. After this protracted reaction time the mixture was diluted with Et20 (50 
mL) and H2O (30 mL) and the layers shaken and then separated. The aqueous layer was then 
extracted (4x15 mL Et20) and the combined organic extracts washed with brine (20 mL), dried 
(MgS04) and then concentrated in vacuo. The residue was then further purified via colunui 
chromatography (eluting with 5% Et20 in hexanes) to yield the sulfone 230 (410 mg, 0.89 
mmol, 73%) as fine white needles: mp 135-137°C (EtOH).
[a]D = -10.4 (c = 0.52, CHCI3).
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IR (KBr): v = 2953 (s), 1470 (m), 1369 (w), 1321 (s), 1302 (s), 1258 (w), 1151 (m), 1128 
(s), 1081 (w), 968 (w), 762 (s), 730 (m), 704 (w), 690 (w), 671 (m), 618 (w), 601 (m), 553 
(w), 527 (m) cm-i.
IH NMR (360 MHz, CDCI3): 5 = 8.20 (IH, dm, J = 8.1 Hz, BT), 8.01 (IH, dm, J  = 7.8 
Hz, BT), 7.63 (IH, tm, / =  7.2 Hz, BT), 7.58 (IH, tm, 7 = 7 .2  Hz, BT), 5.26 (IH, dd, J =
15.3, 7.4 Hz, H22), 5.16 (IH, dd, J=  15.3, 8.3 Hz, H23), 4.26 (IH, br t, 7 = 5.4 Hz, 
H8), 2.34 (IH, qd, 7 = 12.7, 6.0 Hz), 2.24-2.00 (4H, m), 1.96-1.62 (4H, m), 1.60-1.43 
(4H, m), 1.38-1.26 (IH, m), 1.20-1.14 (IH, m), 1.14 (3H, s, H18), 1.04 (3H, d, 7 = 6.6 
Hz, H28), 0.93 (3H, d, 7 = 6.8 Hz, H21), 0.85 (3H, d, 7 = 6.5 Hz, H27), 0.83 (3H, d, 7 = 
6.6 Hz, H26) ppm.
13C NMR (90 MHz, CDCI3): ô = 168.5 (0, BT), 152.9 (0, BT), 137.0 (0, BT), 135.3 (1, 
C22), 132.5 (1, C23), 127.9 (1, BT), 127.7 (1, BT), 125.5 (1, BT), 122.5 (1, BT), 61.2 (1, 
C8), 56.1 (1, C17), 52.1 (1, C14), 43.0 (1, C24), 41.3 (0, C13), 40.5 (1, C20), 40.2 (2), 
33.2 (1, C25), 27.5 (2), 27.1 (2), 23.9 (2), 21.1 (3, C28), 20.2 (3, C27), 19.8 (3, C26),
18.5 (2), 17.8 (3, C21), 13.1 (3, C18) ppm.
LRMS (EH- mode): m/z = 459 (3%), 416 (11), 395 (35), 352 (30), 334 (30), 261 (57), 200 
(58), 136 (100).
HRMS (El4- mode): Found M+% 459.2269. C26H37NO2S2 requires 459.2266.
Anal. Calcd. for C26H37NO2S2 (M = 459): C, 67.93; H, 8.11; N, 3.05. Found C, 67.98; H, 
8.12; N, 3.05.
Vitamin D2 (163):
To a stirred solution of the j3-sulfone 230 (50 mg, 0.11 mmol) in anhydrous Et20 (4 mL) at 
-78°C under N2(g) was added dropwise a solution of sodium hexamethyldisilazide (NaHMDS, 
65 fjL, 2.0 M in THF, 0.13 mmol) and the resultant yellow solution stirred for 1 h. After this 
time the mixture was cooled to -100°C and a solution of the freshly prepared aldehyde-pyran 
mixture (198:229 = 4:1, 80 mg, 0.31 mmol) in anhydrous Et20 (2 mL) added dropwise. The 
reaction was then allowed to warm steadily to rt over the next 1.5 h and then stirred 0/N. After 
this time the mixture was diluted with Et20 (10 mL) and H2O (10 mL) and the layers shaken 
and then separated. The aqueous phase was then extracted (2x5 mL Et20) and the combined 
organic extracts washed with brine (10 mL), dried (MgS04) and then concentrated in vacuo to 
yield 111 mg of a crude oil. The residue was then further purified via column chromatography 
(eluting with 1-10% Et2Û in hexanes) to yield: 57 mg of non-polar material (containing vitamin
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(a) NaHMDS, Et2 0  
-7 8 °C ,1 h
(b)
TBSO,
(266) 4  
230 -1GG°C-> rt, O/N
C2 6 H3 7 NO2 S 2  (459.71 ) (c) TBAF-3 H2 Ü (315.5) HO'"
THF, rt, 0/N 163:231
C2 8 H4 4O (396.65)
: H 15 
BTSO2
232
C2 6 H3 7 NO2 S2  (459.71)
D2 TBS ethers and pyran 229), recovered aldehyde (198, 13 mg, 0.05 mmol, 16%) and 
epimeric a-sulfone 232 (9 mg, 0.02 mmol, 18%). A solution of the non-polar material in 
anhydrous THF (2 mL) at rt under N2(g) was then treated with tetrabutylammonium fluoride 
trihydrate (TBAF*3H20, 135 mg, 0.43 mmol) and stirred O/N. After this time the mixture was 
diluted with Et20 (10 mL) and H2O (10 mL) and the layers shaken and then separated. The 
aqueous phase was then extracted (2x5 mL Et20) and the combined organic extracts washed 
with brine (5 mL), dried (MgS04) and then concentrated in vacuo. The residue was then 
further purified via column chromatography (eluting with 20% Et20 in hexanes) to yield a pure 
mixture of natural vitamin D2 (163) and (7Z)-vitamin D2 (231) as a clear oil [30 mg, 0.076 
mmol, 70% (2 steps), 163:231 = 72:28]. The vitamin D2 isomers could be successfully 
separated by careful chromatography (eluting with 10-15% Et20 in hexanes); the previously 
unreported unnatural isomer 231 exhibited only limited stability in CDCI3.
( l/?,3a/?,4/?,7a/?)-4-(Benzothiazol-2-yl)sulfonyl-7a-methyl-1 -[(£", l/?,4/?)-1,4,5-trimethyl-2- 
hexenyljoctahydro- 1/7-indene (232).
iR NMR (360 MHz, CDCI3): Ô = 8.24 (IH, dm, J = 7.7 Hz, BT), 8.02 (IH, dm, 7 = 7.1 Hz, 
BT), 7.65 (IH, td, J  = 7.2, 1.4 Hz, BT), 7.60 (IH, td, J  = 1.3 Hz, BT), 5.21 (IH, dd, J  = 
15.2, 7.1 Hz, H22), 5.14 (IH, dd, J  = 15.2, 7.7 Hz, H23), 3.67 (IH, td, / =  11.7, 3.4 Hz, 
H8), 2.07-1.89 (3H, m), 1.84 (IH, hextet, J = 6.7 Hz), 1.76-1.65 (3H, m), 1.62-1.52 (3H, 
m), 1.50-1.13 (5H, m), 1.01 (3H, d, 7 =  6.6 Hz, H28), 0.90 (3H, d, 7 =  6.8 Hz, H21), 0.83 
(3H, d, 7 = 6.5 Hz, H27), 0.81 (3H, d, 7 = 6 .5  Hz, H26), 0.75 (3H, s, H18) ppm.
Vitamin D2 (163).
mp 109-110°C (Me0 H-H20). (lit.^ 01 H 6°C).
iR and NMR data was in complete agreement with that previously reported^^'^^^.
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(7Z)-Vitamin D2 (231).
iH NMR (360 MHz, CDCI3): 5 =  6.36 (IH, d , J =  11.6 Hz, H6), 6.23 (IH, d, 7 =  11.6 Hz, 
H7), 5.28-5.15 (2H, m, H22, H23), 5.09 (IH, m, H19e), 4.85 (IH, m, H19z), 3.82 (IH, tt, 
J  = 9.1, 4.1 Hz, H3), 2.52 (IH, dd, J = 12.3, 3.2 Hz), 2.38 (IH, dt, J = 13.9, 5.0 Hz), 
2.30-1.20 (20H, m), 1.03 (3H, d, 7 = 6.6 Hz, H28), 0.93 (3H, d, 7 =  6.5 Hz, H21), 0.85 
(3H, d, 7 =  6.4 Hz, H27), 0.83 (3H, d, 7 = 6.1 Hz, H26), 0.66 (3H, s, H18) ppm.
1% NMR (90 MHz, CDCI3): S =  144.4 (0, CIO), 141.7 (0, C8), 136.0 (0, C5), 135.8 (1, 
C22), 132.2 (1, C23), 123.5 (1, 06), 121.8 (1, C7), 113.3 (2, C l9), 70.2 (1, C3), 56.3 (1, 
C17), 55.1 (1, C14), 46.7 (0, C13), 46.6 (2), 43.0 (1, C24), 40.8 (2), 40.5 (1, C20), 39.1 
(2), 35.9 (2), 33.3 (1, C25), 32.7 (2), 28.5 (2), 26.5 (2), 24.3 (2), 21.6 (3, C28), 20.2 (3, 
C27), 19.8 (3, C26), 17.8 (3, C21), 13.1 (3, C18) ppm.
The stereochemistry of the olefin linkage in 231 was assigned as for 220 by comparison of 
*H NMR data with the results of Okamura®  ^and Mourino'®®.
-SECTION 6.2-
Hex-5-enoic acid (342):
O (a) 27.5% HsOsoq) (34)
(b) CuS04*5H20 (249.7) 
FeS04»7H20 (278.0) 
H2S04(|), H2O, 0°C, 3 h
338 ^  *  ( . )
CgHioO (98.14) C 6 H10O2  (114.14)
Prepared by the method of Rust*^ .^ To mechanically stirred cyclohexanone (338, 40 mL, p = 
0.947, 37.9 g, 0.39 mol) was added in one portion aqueous hydrogen peroxide (22 mL, p  = 
1.11, 24.4 g, 27.5 wt.%, 0.20 mol). A slight exotherm was noted and the internal temperature 
rose to 35°C. The mixture was allowed to stir for 40 min, placed under an atmosphere of N2(g) 
and then cooled to -5°C resulting in the formation of a thick paste (ketone hydroperoxide). A 
solution of copper (II) sulfate pentahydrate (100 g, 0.40 mol) and iron (H) sulfate heptahydrate 
(111 g, 0.40 mol) in H2S04(aq) (22 mL in 400 mL H2O) was then added at such a rate that the 
reaction temperature did not rise above 0°C. The mixture was then stirred for 3 h at 0°C before 
being allowed to warm to rt and stirred until the complete disappearance of the solid ketone 
hydroperoxide (2 h). The reaction was then extracted with CH2CI2 (5x75 mL) and the 
combined organic extracts dried (MgS04) and then concentrated in vacuo. The crude residue 
was then further purified via distillation to yield hex-5-enoic acid (342, 8.42 g, 74 mmol, 
37%) as a clear liquid: bp 120-123°C, 18 mmHg. (lit.^^« bp 95°C, 7 mmHg; CAS No. 1577- 
22-6).
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IR (film): v=  2939 (br s), 1708 (s), 1642 (w), 1415 (s), 1245 (s), 993 (w), 914 (s) cm-i.
'H  NMR (360 MHz, CDCI3): 5 =  5.78 (IH, ddt, J  = 17.1, 10.3, 6.7 Hz, H3), 5.07-4.96 
(2H, m, CH=CH2), 2.37 (2H, t, /  = 7.5 Hz, H6), 2.14-2.06 (2H, m, H4), 1.74 (2H, quintet, 
J  = 7.4 Hz, H5) ppm.
13c NMR (90 MHz, CDCI3): 5=  180.5 (0, Cl), 137.6 (1, C3), 115.7 (2, CH=CH2), 33.5 
(2, C6), 33.1 (2, C4), 23.9 (2, C5) ppm.
Hex-5-enoyl chloride (344):
O
OH 
342
C6 H10O2  (114.14)
SOCI2  (119)
CeHgCIO (132.59)
Prepared by the method of Heck*^ .^ To stirred hex-5-enoic acid (342, 16.7 g, 146 mmol) at rt 
under N2(g) was added dropwise freshly distilled thionyl chloride (35 mL, p  = 1.63, 57.1 g, 
431 mmol). Once the spontaneous emission of gas had ceased the mixture was heated to 80°C 
and stirred for 30 min. The reaction mixture was then allowed to cool and distilled at reduced 
pressure to yield hex-5-enoyl chloride (344, 14.5 g, 109 mmol, 75%) as a clear liquid: bp 52- 
54°C, 22 mmHg. (lit.^^g 53-54°C, 21.5 mmHg; CAS No. 36394-07-7).
IR (film): v=  2980 (m), 2942 (m), 1801 (s), 1642 (m), 1405 (m), 1054 (w), 995 (s), 963 (s), 
919 (s), 787 (w), 728 (m), 684 (m), 634 (w), 582 (m) cm~l.
IH NMR (360 MHz, CDCI3): 5=  5.75 (IH, ddt, J  = 17.0, 10.3, 6.7 Hz, H3), 5.10-5.00 
(2H, m, CH=CH2), 2.91 (2H, t, 7 = 7.3 Hz, H6), 2.17-2.08 (2H, m, H4), 1.82 (2H, quintet, 
J = 7.2 Hz, H5) ppm.
13c NMR (90 MHz, CDCI3): 5=  173.9 (0, Cl), 136.8 (1, C3), 116.4 (2, CH=CH2), 46.4 
(2, C6), 32.4 (2, C4), 24.2 (2, C5) ppm.
(2S)-A -(H ex-5-enoyl)bornane-10,2-sultam  (337):
(a) NaH (24), PhMe, rt, 1.5 h
HN
C 1 0 H17NO2 S (215.31)
(132.5)
344 CieHa^OsS (311.44)
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To a mechanically stirred suspension of sodium hydride (6.0 g, 60 wt.%, 150 mmol) in PhMe 
(125 mL) at rt under N2(g) was added dropwise a solution of (25)-bomane-10,2-sultami^^ (25 
g, 116 mmol) in PhMe (250 mL) over 30 min. The mixture was stirred for a further 1 h before 
being treated dropwise with hex-5-enoyl chloride (344, 17.4 g, 131 mmol) in PhMe (125 mL) 
over 30 min and then allowed to stir O/N. The reaction mixture was then quenched by the 
addition of sat. NH4CI (aq) (100 mL) and the layers shaken and then separated. The aqueous 
phase was extracted (2x50 mL Et20) and the combined organic extracts washed successively 
with IM NaOH(aq) (2x20 mL), brine (40 mL), dried (MgSO^) and then concentrated in vacuo. 
The residue was then further purified via column chromatography (eluting with 30% Et20 in 
hexanes) to yield the desired product contaminated by hex-5-enoic acid (342). The impurity 
was subsequently removed by dissolving the material in Et2Û (250 mL), washing with sat. 
NaHC03(aq) (4x75 mL), drying (MgS04) and then concentrating in vacuo to yield the pure 
unsaturated acyl sultam 337 (34.0 g, 109 mmol, 94%) as a clear oil: bp (kugelrohr oven) 
250°C, 0.2 mmHg.
[a]D = +91.8 (c = 1.02, CHCI3).
IR (film): v = 2962 (s), 1701 (s), 1640 (w), 1482 (w), 1457 (m), 1414 (m), 1385 (m), 1335 
(s), 1269 (s), 1238 (s), 1212 (s), 1112 (m), 1083 (m), 1057 (m), 1039 (m), 989 (m), 912 
(m), 808 (w), 771 (m) 540 (s) cm~h
IH NMR (360 MHz, CDCI3): <5= 5.78 (IH, ddt, J = 17.0, 10.3, 6.7 Hz, H3), 5.02 (IH, dq, 
J = 17.1, 1.7 Hz, CH=CHzHe), 4.96 (IH, ddt, 7 =  10.2, 1.9, 1.1 Hz, CH=CHzHe), 3.85 
(IH, dd, 7 = 7.3, 5.3 Hz, CHN), 3.49 (IH, d, 7 =  13.8 Hz, CH aH bS0 2 ), 3.42 (IH, d, 7 = 
13.8 Hz, CH aH bS0 2 ), 2.78-2.63 (2H, m), 2.15-2.03 (4H, m), 1.95-1.83 (3H, m), 1.77 
(2H, quintet, 7 = 7.5 Hz), 1.44-1.30 (2H, m), 1.14 (3H, s, MeC(CH)Me), 0.96 (3H, s, 
MeC(CH)Me) ppm.
13C NMR (90 MHz, CDCI3): S=  171.9 (0, C7), 137.8 (1, C3), 115.5 (2, CH=CH2), 65.3 
( 1, CHN), 53.1 (2, CH2SO 2), 48.5 (0, Ç C H 2SO 2), 47.9 (0, MeC(CH)Me), 44.8 (1, 
M eC(CH)M e), 38.6 (2), 34.9 (2), 33.0 (2), 32.9 (2), 26.6 (2), 23.7 (2), 21.0 (3, 
MeC(CH)Me), 20.0 (3, MeC(CH)Me) ppm.
LRMS (EI+ mode): m/z = 311 (92%), 257 (31), 135 (100), 97 (47), 69 (69).
Anal. Calcd. for C16H25NO3S (M = 311): C, 61.70; H, 8.09; N, 4.50. Found C, 61.62; H, 
8.05; N, 4.51.
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(2S)-A -[(5)-2-M ethylhex-5-enoyl]bornane-10,2-sultam  (336):
(a) BuLi, THF, -80°C, 2 h
(b) Mel (141.9), DMPU (128) 
-80°C -60°C rt
337
C 1 6 H2 5NO3 S (311.44)
336
C 1 7 H2 7NO3 S (325.47)
To a stirred solution of the acyl sultam 337 (15.6 g, 50.2 mmol) in anhydrous THF (250 mL) 
at -80°C (internal temperature) under N2(g) was added n-butyl lithium (21.7 mL, 2.31 M in 
hexanes, 50.1 mmol) smoothly via syringe-pump over 1 h. After the complete addition the 
reaction was stirred at -80°C for a further 1 h before being treated dropwise with a solution of 
methyl iodide (9.4 mL, p  = 2.28, 21.4 g, 151 mmol) in anhydrous dimethylpropylene urea 
(DMPU, 18.2 mL, p = 1.06, 19.3 g, 151 mmol) over 25 min. The reaction mixture was then 
allowed to warm slowly to -60°C, stirred for 1 h and then allowed to warm to rt O/N. After 
this time the mixture was diluted with H2O (200 mL) and Et20 (200 mL) and the layers shaken 
and then separated. The aqueous phase was then extracted (3x50 mL Et2Ü) and the combined 
organic extracts washed successively with H2O (3x50 mL), brine (50 mL), dried (MgS04) and 
then concentrated in vacuo to yield 16.0 g of a crude white solid. The solid was further purified 
via recrystallisation (50 mL cyclohexane) to yield the methylated adduct 336 (13.0 g, 40.0 
mmol, 80%) as a white solid: mp 95-97°C.
[a]D = +98.0 (c = 1.09, CHCI3).
IR (KBr): v = 2935 (m), 1685 (s), 1457 (w), 1392 (w), 1327 (s), 1272 (m), 1220 (m), 1134 
(m), 1057 (m), 977 (w), 914 (w), 770 (w), 534 (m) cm“l.
IH NMR (360 MHz, CDCI3): 5 =  5.81 (IH, ddt, 7 =  17.0, 10.3, 6.7 Hz, H3), 5.02 (IH, dq, 
7 =  17.2, 1.8 Hz, CH=CHzHe), 4.95 (IH, dm, 7 =  10.2 Hz, CH=CHzHe), 3.90 (IH, t, 7 
= 6.3 Hz, CHN), 3.51 (IH, d, 7 = 13.8 Hz, C H aH bS 0 2 ), 3.44 (IH, d, 7 = 13.8 Hz, 
C H aH bS0 2 ), 3.09 (IH, sextet, 7 = 6.8 Hz, H6), 2.13-2.02 (4H, m), 1.97-1.84 (4H, m),
1.50-1.32 (3H, m), 1.22 (3H, d, 7 = 6.9 Hz, C6-Me), 1.16 (3H, s, MeC(CH)Me), 0.98 (3H, 
s, MeC(CH)Me) ppm.
13c NMR (90 MHz, CDCI3): <5 = 176.1 (0, Cl), 138.2 (1, C3), 114.8 (2, CH=CH2), 65.1 
(1, CHN), 53.2 (2, CH2SO 2), 48.4 (0, Ç C H 2SO 2), 47.8 (0, MeC(CH)Me), 44.7 (1, 
MeC(CH)Me), 39.9 (1, C6), 38.5 (2), 32.9 (2), 32.0 (2, C5), 31.5 (2, C4), 26.5 (2), 20.9 
(3, MeC(CH)Me), 19.9 (3, MeC(CH)Me), 19.0 (3, C6-Me) ppm.
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LRMS (EI+ mode): m/z = 325 (46%), 271 (100), 214 (17), 191 (22), 135 (88), 111 (50), 93 
(23), 83 (99), 67 (18), 55 (78), 41 (52).
Anal. Calcd. for C17H27NO3S (M = 325): C, 62.74; H, 8.36; N, 4.30. Found C, 62.76; H, 
8.41; N, 4.27.
(2S )-A -[(S )-4 -(5 ,5 -D im eth y l-l,3 -d io x an -2 -y l)-2 -m eth y lb u tan o y l]b o rn an e-
(a) O3 , CH2 Cl2 -MeOH (3:1) 
-78°C, 2 h
(b) DMS, -78°C rt, O/N
10,2-sultam  (345):
\
S
336 ^2
C 1 7 H27NO3 S (325.47)
(c) H o J y ^ O H  (104) 
TsOH, PhMe, A
345
C2 1 H3 5NO5 S (413.57)
Ozone was bubbled through a stirred solution of the olefin 336 (5.64 g, 17.4 mmol) in 
CH2Cl2-MeOH (100 mL: 30 mL) at -78°C for 2 h. After this time the ozone flow was stopped 
and N2(g) bubbled through the cold solution for 10 min to remove excess dissolved ozone. 
Dimethyl sulfide (30 mL) was then added and the mixture allowed to warm slowly to rt O/N. 
All solvent was then removed in vacuo to yield 8.33 g of an oily residue which was 
subsequently dissolved in PhMe (100 mL). Following a negative starch-iodide paper test, the 
solution was treated with 2,2-dimethylpropane-1,3-diol (1.90 g, 18.3 mmol) and a catalytic 
quantity of toslic acid {ca 10 mg). The mixture was then stirred at reflux with azeotropic H2O 
removal (Dean-Stark apparatus) O/N. After this time the reaction was allowed to cool, diluted 
with Et20 (100 mL) and washed succesively with sat. NaHC03(aq) (50 mL), H2O (4x30 mL) 
and brine (30 mL). The organic layer was then dried (MgS04) and concentrated in vacuo to 
yield 7.25 g of a crude solid. The solid was then further purified via recrystallisation (30 mL 
cyclohexane) to yield the pure dioxane product 345 (5.20 g, 12.6 mmol, 72%) as a white 
solid: mp 124-126°C.
[oc]d = +75.0 (c = 1.11, CHCI3).
IR (KBr): v = 2956 (s), 1692 (s), 1470 (w), 1392 (w), 1328 (s), 1272 (w), 1219 (w), 1199 
(w), 1133 (m), 1113 (m), 973 (w), 876 (w). 111 (w), 547 (m), 536 (m) cm~h
iR NMR (MHz, CDCI3): Ô = 4.43 (IH, t, 7 = 4.9 Hz, H3), 3.89 (IH, t, 7 = 6.3 Hz, CHN), 
3.58 (2H, d, 7 = 11.0 Hz, CHaHbO), 3.49 (IH, d, 7 =  13.7 Hz, CHaHbS02), 3.43 (IH, d, 
7=  13.8 Hz, CHaHbS02), 3.41 (2H, d, 7 =  11.3 Hz, CHaHrO), 3.08 (IH, sextet of m, 6.8 
Hz, H6), 2.08-2.03 (2H, m), 1.97-1.82 (4H, m), 1.75-1.48 (3H, m), 1.44-1.30 (2H, m).
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1.22 (3H, d, 7 = 6.9 Hz, C6-Me), 1.17 (3H, s, M e C (C H 2 0 ) 2Me), 1.15 (3H, s, 
MeC(CH)Me), 0.97 (3H, s, MeC(CH)Me), 0.70 (3H, s, MeC(CH20)2Me) ppm.
13c NMR (90 MHz, CDCI3): ô=  176.0 (0, C7), 101.8 (1, C3), 77.2 (2, CH2O), 77.2 (2, 
CH2O), 65.1 (1, CHN), 53.2 (2, CH2SO2), 48.4 (0, ÇCH2SO2), 47.8 (0, MeÇ(CH)Me),
44.7 (1, MeC(ÇH)Me), 39.9 (1, C6), 38.5 (2), 32.9 (2), 32.3 (2, C5), 30.2 (0, 
M eÇ (C H 2 0 )2Me), 26.9 (2, C4), 26.5 (2), 23.1 (3, M eC (C H 2 0 )2Me), 22.0 (3, 
MeC(CH20)2Me), 20.9 (3, MeC(CH)Me), 20.0 (3, MeC(CH)Me), 19.1 (3, C6-Me) ppm.
LRMS (CI+ mode, NH3): m/z = 431 (100%), 414 (26), 350 (16), 250 (14), 233 (49).
Anal. Calcd. for C21H35NO5S (M = 413): C, 60.99; H, 8.53; N, 3.39. Found C, 60.84; H, 
8.49; N, 3.28.
(S )-4 -(5 ,5 -D im ethy l-l,3 -d ioxan -2 -y l)-2 -m ethy lbu tan -l-o l (346):
UAIH4  (38)O
345
OH
346
Et2 0 , rt
C2 1 H3 5 NO5 S (413.57) C 1 1 H2 2O3  (202.29)
To a stirred suspension of lithium aluminium hydride (0.81 g, 21.3 mmol) in anhydrous Et20 
(50 mL) at rt under N2(g) was added dropwise a solution of the acyl sultam 345 (3.50 g, 8.47 
mmol) in anhydrous Et20-THF (30 mL: 10 mL) over 10 min. The resultant mixture was then 
allowed to stir at rt O/N. After this time the reaction was quenched by the dropwise addition of 
20% KOH(aq) (50 mL, CARE! initial reaction very vigorous) and then stirred vigorously for 1 
h. The biphasic mixture was then filtered through a pad of celite and the residue washed well 
(3x10 mL Et20). The layers of the filtrate and combined washings were then separated and the 
organic phase washed successively with 20% KOH(aq) (5x20 mL), H2O (20 mL) and brine (20 
mL). The organic layer was then dried (MgSO^) and concentrated in vacuo to yield essentially 
pure alcohol 346 (1.59 g, 7.87 mmol, 93%) as a clear oil: bp (kugelrohr oven) 170°C, 0.3 
mmHg. The alcohol is unstable under mildly acidic conditions; appreciable decomposition was 
noted after just 30 min in CDCI3.
[ctJo = -7.3 (c = 1.05, CHCI3).
IR (film): v = 3424 (s, br), 2954 (s), 2870 (s), 1472 (m), 1394 (m), 1312 (w), 1236 (w), 
1116 (s), 1078 (m), 1042 (m), 1018 (s), 922 (w), 872 (w), 792 (w) crrrK
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IH NMR (360 MHz, CDCI3): 5 = 4.43 (IH, t, J = 4.9 Hz, H3), 3.61 (2H, d, /  = 11.2 Hz, 
MezCCHAHBO), 3.52 (IH, dd, J  = 10.6, 5.9 Hz, H?a ), 3.45 (IH, dd, J  = 10.6, 6.2 Hz, 
H7b ), 3.43 (2H, d, 7 = 11.4 Hz, M ciCCHaEbO), 1.78-1.49 (4H, m), 1.27 (IH, dddd, J  =
12.8, 10.3, 7.3, 5.1 Hz), 1.20 (3H, s, MeCMe), 0.93 (3H, d, 7 = 6.7 Hz, C6-Me), 0.73 
(3H, s, MeCMe) ppm.
13c NMR (90 MHz, C6Ü6): S=  103.3 (1, C3), 77.6 (2C, 2, MeiCCHiO), 68.1 (2, Cl), 36.4 
(1, C6), 33.2 (2, C4), 30.5 (0, MeCMe), 28.1 (2, C5), 23.6 (3, MeCMe), 22.1 (3, MeCMe),
17.4 (3, C6-Me) ppm.
LRMS (CI+ mode, NH3): m/z = 220 (100%), 203 (3), 133 (17), 122 (64), 116 (44).
(S )-4 -(5 ,5 -D im ethy l-l,3 -d ioxan-2-y l)-2 -m ethy lbu tanal (328):
V ^ O  SOa'pyr (159.2)
L  X  B 3 N  (101) L. J L  ^  6
O ^  Y  OH -------------------------------------O 3^  T  7^0I DMSO, rt, 30 min |
346 328
C 11 H2 ^ 3  (202.29) Ci 1 H2 0 O3  (200.27)
A biphasic mixture of the alcohol 346 (860 mg, 4.26 mmol) and triethylamine (3.55 mL, p = 
0.726, 2.58 g, 25.5 mmol) in anhydrous dimethyl sulfoxide (DMSO, 20 mL) at rt under N2(g) 
was treated portionwise with sulfur trioxide pyridine complex (2.03 g, 12.8 mmol) and stirred 
vigorously for 30 min. The mixture was then poured into 10% NaHS04(aq) (200 mL), stirred 
for 10 min and then extracted with CH2CI2 (4x50 mL). The combined organic extracts were 
then washed successively with H2O (2x50 mL) and brine (50 mL) and then dried (MgSO^) and 
concentrated in vacuo. The residue was then further purified via column chromatography 
(eluting with 20% Et20 in hexanes) to yield the aldehyde 328 (816 mg, 4.08 mmol, 96%) as a 
clear oil: bp (kugelrohr oven) 140°C, 0.3 mmHg.
[a]D = +12.8 (c = 1.07, CHCI3).
IR (film): v = 2956 (s), 2848 (s), 1726 (s), 1472 (m), 1394 (m), 1312 (w), 1236 (w), 1120 
(s), 1018 (m), 984 (m), 910 (w), 872 (w), 792 (w) cm“k
IH NMR (360 MHz, CDCI3): 5 = 9.62 (IH, d, 7 =  1.8 Hz, H7), 4.43 (IH, t, 7 = 4.8 Hz, 
H3), 3.59 (2H, d, 7 =  11.1 Hz, CHaHbO), 3.41 (2H, d, 7 = 11.1 Hz, CHaEbO), 2.36 (IH, 
sextet of d, 7 = 6.9, 1.7 Hz, H6), 1.92-1.82 (IH, m), 1.75-1.60 (2H, m), 1.55-1.44 (IH, 
m), 1.18 (3H, s, MeCMe), 1.10 (3H, d, 7 = 7.0 Hz, C6-Me), 0.72 (3H, s, MeCMe) ppm.
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13c NMR (90 MHz, CDCI3): 8 = 204.9 (1, 07), 101.7 (1, 03), 77.2 (20, 2, OH2O), 46.1 
(1, 06), 32.2 (2, 04), 30.2 (0, MeCMe), 24.7 (2, 05), 23.1 (3, MeOMe), 21.9 (3, MeOMe),
13.4 (3, 06-Me) ppm.
LRMS (01+ mode, NH3): m/z = 218 (100%), 201 (10).
Anal. Oalcd. for O11H20O3 (M = 200): 0 , 65.97; H, 10.07. Found O, 65.81; H, 9.99.
5 -E th an esu lfo n y l-l-p h en y l-lH -te trazo le  (347):
N _ N  (a)KOH(56),ElBr(109)
Ph (b) mCPBA (172.5), NaHCOg (84) ph ^ 2
CH2 CI2 .ll, 18 h
C7 H6 N4 S (178.22) C9 H1 0 N4 O2 S (238.27)
To a suspension of powdered potassium hydroxide (3.3 g, 58.9 mmol) in EtOH (100 mL) was 
added 1-phenyl-li/-tetrazole-5-thiol (10 g, 56.2 mmol) and the resulting mixture stirred at 
reflux for 1 h. After this time ethyl bromide (4.4 mL, p = 1.46, 6.42 g, 58.9 mmol) was added 
dropwise and the reaction stirred at reflux for a further 18 h. The solvent was then removed in 
vacuo and the residue partitioned between H2O (100 mL) and Et20 (100 mL). The layers were 
then separated and the organic phase washed successively with sat. NaHC03(aq) (2x75 mL) 
and brine (75 mL). After drying (MgSO^) the solvent was removed in vacuo to yield 
essentially pure 5-ethanethio-1 -phenyl- 177-tetrazole (9.86 g, 47.9 mmol, 86%) as a brown oil. 
A mechanically stirred suspension of the sulfide (9.86 g, 47.9 mmol) and sodium 
hydrogencarbonate (20 g, 238 mmol) in CH2CI2 (200 mL) was treated portionwise with 3- 
chloroperoxybenzoic acid (m-CPBA, 41.0 g, 50 wt.%, 119 mmol) and stirred vigorously for 
18 h. After this time the reaction mixture was poured into sat. NaHCOg-Na2S203(aq) (200 mL) 
and stirred vigorously for 3 h. The layers were then separated and the aqueous phase extracted 
(2x50 mL CH2CI2). The combined organic extracts were then washed with sat. NaHC03(aq) 
(3x75 mL), brine (75 mL), dried (MgS04) and concentrated in vacuo. The residue was then 
further purified via column chromatography (eluting with 40-55% Et2Û in hexanes) to yield 5- 
ethanesulfonyl-1 -phenyl- 17f-tetrazole (347, 8.33 g, 35.0 mmol, 73%) as a white solid: mp 
70-7r C  (10% EtOAc-hexanes). (lif^^o 73-74°C; CAS No. 3206-46-0).
IH NMR (360 MHz, CDCI3): 5 =  7.71-7.65 (2H, m, PT), 7.64-7.55 (3H, m, PT), 3.75 (2H, 
q, 7 = 7.4 Hz, H8), 1.52 (3H, t, 7 = 7.4 Hz, C8-Me) ppm.
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13c NMR (90 MHz, CDCI3): 5=  153.2 (0, PT), 133.1 (0, PT), 131.6 (1, PT), 129.8 (2C, 1, 
PT), 125.2 (2C, 1, PT), 50.9 (2, C8), 7.0 (3, C8-Me) ppm.
5,5-D im ethyl-2-[(£ ,5)-3-m ethylhex-4-enyl]-l,3-d ioxane (327):
N N KHMDS
O ^  T  O N S DME,-60°C
Ph
328 347 327
C1 1 H2 0 O3  (200.27) C9 H1 0 N4 O2 S (238.27) C 1 3 H2 4O2  (212.33)
To a stirred solution of the aldehyde 328 (3.82 g, 19.1 mmol) and sulfone 347 (5.95 g, 25.0 
mmol) in anhydrous 1,2-dimethoxyethane (DME, 80 mL) at -60°C (bath temperature) under 
Ni(g) was added dropwise via cannula a solution of potassium hexamethyldisilazide (KHMDS,
7.0 g, 80 wt.%, 28.1 mmol) in anhydrous DME (40 mL) over 45 min. After this time H2O (10 
mL) was added and the mixture stirred vigorously whilst warming to rt. The mixture was then 
diluted with Et20 (150 mL) and H2O (80 ml) and the layers shaken and then separated. The 
aqueous phase was then extracted (3x50 mL Et20) and the combined organic extracts washed 
successively with H2O (3x50 mL) and brine (50 mL). The organic phase was then dried 
(MgSO^) and concentrated in vacuo. The residue was further purified via column 
chromatography (eluting with 0-10% Et20 in hexanes) to yield the olefin 327 (3.76 mg, 17.7 
mmol, 93%, E:Z = 93:7) as a clear oil.
[ot]D = +7.2 (c = 1.01, CHCI3).
IR (film): v=  2956 (s), 1454 (m), 1394 (m), 1310 (w), 1122 (s), 1044 (m), 1020 (s), 966 (s), 
910 (w), 878 (w), 792 (w) cm“L
IH NMR (360 MHz, CDCI3): 5=  5.40 (IH, dqd, J  = 15.2, 6.2, 0.7 Hz, H8), 5.26 (IH, ddq, 
J=  15.2, 7.6, 1.3 Hz, H7), 4.39 (IH, t, 7 = 5.1 Hz, H3), 3.60 (2H, d, 7 = 9.9 Hz, 
CHaHbO), 3.42 (2H, d, 7 =  10.6 Hz, CHaHrO), 2.04 (IH, heptet, 7 = 7.0 Hz, H6), 1.63 
(3H, dm, 7 = 6.3 Hz, C8-Me), 1.70-1.52 (2H, m), 1.44-1.27 (2H, m), 1.19 (3H, s, 
MeCMe), 0.96 (3H, d, 7 =  6.7 Hz, C6-Me), 0.72 (3H, s, MeCMe) ppm..
13c NMR (90 MHz, CDCI3): 8=  137.1 (1, C7), 123.5 (1, C8), 102.6 (1, C3), 77.4 (2C, 2, 
ÇH2O), 36.9 (1, C6), 33.0 (2, C4), 31.3 (2, C5), 30.3 (0, MeCMe), 23.1 (3, MeCMe), 22.0 
(3, MeCMe), 21.0 (3, C8-Me), 18.1 (3, C6-Me) ppm.
LRMS (CI+ mode, NH3): m/z = 230 (100%), 213 (25), 126 (36), 96 (86), 79 (26).
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Anal. Calcd. for C13H24O2 (M = 212): C, 73.54; H, 11.39. Found C, 73.36; H, 11.13.
Degradation of 5,5-dim ethyl-2-[(E ,S)-3-m ethylhex-4-enyl]-l,3-dioxane (327) 
to (5 )-4 -(5 ,5 -d im eth y l-l,3 -d ioxan -2-y l)-2 -m eth y lb u tan -l-o l (346) and its 
conversion to a mandelic ester derivative (410):
(a)Os0 4  (254), Nal0 4  (214)
MeaCO-HaO, rt, O/N
(b)LiAIH4  (38), EtgO, rt
327 ?  (194), DCC (206) 4 IO
C 1 3 H24D2  (212.33) oAc (1^^) C2 iH3 (P 6  (378.46) O0/
CH2 CI2 , - 1 0 °C-^rt
Oxidative Cleavage: To a stirred solution of the olefin 327 (51 mg, 0.24 mmol) and 
sodium periodate (216 mg, 1.0 mmol) in acetone-H20 (2 mL: 2 mL) at rt was added 0 s04(aq) 
(8 drops, 0.08 M in H2O) and the resultant mixture stirred O/N. After this time the mixture was 
diluted with Et2Ü (10 mL) and H2O (5 mL) and the layers shaken and then separated. The 
aqueous phase was then extracted (3x5 mL Et20) and the combined organic extracts washed 
successively with sat. Na2S203(aq) (2x10 mL) and brine (10 mL). The organic phase was then 
dried (MgS04) and concentrated in vacuo. The residue was then further purified via column 
chromatography (eluting with 20% Et20 in hexaness) to yield the aldehyde 328 (23 mg, 0.12 
mmol, 48%) as a clear oil. Reduction: To a stirred solution of the aldehyde 328 (23 mg, 
0.12 mmol) in anhydrous Et20 (2 mL) at rt under N2(g) was added lithium aluminium hydride 
(10 mg, 0.26 mmol) and the suspension stirred for 10 min. After this time 20% KOH(aq) (2 
mL) was added dropwise (CARE!) and the mixture diluted with Et20 (2 mL). The layers were 
separated and the aqueous phase extracted (2x2 mL Et20). The combined organic extracts were 
then dried (MgS04) and concentrated in vacuo to yield the alcohol 346 (21 mg, 0.10 mmol, 
90%) as a clear oil. Estérification: To a stirred solution of the alcohol 346 (21 mg, 0.10 
mmol) and (2R)-acetyl mandelic acid (20 mg, 0.10 mmol) in anhydrous CH2CI2 (2 mL) at 
-10°C under N2(g) was added dicyclohexylcarbodiimide (DCC, 42 mg, 0.20 mmol) followed 
by 4-(dimethylamino)pyridine (DMAP, 5 mg, catalytic). The resultant mixture was then stirred 
O/N whilst being allowed to warm slowly to rt. After this time the reaction was filtered and 
concentrated in vacuo. The residue was further purified via column chromatography (eluting 
with 25% Et20 in hexanes) to yield the ester 410 {ca 39 mg, 0.10 mmol, 100%) as a clear oil. 
Comparison of and ^^C NMR spectra with a sample of ester prepared in an analogous way 
from partially racemised olefin suggest that dr > 94:6 (HPLC studies were ineffectual in 
resolving diastereomeric components).
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IH NMR (360 MHz, CDCI3): 5=1.52-1 A5 (2H, m, Ar), 7.44-7.34 (3H, m, Ar), 5.93 (IH, 
s, CHOAc), 4.34 (IH, t, 7 = 4.9 Hz, H3), 4.01 (IH, dd, 7 = 10.7, 6.0 Hz, H7a), 3.93 (IH, 
dd, 7 = 10.7, 6.6 Hz, H7b), 3.59 (2H, d, 7 =  11.1 Hz, MeiCCHAHBO), 3.40 (2H, d, 7 =
11.0 Hz, M c^CCHaHrO), 2.20 (3H, s, MeCO), 1.80-1.37 (5H, m, H4-H6), 1.18 (3H, s, 
MeCMe). 0.82 (3H, d, 7 =  6.8 Hz, C6-Me), 0.72 (3H, s, MeCMe) ppm.
13c NMR (90 MHz, CDCI3): 5=  170.5 (0, PhCHC=0), 169.0 (0, MeC=0), 134.1 (0, Ar), 
129.3 (1, Ar), 128.9 (2C, 1, Ar), 127.7 (2C, 1, Ar), 102.3 (1, C3), 77.4 (2C, 2, 
M eiC C H iO ), 74.7 (1, PhCHCO), 70.4 (2, Cl),  32.6 (1, C6), 32.3 (2, C4), 30.3 (0, 
MeCMe), 27.4 (2, C5), 23.2 (3, MeCMe), 22.0 (3, MeCMe), 20.9 (3, MeC=0), 16.6 (3, C6- 
Me) ppm.
(2S ,35 ,45)-6-(5 ,5-D im ethyl-l,3-d ioxan-2-yl)-4-m ethylhexan-2,3-d iol (349):
AD-mix a  
MeSOaNHa (95)
327
C 1 3 H24O2  (212.33)
f-Bu0H-H20 (2:3) 
0°C, 18 h 349
C 1 3 H2 6O4  (246.34)
To a mechanically stirred solution of AD-mix a^^\25.0 g) in r-BuOH (70 mL) and H2O (80 
mL) was added methane sulfonamide (1.70 g, 17.9 mmol). The mixture was then cooled to 
0°C and a solution of the olefin 327 (3.76 g, 17.7 mmol, E:Z = 93:7) in r-BuOH (10 mL) 
added. The reaction was then stirred vigorously at 0°C for 24 h. Na2S03(s) (26 g) was added 
and the mixture allowed to stir for 1 h whilst being allowed to warm to rt. The biphasic system 
was then extracted (4x50 mL CH2CI2) and the combined organic extracts washed successively 
with 2M KOH(aq) (60 mL) and brine (50 mL). The organic phase was then dried (MgSO^) and 
concentrated in vacuo. The residue was further purified via column chromatography (eluting
with Et20) to yield the diol 349 (3.62 g, 14.7 mmol, 83%, dr ~ 93:7) as a clear oil.
[a]o = -13.5 (c = 0.48, CHCI3).
IR (film): v = 3424 (s, br), 2954 (s), 1472 (s), 1334 (s), 1236 (w), 1120 (s), 1042 (m), 1018
(m), 984 (m), 910 (w), 880 (w) cm“ l.
IH NMR (360 MHz, CDCI3): 5 = 4.41 (IH, t, 7 = 7.6 Hz, H3), 3.85 (IH, quintet, 7 = 6.0 
Hz, H8), 3.60 (2H, d, 7 =  11.1 Hz, CHaHbO), 3.42 (2H, d, 7 =  11.0 Hz, CHaHrO), 3.13 
(IH, t, 7 = 5.2 Hz, H7), 2.40-2.15 (2H, m, OH), 1.80-1.52 (4H, m), 1.37-1.28 (IH, m),
1.20 (3H, d, 7 =  6.3 Hz, C8-Me), 1.18 (3H, s, MeCMe). 0.96 (3H, d, 7 = 6.8 Hz, C6-Me), 
0.72 (3H, s, MeCMe) ppm.
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13c NMR (90 MHz, CDCI3): 5=  102.6 (1, C3), 79.9 (1, Cl), 77.3 (2C, 2, CH2O), 67.9 (1, 
C8), 35.0 (1, C6), 32.2 (2, C4), 30.3 (0, MeCMe), 25.1 (2, C5), 23.1 (3, MeCMe), 21.9 (3, 
MeCMe), 20.2 (3, C8-Me), 16.7 (3, C6-Me) ppm.
LRMS (CI+ mode, NH3): m/z = 264 (36%), 247 (71), 160 (11), 143 (21), 122 (100), 105 
(22).
HRMS (CI+ mode, wobutane): Found (M+H)+*, 247.1911. C13H27O4 requires 247.1909.
(S )-l-[(2S ,3S ,6S )-6 -M eth oxy-3-m eth y loxan -2-y l]eth an ol (355a)  and (S )- l-  
[(2S,3S, 6R)-6-m ethoxy-3-m ethyloxan-2-yl]ethanol (355)3):
"O
MeOH, rt, 3 d OH
349 355
C ig H z A  (246.34) C 9 H18O3  (174.24)
A solution of the diol 349 (3.62 g, 14.7 mmol) and toslic acid (40 mg) in MeOH (60 mL) was 
stirred at rt for 3 d. After this time the mixture was diluted with Et20 (100 mL) and shaken 
with sat. NaHC03(aq) (100 mL). The layers were then separated and the aqueous phase 
extracted (4x20 mL Et20). The combined organic extracts were then washed with brine (50 
mL), dried (MgSO^) and concentrated in vacuo. The residue was further purified via column 
chromatography (eluting with 40% Et20 in hexanes) to yield the methyl acetal 355 (1.88 g,
10.8 mmol, 73%, a;)3 = 3:1) as a white solid: mp = 36-40°C; bp (kugelrohr oven) 100°C, 0.3 
mmHg.
[a]D = + 101.8 (c = 0.50, CHCI3).
IR (film): v = 3474 (s, br), 2930 (s), 1458 (m), 1374 (m), 1350 (w), 1233 (m), 1211 (m), 
1183 (w), 1158 (m), 1129 (m), 1047 (m), 1026 (m), 997 (m), 964 (m), 908 (m), 815 (w) 
cm’■1
IH NMR (360 MHz, CDCI3): Ô = 4.77 (IHoc, t, 7 = 2.4 Hz, H3), 4.33 (1H)3, dd, 7 =  9.7,
2.1 Hz, H3), 4.00-3.90 (IH, m, H8), 3.50 (3H)3, s, OMe), 3.34 (3Ha, s, OMe), 3.17 (IH a, 
dd, 7 = 9.4, 0.8 Hz, H7), 2.86 (1H)3, dd, 7 =  9.8, 1.5 Hz, H7), 2.00-1.39 (5H, m), 1.29 
(3H)3, d, 7 =  6.6 Hz, C8-Me), 1.27 (3Ha, d, 7 =  6.5 Hz, C8-Me), 0.88 (3Ha, d, 7 = 6.5 
Hz, C6-Me), 0.87 (3H)3, d, 7 =  6.5 Hz, C6-Me) ppm.
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13c NMR (90 MHz, CDCI3): a  5 = 98.5 (1, C3), 111  (1, C7), 66.3 (1, C8), 54.5 (3, OMe),
30.7 (1, C6), 30.1 (2, C5), 26.9 (2, C4), 20.8 (3, C8-Me), 17.7 (3, C6-Me) ppm; p 0  =
103.7 (1, C3), 84.2 (1, C7), 66.5 (1, C8), 56.2 (3, OMe), 31.6 (2, C5), 31.4 (2, C4), 30.5 
(1, C6), 20.8 (3, C8-Me), 16.9 (3, C6-Me) ppm.
LRMS (CI+ mode, NH3): m/z = 192 (75%), 160 (100), 143 (75), 96 (22), 79 (40).
Anal. Calcd. for C9H18O3 (M = 174): C, 62.04; H, 10.41. Found C, 62.04; H, 10.22.
4-Methoxybenzyl (S)-l-[(2S,3S,65)-6-methoxy-3-methyloxan-2-yl]ethyl ether 
(356a)  and 4-methoxybenzyl (S)-l-[(25 ,3S ,6 /?)-6-m ethoxy-3-m ethyloxan-2-  
yl]ethyl ether (356p):
(a) KHMDS (199.5)
THF, 0°C
MeO O
« C  ÔH (b) PMBCI (156.6) OPMB
355 (c) cat. TBAI, 0°C ^  rt 356
C 9 H18O3  (174.24) C 1 7H26O4  (294.39)
A stirred solution of potassium hexamethyldisilazide (KHMDS, 1.88 g, 80 wt.%, 7.54 mmol) 
in anhydrous THF (45 mL) under N2(g) at 0°C was treated dropwise with a solution of the 
alcohol 355 (1.01 g, 5.80 mmol, a:p  = 3:1) in anhydrous THF (15 mL). After complete 
addition the mixture was stirred for 20 min; neat 4-methoxybenzyl chloride (PMBCI, 1.02 mL, 
p = 1.16, 1.18 g, 7.56 mmol) was then added dropwise. A small portion of 
tetrabutylammonium iodide (TBAI, 60 mg) was then added and the mixture allowed to warm to 
rt and stirred for 24 h. The reaction mixture was then partitioned between Et20 (40 mL) and 
brine (50 mL). The layers were then shaken and separated and the aqueous layer extracted 
(3x10 mL Et20). The combined organic extracts were then dried (MgSÛ4) and concentrated in 
vacuo. The crude residue was then further purified via column chromatography (eluting with 
20-50% Et20 in hexanes) to yield the ether 356 (1.58 g, 5.37 nunol, 93%, a;j3 = 3:1) as a 
clear oil.
[a]D = +103.1 (c = 0.52, CHCI3).
IR (film): V = 2932 (s), 1613 (m), 1586 (w), 1514 (s), 1458 (m), 1373 (m), 1348 (w), 1302 
(m), 1248 (s), 1210 (w), 1172 (m), 1128 (s), 1057 (s), 1035 (s), 998 (m), 974 (w), 964 (w), 
906 (m), 821 (m) 754 (w) cm~l.
IH NMR (360 MHz, CDCI3): S = 7.27 (2H, d, 7 = 8.7 Hz, Ar), 6.85 (2H, d , J =  8.6 Hz, 
Ar), 4.78 (IH a, d, 7 = 3.1 Hz, H3), 4.64 (IH, d, 7 =  11.8 Hz, CHAHgAr), 4.34 (lHj3, 7 =
162
11.9 Hz, CHAHfiAr), 4.33 (IH a, d, 7 = 11.8 Hz, CHAHeAr), 4.21 (lHj3, dd, J = 9.6, 2.0 
Hz, H3), 3.78 (3H, s, MeOAr), 3.65 (IH, qd, J  = 6.3, 1.6 Hz, H8), 3.47 (3Hj3, s, OMe), 
3.32 (3Ha, s, OMe), 3.19 (IH a, dd, J  = 10.1, 1.6 Hz, H7), 2.87 (IHjS, dd, J  = 9.6, 2.1 
Hz, H7), 1.93-1.61 (3H, m), 1.55-1.36 (2H, m), 1.27 (3H)3, d, 7 =  6.4 Hz, C8-Me), 1.27
(3Ha, d, 7 = 6.4 Hz, C8-Me), 0.64 (3H, d, 7 = 6.6 Hz, C6-Me) ppm.
13c NMR (MHz, CDCI3): a  5 = 159.2 (0, Ar), 130.9 (0, Ar), 129.8 (2C, 1, Ar), 113.7 (2C, 
1, Ar), 98.6 (1, C3), 77.1 (1, C7), 71.8 (1, C8), 70.4 (2, ÇHiAr), 55.3 (3, MeOAr), 54.5 
(3, OMe), 30.4 (1, C6), 29.9 (2, C5), 27.2 (2, C4), 17.4 (3, C8-Me), 15.5 (3, C6-Me) ppm; 
P S  = 159.2 (0, Ar), 131.0 (0, Ar), 129.7 (2C, 1, Ar), 113.7 (2C, 1, Ar), 104.0 (1, C3), 83.9 
(1, C7), 72.4 (1, C8), 70.1 (2, ÇHiAr), 56.0 (3, OMe), 55.3 (3, MeOAr), 31.7 (2, C5), 31.5
(2, C4), 30.2 (1, C6), 16.6 (3, C8-Me), 15.3 (3, C6-Me) ppm.
LRMS (CI+ mode, wobutane): m/z = 312 (100%), 280 (14), 155 (37), 138 (55), 121 (36).
Anal. Calcd. for C 17H26O4 (M = 294): C, 69.36; H, 8.90. Found C, 69.22; H, 8.98.
(2S,3S,6S)-2-[(S)-l-[(4-M ethoxybenzyl)oxy]ethyl]-3-m ethyloxan-6-ol (357a)  
and (2 S ,3S ,6R )-2 -[(5 )- l-[ (4 -m eth oxyb en zy l)oxy]e th y l]-3 -m eth y l-oxan -6 -o l
(357/3):
AcOH-THF-HgO (3:2:2)
°  65°C, 2 h
OPMB OPMB
356 357
Ci7H2é04 (294.39) C 1 6H24O4  (280.36)
A solution of the methyl glycoside 356 (1.73 g, 5.88 mmol, a:P = 3:1) in ACOH-THF-H2O 
(3:2:2, 30 mL) was stirred at 65°C for 2 h. After this time the mixture was allowed to cool and 
diluted with Et20 (40 mL) and H2O (20 mL). The layers were then shaken and separated and 
the aqueous phase extracted (3x15 mL Et20). The combined organic extracts were then 
successively washed with H2O (4x15 mL), sat. NaHC03(aq) (3x15 mL), dried (MgS04) and 
then concentrated in vacuo. The residue was further purified via column chromatography 
(eluting with 40% Et20 in hexanes) to afford some recovered starting material (311 mg, 1.06 
mmol, 18%) and the lactol 357 (1.22 g, 4.36 mmol, 74%, a:p = 1.4:1) as a clear oil.
[a]D = +73.1 (c = 0.54, CHCI3).
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IR (film): v = 3405 (br m), 2930 (s), 2855 (s), 1612 (m), 1586 (w), 1514 (s), 1459 (m), 1376 
(m), 1302 (w), 1247 (s), 1173 (m), 1112 (m), 1035 (s), 1001 (s), 931 (w), 910 (w), 821 (m) 
cm~, - l
iH NMR (360 MHz, CDCI3): 5= 7 .28  (2H^. d, J  = 8.6 Hz, Ar), 7.27 (2Ha, d, J  = 8.6 Hz, 
Ar), 6.87 (2H, d, /  = 8.7 Hz, Ar), 5.40 (IH a , m, H3), 4.64 (IHjS, d, 7 = 11.8 Hz, 
CHAHgAr), 4.64 (IH a, d, 7 = 11.8 Hz, CHAHgAr), 4.67-4.60 (1H)3, signal obscured, H3), 
4.36 (IHA d , 7 =  11.8 Hz, CHAHfiAr), 4.35 (IH a, d, 7 = 11.8 Hz, CHAHgAr), 3.81 (3H, 
s, OMe), 3.70-3.60 (IH, m, H8), 3.46 (IH a, dd, 7 = 10.3, 2.0 Hz, H7), 2.97 (IH#, dd, 7 = 
9.4, 2.0 Hz, H7), 2.80-2.65 (IH#, br s, OH), 2.32-2.23 (IH a, br s, OH), 1.92-1.65 (3H, 
m), 1.60-1.33 (2H, m), 1.28 (3H#, d, 7 = 6.4 Hz, C8-Me), 1.23 (3Ha, d, 7 =  6.4 Hz, C8- 
Me), 0.68 (3Ha, d, 7 =  6.4 Hz, C6-Me), 0.66 (3H#, d, 7 = 6.4 Hz, C6-Me) ppm.
13c NMR (90 MHz, CDCI3): a S  = 159.3 (0, Ar), 130.9 (0, Ar), 129.8 (20, 1, Ar), 113.7 
(2C, 1, Ar), 91.9 (1, C3), 77.2 (1, C7), 72.0 (1, C8), 70.4 (2, CHzAr), 55.4 (3, OMe), 30.7 
(1, 06), 30.1 (2, 05), 26.5 (2, 04), 17.6 (3, 08-Me), 15.7 (3, 06-Me) ppm; # 5 =  159.3 (0, 
Ar), 130.9 (0, Ar), 129.8 (20, 1, Ar), 113.8 (20, 1, Ar), 97.2 (1, 03), 84.3 (1, 07), 72.3 
(1, 08), 70.3 (2, CHzAr), 55.4 (3, OMe), 33.8 (2, 05), 31.6 (2, 04), 30.0 (1, 06), 16.7 (3, 
08-Me), 15.5 (3, 06-Me) ppm.
LRMS (OI+ mode, NH3): m/z = 298 (100%), 280 (19), 155 (27), 138 (44), 121 (34).
HRMS (Ol4- mode): Found (M+NH4)'''*, 298.2013. O16H24O4+NH4 requires 298.2018.
Prop-2-enyl [(2 S ,3 S ,6 /? )-2 -[(S )-l-[(4 -m eth o x y b en zy l)o x y ]eth y l]-3 -m eth y I-  
oxan-6-yl]ethanoate (358c):
p X
(EtO)2 " '"-^OAII (236)
CS2 CO3  (326)
ÔPMB THF, A, 18 h b02AII ÔPMB
357 (b) f-BuOK(112),THF,-65°C 3 5 8 c
C 1 6 H24O4  (280.36) C2 1 H3 CP5  (362.46)
A stirred suspension of the lactol 357 (1.22 g, 4.36 mmol, a:p =1.4:1) and cesium carbonate 
(2.90 g, 8.90 mmol) in anhydrous THF (20 mL) under N2(g) was treated with allyl 
diethylphosphonoacetate (1.85 mL, p = 1.12, 2.07 g, 8.77 mmol) and heated at reflux O/N. 
After this time the reaction mixture was allowed to cool and partitioned between Et20 (40 mL) 
and H2O (20 mL). The layers were shaken and separated and the aqueous phase extracted 
(3x10 mL Et20). The combined organic extracts were then washed with brine (20 mL), dried
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(MgSO^) and concentrated in vacuo. The residue was then further purified via column 
chromatography (eluting with 40% Et20 in hexanes) to afford 1.30 g of tetrahydropyran 
isomers 358cf (cis:trans = 4:6, 82%). A solution of the isomers (1.30 g, 3.59 nunol) in 
anhydrous THE (30 mL) at -65°C under N2(g) was then treated dropwise with a solution of 
potassium tert-buioxide (485 mg, 4.33 mmol) in anhydrous THE (10 mL). After stirring for 10 
min sat. NH4Cl(aq) (2 mL) was added and the mixture allowed to warm to rt. The reaction 
mixture was then partitioned between Et2Û (40 mL) and H2O (20 mL) and the layers shaken 
and separated. The aqueous phase was extracted (3x10 mL Et20) and the combined organic 
extracts washed with brine (15 mL), dried (MgSO^) and concentrated in vacuo. The residue 
was then further purified via column chromatography (eluting with 20% Et20 in hexanes) to 
yield the diastereomerically pure cis tetrahydropyran 358c (1.15 g, 3.18 mmol, 73% overall) 
as a clear oil.
Prop-2-enyl [(25,3»S,6/?)-2-[(5)-l-[(4-methoxybenzyl)oxy]ethyl]-3-methyloxan-6-yl] 
ethanoate (358c).
[a]D = +29.8 (c = 0.60, CHCI3).
IR (film): v = 2928 (s), 1738 (2), 1613 (m), 1514 (s), 1456 (m), 1372 (m), 1339 (w), 1302 
(m), 1276 (m), 1248 (s), 1194 (m), 1170 (m), 1084 (m), 1036 (m), 930 (w), 822 (w), 755 
(w) cm~L
IH NMR (360 MHz, CDCI3): Ô = 7.27 (2H, d, 7 = 8.6 Hz, Ar), 6.86 (2H, d, 7 = 8.7 Hz, 
Ar), 5.92 (IH, ddt, 7 = 17.2, 10.4, 5.7 Hz, CH2CH=CH2), 5.31 (IH, dq, 7 = 17.2, 1.5 Hz, 
CH2CH=CHzHe), 5.22 (IH, dq, 7 =  10.4, 1.3 Hz, CH2CH=CHzHe), 4.63 (IH, d, 7 =
11.9 Hz, CHAHBAr), 4.58 (2H, dt, 7 = 5.7, 1.3 Hz, CH2CH=CH2), 4.33 (IH, d, 7 =  11.9 
Hz, CHAHnAr), 3.80 (3H, s, OMe), 3.70 (IH, dddd, 7 = 11.2, 8.5, 5.6, 3.0 Hz, H3), 3.61 
(IH, qd, 7 = 6.4, 2.1 Hz, H8), 2.84 (IH, dd, 7 =  9.5, 3.1 Hz, H7), 2.68 (IH, dd, 7 = 15.3,
8.1 Hz, H2a ), 2.43 (IH, dd, 7 = 15.3, 5.3 Hz, H2b ), 1.85-1.75 (2H, m), 1.62 (IH, ddt, 7 = 
12.9, 4.2, 2.1 Hz), 1.39 (IH, tdd, 7 = 12.9, 11.1, 3.7 Hz, H4ax), 1.28-1.15 (IH, signal 
obscured), 1.20 (3H, d, 7 =  6.4 Hz, C8-Me), 0.63 (3H, d, 7 = 6.3 Hz, C6-Me) ppm.
13c NMR (90 MHz, CDCI3): Ô = 171.5 (0, C l), 159.3 (0, Ar), 132.4 (1, CH2£H =CH 2),
131.1 (0, Ar), 129.8 (2C, 1, Ar), 118.2 (2, CH=CH2), 113.8 (2C, 1, Ar), 86.5 (1, C7), 75.3 
(1, C3), 72.2 (1, C8), 70.2 (2, CH2Ar), 65.2 (2, CH2CH=CH2), 55.4 (3, OMe), 41.4 (2, 
C2), 33.0 (2, C5), 31.7 (2, C4), 30.4 (1, C6), 17.2 (3, C8-Me), 15.3 (3, C6-Me) ppm.
LRMS (CI+ mode, NH3): rn/z = 380 (100%), 121 (36).
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HRMS (EI+ mode): Found M+% 362.2095. C21H30O5 requires 362.2093.
Prop-2-enyl [(25,35,65)-2-[(5)-l-[(4-methoxybenzyl)oxy]ethyl]-3-methyloxan-6-yl] 
ethanoate (358^).
IH NMR (360 MHz, CDCI3): Ô = 7.27 (2H, d, 7 = 8.6 Hz, Ar), 6.86 (2H, d, 7 =  8.6 Hz, 
Ar), 5.92 (IH, ddt, 7 = 17.2, 10.5, 5.8 Hz, CH2CH=CH2), 5.32 (IH, dm, 7 = 17.2 Hz, 
CH 2CH =CH zH e), 5.23 (IH, dm, 7 = 10.4 Hz, CH2CH =CH zH e), 4.65-4.50 (4H, m, 
CH2CH=CH2, CHAHBAr, H3), 4.32 (IH, d, 7 =  11.9 Hz, CHAHnAr), 3.81 (3H, s, OMe), 
3.62 (IH, qd, 7 = 6.4, 2.1 Hz, H8), 3.11 (IH, dd, 7 = 9.3, 2.2 Hz, H7), 2.88 (IH, dd, 7 = 
14.1, 9.6 Hz, H2a ), 2.40 (IH, dd, 7 = 14.1, 5.6 Hz, H2b ), 1.97-1.77 (2H, m), 1.69-1.58 
(IH, m), 1.50-1.43 (IH, m), 1.35-1.26 (IH, m), 1.16 (3H, d, 7 = 6.4 Hz, C8-Me), 0.69 
(3H, d, 7 = 6.6 Hz, C6-Me) ppm.
Prop-2-enyl [(2S ,3S ,6R )-2-[(S )-l-hydroxyethyl]-3-m ethyloxan-6-yl] 
ethanoate (240):
" DDQ (227)
CH2 CI2 -H2 O (15:1)
CO2 AII OPMB CO2 AII
358c 240
C2 iH3 (P 5  (362.46) C i3 H2 ^ 4  (242.31)
A vigorously stirred solution of the PMB ether 358c (508 mg, 1.40 mmol) in CH2CI2-H2O 
(30 mL: 2 mL) at rt was treated with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ, 470 
mg, 2.07 mmol) and the resulting brown mixture stirred for 30 min. Anhydrous MgS04(s) {ca 
20 g) was then added and the mixture stirred for a further 10 min. The thick suspension was 
then filtered and the filtrate concentrated in vacuo. The resulting residue was then further 
purified via column chromatography (eluting with 30% Et2Û in hexanes) to yield the alcohol 
240 (321 mg, 1.33 nunol, 95%) as a clear oil.
[a]D = +7.8 (c = 0.97, CHCI3). [lit.^  ^ [a]o  = +5.7 (c = 0.7, CHCI3)].
^H and ^^C NMR in complete agreement with that previously reported"^ .^
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-SECTION 6.3-
(2jR )-A -[(2/î,3R ,4S)-4-[(l,l-D im ethylethyl)d im ethyIsiIyI]oxy-3-hydroxy-2-  
methylpentanoyl]bornane-10,2-sultam (359):
(alBEta.CFgSOaH (150)
CH2 CI2 , -5°C  
(b)/-Pr2 NEt (129), 30 min
H (188),-78°C, 3h
C 1 3 H2 1 NO3 S (271.38) OTBS 244
359
C2 2 H4 iNG5 SSI (459.72)
Prepared by the method of Oppolzer^^*. To a stirred solution of triethyl borane (32.0 mL, 1.0 
M in hexanes, 32.0 mmol) at rt under N2(g) was added dropwise triflic acid (2.83 mL, p  = 
1.70, 4.80 g, 32.0 mmol). Evolution of ethane was noted and the temperature of the reaction 
mixture rose to 38°C. The mixture was then stirred for 15 min before being cooled to -10°C 
and treated dropwise with (2R)-N-propanoylbornane-10,2-sultam^^^ (331, 4.34 g, 16.0 
mmol) in anhydrous CH2CI2 (60 mL) at such a rate that the internal temperature did not rise 
above -5°C. After 5 min diwopropylethylamine (Hunig's base, 5.90 mL, p = 0.742, 4.40 g,
33.9 mmol) was added dropwise and the reaction stirred for 30 min at -5°C before cooling to 
-78°C. The neat aldehyde 244"^  ^ (9.14 g, 48.6 mmol) was then added dropwise and stirring 
continued for 3 h. The reaction mixture was then quenched by the addition of sat. NH4Cl(aq) 
(50 mL), allowed to warm to rt and diluted with Et20 (100 mL). The layers were then well 
shaken and separated. The aqueous phase was then further extracted (3x30 mL Et20) and the 
combined organic extracts dried (MgS04) and then concentrated in vacuo to yield 15.2 g of a 
crude oil. The residue was then further purified via column chromatography (eluting with 20% 
Et2Û in hexanes) followed by recrystallisation (hexanes) to yield the aldol 359 (5.50 g, 12.0 
mmol, 75%) as a white solid: mp = 92-95°C.
[a]o = -65.8 (c = 1.20, CHCI3).
IR (KBr): v =  3517 (br), 2967 (s), 1680 (m), 1335 (s), 1139 (m) cm-i.
iR NMR (400 MHz, CDCI3): 8 = 3.86 (IH, dd, J = 5.9, 5.9 Hz, CHN), 3.80-3.71 (2H, m, 
H17, H18), 3.47 (IH , d, J = 13.8 Hz, C H a H b S 0 2 ), 3.40 (IH , d, 7 = 13.8 Hz, 
CH aHrSO ?), 3.36 (IH, qd, 7 = 7.1, 4.2 Hz, H16), 2.04-1.99 (2H, m), 1.91-1.82 (3H, m), 
1.42-1.36 (IH, m), 1.35-1.29 (IH, m), 1.27 (3H, d, 7 = 7.1 Hz, H19), 1.17 (3H, d, 7 =  5.9 
Hz, C16-Me), 1.15 (3H, s, MeC(CH)Me), 0.96 (3H, s, MeC(CH)Me), 0.90 (9H, s, CMeg), 
0.09 (3H, s, SiMe2), 0.08 (3H, s, SiMe2) ppm.
13C NMR (125 MHz, CDCI3): 8 = 176.7 (0, C15), 75.0 (1, C17), 68.1 (1, C18), 64.7 (1, 
CHN), 53.0 (2, CH2SO2), 48.3 (0, ÇCHN), 47.7 (0, MeC(CH)Me), 44.5 (1, MeC(CH)Me),
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40.4 (1, C16), 38.2 (2), 32.8 (2), 26.4 (2), 25.8 (3, 3C, CMeg), 20.7 (3, MeC(CH)Me), 
19.8 (3, MeC(CH)Me), 19.1 (3, C19), 17.9 (0, CMes), 12.9 (3, C16-Me), -4.2 (3, SiMei), 
-5.0 (3, SiMc2) ppm.
LRMS (CI+ mode): m/z = 460 (12%), 442 (4), 328 (100), 289 (3), 272 (3), 245 (5).
Anal. Calcd. for C22H41NO5SS1 (M = 459): C, 57.48; H, 8.99; N, 3.05. Found C, 57.51; H, 
8.98; N, 2.97.
(2R )-A -[(2R ,3R ,4S)-4-[(l,l-D im ethylethyl)d im ethylsily l]oxy-3-m ethoxy-2-  
methylpentanoyl]bornane-10,2-sultam (360):
MG2N NMG2
OTBS
359
C22H4iN05SSi (459.72)
(214)
MGOTf (164) 
PhMG, 80°C, 24 h
O OMg
OTBS 
C2 3 H4 3 NO5 S S 1 (473.74)
To a stirred solution of the aldol 3 5 9  (12.1 g, 26.4 mmol) and 1,8-
bis(dimethylamino)naphthalene (proton sponge®, 17.0 g, 79.4 mmol) in anhydrous PhMe 
(100 mL) at rt under N2(g) was added methyl triflate (9.0 mL, p = 1.45, 13.1 g, 79.6 mmol). 
The resulting mixture was then heated to 80°C and stirred for 24 h. After this time the 
suspension was allowed to cool to rt, treated with conc. NH40H(aq) (15 mL) and then stirred 
for 30 min. The biphasic mixture was then further diluted with CH2CI2 (100 mL) and H2O (50 
mL) and the layers shaken well and then separated. The aqueous phase was then extracted 
(2x30 mL CH2CI2) and the combined organic extracts washed successively with 2M HCl(aq) 
(4x50 mL) and brine (50 mL). The organic phase was then dried (MgS04) and concentrated in 
vacuo. The resulting crude residue was then further purified via column chromatography 
(eluting with 20% Et20 in hexanes) to yield the methyl ether 360 (11.3 g, 23.9 mmol, 90%) 
as a white solid: mp 106-108°C (hexanes).
[a]D = -74.9 (c = 0.39, CHCI3).
IR (KBr): v =  2971 (m), 1691 (m), 1466 (w), 1388 (w), 1342 (s), 1269 (w), 1142 (m), 1107 
(s), 1065 (w), 847 (w), 776 (m) cm“L
m  NMR (400 MHz, CDCI3): Ô = 3.84 (IH, dd, J = 7.5, 5.1 Hz, CHN), 3.79 (IH, qd, J = 
6.4, 2.6 Hz, H18), 3.52 (3H, s, OMe), 3.46 (IH, dd, J  = 8.4, 2.6 Hz, H17), 3.45 (IH, d, 
J=  13.6 Hz, CHaHbS0 2 ), 3.39 (IH, d, /  = 14.0 Hz, CHaHrSO?), 3.07 (IH, dq, / =  8.3,
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7.0 Hz, H 16), 2.04 (IH, dd, J  = 13.7, 7.8 Hz), 1.98 (IH, dm, J  = 14.0 Hz), 1.93-1.81 (3H, 
m), 1.42-1.36 (IH, m), 1.35-1.29 (IH, m), 1.27 (3H, d, 7 =  7.0 Hz, H19), 1.12 (3H, s, 
MeC(CH)Me), 1.11 (3H, d, 7 = 6.1 Hz, C16-Me), 0.94 (3H, s, MeC(CH)Me), 0.87 (9H, s, 
CMes), 0.06 (3H, s, SiMc2), 0.02 (3H, s, SiMc2) ppm.
13C NMR (125 MHz, CDCI3): ô = 174.7 (0, C15), 85.5 (1, C17), 70.1 (1, C18), 64.9 (1, 
CHN), 61.2 (3, OMe), 53.1 (2, CH2SO2), 48.3 (0, ÇCHN), 47.7 (0, MeÇ(CH)Me), 44.6 (1, 
MeC(ÇH)Me), 42.4 (1, C16), 38.3 (2), 32.7 (2), 26.4 (2), 25.8 (3, 3C, CMeg), 20.8 (3, 
MeC(CH)Me), 19.9 (3, MeC(CH)Me), 17.9 (0, ÇMeg), 17.3 (3, C19), 15.7 (3, C16-Me), 
-4.7 (3, 2C, SiMe2) ppm.
LRMS (CI+ mode): m/z = 474 (4%), 342 (100), 310 (1), 278 (2).
Anal. Calcd. for C23H43N05SSi (M = 473): C, 58.31; H, 9.15; N, 2.96. Found C, 58.34; H, 
9.12; N, 2.92.
(2S ,3R ,4S)-4-[(l,l-D im ethylethyl)d im ethylsily l]oxy-3-m ethoxy-2-m ethyl-  
pentan-l-ol (361):
O OMe
L1AIH4  (38)
 ^ ÔTBS B 2 0 ,0°C, 15 min jbSG  
O2  360 361
C23H43N05SSi (473.74) CisHaoO^Si (262.46)
A solution of the acyl sultam 360 (2.03 g, 4.3 mmol) in anhydrous Et20 (20 mL) was added 
dropwise to a stirred suspension of lithium aluminium hydride (0.50 g, 13.2 mmol) in Et20 
(10 mL) at 0°C under N2(g). After 15 min the reaction was quenched by the addition of sat. 
NH4Cl(aq) (10 mL, CARE!) and stirred vigorously for 10 min. The biphasic mixture was then 
filtered through a celite pad and the residue washed well (3x5 mL Et20). The layers of the 
filtrate and combined washings were then separated and the aqueous layer extracted (2x10 mL 
Et20). The combined organic extracts were then dried (MgS04) and concentrated in vacuo. 
The residue was then further purified via column chromatography (eluting with 40% Et2Û in 
hexanes) to yield (2R)-bomane-10,2-sultam^^*’^ ^^  (0.87 g, 4.05 mmol, 94%) as a white solid 
and the alcohol 361 (1.11 g, 4.24 mmol, 99%) as a clear oil.
[a]o = +25.5 (c = 1.07, CHCI3).
IR (film): v =  3410 (br), 2941 (s), 1476 (m), 1385 (m), 1265 (m), 1110 (s), 1065 (m), 836 
(s), 776 (s) cm-i.
169
‘H NMR (400 MHz, CDCI3): 5 =  3.84 (IH, dq, J = 6.1, 6.1 Hz, HIS), 3.62-3.54 (2H, m, 
H15), 3.47 (3H, s, OMe), 3.07 (IH, dd, J = 6.0, 3.5 Hz, H 17), 1.99 (IH, qddd, 7 =  6.8,
6.8, 5.6, 3.4 Hz, H 16), 1.19 (3H, d, J = 6.1 Hz, H19), 0.89 (3H, d, 7 = 7.1 Hz, C16-Me), 
0.85 (9H, s, CMes), 0.05 (3H, s, SiMei), 0.03 (3H, s, SiMez) ppm.
" C  NMR (125 MHz, CDCI3): 5 = 87.2 (1, C17), 69.0 (1, C l8), 66.3 (2, 015), 60.3 (3, 
OMe), 36.8 (1, 016), 25.8 (3, 30, OMeg), 20.4 (3, 019), 18.0 (0, ÇMeg), 11.3 (3, 016- 
Me), -4.2 (3, SiMe2), -4.8 (3, SiMei) ppm.
LRMS (01+ mode): m/z = 606 (31%), 492 (100), 263 (48), 131 (19), 117 (21).
Anal. Oalcd. for OnHsoOsSi (M = 262): O, 59.49; H, 11.52. Found 0 , 59.57; H, 11.41.
(2S ,3R ,4S )-4-[(l,l-D im eth yleth yl)d im eth ylsily l]oxy-3-m eth oxy-2-
methylpentanal (335):
MeO
DMP (424)
TBSO - CH2 CI2 , 0 °C rt, 2  h TBSO
361 335
CiaHsoOsSi (262.46) Ci3 H2 eQ3Si (260.45)
A stirred solution of the alcohol 361 (6.80 g, 26.0 mmol) in anhydrous CH2CI2 (120 mL) at 
0°C under N2(g) was treated in one portion with Dess-Martin reagent^^’^ ^^  (DMP, 13.4 g, 31.6 
mmol). The resulting solution was allowed to warm to rt and stirred for 2 h. After this time the 
reaction mixture was poured into sat. Na2S203-NaHC03(aq) (200 mL) and stirred vigorously 
for 30 min. The biphasic system was then further diluted with Et20 (100 mL) and the layers 
shaken and then separated. The aqueous phase was then extracted (2x20 mL Et2Û) and the 
combined organic extracts washed with sat. NaHC03(aq) (4x30 mL), dried (MgSO^) and then 
concentrated in vacuo. The residue was then further purified via column chromatography 
(eluting with 10% Et20 in hexanes) to yield the aldehyde 335 (6.15 g, 23.7 mmol, 91%) as a 
clear oil.
[a]o = —7.5 (c = 1.0, CHCI3).
IR (film): V = 2932 (s), 1728 (s), 1472 (m), 1372 (w), 1334 (w), 1308 (w), 1258 (m), 1200 
(w), 1114 (s), 1004 (m), 940 (m), 836 (s), 812 (m), 776 (m) cm -f
iH NMR (360 MHz, CDCI3): 5 = 9.81 (IH, s, H15), 3.76 (IH, quintet, J = 6.3 Hz, H18), 
3.47 (IH, dd, J  = 7.1, 3.0 Hz, H17), 3.34 (3H, s, OMe), 2.78 (IH, qd, J  = 7.2, 3.0 Hz,
170
H16), 1.25 (3H, d, 7 =  6.0 Hz, H19), 1.04 (3H, d, /  = 7.0 Hz, C16-Me), 0.88 (9H, s, 
CMes), 0.08 (3H, s, SiMc2), 0.06 (3H, s, SiMe2) ppm.
13C NMR (90 MHz, CDCI3): ô = 204.8 (1, C15), 84.9 (1, C17), 68.7 (1, C18), 59.7 (3, 
OMe), 48.3 (1, C16), 25.9 (3, 3C, CM ei), 20.9 (3, C19), 18.0 (0, ÇMeg), 7.6 (3, C16-Me), 
-3.9 (3, SiMc2), -4.8 (3, SiMc2} ppm.
LRMS (CI+ mode, NH3): m/z = 278 (100%), 261 (48), 249 (16).
(4R ,5R ,65)-2 ,4-D im eth yl-6-[(l,l-d im eth yleth yl)d im eth ylsily l]oxy-5-
m ethoxyhept-l-en-3-one (362):
MeO (a)/sopropenyl bromide (1 2 1 ) MeO O
Mg (24), EtaO, 0°C, 1 h 19^ 1^  isX  ^13  
O --------------------------------- ►
TBSO (b) DMP (424), CH2 CI2 , rt, 4 h TBSO
335 362
Ci3H28CbSI (260.45) Ci6H32Q3SI (300.51)
A stirred suspension of activated magnesium (2.7 g, 113 nunol) in anhydrous Et20 (130 mL) 
at rt under N2(g) was provided with 1 crystal of re-sublimed iodine. The brown mixture was 
then treated with one quarter of a solution of r\sopropenylbromide (10 g, 82.6 mmol) in 
anhydrous Et20 (20 mL). The resultant suspension was heated to reflux until the brown colour 
had dissipated and Grignard formation had initiated. The remainder of the solution of bromide 
was then added at such a rate as to maintain a gentle reflux (ca 30 min). After the complete 
addition the cloudy solution of /jopropenyl magnesium bromide was heated at reflux for an 
additional 2.5 h before being cooled to 0°C. A solution of the freshly prepared aldehyde 335 
(6.15 g, 23.7 mmol) in anhydrous Et20 (50 mL) was then added dropwise over 10 min and 
the reaction mixture stirred at 0°C for 1 h. H2O (50 mL) was then added cautiously followed by 
IM HCl(aq) (50 mL) and the biphasic mixture stirred for 10 min. The layers were then 
separated and the aqueous phase extracted (3x30 mL Et20). The combined organic extracts 
were then washed with sat. NaHC03(aq) (50 mL), dried (MgS04) and concentrated in vacuo. 
The residue was then further purified via column chromatography (eluting with 10% Et20 in 
hexanes) to afford 363 (6.51 g, 21.6 mmol, 91%) as a mixture of diastereoisomers (dr (C l5) 
= 43:57 in favour of the syn isomer). The alcohols 363 (6.37 g, 21.1 mmol) were then 
dissolved in anhydrous CH2CI2 (100 mL) and the resulting solution treated with Dess-Martin 
reagent^^’^ ^^  (DMP, 11.0 g, 25.9 mmol) and stirred at rt under N2(g) for 4 h. After this time the 
mixture was poured into sat. Na2S203-NaHC03(aq) (100 mL) and stirred vigorously for 1 h. 
The biphasic mixture was then diluted with Et20 (100 mL) and the layers separated. The 
aqueous phase was extracted (3x30 mL Et20) and the combined organic extracts washed with 
brine (30 mL), dried (MgS04) and then concentrated in vacuo. The crude ketone was then
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further purified via column chromatography (eluting with 5% Et20 in hexanes) to yield pure 
362 (5.58 g, 18.6 mmol, 88%, 80% from 335) as a clear inviscid oil.
[a]D = -35.2 (c = 1.02, CHCI3).
IR (film): v =  2956 (s), 2931 (s), 2858 (s), 1676 (s), 1462 (m), 1380 (m), 1257 (s), 1115 (s), 
1058 (m), 1028 (w), 981 (w), 932 (s), 835 (s), 776 (s) cm-i.
iH NMR (360 MHz, CDCI3): 5 = 5.97 (IH, m, H13e ), 5.80 (IH, m, H13z), 3.66 (IH, 
quintet, J  = 6.0 Hz, H18), 3.52 (IH, qd, J  = 6.9, 5.1 Hz, H16), 3.37-3.34 (IH, signal 
obscured, H17), 3.35 (3H, s, OMe), 1.88 (3H, m, C14-Me), 1.13 (3H, d, 7 = 6.1 Hz, H19),
1.09 (3H, d, 7 =  6.8 Hz, C16-Me), 0.88 (9H, s, CMeg), 0.06 (3H, s, SiMei), 0.05 (3H, s, 
SiMe2) ppm.
13C NMR (90 MHz, CDCI3): J  = 205.3 (0, C15), 143.8 (0, C14), 124.9 (2, C l3), 87.6 (1, 
C17), 69.4 (1, C18), 60.6 (3, OMe), 41.4 (1, C16), 26.0 (3C, 3, CM eil  19.8 (3, C19), 18.3 
(3, C14-Me), 18.1 (0, CMeg), 11.8 (3, C16-Me). -4.2 (3, SiMe2), -4.7 (3, SiMe2) ppm.
LRMS (CI+ mode, wobutane): m/z = 301 (100%), 285 (3), 269 (5), 243 (16), 169 (63).
Anal. Calcd. for C i6H3203Si (M = 300): C, 63.95; H, 10.73. Found C, 63.73; H, 10.53.
(3R ,4R ,5/? ,6S)-2 ,4-D im ethyl-6-[(l,l-d im ethyIethyl)d im ethylsiIy l]oxy-5-
m ethoxyhept-l-en-3-ol (363):
MeO O
UAIH4  (38), Lil (134)
TBSO ' Et2 O ,- 1 0 0 X , 1 h TBSO
362 363
Ci6H32p3Si (300.51) Ci6H3403Si (302.52)
To a stirred solution of anhydrous lithium iodide (25.0 g, 187 mmol) in anhydrous Et20 (200 
mL) at -30°C under N2(g) was added the enone 362 (5.58 g, 18.6 mmol) in anhydrous Et20 
(20 mL). The resulting mixture was stirred vigorously for 20 min and then further cooled to 
-95°C (internal temperature). A solution of lithium aluminium hydride (20 mL, 1.0 M in Et20, 
20 mmol) was then added dropwise via syringe pump over 30 min. The reaction mixture was 
then quenched by the careful addition of MeOH (20 mL) followed by H2O (50 mL) and then 
allowed to warm to rt. The biphasic system was then filtered through a celite pad and the 
residue washed well (3x50 mL Et20). The layers of the filtrate and combined washings were 
then separated and the aqueous phase extracted (2x20 mL Et2 0 ). The combined organic 
extracts were then washed successively with H2O (2x50 mL), brine (50 mL), dried (MgS04)
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and then concentrated in vacuo. The resulting crude solid product (5.22 g, ca 93%, dr (C l5) = 
85:15) was then further purified via recrystallisation (5% H20-EtOH 30 mL) to afford 3.46 g 
of the title compound 363 as a white crystalline solid: mp 63-65°C. The mother liquor was 
concentrated in vacuo and the residue (1.65 g) further purified via column chromatography 
(eluting with 7% Et20 in hexanes) to yield an additional 0.76 g of pure product as a white solid 
(desired isomer is the less polar component). The above procedure yielded in total 4.22 g of 
diastereomerically pure 363 (14.0 mmol, 75%).
[a]D = +9.2 (c = 1.07, CHCI3).
IR (KBr): v = 3444 (br s), 2953 (s), 2858 (s), 1655 (m), 1507 (w), 1473 (w), 1446 (w), 
1373 (m), 1334 (w), 1295 (w), 1257 (m), 1115 (s), 1086 (m), 1061 (w), 1043 (m), 993 (m), 
974 (w), 934 (s), 899 (m), 835 (s), 810 (m), 772 (s), 745 (w) cm-i.
iR NMR (360 MHz, CDCI3): 5 =  5.06 (IH, m, H13e), 4.92 (IH, m, H13z), 3.95 (IH, d, J  
= 7.4 Hz, H15), 3.81 (IH, quintet, J  = 6.2 Hz, H18), 3.46 (3H, s, OMe), 3.30 (IH, dd, J  =
6.9, 2.0 Hz, H17), 2.66-2.59 (IH, m, OH), 2.08 (IH, dqd, J  = 7.2, 7.1, 1.9 Hz, H16), 1.68 
(3H, s, C14-Me), 1.22 (3H, d, / =  6.1 Hz, H19), 0.88 (3H, d, 7 = 7.1 Hz, C16-Me), 0.87 
(9H, s, CMeg), 0.07 (3H, s, SiMe2), 0.05 (3H, s, SiMe2) ppm.
13C NMR (90 MHz, CDCI3): 5 = 146.7 (0, C14), 112.8 (2, C13), 85.4 (1, C17), 79.3 (1, 
€15), 68.9 (1, €18), 59.9 (3, OMe), 35.7 (1, €16), 26.0 (3€, 3, € M ei). 21.1 (3, €19), 18.1 
(0, CMes), 17.5 (3, €14-Me), 1L3 (3, €16-Me), -3.9 (3, SiMe2), -4.7 (3, SiMe2) ppm.
LRMS (€1+ mode, NH3): m/z = 303 (100%), 285 (13), 253 (8), 132 (7), 96 (28).
Anal. Calcd. for € i6H3403Si (M = 302): € , 63.52; H, 11.33. Found € , 63.48; H, 11.26.
(3/?,4/?,5R ,6S)-2,4-D im ethyI-5-m ethoxyhept-l-en-3,6-diol (365):
MeO OH    ^ MeO OH
TBAF*3H20 (315.5) 1 7 : 1 5 I 13
TBSO ' THF, rt. 15 min HO
363 365
Ci6H34Q3SI (302.52) CioHsdOa (188.26)
A stirred solution of the silyl ether 363 (100 mg, 0.33 mmol) in anhydrous THF (5 mL) at rt 
under N2(g) was treated with tetra-n-butylammonium fluoride trihydrate (TBAF*3H20, 520 
mg, 1.65 mmol). After stirring for 15 min the mixture was partitioned between EtOAc (20 mL) 
and H2O (20 mL) and the layers shaken and then separated. The aqueous phase was then
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extracted (3x10 mL EtOAc) and the combined organic extracts washed with brine (10 mL), 
dried (MgS04) and then concentrated in vacuo. The residue was then further purified via 
column chromatography (eluting with 50% EtOAc in hexanes) to yield the diol 365 (45 mg, 
0.24 mmol, 72%) as a white solid: mp 128-130°C (EtOAc). Slow recrystallisation from EtOAc 
enabled the growth of fine needles appropriate for single X-ray diffraction studies (see the 
appendix for crystal structure details).
[a]o = +3 (c = 0.34, CHCI3).
IR (KBr): v = 3328 (m), 2926 (m), 1460 (m), 1375 (w), 1310 (w), 1133 (w), 1097 (s), 1051 
(w), 1018 (s), 961 (w), 902 (m), 881 (w), 733 (m) cm~L
iR NMR (360 MHz, CDCI3): Ô = 5.07 (IH, m, H13e ), 4.94 (IH, m, H13z), 4.03 (IH, 
quintet, J  = 6.2 Hz, H18), 3.99 (IH, d, J = 7.0 Hz, H15), 3.47 (3H, s, OMe), 3.36 (IH, dd, 
J  = 5.8, 2.1 Hz, H17), 2.67-2.60 (IH, m, OH), 2.05 (IH, quintet of d, /  = 7.1, 2.0 Hz, 
H16), 1.98-1.90 (IH, m, OH), 1.70 (3H, s, C14-Me), 1.25 (3H, d, 7 = 6.4 Hz, H19), 0.98 
(3H, d, 7 = 7.1 Hz, C16-Me) ppm.
13C NMR (90 MHz, CDCI3): Ô = 146.6 (0, C14), 113.0 (2, C13), 84.0 (1, C17), 79.4 (1, 
C15), 67.2 (1, C18), 58.9 (3, OMe), 35.5 (1, C16), 19.6 (3, C19), 17.7 (3, C14-Me), 11.9 
(3, C16-Me) ppm.
LRMS (CI+ mode, NH3): m/z = 206 (59%), 188 (21), 171 (100), 139 (18).
HRMS (CI+ mode, wobutane): Found (M-hH)+, 189.1490. C10H21O3 requires 189.1491.
(3R ,4R ,5/? ,6S )-2 ,4-D im eth yl-6-[(l,l-d im eth yleth yl)d im eth ylsily l]oxy-5-  
methoxyhept-l-en-3-yI propionate (364):
O
MeO OH (EtC0 ) 2 0  (130), DMAP (1 2 2 )
TBSO = I pyridine, rt, 16 h TBSO = I
363 364
Ci6H34Q3Si (302.52) CigH3804Si (358.59)
A stirred solution of the alcohol 363 (4.0 g, 13.2 mmol) in anhydrous pyridine (30 mL) at rt 
under N2(g) was treated with propionic anhydride (3.4 mL, p  = 1.015, 3.45 g, 26.5 mmol) 
followed by 4-(dimethylamino)pyridine (30 mg, 0.25 mmol) and then stirred for 16 h. The 
mixture was then diluted with Et20 (250 mL) and the organic phase washed successively with
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2M HCl(aq) (5x50 mL) and sat. NaHC03(aq) (2x50 mL). The ethereal liquor was then dried 
(MgS04) and concentrated in vacuo. The crude residue was then further purified via column 
chromatography (eluting with 5% Et20 in hexanes) to yield the ester 364 (4.60 g, 12.8 mmol, 
97%) as a clear oil which later crystallised upon standing: mp 46-47°C; bp (kugelrohr oven) 
160°C, 0.8 mmHg.
[aJo = -5.1 (c = 0.60, CHCI3).
IR (film): v = 2932 (s), 2858 (m), 1740 (s), 1463 (m), 1361 (m), 1257 (m), 1185 (s), 1108 
(s), 1003 (m), 958 (m), 926 (m), 835 (s), 775 (m) cm-^.
iR NMR (360 MHz, CDCI3): 5 =  5.11 (IH, d, 7 =  10.0 Hz, H15), 5.04 (IH, m, H13e), 
4.96 (IH, quintet, 7 = 1.7 Hz, H13z), 3.74 (IH, dq, 7 =  7.7, 6.0 Hz, H18), 3.38 (3H, s, 
OMe), 2.99 (IH, dd, 7 =  7.8, 1.5 Hz, H17), 2.36 (2H, qd, 7 = 7.7, 1.4 Hz, H12), 2.23 
(IH, dqd, 7 = 10.0, 7.1, 1.5 Hz, H I6), 1.66 (3H, hr s, C14-Me), 1.22 (3H, d, 7 =  6.1 Hz, 
H19), 1.16 (3H, t, 7 =  7.5 Hz, C12-Me), 0.89 (9H, s, CMeg), 0.75 (3H, d, 7 =  7.1 Hz, 
C16-Me), 0.07 (3H, s, SiMe2), 0.05 (3H, s, SiMe2) ppm.
13C NMR (90 MHz, CDCI3): 8=  173.8 (0, C ll) , 142.1 (0, C14), 115.8 (2, C13), 84.7 (1, 
C17), 79.5 (1, C15), 69.0 (1, C18), 60.9 (3, OMe), 34.9 (1, C16), 28.2 (2, C12), 25.9 (3C, 
3, CM ei). 21.2 (3, C19), 18.1 (0, CMeg), 17.3 (3, C14-Me), 9.5 (3, C16-Me), 9.4 (3, C12- 
Me), -3.7 (3, SiMe2), -4.8 (3, SiMe2) ppm.
LRMS (CI+ mode, NH3): m/z = 376 (100%), 359 (15), 285 (70), 277 (25), 253 (15) 188 
(10), 132(10), 96 (30).
Anal. Calcd. for Ci9H3g04Si (M = 358): C, 63.64; H, 10.68. Found C, 63.72; H, 10.61.
(.E,2 5 ,6 5 ,7 R ,8 5 )-8 -[(l,l-D im eth y leth y l)d im eth y lsily l]oxy-7 -m eth oxy-2 ,4-6- 
trimethylnon-4-enoic acid (333):
(a) APrgNH (101), BuLi 
THF,-78°C, 30 minMeO O
TBSO I (b) TBSCI, DMPU p g g o
364 -7 8 °C _ A ,1 h
C1 9 H3 8 O4 S 1 (358.59) Ci9H3804Si (358.59)
To a stirred solution of diî\sc>propylamine (0.65 mL, p  = 0.722, 0.47 g, 4.6 mmol) in 
anhydrous THF (10 mL) at 0°C under N2(g) was added dropwise n-butyl lithium (1.85 mL,
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2.27 M in hexanes, 4.2 mmol). The resulting solution of lithium diwopropylamide was stirred 
for 5 min and then further cooled to -78°C. A solution of the ester 364 (1.0 g, 2.79 mmol) in 
anhydrous THF (5 mL) was then added continously down the cold flask side-wall over 5 min 
whilst the base solution was vigorously stirred. The clear reaction mixture was stirred for 30 
min and then treated dropwise with rgrr-butyldimethylsilyl chloride (TBSCI, 3.0 mL, 1.03 M in 
hexanes, 3.1 mmol) followed by anhydrous dimethylpropylene urea (DMPU, 4 mL). After 
stirring for 5 min the solution was allowed to warm it (cold bath removed) and then heated at 
reflux for 1 h. The colourless mixture was then allowed to cool to rt, treated with 2M HCl(aq) 
(10 mL) and stirred vigorously for 30 min. The layers were then separated and the aqueous 
phase extracted (5x10 mL CH2CI2). The combined organic extracts were dried (MgS04) and 
concentrated in vacuo. The crude residue was then further purified via column chromatography 
(eluting with 25-50% Et20 in hexanes) to yield the acid 333 [835 mg, 82 wt.% (contaminated 
by TBSOH), 1.91 mmol, 68%, dr (C l2) « 6:1 determined by integration of OMe resonances 
in the ^H NMR (360 MHz, CDCI3): ^M e = 3.52 (major), ^M e = 3.50 (minor)] as a clear oil. 
An analytical sample of the acid free from TBSOH was obtained by repeated chromatography, 
diastereoisomers were not separated.
[a]o = -0.8 (c = 0.51, CHCI3).
IR (film): V = 2957 (s), 2930 (s), 2857 (s), 1709 (s), 1462 (m), 1382 (w), 1255 (m), 1104 
(m), 1048 (w), 932 (w), 835 (m), 775 (m) cm"h
iH NMR (360 MHz, CDCI3): 5 = 5.06 (IH, dm, J  = 9.2 Hz, H15), 3.83 (IH, qd, J  = 6.2,
3.5 Hz, H18), 3.52 (3H, s, OMe), 2.86 (IH, dd, J  = 7.8, 3.6 Hz, H17), 2.70-2.59 (IH, m, 
H12), 2.50-2.38 (2H, m, H16, H13b), 2.05 (IH, dd, 7 =  13.5, 8.4 Hz, H13a), 1.60 (3H, 
d, 7 = 1.2 Hz, C14-Me), 1.12 (3H, d, 7 =  6.9 Hz, C12-Me), 1.09 (3H, d, 7 = 6.2 Hz, H19), 
0.95 (3H, d, 7 = 6.6 Hz, C16-Me), 0.89 (9H, s, CMeg), 0.04 (6H, s, SiMe2) ppm.
13C NMR (90 MHz, CDCI3): 5=  182.8 (0, C ll) , 131.2 (1, C15), 131.2 (0, C14), 90.3 (1, 
C17), 70.4 (1, C18), 61.5 (3, OMe), 44.0 (2, C13), 37.9 (1, C12), 35.2 (1, C16), 26.0 (3C, 
3, CMeg), 18.2 (0, CMeg), 17.8 (3, C19), 17.0 (3, C16-Me), 16.4 (3, C12-Me), 15.8 (3, 
C14-Me), -4.3 (3, SiMe2), -4.7 (3, SiMe2) ppm.
LRMS (CI+ mode, NH3): m/z = 375 (31%), 358 (34), 327 (9), 227 (100), 212 (18), 195 
(15), 172 (10).
HRMS (EI+ mode): Found M+% 358.2538. Ci9H3g04Si requires 358.2539.
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(£;,25,65,7 /î ,8 S )-8 - [ ( l , l-D im eth yleth yl)d im eth ylsilyI]oxy-7-m eth oxy-2 ,4,6- 
trim ethylnon-4-en-l-ol (375):
, ,  ^  HOgC.
UAIH4  (38)
TBSO I EtgO, 0°C, 10 min j b s q
333 375
Ci9H38G4SI (358.59) C19H40O3SI (344.60)
A stirred suspension of lithium aluminium hydride (0.35 g, 9.2 mmol) in anhydrous Et20 (15 
niL) at 0°C under N2(g) was treated dropwise with a solution of the acid 333 (1.64 g, 82 
wt.%, 3.76 mmol, dr (C l2) = 6:1) in anhydrous Et20 (5 mL). A vigorous reaction ensued and 
after stirring for 10 min the reaction mixture was quenched by the careful addition of sat. 
NH4Cl(aq) (10 mL). The biphasic system was then filtered through a celite pad and the residue 
washed well (4x10 mL Et20). The layers of the combined washings and filtrate were then 
separated and the aqueous phase extracted (10 mL Et2Û). The combined organic extracts were 
then dried (MgS04) and concentrated in vacuo. The crude residue was then further purified 
via column chromatography (eluting with 30% Et20 in hexanes) to yield the alcohol 375 (1.17 
g, 3.40 mmol, 90%, dr (C l2) « 6:1) as a clear oil.
The two diastereoisomers (at C l2) can be separated as follows: 1.0 g of 375 (dr (C12) > 4:1) 
was loaded onto a silica column (0  7 cm, depth 12 cm) and eluted with 15% Et20 in hexanes 
taking a pre-fraction of 2.2 L followed by 20 mL fractions to yield in order of elution, 303 mg 
of mixed material (dr « 3:1) followed by 590 mg of pure material (dr > 95:5).
(£',25,65,7/?,85)-8-[( 1,1 -Dimethylethyl)dimethylsilyl]oxy-7-methoxy-2,4,6-trimethylnon-4- 
en-l-ol (375).
[ oc] d  = +1.5 (c = 0.62, CHCI3).
IR (film): v=  3365 (br m), 2956 (s), 2929 (s), 2857 (s), 1461 (m), 1382 (w), 1256 (m), 1103 
(m), 1047 (m), 1005 (w), 932 (w), 836 (m), 775 (m), 735 (w) cm -f
iR NMR (360 MHz, CDCI3): Ô = 5.00 (IH, dm, J = 10.0 Hz, H15), 3.85 (IH, qd, J = 6.2, 
3.4 Hz, H18), 3.52 (3H, s, OMe), 3.48 (IH, dd, 7 =  10.5, 5.8 Hz, H IIa ), 3.41 (IH, dd, 7 = 
10.6, 5.9 Hz, HI 1b ), 2.86 (IH, dd, 7 = 7.7, 3.4 Hz, H17), 2.42 (IH, ddq, 7 = 9.9, 8.0, 6.7 
Hz, H16), 2.11 (IH, dd, 7 =  12.2, 5.1 Hz, H13a ), 1.88-1.79 (IH, m, H12), 1.79-1.70 (2H, 
m, H13b , OH), 1.58 (3H, d, 7 = 1.3 Hz, C14-Me), 1.08 (3H, d, 7 = 6.2 Hz, H19), 0.95
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(3H, d, 7 = 6.6 Hz, C16-Me), 0.87 (9H, s, CMes), 0.84 (3H, d, 7 = 6.5 Hz, C12-Me), 0.03 
(6H, s, SiMe2) ppm.
" C  NMR (90 MHz, CDCI3): 5=  133.0 (0, C14), 130.0 (1, C15), 90.4 (1, C17), 70.4 (1, 
C18), 68.6 (2, C ll) , 61.5 (3, OMe), 44.5 (2, €13), 35.3 (1, €16), 33.8 (1, €12), 26.0 (3€, 
3, €M £3), 18.1 (0, ÇMea), 17.6 (3, €19), 17.2 (3, €16-Me), 16.7 (3, €12-Me), 16.0 (3, 
€14-Me), -4.3 (3, SiMe^), -4.7 (3, SiMei) ppm.
LRMS (€1-1- mode, wobutane): m/z = 345 (100%), 313 (45), 213 (82), 181 (34).
Anal. Calcd. for CigH^oOgSi (M = 344): € , 66.22; H, 11.70. Found € , 66.07; H, 11.61.
(£,2/î,6S,7/?,8S)-8-[(l,l-Dimethylethyl)dimethylsilyl]oxy-7-methoxy-2,4,6-trimethylnon-4- 
en-l-ol (12-epi-375):
[a]o = +6.9 (c = 0.58, €H €l3).
IR (film): v =  3373 (br m), 2955 (s), 2928 (s), 2857 (s), 1462 (m), 1382 (m), 1256 (m), 1102 
(s), 1047 (s), 1005 (w), 932 (m), 835 (m), 809 (w), 775 (m) cm -'.
IH NMR (360 MHz, CDCls): 5 =  5.02 (IH, d, 7 = 9 .9  Hz), 3.84 (IH, qd, 7 =  6.0, 3.5 Hz), 
3.53 (3H, s), 3.50 (IH, dd, 7 =  10.5, 5.6 Hz), 3.41 (IH, dd, 7 =  10.5, 6.0 Hz), 2.87 (IH, 
dd, 7 = 7.7, 3.5 Hz), 2.47 (IH, ddq, 7 = 9.6, 7.3, 7.3 Hz), 2.10 (IH, dd, 7 = 12.1, 5.1 Hz), 
1.90-1.74 (2H, m), 1.60 (3H, m), 1.51 (IH, br s), 1.11 (3H, d, 7 = 6.2 Hz), 0.97 (3H, d, 
7 =  6.6 Hz), 0.92 (9H, s), 0.90-0.87 (3H, m), 0.05 (6H, s) ppm.
13c NMR (90 MHz, €D €l3): 5 =  132.8 (0), 130.1 (1), 90.4 (1), 70.3 (1), 68.5 (2), 61.4 (3),
44.3 (2), 35.2 (1), 33.9 (1), 26.0 (3€, 3), 18.2 (0), 17.9 (3), 17.1 (3), 16.7 (3), 16.3 (3), 
—4.2 (3), —4.7 (3) ppm.
LRMS (El-t- mode): m/z = 344 (3%), 287 (4), 255 (12), 229 (3), 203 (100), 181 (34), 159 
(40), 123 (39), 89 (43), 73 (96), 69 (41).
HRMS (EI-h mode): Found M+", 344.2744. CigHaoOsSi requires 344.2747.
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2-{[(Æ :,2S ,65 ,7 /î,8S )-8-[(l,l-D im ethylethyl)d im ethylsily l]oxy-7-m ethoxy-  
2,4,6-trim ethylnon-4-enyl]thio}benzothiazole (376):
BTSH (167), PPhs (262)
DIAD (202)
TBSO ' ^  rt, 2 h jg g Q
375 376
Ci9H4o03Si (344.60) C26H43N02^Si (493.84)
To a stirred solution of the alcohol 375 (1.47 g, 4.27 mmol) in anhydrous THF (25 mL) at rt 
under N2(g) was added 2-mercaptobenzothiazole (BTSH, 0.86 g, 5.15 mmol) and 
triphenylphosphine (1.34 g, 5.11 mmol). The resulting solution was cooled to 0°C and 
diwopropyl azodicarboxylate (DIAD, 1.10 mL, p = 1.027, 1.13 g, 5.59 mmol) added 
dropwise. The cooling bath was then removed and the mixture allowed to stir for 2 h. After 
this time the solvent was removed in vacuo and the residue further purified via column 
chromatography (eluting with 3% EtOAc in hexanes) to yield the sulfide 376 (2.08 g, 4.21 
mmol, 99%) as a clear oil.
[a]D = +0.3 (c = 0.65, CHCI3).
IR (film): V = 2956 (s), 2928 (s), 2894 (s), 2856 (s), 1461 (s), 1428 (s), 1380 (w), 1255 (m), 
1103 (m), 1048 (w), 995 (m), 932 (w), 836 (m), 775 (m), 755 (m), 726 (w), 670 (w) cm“h
iH NMR (360 MHz, CDCI3): Ô = 7.86 (IH, dm, 7 =  8.1 Hz, BT), 7.75 (IH, dm, J  = 8.0 
Hz, BT), 7.41 (IH, ddd, J=  8.5, 7.3, 1.3 Hz, BT), 7.29 (IH, ddd, J  = 8.1, 7.4, 1.2 Hz, 
BT), 5.06 (IH, dm, J = 9.9 Hz, H15), 3.87 (IH, qd, J = 6.2, 3.4 Hz, H18), 3.54 (3H, s, 
OMe), 3.45 (IH, dd, J  = 12.9, 5.3 Hz, H IU ), 3.12 (IH, dd, J  = 12.9, 7.5 Hz, H IIr), 2.88 
(IH, dd, J  = 7.9, 3.4 Hz, H17), 2.47 (IH, ddq, J  = 9.9, 7.8, 6.7 Hz, H I6), 2.27-2.10 (2H, 
m, H12, H13a ), 1.93 (IH, dd, J  = 12.8, 8.0 Hz, H13b ), 1.62 (3H, d, 7 =  1.2 Hz, C14-Me), 
1.11 (3H, d, 7 = 6.2 Hz, H19), 1.03 (3H, d, 7 =  6.5 Hz, C12-Me), 1.00 (3H, d, 7 = 6.6 Hz, 
C16-Me), 0.90 (9H, s, CMeg), 0.05 (3H, s, SiMe2), 0.05 (3H, s, SiMe2) ppm.
13C NMR (90 MHz, CDCI3): ô = 167.6 (0, BT), 153.4 (0, BT), 135.3 (0, BT), 132.2 (0, 
C14), 130.7 (1, C15), 126.1 (1, BT), 124.2 (1, BT), 121.5 (1, BT), 121.0 (1, BT), 90.3 (1, 
C17), 70.4 (1, C18), 61.5 (3, OMe), 47.2 (2, C13), 40.4 (2, C ll) , 35.3 (1, C l6), 31.5 (1, 
C 12), 26.0 (3C, 3, CMeg), 19.4 (3, C12-Me), 18.2 (0, CMeg), 17.7 (3, C19), 17.2 (3, C16- 
Me), 16.1 (3, C14-Me), -4.3 (3, SiMe2), -4.7 (3, SiMe2) ppm.
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LRMS (EI+ mode): m/z = 493 (10%), 446 (6), 436 (4), 330 (47), 203 (97), 159 (33), 123 
(63), 73 (100).
HRMS (EI+ mode): Found M+", 493.2508. C26H43N02S2Si requires 493.2505.
Anal. Calcd. for C26H43N02S2Si (M = 493): C, 63.23; H, 8.78; N, 2.84. Found C, 63.36; 
H, 8.84; N, 2.82.
(£^,2S,6S,7R,8S)-l-(Benzothiazol-2-ylthio)-7-methoxy-2,4,6-trim ethylnon-4-  
en-8-ol (377):
SBT SBT
MeO
TBSO
376
TBAF-3H20 (315.5)
THF, rt, 32 h HO
377
C26H43N02^Si (493.84) C2 0 H2 9 NO2 S2  (379.58)
A stirred solution of the silyl ether 376 (631 mg, 1.28 mmol) in anhydrous THE (15 mL) at rt 
under N2(g) was treated with tetra-M-butylammonium fluoride trihydrate (TBAF*3H20, 2.0 g,
6.3 mmol) and the resulting clear mixture stirred for 28 h. After this time TLC analysis 
indicated incomplete consumption of the silyl ether; additional TBAF*3H20 (0.5 g, 1.6 mmol) 
was then added and the reaction stirred for a further 4 h. The solution was then partitioned 
between Et20 (30 mL) and H2O (30 mL) and the layers shaken well and then separated. The 
aqueous phase was extracted (3x15 mL Et20) and the combined organic extracts washed with 
brine (20 mL), dried (MgS04) and then concentrated in vacuo. The crude residue was then 
further purified via column chromatography (eluting with 30% EtOAc in hexanes) to yield the 
alcohol 377 (475 mg, 1.25 mmol, 98%) as a clear oil.
[a]D = -22.1 (c = 1.00, CHCI3).
IR (film): y = 3441 (br s), 2979 (s), 2829 (s), 1458 (s), 1427 (s), 1239 (m), 1126 (m), 1096 
(s), 1033 (w), 1048 (w), 994 (s), 904 (m), 756 (s), 727 (s) cm 'L
iR NMR (360 MHz, CDCI3): 5 =  7.85 (IH, dm, 7 = 8 .1  Hz, BT), 7.75 (IH, dm, J  = 8.0 Hz, 
BT), 7.40 (IH, ddd, J  = 8.2, 7.3, 1.3 Hz, BT), 7.28 (IH, ddd, J  = 8.0, 7.4, 1.2 Hz, BT),
5.07 (IH, dm, J = 9.9 Hz, H15), 3.84 (IH, m, H18), 3.53 (3H, s, OMe), 3.44 (IH, dd, J  = 
12.9, 5.1 Hz, H IIa ), 3.09 (IH, dd, J  = 12.9, 7.4 Hz, HI 1b ), 2.96 (IH, dd, J  = 8.2, 3.8 
Hz, H17), 2.51 (IH, ddq, J  = 9.8, 8.2, 6.7 Hz, H16), 2.23-2.09 (2H, m, H12, H13a ),
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1.98-1.89 (2H, m, H13b , OH), 1.63 (3H, d, /  = 1.3 Hz, C14-Me), 1.14 (3H, d, J = 6.4 Hz, 
H19), 1.05 (3H, d ,J =  6.7 Hz, C12-Me), 1.01 (3H, d, J = 6.5 Hz, C16-Me) ppm.
13C NMR (90 MHz, CDCI3): d = 167.6 (0, BT), 153.4 (0, BT), 135.3 (0, BT), 132.6 (0, 
C14), 130.1 (1, C15), 126.1 (1, BT), 124.2 (1, BT), 121.5 (1, BT), 121.0 (1, BT), 89.6 (1, 
C17), 69.4 (1, C18), 61.6 (3, OMe), 47.0 (2, C13), 40.3 (2, C ll) , 35.7 (1, C16), 31.5 (1, 
C 12), 19.4 (3, C12-Me), 17.7 (3, C19), 17.5 (3, C16-Me), 16.2 (3, C14-Me) ppm.
LRMS (El-h mode): m/z = 379 (3%), 332 (14), 290 (18), 248 (7), 223 (6), 208 (10), 167 
(73), 123 (100%), 89 (41), 81 (37).
Anal. Calcd. for C20H29NO2S2 (M = 379): C, 63.28; H, 7.70; N, 3.69. Found C, 63.13; H, 
7.62; N, 3.61.
(Æ ^,2S,6S,7/î,8S)-l-(Benzothiazol-2-ylsulfonyl)-7-methoxy-2,4,6-
trimethylnon-4-en-8-ol (378):
SBT SO2 BT
11
(NH4)6Mo7024*4H20 (1235.9)MeO
HO
377
H2 O2  (34), EtOH, 11, 24 h
378
C2 0 H2 9 NO2 S2  (379.58) C2 0 H2 9 NO4 S 2  (411.58)
To a stirred solution of the sulfide 377 (870 mg, 2.30 mmol) in EtOH (20 mL) at rt was added 
dropwise a yellow solution of ammonium heptamolybdate tetrahydrate (280 mg, 0.23 mmol) in 
aqueous hydrogen peroxide (2.6 g, 30 wt.%, 22.9 mmol). The resultant mixture was stirred 
vigorously for 24 h and then partitioned between Et%0 (30 mL) and H2O (20 mL). The layers 
were shaken and then separated and the aqueous phase extracted (3x10 mL Et20). The 
combined organic extracts were washed with H2O (2x20 mL), dried (MgSO^) and then 
concentrated in vacuo. The crude residue was then further purified via  colum n 
chromatography (eluting with 40% EtOAc in hexanes) to yield the sulfone 378 (835 mg, 2.03 
mmol, 88%) as a clear oil.
[a]D = -24.0 (c = 1.09, CHCI3).
IR (film): v=  3447 (br s), 2962 (s), 2929 (s), 1472 (m), 1458 (m), 1318 (m), 1146 (m), 1097 
(m), 1026 (w), 906 (w), 854 (w), 763 (m), 731 (m), 632 (m) cm~f
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iR NMR (360 MHz, CDCI3): 6= 8 .19  (IH, dm, 7 = 7.8 Hz, BT), 8.01 (IH, dm, 7 =  8.1 Hz, 
BT), 7.63 (IH, ddd, 7 = 8.1, 7.2, 1.4 Hz, BT), 7.58 (IH, ddd, 7 = 7.9, 7.2, 1.4 Hz, BT),
5.02 (IH, dm, 7 = 9.9 Hz, H15), 3.79 (IH, qd, 7 = 6.4, 3.8 Hz, H18), 3.58 (IH, dd, 7 = 
14.4, 3.7 Hz, H IIa ), 3.50 (3H, s, OMe), 3.23 (IH, dd, 7 = 14.4, 8.7 Hz, HI 1b ), 2.92 (IH, 
dd, 7 = 8.0, 3.8 Hz, H17), 2.50-2.39 (2H, m, H16, H12), 2.07 (IH, ddd, 7 = 13.4, 7.9, 1.1 
Hz, H13a ), 1.98 (IH, dd, 7 = 13.6, 6.8 Hz, H13b), 2.0-1.80 (IH, br, OH), 1.49 (3H, d, 7 =
1.3 Hz, C14-Me), 1.10 (6H, d, 7 = 6.4 Hz, C12-Me, H19), 1.01 (3H, d, 7 = 6.7 Hz, C16- 
Me) ppm.
13C NMR (90 MHz, CDCI3): ô = 166.7 (0, BT), 152.8 (0, BT), 136.8 (0, BT), 131.6 (0, 
C14), 131.3 (1, C15), 128.2 (1, BT), 127.8 (1, BT), 125.5 (1, BT), 122.5 (1, BT), 89.4 (1, 
C17), 69.2 (1, C18), 61.4 (3, OMe), 60.0 (2, C ll) , 47.4 (2, C13), 35.5 (1, C16), 26.6 (1, 
C 12), 20.2 (3, C12-Me), 17.6 (3, C19), 17.5 (3, C16-Me), 15.9 (3, C14-Me) ppm.
LRMS (CI+ mode, wobutane): m/z = 412 (100%), 380 (26), 362 (42), 322 (54).
HRMS (CI+ mode, wobutane): Found (M+H)+, 412.1614. C20H30NO4S2 requires 412.1616.
Anal. Calcd. for C20H29NO4S2 (M = 411): C, 58.36; H, 7.10; N, 3.40. Found C, 58.17; H, 
7.15; N, 3.42.
(2S ,4/? ,5R ,6S ,7R ,8S)-l-(B enzothiazol-2-yIsulfonyl)-4 ,5-epoxy-7-m ethoxy-  
2y4,6-trimethylnon-8-ol (379):
MeO
HO
378
SO2BT
VO(acac)2  (265), TBHP
CH2 CI2 , - 8 X , 72 h
MeO H
19 17:
C2 0 H2 9 NO4 S 2  (411.58)
379
C2 0 H2 9 NO4 S2  (427.58)
A stirred solution of the hydroxy olefin 378 (519 mg, 1.26 nunol) in anhydrous CH2CI2 (10 
mL) at -8°C under N2(g) was treated with vandyl bis(acetylacetonate) (3.4 mg, 13 jimol) 
followed by the slow addition of a solution of tert-buiy\ hydroperoxide (TBHP, 0.71 mL, 5.32 
M in fjooctane, 3.8 mmol) in anhydrous CH2CI2 (9 mL) via syringe pump over 48 h. After 
the complete addition of the stoichiometric oxidant the colourless solution was allowed to stir 
for a further 24 h at -8°C. After this time the mixture was diluted with Et20 (20 mL) and H2O 
(20 mL) and the layers shaken well and then separated. The aqueous phase was then extracted 
(2x10 mL) and the combined organic extracts washed with brine (10 mL), dried (MgSÛ4) and 
then concentrated in vacuo. The residue was further purified via column chromatography
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(eluting with 35-60% EtOAc in hexanes) to afford in order of elution: the tetrahydrofuran by­
product 380 (25 mg, 0.06 nunol, 5%), recovered starting material 378 (136 mg, 0.33 mmol, 
26%) and the epoxide 379 (373 mg, 0.87 mmol, 69%) all as clear oils. *H and NMR 
analysis revealed the latter compound to be a single diastereoisomer.
(2S,4/?,5R,6S,7R,8S)-l-(Benzothiazol-2-ylsulfonyl)-4,5-epoxy-7-methoxy-2,4,6-trimethyl- 
non-8-ol (379).
[ « ] d  = -4.0 (c = 1.98, CHCI3).
IR (film): V = 3452 (br s), 2966 (s), 2932 (s), 1471 (m), 1318 (s), 1148 (s), 1097 (s), 910 
(w), 763 (m), 730 (w) cm-*.
*H NMR (360 MHz, CDCI3): 5 =  8.18 (IH, dm, / =  7.6 Hz, BT), 8.01 (IH, dm, ]  = 7.5 Hz, 
BT), 7.66-7.56 (2H, m, BT), 3.94 (IH, quintet, J  = 5.8 Hz, H18), 3.61 (IH, dd, J  = 14.2,
4.7 Hz, H IIa ), 3.48 (3H, s, OMe), 3.34 (IH, dd, J  = 14.3, 7.9 Hz, HI 1b ), 3.06 (IH, t, 7 =
5.0 Hz, H17), 2.61 (IH, d, 7 = 9.5 Hz, H15), 2.62-2.50 (IH, m), 2.08-2.00 (IH, m), 1.80 
(IH, dd, 7 = 14.2, 7.3 Hz, H13a ), 1.67-1.55 (IH, m), 1.59 (IH, dd, 7 = 14.2, 7.4 Hz, 
H13b ), 1.27 (3H, s ,  C14-Me), 1.22 (3H, d, 7 = 6.8 Hz, H19), 1.20 (3H, d, 7 = 6.5 Hz, 
C12-Me), 1.01 (3H, d, 7 = 6.9 Hz, C16-Me) ppm.
13C NMR (90 MHz, CDCI3): Ô = 166.6 (0, BT), 152.7 (0, BT), 136.8 (0, BT), 128.2 (1, 
BT), 127.9 (1, BT), 125.5 (1, BT), 122.5 (1, BT), 86.6 (1, C17), 68.1 (1, C18), 64.9 (1, 
C15), 60.5 (3, OMe), 60.3 (2, C ll) , 60.2 (0, €14), 45.4 (2, €13), 34.7 (1, €16), 26.1 (1, 
€12), 20.9 (3, €12-Ms), 19.1 (3, €19), 16.4 (3, €14-Me), 11.8 (3, €16-Me) ppm.
LRMS (€1+ mode, wobutane): m/z = 428 (11%), 410 (15), 378 (100), 322 (14), 298 (12), 
213 (14), 136 (27).
HRMS (€1+ mode, Aobutane): Foimd (M+H)+, 428.1561. € 2oH3oNO;S2 requires 428.1565.
Anal. Calcd. for € 2oH29N05S2 (M = 427): € , 56.18; H, 6.84; N, 3.28. Found € , 56.19; H, 
6.84; N, 3.23.
(2S,3S,4R,5S)-3,5-Dimethyl-2-[(l/î,3S)-4-(benzothiazol-2-ylsulfonyl)-l,3-dimethyl-l- 
hydroxybutyl]-4-methoxyoxolane (380).
*H NMR (360 MHz, CDCls): S = 8.22 (IH, dm, 7 = 7.5 Hz), 8.03 (IH, dm, 7 =  7.9 Hz), 
7.68-7.55 (2H, m), 3.80 (IH, qd, 7 = 6.7, 2.6 Hz), 3.57 (IH, dd, 7 = 14.3, 6.7 Hz), 3.57
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(IH, d ,J  = 4.6 Hz), 3.48 (IH, dd, J  = 14.3, 6.0 Hz), 3.29 (3H, s), 3.08 (IH, d, 7 = 2.5 
Hz), 2.73-2.60 (IH, m), 2.20-2.10 (2H, m), 1.77 (IH, dd, J  = 14.1, 3.4 Hz), 1.65 (IH, dd, 
J  = 14.2, 8.8 Hz), 1.31 (3H, d, 7 = 6.6 Hz), 1.28 (3H, d, 7 = 6.8 Hz), 1.27 (3H, s), 1.03 
(3H, d, 7 = 7.4 Hz) ppm.
13C NMR (90 MHz, CDCI3): 6=  166.9 (0), 152.8 (0), 136.8 (0), 128.2 (1), 127.8 (1), 125.6 
(1), 122.5 (1), 95.1 (1), 85.6 (1), 79.8 (1), 73.3 (0), 62.1 (2), 56.9 (3), 42.9 (2), 40.2 (1),
26.2 (3), 25.3 (1), 22.3 (3), 20.7 (3), 15.0 (3) ppm.
(l/? ,2 /? ,3R ,4R ,5R ,75)-8-(B enzoth iazol-2-y lsu lfonyl)-4 ,5-epoxy-2-m ethoxy-  
1,3,5,7-tetramethyloctyl 4-chlorobenzoate (332):
(a) PPha (262), DMAD (146)
THF, 0°C, 10 min
SO2 BT
MeO
HO
379
(b) 4-CIPhC02H (156.6) 
0°C ^  rt, 3 h POBO
332
C2 0 H2 9 NO4 S2  (427.58) PCB = 4-chlorobenzoyl C2 7 H3 2 CINO6 S2  (566.13)
A solution of triphenylphosphine (393 mg, 1.50 mmol) in anhydrous THF (3 mL) at 0°C under 
N2(g) was treated with neat dimethyl azodicarboxylate^^^ (DMAD, 170 u^L, p = 1.22, 207 mg,
1.42 mmol) and the resultant colourless suspension stirred for 5 min. A solution of the alcohol 
379 (304 mg, 0.71 mmol) in anhydrous THF (3 mL) was then added dropwise and the 
mixture stirred for a further 5 min. One third of a solution of 4-chlorobenzoic acid (138 mg, 
0.88 mmol) in anhydrous THF (1.8 mL) was then added dropwise and the cooling bath 
removed. After 1 h a further one third of the acid solution was added, followed by the 
remainder after a subsequent hour. The reaction was then stirred for a final 1 h period after 
complete addition of the acid component and then worked-up as follows: the mixture was 
diluted with EtOAc (20 mL) and washed successively with sat. NaHC03(aq) (15 ml), H2O 
(4x10 mL) and brine (10 mL). The resulting organic phase was dried (MgSO^) and then 
concentrated in vacuo. The residue was then further purified via column chromatography 
(eluting with 20% EtOAc in hexanes) to afford the benzoate 332 (297 mg, 0.52 mmol, 74%) 
as a white foam.
[aJo = -17.3 (c = 1.60, CHCI3).
IR (film): v = 2964 (s), 2933 (s), 1712 (s), 1594 (m), 1472 (m), 1459 (m), 1321 (s), 1273 
(s), 1148 (s), 1090 (s), 1015 (m), 910 (w), 852 (w), 760 (m), 730 (m), 632 (m) cm~L
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iR NMR (360 MHz, CDCI3): 5 = 8.19 (IH, dm, J  = 1 1  Hz, BT), 8.02 (IH, dm, 3 = 7.6 Hz, 
BT), 7.99 (2H, d, 7 = 8.7 Hz, Ar), 7.65 (IH, ddd, J  = 7.3, 7.3, 1.4 Hz, BT), 7.60 (IH, ddd, 
3 = 7.3, 7.3, 1.4 Hz, BT), 7.40 (2H, d, 7 = 8.7 Hz, Ar), 5.29 (IH, quintet, 7 = 6.6 Hz, 
H18), 3.61 (IH, dd, 7 = 14.2, 4.7 Hz, H IIa ), 3.51 (3H, s, OMe), 3.37 (IH, dd, 7 = 6.8,
4.2 Hz, H17), 3.34 (IH, dd, 7 = 14.2, 7.9 Hz, HI 1b ), 2.65 (IH, d, 7 = 9.3 Hz, H15), 2.64- 
2.51 (IH, m, H16), 1.80 (IH, dd, 7 = 14.1, 7.3 Hz, H13a ), 1.62 (IH, dd, 7 = 14.1, 7.5 Hz, 
H13b ), 1.63-1.52 (IH, m, H12), 1.30 (3H, d, 7 = 6.5 Hz, H19), 1.27 (3H, s, C14-Me),
1.24 (3H, d, 7 = 6.7 Hz, C12-Me), 1.02 (3H, d, 7 = 6.9 Hz, C16-Me) ppm.
13C NMR (90 MHz, CDCI3): 5 =  166.6 (0, BT), 165.2 (0, ArC=0), 152.7 (0, BT), 139.4 (0, 
Ar), 136.8 (0, BT), 131.1 (2C, 1, Ar), 129.2 (0, Ar), 128.8 (2C, 1, Ar), 128.3 (1, BT),
127.9 (1, BT), 125.5 (1, BT), 122.5 (1, BT), 84.5 (1, C17), 73.1 (1, C18), 64.6 (1, C15),
61.5 (3, OMe), 60.3 (2, C ll) , 59.9 (0, C14), 45.5 (2, C13), 35.0 (1, C16), 26.1 (1, C12),
20.9 (3, C12-Me), 16.8 (3, C19), 16.4 (3, C14-Me), 10.8 (3, C16-Me) ppm.
LRMS (CI+ mode, NH3); m/z = 583 (8%), 548 (23), 378 (67), 213 (92), 136 (100).
HRMS (CI+ mode, wobutane): Found (M-i-H)+, 566.1433. C27H 33CINO6S2 requires 
566.1438.
-SECTION 6.4- 
180-(4-Chlorobenzoyl)herboxidiene allyl ester (394):
SO2 BT (a) LDA, THF, -78°C, 15 min
MeO H ^
,0  I ( m  r  2 3 8
C 1 5 H 2 2 P 4
PCBO
332 CO2AII ^QHO
C2 7 H3 2 CINO6 S2  (566.13) -78°C -20°C, 1.5 h
PCB = 4-chlorobenzoyl
CO2 AII
PCBO
394
C 3 5 H 4 9 C I0 7 (6 1 7 .2 1 )
To a stirred solution of the sulfone 332 (331 mg, 0.58 mmol) in anhydrous THF (6 mL) at 
-78°C under N2(g) was added dropwise a solution of freshly prepared lithium diwopropylamide 
(LDA, 1.3 mL, 0.41 M in THF, 0.53 mmol) and the resulting deep yellow solution stirred for 
15 min. A solution of the enal 238 (131 mg, 0.49 mmol, prepared in 4 steps from 240 as 
previously described"^^) in anhydrous THF (2 mL) was then added dropwise. The colour of the 
reaction mixture lightened. The mixture was stirred for 30 min at -78°C and then allowed to 
warm slowly to -20°C over 1 h. The resulting colourless solution was then quenched by the
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addition sat. NHaCl(aq) (2 mL) and allowed to warm to rt with vigorous stirring. After further 
dilution with EtOAc (15 mL) and H2O (15 mL) the layers were well shaken and separated. The 
aqueous phase was then extracted (3x5 mL EtOAc) and the combined organic extracts washed 
with brine (5 mL), dried (MgSOq) and concentrated in vacuo. The residue was further purified 
via column chromatography (eluting with 15% EtOAc in hexanes) to yield the diene 394 (246 
mg, ca 0.40 mmol, 81%) as a clear oil. *H NMR analysis indicated the presence of a small 
quantity of the associated lOZ isomer together with other minor impurities (<5%). Conversion 
to the methyl ester 303 as outlined helow facilitated purification and enabled accurate 
measurement of the E:Z ratio for the olefination step as 91:9 in favour of the natural 10£ 
geometry. Repeated chromatography (eluting with 20% Et20 in hexanes) provided a good 
purity sample of 394 for characterisation purposes.
[ct]D — —25 (c — 0.4, CHCI3).
IR (film): V = 2927 (m), 1720 (s), 1594 (w), 1456 (w), 1191 (w), 1159 (w), 1091 (m), 1015 
(w) cm"'.
'H  NMR (360 MHz, CDCI3): 5 = 8.00 (2H, d, 7 = 8.7 Hz, Ar), 7.41 (2H, d, 7 = 8.7 Hz, 
Ar), 6.22 (IH, dd, 7 = 15.0, 10.9 Hz, HIO), 5.94-5.82 (IH, m, CH2CH=CH2), 5.88 (IH, 
dm, 7 = 10.4 Hz, H9), 5.42 (IH, dd, 7 = 15.0, 8.9 Hz, H ll) , 5.30 (IH, dm, 7 = 17.9 Hz, 
C H 2C H =C H zH e), 5.27 (IH, quintet, 7 = 6.9 Hz, H I8), 5.20 (IH , dm, 7 = 10.5 Hz, 
CH2CH=CHzHe), 4.58 (2H, d, 7 = 5.5 Hz, CH2CH=CH2), 3.83-3.74 (IH, m, H3), 3.52 
(3H, s, OMe), 3.37 (IH, dd, 7 = 6.9, 3.9 Hz, H17), 3.31 (IH, d, 7 = 9.9 Hz, H7), 2.62 
(IH, d, 7 = 9.7 Hz, H15), 2.61 (IH, dd, 7 = 15.1, 6.5 Hz, H2a ), 2.43 (IH, dd, 7 = 15.2,
6.5 Hz, H2b), 2.47-2.34 (IH, m, H I2), 1.91 (IH, dd, 7 = 13.5, 4.6 Hz, H13a), 1.88-1.80 
(IH, m, H5a), 1.72-1.65 (IH , m, H4a), 1.69 (3H, s, C8-Me), 1.57-1.46 (2H, m, H6, 
H I6), 1.40-1.15 (3H, m, H4b, H5b, H13b), 1.29 (3H, d, 7 = 6.5 Hz, H19), 1.24 (3H, s, 
C14-Me), 1.03 (3H, d, 7 = 6.6 Hz, C12-Me), 0.88 (3H, d, 7 = 6.9 Hz, C16-Me), 0.64 (3H, 
d, 7 = 6.6 Hz, C6-Me) ppm.
NMR (90 MHz, CDCI3): 5=  171.2 (0, C l), 165.3 (0, A r£=0), 139.4 (1, C ll) , 139.4 
(0, Ar), 135.3 (0, C8), 132.3 (1, CH2£H =C H 2), 131.2 (2C, 1, Ar), 129.3 (0, Ar), 128.8 
(2C, 1, Ar), 128.3 (1, C9), 125.3 ( 1, CIO), 118.0 (2, CH=CH2), 90.8 (1, C7), 84.7 (1, 
C17), 74.0 (1, C3), 73.3 (1, C18), 66.0 (1, C15), 65.1 (2, CH iC H ^CH i), 61.5 (3, OMe),
60.9 (0, C14), 47.1 (2, C13), 41.6 (2, C2), 35.4 (1, C12), 35.2 (1, C16), 32.4 (2, C5), 32.2 
(1, C6), 31.8 (2, C4), 22.3 (3, C 12-Me), 17.7 (3, C6-Me), 16.8 (3, C19), 16.8 (3, C14-Me),
12.0 (3, C8-Ms), 10.8 (3, C16-Me) ppm.
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LRMS (EI+ mode): m/z = 616 (0.6%), 460 (2), 361 (4), 304 (16), 290 (24), 227 (46), 183 
(15), 139 (100), 95 (41).
HRMS (EI+ mode): Found M+', 616.3169. C35H49CIO7 requires 616.3167.
Herboxidiene methyl ester (303):
K2 CO3  (138)CO2 AII
MeO H MeOH, A, 2 h
PCBO
394
HO
303
C3 5 H4 9 CIO7  (617.21 ) PCB = 4-chlorobenzoyl C2 6 H4 4 O6  (452.62)
A stirred suspension of the benzoate 394 (223 mg, 0.36 mmol) and potassium carbonate (100 
mg, 0.72 mmol) in anhydrous MeOH (5 mL) was heated at reflux for 2 h. After this time the 
mixture was allowed to cool to rt and subsequently diluted with EtOAc (20 mL) and H%0 (10 
mL). The layers were then shaken and separated and the aqueous phase extracted (3x5 mL 
EtOAc). The combined organic extracts were washed with brine (5 mL), dried (MgS04) and 
then concentrated in vacuo. The residue was further purified via column chromatography 
(eluting with 35% EtOAc in hexanes) to yield the pure methyl ester 303 (117 mg, 0.26 mmol, 
72%) as a clear oil. The \OE:Z ratio of this material reflected that of the starting material [E:Z = 
91:9, determined by integration of the HI 1 resonance in the ^H NMR; (lOE) = 5.44 (IH, 
dd, J  = 15.0, 8.7 Hz), (lOZ) = 5.21 (IH, t, J  = 10.0 Hz)]. The pure natural isomer could 
be isolated if desired by subsequent careful column chromatography (eluting with 20% EtOAc 
in hexanes, the lOE isomer is the less polar component). ^H and NMR data was in 
complete agreement with that previously reported by Isaac et al^^ (DEPT data and proton 
resonance coupling constants were not reported by Isaac and so are listed here).
[ocJd = +0.9 (c = 0.66, CHCI3).
IR (film): v=  3501 (br m), 2954 (s), 2925 (s), 2849 (m), 1740 (s), 1455 (m), 1382 (w), 1198 
(w), 1090 (w), 1067 (m), 1019 (w), 966 (w), 731 (w) cm“L
IH NMR (360 MHz, CDCI3): 5 = 6.24 (IH, dd, J = 15.0, 10.8 Hz, HIO), 5.90 (IH, d, /  =
11.0 Hz, H9), 5.45 (IH, dd, J  = 14.9, 8.8 Hz, H ll) , 3.90-3.83 (IH, m, H18), 3.82-3.73 
(IH, m, H3), 3.67 (3H, s, C02Me), 3.55 (3H, s, OMe), 3.33 (IH, d, /  = 9.8 Hz, H7), 2.98
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(IH, t, /  = 5.3 Hz, H17), 2.60 (IH, dd, J  = 15.2, 6.2 Hz, H2a ), 2.60-2.53 (IH, m, OH), 
2.56 (IH, d, /  = 9.7 Hz, H15), 2.45-2.37 (IH, m, H12), 2.41 (IH, dd, /  = 15.2, 6.7 Hz, 
H2b ), 1.90 (IH, dd, J = 13.6, 4.7 Hz, H13a ), 1.88-1.81 (IH, m, H5a ), 1.71 (3H, s, C8- 
Me), 1.70-1.50 (3H, m, H4a , H6, H16), 1.40-1.20 (3H, m, H4b , H5b , H13b ), 1.29 (3H, s, 
C14-Me), 1.19 (3H, d, /  = 6.4 Hz, H19), 1.05 (3H, d, 7 = 6.7 Hz, C12-Me), 0.88 (3H, d, J 
= 6.9 Hz, C16-Me), 0.67 (3H, d, 7 = 6.6 Hz, C6-Me) ppm.
13C NMR (90 MHz, CDCI3): 8=  172.0 (0, C l), 139.4 (1, C ll) , 135.4 (0, C8), 128.3 (1, 
C9), 125.4 (1, CIO), 90.8 (1, Cl), 87.8 (1, C17), 74.0 (1, C3), 68.4 (1, C18), 66.2 (1, 
C15), 61.5 (0, C14), 61.5 (3, OMe), 51.7 (3, COiM e l 47.1 (2, C13), 41.5 (2, C2), 35.5 (1, 
C l2), 35.3 (1, C16), 32.4 (2, C5), 32.3 (1, C6), 31.8 (2, C4), 22.2 (3, C12-Me), 19.2 (3, 
C19), 17.8 (3, C6-Me), 16.7 (3, C14-Me), 12.1 (3, C8-Me), 12.0 (3, C16-Me) ppm.
LRMS (EI+ mode): m/z = 452 (28%), 434 (9), 351 (12), 305 (10), 278 (22), 265 (19), 237 
(12), 211 (11), 197 (15), 173 (44), 157 (42), 129 (100), 123 (55), 95 (56), 69 (50).
HRMS (EI+ mode): Found M+*, 452.3136. C26H44O6 requires 452.3138. 
Herboxidiene (233):
K2 CO3  (138)C02Me
MeO
HO
303
H20-Me0H (1:4) 
A, 1 h
HO
233
C2 6 H4 4 O6  (452.62) C2 5 H4 2 O6  (438.60)
A solution of the methyl ester 303 (16 mg, 35 nmol) in MeOH (2 mL) was treated with an 
aqueous solution of potassium carbonate (24 mg, 174 fjmol in 0.5 mL H2O) and the resultant 
mixture stirred at reflux for 1 h. After this time the reaction was allowed to cool and diluted 
with EtOAc (10 mL) and H%0 (5 mL). The aqueous layer was then acidified to pH 2 by the 
careful addition of 2M HCl(aq) {ca 0.5 mL) and the layers shaken well and then separated. The 
aqueous phase was extracted (4x5 mL EtOAc) and the combined organic extracts washed with 
brine (5 mL), dried (Na%S04) and then concentrated in vacuo. The residue was further purified 
via column chromatography (eluting with 7% MeOH in CH2CI2) to yield herboxidiene (233, 
13 mg, 30 jttmol, 84%) as a clear oil. ^H and ^^C NMR data recorded in CD3OD are listed in 
Tables 10 and 11 respectively.
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[a]D = -30 (c = 0.2, CHCI3, T = 293K).
IR (film): v = 3470 (br w), 2962 (s), 2919 (s), 2849 (m), 1731 (m), 1456 (m), 1382 (w), 
1276 (w), 1198 (w), 1154 (w), 1068 (m), 1018 (w), 967 (w), 798 (w) cm-'.
'H  NMR (360 MHz, CDCI3): 5 = 6.24 (IH, dd, J = 15.0, 10.8 Hz, H 10), 5.95 (IH, d ,J  =
10.7 Hz, H9), 5.50 (IH, dd, /  = 15.1, 8.9 Hz, H ll) ,  3.87 (IH, quintet, J  = 6.2 Hz, H18), 
3.84-3.74 (IH, m, H3), 3.55 (3H, s, OMe), 3.43 (IH, d, J  = 10.0 Hz, H7), 3.01 (IH, t, 7 =
5.3 Hz, H17), 2.58-2.54 (3H, m, H2a , H2b , H15), 2.50-2.38 (IH, m, H12), 1.95-1.85 
(IH, m, H5a ), 1.93 (IH, dd, J  = 13.5, 4.6 Hz, H13a ), 1.73 (3H, s, C8-Me), 1.63 (IH, m, 
H4a ), 1.54 (IH, m, H6), 1.43 (IH, qm, J  = 12.7 Hz, H16), 1.32-1.17 (3H, m, H4b , H5b , 
H13b ), 1.29 (3H, s, C14-Me), 1.19 (3H, d, 7 = 6.4 Hz, H19), 1.07 (3H, d, 7 = 6.7 Hz, 
C12-Me), 0.87 (3H, d, 7 = 6.9 Hz, C16-Me), 0.72 (3H, d, 7 = 6.6 Hz, C6-Me) ppm.
13C NMR (90 MHz, CDCI3): ô = 172.2 (0, C l), 140.5 (1, Cl l ) ,  133.9 (0, C8), 129.4 (1, 
C9), 125.0 (1, CIO), 91.2 (1, C7), 87.7 (1, C17), 74.0 (1, C3), 68.5 (1, C18), 66.2 (1, 
C15), 61.4 (0, C14), 61.4 (3, OMe), 47.1 (2, C13), 40.9 (2, C2), 35.5 (1, C12), 35.3 (1, 
C l6), 32.6 (1, C6), 32.0 (2, C5), 31.6 (2, C4), 22.1 (3, C12-Me), 19.2 (3, C l9), 17.6 (3, 
C6-Me), 16.7 (3, C14-Me), 12.4 (3, C8-Me), H .9 (3, C16-Me) ppm.
LRMS (EI+ mode): m/z = 438 (10%), 420 (4), 337 (7), 293 (7), 251 (58), 183 (18), 173 
(34), 129 (85), 95 (100), 69 (82).
HRMS (EI+ mode): Fotmd M+", 438.2980. C25H42O6 requires 438.2981.
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9. Appendix - Crystal Structure of Diol 365
C10 \  0 2  G1
O OH
The following study was conducted by Dr K. W. Muir of the University of Glasgow. The 
structure will be deposited in the Cambridge Structural Database.
9.1. Crystal and molecular structure of C10H 20O 3 (365)
The asymmetric unit contains two independent molecules which have nearly indistinguishable 
structures (Figure 19, Tables 13 to 16): a change of 6° in the C4-C5-C6-03 torsion angle is 
their most obvious difference. They are approximately related by the operation 1/2+x, -y , 
0.815-z which defines the action of a non-crystallographic 2% screw axis parallel to a at y = 0, 
z = 0.4075. Bond lengths in both agree with standard values^to within 0.026Â. Based on the 
known stereochemistry of C4 (S), C5 (R), and C6 (<S) the absolute configuration at C3 is R.
Each molecule adopts a conformation in which the C2-C3-C4-C5-C6-C7 chain defines nearly a 
planar zigzag and the C2-C8 bond is staggered with respect to C3-C4 and C3-01. In 
consequence the two hydroxyl groups lie above the same face of the zigzag. This facilitates 
formation of a cooperative 0 -H ...0  hydrogen bond network which links 01 in each 
independent molecule to 03 in the corresponding molecule at 1+x, y, z. Two parallel chains of 
molecules running parallel to the a-axis are thereby generated. They are interlinked by 03-
H...01 bonds (Figure 18) so that the unit 011-H ...03F-H ...012-H ...032i-H ...01F repeats 
continually along the a-axis. The uni-directional nature of the hydrogen bonding is reflected in 
the morphology of the crystals which are fine needles elongated in the a-direction.
9.2. Crystal structure analysis of C10H 2 0 O 3 (365)
Measurements were made at 20°C on an Enraf-Nonius CAD4 diffractometer with graphite- 
monochromatised Mo K a  radiation, A = 0.71073 Â. The crystals were long, extremely fine 
needles which invariably shattered on cutting. Data were therefore collected using an uncut 
crystal of dimensions 3.0 x 0.15 x 0.02 mm and a beam diameter of 0.80 mm.
Crystal data:- C10H20O3, M  = 188.26, monoclinic, space group P2\, a = 7.3028(10), b = 
19.019(3), c = 8.1976(12) Â, ;3 = 90.816(12) \ V =  1138.5(3) Â3, Z = 4, Dc = 1.098 g cm-3, 
|i(Mo Ka) = 0.079 nun”'.
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Cell dimensions are based on the setting angles of 25 reflections with 7.5 < 8(Mo Ka) < 
16.2°. The intensities of 3957 reflections with 2 < 0(Mo Ka) < 23°, -8  < h < 1, -20 < k < 20 
and -9  < 1 < 9 were estimated from cû scans and corrected for Lp effects, 25% crystal 
decomposition and for variations in the irradiated volume (correction factors 1.000-0.921)'*^, 
Averaging gave 3115 unique reflections (Rint = 0.049); of these 1620 were deemed observed 
[1 > 2o(l)]. The structure was solved by direct methods'*^ and refined to convergence (A/a < 
0.001 for 245 parameters) using all 3115 values, with w = [a^(F^) + (0.069P)2]-l where P 
= (Fobs^ + 2Fcaic^)/3. Final agreement indices were R[l<2a(l)] = 0.054 and wR2(all data) =
0.14 and in the final difference map lApI < 0.24 eÂ^. Anisotropic Uÿ were refined for all non­
hydrogen atoms. H atoms rode on parent C atoms and an orientation parameter was 
successfully refined for each CH3 and OH group except for those bonded to CIO 1 and O il 
whose positions were determined from stereochemical considerations. Although the data 
contained 1495 Friedel pairs the absolute configuration of the model could not be reliably 
determined; it was therefore chosen to accord with the known absolute stereochemistry of 
atoms C4n, C5n and C6n (n = 1, 2). Scattering factors and dispersion corrections were those 
incorporated in the least-squares refinement program SHELXL-97 and the WINGX package 
was used for other calculations
Figure 18. The cooperative hydrogen bonding network in 365. The direction of view is 
approximately down c and the a-axis runs horizontally left to right. Only the molecules of the 
asymmetric unit and those derived from them by translation along the a-axis are shown. Labels 
are shown for the hydroxyl oxygen atoms in the reference asymmetric unit.
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CIO]
021 Oil
Cll
C71 C31 C21C51C61
C81C91
031
Cl 02
022
012
072
012
0 6 2 0 5 2 0 3 20 4 2
1022
09 2
08 20 3 2
Figure 19. Views of the two independent molecules of 365 in the same orientation showing 
20% probability ellipsoids. Hydrogen atoms are shown as spheres of arbitrary size. The final 
digit of the atom number n is either 1 or 2 to distinguish corresponding atoms in the two 
independent molecules (see Tables 13 to 16).
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Atomic coordinates (x 10^) and equivalent isotropic displacement parameters (Â^ x 10^) for
atom X y z ^eq
011 2364(5) 530(2) 2952(4) 56(1)
021 -486(5) 1888(2) 4140(4) 52(1)
031 -3833(5) 509(2) 3210(4) 51(1)
011 3558(10) 1496(4) -344(8) 80(2)
021 2509(8) 994(3) 232(7) 52(2)
031 1718(7) 1083(3) 1891(6) 40(1)
041 -391(7) 1049(3) 1928(6) 40(1)
051 -1047(7) 1197(3) 3639(6) 39(1)
061 -3164(7) 1173(3) 3814(6) 48(2)
071 -3756(8) 1296(4) 5552(7) 74(2)
081 2108(10) 346(4) -699(9) 93(2)
091 -1214(8) 1566(3) 678(7) 62(2)
O101 642(10) 1909(4) 5563(8) 85(2)
012 7355(5) -538(2) 5305(5) 56(1)
022 4518(6) -1847(2) 3844(5) 61(1)
0 3 2 1159(5) -524(2) 5017(5) 55(1)
012 8674(9) -1581(4) 8479(8) 79(2)
022 7582(7) -1074(3) 7959(7) 50(2)
032 6769(6) -1122(3) 6268(6) 39(1)
042 4638(6) -1124(3) 6236(6) 42(1)
052 3907(7) -1195(3) 4496(6) 40(1)
062 1797(7) -1186(3) 4375(7) 50(2)
072 1109(8) -1286(4) 2625(7) 77(2)
082 7152(9) -452(4) 8977(8) 79(2)
092 3929(9) -1700(4) 7363(7) 75(2)
0102 5508(11) -1801(4) 2392(9) 96(3)
Hydrogen bonds [Â and °] for 365. T ab le  14
D-H...A d(D-H) d(H...A) d(D...A) <(DHA)
O il -H ll . ..031' 0.82 1.96 2.782(5) 176.3
031- H31...012" 0.82 1.94 2.762(5) 175.7
012-H 12...032' 0.82 1.97 2.791(5) 176.2
032-H 32...011 0.82 1.96 2.776(5) 176.9
symmetry transformations used to generate equivalent atoms: (i) x+1, y, z; (ii) x-1, y, z.
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Bond lengths [Â] and angles [°] in the two independent 365 molecules. T able  15
bond molecule 1 molecule 2 bond molecule 1 molecule 2
01-C3 1.440(5) 1.433(6) C2-C3 1.495(7) 1.503(7)
O2-C10 1.420(7) 1.405(8) C3-C4 1.542(6) 1.556(7)
02-C5 1.434(6) 1.425(6) C4-C5 1.514(6) 1.522(6)
03-C6 1.438(6) 1.444(7) C4-C9 1.536(7) 1.529(7)
C1-C2 1.315(8) 1.319(8) C5-C6 1.556(7) 1.543(7)
C2-C8 1.477(8) 1.484(8) C6-C7 1.512(7) 1.526(7)
angle angle
C10-O2-C5 114.9(4) 115.5(5) C5-C4-C3 109.9(4) 110.7(4)
C1-C2-C8 122.2(6) 122.3(6) C9-C4-C3 109.9(4) 109.8(5)
C1-C2-C3 118.6(6) 118.8(6) 02-C5-C4 110.1(4) 108.7(4)
C8-C2-C3 119.2(6) 118.9(6) 02-C5-C6 106.3(4) 107.6(4)
01-C3-C2 109.8(4) 110.1(4) C4-C5-C6 114.1(4) 113.3(4)
01-C3-C4 106.0(4) 107.4(4) 03-C6-C7 111.1(4) 110.3(5)
C2-C3-C4 114.3(4) 113.4(4) 03-C6-C5 109.1(4) 108.2(4)
C5-C4-C9 111.9(4) 112.7(4) C7-C6-C5 112.4(4) 112.0(5)
Torsion angles [°] in the two independent 365 molecules. T able  16
angle mol. 1 mol. 2 angle mol. 1 mol. 2
C1-C2-C3-01 -118.7(6) 118.8(6) C10-O2-C5-C6 115.3(5) 113.3(6)
C8-C2-C3-01 60.6(7) 60.2(6) C9-C4-C5-02 -61.6(5) -62.0(6)
C1-C2-C3-C4 122.3(6) 120.9(6) C3-C4-C5-02 60.8(5) 61.4(5)
C8-C2-C3-C4 -58.4(7) -60.1(7) C9-C4-C5-C6 57.8(6) 57.7(7)
01-C3-C4-C5 62.9(5) 59.7(6) C3-C4-C5-C6 -179.8(4) -178.9(5)
C2-C3-C4-C5 -176.0(5) -178.4(5) 02-C5-C6-03 175.6(4) -179.4(4)
01-C3-C4-C9 -173.5(4) -175.2(5) C4-C5-C6-03 54.1(6) 60.3(6)
C2-C3-C4-C9 -52.4(6) -53.4(7) 02-C5-C6-C7 -60.7(6) -57.6(6)
C10-O2-C5-C4 -120.6(5) -123.6(5) C4-C5-C6-C7 177.8(5) -177.8(5)
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